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Abstract   
The issue of antimicrobial resistance (AMR) is one that is escalating nationally and 
globally, with significant burden to human health and to the economy.  It is 
estimated that if left unchecked, globally by ͲͰ͵Ͱ, AMR will cause ͱͰ million deaths 
per year and cost up to a hundred trillion US dollars in lost Gross Domestic Product.  
Currently in Australia, the cost of AMR is estimated to be over $Ͳ͵Ͱ million per year.  
Our consumption of antibiotics is amongst the highest in the world. 
Despite much published research in various disciplines such as medicine, public 
health, sociology, and behavioural psychology, it is not known which factors are 
dominant in influencing antibiotic use in the Australian primary healthcare sector.  
There is also a paucity of research in the area of antibiotic use which focusses on the 
multiple views of GPs, community pharmacists and consumers in the Australian 
context.  This research sought to address these evidence gaps.   
The research aim was to establish the dominant factors influencing decisions to use 
antibiotics by GPs, community pharmacists and consumers in the Australian primary 
healthcare sector.  The purpose is to inform ongoing national programs working to 
reduce inappropriate antibiotic use.  Two research questions (RQ) were posed and 
addressed:  RQͱ.  What influences antibiotic use from the perspectives of GPs, 
community pharmacists and consumers?; RQͲ.  How do GPs and consumers trade-off 
on factors influencing antibiotic use? 
An exploratory sequential mixed method design was used, with the qualitative and 
quantitative components being of equal importance.  This was a fully integrated 
design comprising a substantial qualitative component — semi-structured interviews 
(QUAL) conducted first, in order to answer RQͱ and also to inform the development 
of the quantitative research instrument — discrete choice experiments (DCEs) 
(QUAN).  The DCEs addressed RQͲ.  The underpinning research paradigm and 
research framework used were pragmatism and the Theoretical Domains Framework 
(TDF), respectively. 
Fifty-four interviews were conducted comprising ͱͰ GPs, ͱͲ community pharmacists 
and ͳͲ consumers.  Convenience and snowball sampling were used to recruit these 
participants and interviews were conducted between late April and mid-October 
ͲͰͱ͵.  Transcriptions of interview recordings were coded using a blend of deductive 
and inductive coding.  NVivo® software (Version ͱͱ.ͳ.ͱ.ͷͷͷ; (ͲͰͱͶ)) was used to store 
and code the transcripts.  First cycle coding was done with the raw data followed by 
three iterations of code mapping to arrive at three meta-categories to explain the 
phenomenon of what influences antibiotic use from the perspectives of GPs, 
community pharmacists and consumers: (a) clinical processes and challenges, (b) 
consumer attitudes, behaviours, skills and knowledge, and (c) engaging with 
antibiotic resistance.  The Enabling Antibiotic Eupraxis (EABE) model was developed 
using these meta-categories.  Briefly, the EABE model shows how the three meta-
categories lie in tension and converge when aligned to allow antibiotic eupraxis — 
where eupraxis is good/right theoretically informed practice — and vice versa. 
The problematic sequelae of delayed antibiotic prescriptions were surfaced from the 
qualitative component.  This was used to focus the scenario created for the DCEs as 
well as to locate suitable attributes and levels from the interview data.  Two DCE 
surveys were developed using essentially the same scenario, but with different 
decision-making questions for the two target cohorts — GPs and consumers.  The 
DCE experimental designs were generated using NGENE® software (Version ͱ.ͱ.Ͳ; 
(ͲͰͱʹ)).  DCEs were launched online via the Key Survey® platform (Version ͸.ͷ.͵; 
(ͲͰͱͶ)) in late July and closed on the ͳͱst October ͲͰͱͶ.  Recruitment was by 
convenience sampling.  A total of Ͳͳ GPs/GP Registrars and ͲͰ͵ consumers 
completed the respective DCE surveys.  Data analysis was conducted using NLOGIT® 
(Version Ͷ; (ͲͰͱͶ)) software to fit a model and estimate parameters associated with 
each attribute level.  A mixed logit model was fitted to both sets of data.  Eleven out 
of ͱʹ parameters estimated were found to be statistically significant either at the p < 
Ͱ.Ͱͱ or p < Ͱ.Ͱ͵ level, confirming the importance of all attributes (apart from 
“Familiarity with patient” in the GP DCE) in influencing decision-making. 
In the GP DCE, all attributes were important in influencing GP preferences apart 
from the “Familiarity with patient” attribute.  The attribute levels which exerted the 
strongest influence on GP decision-making when compared against the reference 
levels were: “Duration of symptoms – ͱ week”, “Patient expectations – Says they want 
antibiotics”, “Life event – No” (the patient had no important events or deadlines 
coming up), and “Reassessment – No” (the patient is unable to return for 
reassessment).  Overall, the dominant factors influencing GP prescribing behaviours 
were the patient's duration of symptoms followed by patient expectations for 
antibiotics.   
In the consumer DCE, all attributes were important in influencing consumer 
preferences.  The attribute levels which exerted the strongest influence on consumer 
decision-making when compared against the reference levels were: “Doctor’s advice – 
Says it’s probably a viral infection and antibiotics won’t help”, “Duration of symptoms 
– ͱ week”, “Life event – No” (the consumer did not have an important event or 
deadline coming up), “Past experience – No” (the consumer had not taken antibiotics 
for similar symptoms in the past), and “Time off – No” (the consumer is unable to 
take time off from work/study to recover).  Overall, the dominant factor influencing 
consumer antibiotic use behaviour was the GP's advice when prescribed an antibiotic.   
Interestingly, the modifiable factors i.e. patient expectations for antibiotics (GP DCE) 
and GP's advice on the use of prescribed antibiotics (consumer DCE) are not only 
dominant factors, but are also mutually influencing factors for antibiotic decision-
making on the part of GPs and consumers. 
Results from both the qualitative and quantitative components were mutually 
confirming.  The conclusions from both sets of findings gave rise to the hypothesis 
that:  equipping GPs with clear strategies and communication skills to confidently 
convey their decision-making on the one hand; as well as equipping consumers with 
accurate information and communication skills to confidently convey their 
preference to avoid antibiotics where possible on the other hand; would lead to 
antibiotic eupraxis and the mitigation of antibiotic resistance.   
These findings not only addressed the research aim and research questions posed, but 
also contributed to: (a) theoretical and methodological innovations — which 
demonstrate the significance and novelty of the research; (b) implications for policy 
and practice and (c) recommendations relevant to Australia’s National AMR Strategy 
ͲͰͱ͵ – ͲͰͱ͹ — which show the significance and importance of this study.   
Two theoretical innovations were claimed — the novel use of the TDF and the 
creation of the EABE model which served to more fully explain the tensions between 
factors influencing antibiotic use not easily surfaced using the TDF alone.  The 
methodological contribution was the adaptation of the DCE method for eliciting 
preferences to reveal dominant drivers in decision-making on antibiotic use, rather 
than preferences for jobs, goods or services as is usual.  Implications for policy and 
practice, and recommendations were made to inform Australia’s implementation of 
the National AMR Strategy ͲͰͱ͵ – ͲͰͱ͹.  The thesis concluded with suggestions for 
future research, ranging from applied research to research on methods. 
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Antibiotic resistance occurs when bacteria change in ways that render 
ineffective the antibiotics used to cure the infections they cause. 
Antimicrobial resistance Antimicrobial resistance occurs when micro-organisms such as 
bacteria, viruses, fungi and parasites change in ways that render 
ineffective the medications e.g. antibiotics, antivirals, antifungals used 
to cure the infections they cause (World Health Organisation, 2016) 
Antimicrobial 
stewardship 
An organised antimicrobial management program implemented by 
healthcare institutions to ensure appropriate antimicrobial use, 
improve patient outcomes and reduce adverse consequences of 
antimicrobial use e.g. antimicrobial resistance, toxicity and 
unnecessary costs (MacDougall & Polk, 2005). 
Consumers People who make choices, and — usually though not always — pay 
for them.  This term is used where information is being produced to 
inform a choice i.e. by patients, service users or their families and 
carers (Greenhalgh, in press).  
Decision-making The mental processing leading to the selection of one among several 
choices or actions (Newell & Shanks, 2014).  
Delayed antibiotic 
prescription 
This is an antibiotic prescription given to a patient with instructions to 
use it only if their symptoms persist or worsen.  The delayed 
prescription is usually given to the patient during the initial 
consultation, although some GPs prefer to leave it with clinic 
reception for collection by the patient at a later date. 
Discrete Choice 
Experiment 
A quantitative method for eliciting preferences i.e. stated 
preferences, which can be used in the absence of revealed preference 
data. 
Discounting the future The tendency of people to discount rewards or benefits when the 
temporal horizon is in the future or in the past, so that the rewards or 
benefits cease to be valuable or to have additive effects. 
Eupraxis Good/right theoretically informed practice. 
Inappropriate use of 
antibiotics 
Antibiotics are prescribed when they are not needed.  In cases where 
there is a clinical need, inappropriate use includes:  for the prescriber 
— incorrect dose, incorrect treatment duration (too long or too 
short), incorrect route, selecting broad spectrum agents when 
targeted therapy is an option; for the consumer — incorrect use for 
example, not taking antibiotics as prescribed, sharing of antibiotics, or 
keeping leftover antibiotics for next time. 
One Health A concept that emphasises the inter-dependence and connectivity of 
human, animal and environmental health.  According to the US 
Centres for Disease Control and Prevention, 6 out of every 10 
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infectious diseases affecting humans are spread from animals 
(Centers for Disease Control and Prevention, 2016b) 
Patients People who are seeking or receiving healthcare.  This term is used 
when looking for expertise in what it means to be ill and/or receive 
care (Greenhalgh, in press).   
Prescribing An iterative process involving the steps of information gathering, 
clinical decision-making, communication and evaluation that results in 
the initiation, continuation, or cessation of a medicine (NPS: Better 
Choices Better Health, 2012). 
Repeat prescription Repeat prescriptions enable a regular re-supply of the prescribed 
medicine without the patient having to see the GP each time.  The 
number of repeats is authorised by the GP on the original 
prescription.  The Pharmaceutical Benefits Scheme (PBS) Schedule 
lists medicines and the maximum number of repeats subsidised under 
the scheme.  Time intervals between supplies must meet PBS criteria.  
Theoretical Domains 
Framework 
A theory for behaviour change in healthcare developed by Michie et 
al. (Cane, O'Connor, & Michie, 2012; Michie et al., 2005). 
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 Introduction 
 BACKGROUND 
Antimicrobial resistance (AMR) occurs when micro-organisms such as bacteria, 
viruses, fungi and parasites change in ways that render ineffective the medications 
(e.g. antibiotics, antivirals, antifungals) used to treat the infections they cause (World 
Health Organisation, ͲͰͱͶ).  Every dose of antibiotic prescribed and used, increases 
the likelihood of AMR (Phelps, ͱ͹͸͹). 
Australia is contributing to the global problem of AMR with one of the highest rates 
of antibiotic use, ranking ninth amongst ͲͶ OECD countries in the ͲͰͱͱ and eleventh 
in the ͲͰͱ͵ Health at a Glance reports, respectively.  Nationally, antibiotic 
consumption for human health grew from ͲͲ Defined Daily Doses (DDD) per ͱͰͰͰ 
population per day in ͲͰͰͰ to Ͳͳ.Ͷ DDD/ͱͰͰͰ population/day in ͲͰͰ͹ – well above 
the OECD average of Ͳͱ.ͱ DDD/ͱͰͰͰ population/day (OECD, ͲͰͱͱ, ͲͰͱ͵)    
Antibiotics are not always used appropriately.  The ͲͰͱ͵ National Antimicrobial 
Prescribing Survey involving Ͳ͸ͱ hospitals across Australia found Ͳͱ.͹% of antibiotic 
prescriptions in hospitals were inappropriate when compared with best practice 
(Australian Commission on Safety and Quality in Health Care & National Centre for 
Antimicrobial Stewardship, ͲͰͱͶ).  However, ͸͸% of antibiotic prescriptions were 
generated by GPs in the primary healthcare sector (Australian Commission on Safety 
and Quality in Health Care, ͲͰͱͶ). 
In the Australian primary healthcare sector, where over Ͳͷ million prescriptions for 
antibiotics are written annually (Department of Health, ͲͰͱͳ), data from general 
practice suggests unnecessary antibiotics were prescribed for conditions that will 
resolve without it (Britt & Miller, ͲͰͰ͹).  These figures have since increased.  Recent 
reports show that ͳͰ million antibiotic prescriptions were dispensed in ͲͰͱʹ alone 
(Australian Commission on Safety and Quality in Health Care, ͲͰͱͶ; Drug Utilisation 
Sub Committee, ͲͰͱ͵), and that more than ͵Ͱ% of people with colds and other upper 
respiratory tract infections were prescribed an antibiotic unnecessarily (Australian 
Commission on Safety and Quality in Health Care, ͲͰͱͶ). 
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Over or inappropriate use of antibiotics serve only to increase selection pressure 
resulting in more resistant micro-organisms (World Health Organization, ͲͰͱͲa), 
which are increasingly untreatable with existing antibiotics (World Health 
Organization, ͲͰͱʹa).  In addition, AMR is no longer a problem confined within 
hospital walls.  Surveillance reports by the Australian Group on Antimicrobial 
Resistance and the recent AURA ͲͰͱͶ report showed rising rates of multi-drug 
resistant organisms in the community (Australian Commission on Safety and Quality 
in Health Care, ͲͰͱͶ; Turnidge, Gottlieb, Mitchell, Daley, & Bell, ͲͰͱͳ).   
AMR is complex, intractable and costly — in terms of the significant health burden 
and costs to individuals and to society.  If left unchecked, by ͲͰ͵Ͱ AMR could cause 
ͱͰ million deaths1 per year and a loss of Gross Domestic Product worth up to USD 
$ͱͰͰ trillion globally (Review on Antimicrobial Resistance, ͲͰͱʹ).  In Australia, it is 
estimated that AMR adds over $Ͳ͵Ͱ million per year to the healthcare budget, and 
costs the community another $͵ͰͰ million per year (Australian Commission on 
Safety and Quality in Health Care, ͲͰͱͳ). 
AMR cannot be eradicated, only managed.  Management of this issue in hospitals is 
through antimicrobial stewardship programs to optimise the appropriate use of 
antibiotics, improve patient outcomes and reduce unwanted effects such as toxicity 
and unnecessary costs (MacDougall & Polk, ͲͰͰ͵).  In the absence of an established 
equivalent of antimicrobial stewardship for the primary healthcare sector, prudent 
use of antibiotics relies heavily on self-regulation and clinical practice of individual 
prescribers.  AMR is fast becoming a societal issue that requires partnership and 
conscious participation of individuals — every prescriber, health professional and 
consumer, for its successful management. 
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1 This estimated figure is being disputed currently due to the uncertainties regarding the 
incidence of infections, prevalence of resistant infections and attributable mortality (de 
Kraker, Stewardson, & Harbath, ͲͰͱͶ). 
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 CONTEXT AND SCOPE 
AMR is increasingly a public health concern internationally.  The World Health 
Organisation was tasked in ͲͰͱʹ to devise a Global Action Plan with Member States, 
to be reported to the World Health Assembly in May ͲͰͱ͵ (World Health 
Organization, ͲͰͱʹb).  Globally, some momentum has been gained with the 
ratification of the WHO Global Action Plan at the Ͷ͸th World Health Assembly in 
May ͲͰͱ͵ (World Health Organization, ͲͰͱ͵), which takes a One Health2 approach 
(Centers for Disease Control and Prevention, ͲͰͱͶb).  Member states are expected to 
establish their own action plan by ͲͰͱͷ.  This was reaffirmed through a landmark 
declaration at the UN General Assembly recently (General Assembly of the United 
Nations, ͲͰͱͶ).  For the first time, Australia now has a National AMR Strategy which 
encompasses both human and animal health (Australian Government, ͲͰͱ͵) and an 
implementation plan launched in November ͲͰͱͶ (Australian Government, 
Department of Health, & Department of Agriculture and Water Resources, ͲͰͱͶ). 
A comprehensive synopsis of the current global situation of AMR, including key areas 
for urgent action is provided by Laxminarayan et al (ͲͰͱͳ).  Figure ͱ illustrates the 
three areas requiring urgent action to mitigate AMR: (a) appropriate use and access 
to antibiotics, (b) infection prevention and control, and (c) investment in research 
and development.  Solutions to mitigate AMR involve many stakeholders spread 
across diverse industries and government agencies.  These include stakeholders in the 
tertiary, secondary and primary healthcare sectors for human health; agriculture and 
aquaculture for food production; animal health; the pharmaceutical industry; 
universities and research institutes; professional and regulatory bodies; local, state, 
national and global agencies (Laxminarayan et al., ͲͰͱͳ).  Globally, solutions would 
need to balance excessive use with appropriate access to antibiotics.   
Antibiotic usage both in human health and in agriculture contribute to selection 
pressure of micro-organisms which result in AMR (World Health Organization, 
ͲͰͱʹa).  Adding to the complexity of the management of AMR, it is well documented 
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2 One Health: A concept that emphasises the inter-dependence and connectivity of human, 
animal and environmental health.  According to the US Centres for Disease Control and 
Prevention, Ͷ out of every ͱͰ infectious diseases affecting humans are spread from animals. 
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that resistant strains of bacteria such as Methicillin Resistant Staphylococcus Aureus 
(MRSA) can spread from animals to humans, and vice versa (Laxminarayan et al., 
ͲͰͱͳ; US Department of Health and Human Services Centres for Disease Control and 
Prevention, ͲͰͱͳ).  Given the importance of viable antibiotics in modern medicine for 
the preservation of human health, current global estimates of antibiotic consumption 
found disproportionately heavy usage in food production e.g. for growth promotion 
in animals (Nathan & Cars, ͲͰͱʹ).   
In Australia, the Antimicrobial Resistance Summit ͲͰͱͱ – an interdisciplinary meeting 
of experts from medical, veterinary, agricultural, infection control and public health 
sectors, identified and agreed on urgent action in the following key areas (Gottlieb & 
Nimmo, ͲͰͱͱ):  
 National surveillance of AMR and antibiotic usage 
 Strengthening regulatory processes 
 Education and stewardship 
 Infection prevention and control 
 Research agenda with a focus on epidemiology and effective education and 
behavioural change interventions 
With reference to Figure ͱ, my research study was situated in human health, within 
the area of education and stewardship, and specifically investigated the factors 
influencing decision-making of general practitioners (GPs), community pharmacists 
and consumers.  The focus on GPs, community pharmacists and consumers is 
justified, as these are the key individuals involved in the use of antibiotics in the 
Australian primary healthcare sector.   Research findings and recommendations 
which contribute to policy and practice, such as national programs targeted at GPs, 
community pharmacists and consumers run by NPS MedicineWise (ͲͰͱʹa) and the 
Australian Commission on Safety and Quality in Health Care (ͲͰͱʹ) have been 
detailed in Chapter Ͷ, Sections Ͷ.ͳ.ͳ and Ͷ.ͳ.ʹ. 
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 RESEARCH AIM 
This research aimed to establish the dominant factors influencing decisions to use 
antibiotics by GPs, community pharmacists and consumers in the Australian primary 
healthcare sector, in order to inform ongoing national programs to reduce antibiotic 
use.   
 
1.3.1 Research questions 
Two research questions (RQs) were posed and addressed: 
RQͱ.  What influences antibiotic use from the perspectives of GPs, community 
pharmacists and consumers? 
RQͲ.  How do GPs and consumers trade-off on factors influencing antibiotic use? 
 
 SIGNIFICANCE OF THE RESEARCH  
This research is innovative in its cross-disciplinary approach — bringing together key 
principles used in healthcare behavioural change, clinical education, judgement and 
decision-making, and behavioural economics.  The project is novel in the use of 
discrete choice experiments (DCEs) as a method to quantify the relative importance 
of factors influencing individual decision-making in the use of antibiotics for GPs and 
consumers. 
The outcomes of this research confirmed the findings of previous research and 
contributed new knowledge in decision-making within the field of antibiotic use in 
the Australian primary healthcare sector.  The factors influencing antibiotic use from 
the perspectives of GPs, community pharmacists and consumers were identified (a 
first, in the case of Australian community pharmacists and consumers), out of which 
a model was developed to both explain the phenomenon as well as to inform 
individual and collective action on enabling wise use of antibiotics.  GP and consumer 
preferences in antibiotic prescribing and antibiotic consumption, respectively, were 
quantified (for the first time to the best of my knowledge), so as to enable the design 
of effective public health interventions for desired behaviour change for GPs, 
community pharmacists and consumers.  
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 THESIS OUTLINE 
This chapter (Chapter ͱ) introduces the thesis and provides an overview of the 
rationale for the research.  Chapter Ͳ comprises a review of the literature on: (a) what 
is currently known about barriers and enablers of antibiotic use for GPs, community 
pharmacists and consumers in the primary healthcare sector, (b) behaviour change 
strategies, and (c) decision-making.  It concludes with a summary of research gaps 
and highlights the research questions addressed in this thesis. 
Chapter ͳ outlines and justifies the research paradigm (pragmatism), research design, 
the selection of methods used and the respective strengths and limitations of each 
method.  Implementation of the method including development of research 
instruments, and sampling and recruitment are also discussed. 
Chapter ʹ extensively details the coding and data analysis of the qualitative 
component — semi-structured interviews conducted with GPs, community 
pharmacists and consumers.  The results for each participant cohort in answer to 
Research Question ͱ are reported in this chapter.  A new model (EABE model, Section 
ʹ.͵) to explain the phenomenon of what influences antibiotic use from the 
perspectives of GPs, community pharmacists and consumers and to inform individual 
and collective action on how to enable wise use of antibiotics, emerged from the 
qualitative data.  The chapter concludes with a bridging section which explains the 
transformation of selected qualitative data in the development of the quantitative 
research instrument — the discrete choice experiments (DCEs).  Justification for not 
conducting a DCE for community pharmacists is provided in Section ʹ.Ͷ.Ͳ. 
Chapter ͵ comprises the data analysis and results of the quantitative component — 
DCEs — conducted with GPs and consumers to answer Research Question Ͳ.  
Dominant factors which influenced antibiotic prescribing behaviours and consumer 
antibiotic consumption behaviours were found. 
Chapter Ͷ presents the discussion and synthesis of findings from both the qualitative 
and quantitative phases, in line with a mixed methods approach.  Where appropriate, 
intentional application of the research paradigm was discussed.  Strengths and 
limitations of the research overall, including the application of the chosen methods 
and reflections on how the research has shaped the researcher, are presented.  The 
significance, novelty and importance of research contributions are claimed and 
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discussed — theoretical and methodological innovations, implications for policy and 
practice, and recommendations.   
Chapter ͷ concludes the thesis with a succinct grand summary of the research and 
offers several suggestions for future research.  The thesis ends with a concluding 
statement.  
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 Literature Review 
Chapter Ͳ comprises a review of the literature on: (a) what is currently known about 
barriers and enablers of antibiotic use for GPs, community pharmacists and 
consumers in the primary healthcare sector, (b) behaviour change strategies, and (c) 
decision-making.  The literature review is used to problematise the research gaps.  
The chapter concludes with a summary of research gaps and highlights the research 
questions addressed in this thesis. 
 
The literature review focuses on three areas in the context of primary healthcare:  
barriers and enablers of antibiotic use affecting GPs, community pharmacists and 
consumers; behaviour change strategies; and decision-making.  The primary aim of 
the literature search was to identify contextually relevant barriers and enablers of 
antibiotic use for GPs, community pharmacists and consumers, respectively.  
Secondary aims were to identify behaviour change strategies reported to be useful for 
GPs and consumers; and to explore medical decision-making contextualised for 
prescribing. 
A literature search3 was carried out using the following key words:  antibiotic, 
antimicrobial, antibiotic resistance, antimicrobial resistance, antibiotic use, decision-
making, judgment, behaviour, interventions, strategies, prescribing, prescriber, 
doctor, general practitioner, pharmacist, community pharmacist, consumer, patient, 
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3 While the literature search was conducted systematically, a systematic review was not 
justifiable due to the availability of a newly published review at the time (Teixeira 
Rodrigues, Roque, Falcão, Figueiras, & Herdeiro, ͲͰͱͳ). 
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An example of a key word search using Medline is shown below: 
S1: antibiotic* OR antimicrobial OR antibiotic resistance OR antimicrobial resistance 
S2: prescrib* OR decision?making OR judg?ment 
S3: doctor OR prescri* OR general practitioner OR gp 
S4: ambulatory OR primary care OR primary health?care 
S5: S1 AND S2 AND S3  
S6: S4 AND S5 
 
The search was limited to peer-reviewed journal articles in the English language, 
published between January ͲͰͰͰ and March ͲͰͱʹ, abstracts being available, and 
subjects being adults.  Databases searched included Medline, CINAHL, PsycINFO and 
Scopus.  These searches resulted in a final number of articles found as follows:  for the 
primary aim — to identify barriers and enablers of antibiotic use for GPs (Ͳ͵ͳ 
articles), community pharmacists (ͳͷ articles) and consumers (ʹͳ articles); for the 
secondary aims — to identify behaviour change strategies for GPs (ͱͱ͸ articles) and 
consumers (ͷͰ articles); and to explore medical decision-making contextualised for 
prescribing (ͱͷ articles) (see Appendix C for details).   
Reference lists of key articles were examined for publications not captured in the 
original search, and included if relevant.  Relevant literature published after March 
ͲͰͱʹ were added via an alert service tagged to landmark papers or articles of 
importance from the original literature search. 
Grey literature was identified by searching websites of national and international 
entities engaged in the area of AMR, such as the World Health Organization, US 
Centers for Disease Control and Prevention, European Centre for Disease Prevention 
and Control, the Australian Department of Health, the Australian Commission on 
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 RESEARCH FRAMEWORK 
The conceptual framework for this research – the Theoretical Domains Framework 
(TDF), was chosen based on the following considerations: (a) ability to encompass 
the fields of behaviour change, clinical education, judgement and decision-making, 
and behavioural economics, (b) commonly used in healthcare or health services 
interventions, and (c) utility for translation of research outcomes into practice. 
 
2.1.1 Theoretical Domains Framework  
The TDF was developed specifically as a theory for behaviour change in healthcare 
(French et al., ͲͰͱͲ).  It is based on ͳͳ psychological and organisational theories for 
cross-disciplinary use in the area of clinician behaviour change (Michie et al., ͲͰͰ͵).  
The domains within the TDF encompass potential barriers to change at an individual 
level, which when analysed in the context of a clinical area, can be used to select or 
design an appropriate clinical or educational intervention to overcome modifiable 
barriers (French et al., ͲͰͱͲ).  French et al (ͲͰͱͲ) argue that the use of theory to 
inform the design of complex healthcare interventions can narrow the gap between 
evidence and clinical practice.  Apart from its original purpose, the TDF has also been 
used in the selection of theories of behaviour change to inform interventions (Francis, 
Tinmouth, et al., ͲͰͰ͹), as well as to identify and verify key domains influencing 
clinical practice (Francis, Stockton, et al., ͲͰͰ͹).  As such, it is reasonable to adopt 
the TDF based on the barriers and enabling strategies identified in the literature 
affecting behaviour change and decision-making in the area of antibiotic use in 
primary healthcare. 
The TDF has recently been validated, refined and expanded from ͱͲ to ͱʹ domains 
(Cane et al., ͲͰͱͲ), summarised in Table ʹ. 
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Table 1.  Theoretical Domains Framework4 
Domain Definition 
D1.  Knowledge An awareness of the existence of something 
D2.  Skills An ability or proficiency acquired through practice 
D3.  Social/ Professional Role and Identity 
 
A coherent set of behaviours and displayed personal 
qualities of an individual in a social or work setting 
D4.  Beliefs about Capabilities 
 
Acceptance of the truth, reality or validity about an ability, 
talent or facility that a person can put to constructive use 
D5.  Optimism 
 
The confidence that things will happen for the best or that 
desired goals will be attained 
D6.  Beliefs about Consequences 
 
Acceptance of the truth, reality or validity about outcomes 
of a behaviour in a given situation 
D7.  Reinforcement 
 
Increasing the probability of a response by arranging a 
dependent relationship, or contingency, between the 
response and a given stimulus 
D8.  Intentions 
 
A conscious decision to perform a behaviour or a resolve to 
act in a certain way 
D9.  Goals 
 
Mental representations of outcomes or end states that an 
individual wants to achieve 
D10. Memory, Attention and Decision 
Processes 
 
The ability to retain information, focus selectively on aspects 
of the environment and choose between two or more 
alternatives 
D11. Environmental Context and Resources 
 
Any circumstance of a person’s situation or environment 
that discourages or encourages the development of skills 
and abilities, independence, social competence, and 
adaptive behaviour 
D12. Social Influences 
 
Those interpersonal processes that can cause individuals to 
change their thoughts, feelings or behaviours 
D13. Emotion 
 
A complex reaction pattern, involving experiential, 
behavioural and physiological elements, by which the 
individual attempts to deal with a personally significant 
matter or event 
D14. Behavioural Regulation 
 
Anything aimed at managing or changing objectively 
observed or measured actions 
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4 Adapted from “Validation of the theoretical domains framework for use in behaviour 
change and implementation research,” by J. Cane, D. O’Connor, S. Michie, ͲͰͱͲ, 
Implement Sci, ͷ(ͳͷ). 
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Proponents of the TDF encourage further testing of the framework in different 
contexts and to examine the links between theoretical assessment and behaviour 
change strategies (Francis, O'Connor, & Curran, ͲͰͱͲ; French et al., ͲͰͱͲ).  This 
research takes up the challenge by using the TDF in four novel ways:  (a) as the 
theoretical basis for establishing the dominant factors in decision-making in both an 
area (antibiotic use in Australian primary healthcare) and in individuals (community 
pharmacists and consumers), naïve to the TDF, (b) as a coding framework for 
qualitative data gained from semi-structured interviews, (c) as a conceptual 
framework for selection of attributes of interest for the DCEs, and (d) as a translation 
framework for recommendations to national programs targeting desired behaviour 
change in antibiotic use.  In addition, the mapping of evidence to the TDF on 
antibiotic prescribing and antibiotic use in primary care has not been done before in 
peer-reviewed journals5.  This work therefore builds upon existing knowledge, adds to 
implementation science/behaviour change research, and extends the application of 
the TDF. 
 
 BARRIERS AND ENABLERS FOR INFLUENCING ANTIBIOTIC PRESCRIBING IN PRIMARY 
CARE 
GPs, community pharmacists and consumers experience different types of barriers 
and enablers in relation to antibiotic use.  The magnitude or relative importance of 
these barriers for the individual is not known – whether GP, community pharmacist 
or consumer.   
This section outlines what influences antibiotic use in the primary healthcare sector 
and highlights contrasting findings or controversies.  Detailed mapping of influencing 
factors found in the literature to the Theoretical Domains Framework (TDF) is 
provided for GPs, consumers and community pharmacists in Tables ͱ, Ͳ and ͳ, 
respectively.  An explanation of the TDF was provided in Section Ͳ.ͱ.ͱ.  
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5 The mapping of evidence for this thesis was completed in ͲͰͱʹ.  Since then, grey 
literature has been found, produced by Public Health England in ͲͰͱ͵, which used the TDF 
to organise evidence in this area (Public Health England, ͲͰͱ͵). 
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2.2.1 What influences general practitioners? 
It is important to understand what factors influences antibiotic prescribing 
behaviour, as national programs aimed at reducing inappropriate use are predicated 
on determinants of behaviour (Weissman & Besser, ͲͰͰʹ).  Barriers to appropriate 
prescribing of antibiotics reported in the literature include (a) patients demanding 
antibiotics, (b) the perception that patients expect antibiotics, (c) prescribing 
antibiotics to save time due to the perception that it takes longer to explain why 
antibiotics are not needed, (d) concerns that the patient may not return for follow up, 
(e) uncertainty in the diagnosis where antibiotics may be warranted, (f) concern 
about possible complications, (g) preservation of the doctor-patient relationship, and 
(h) knowledge and attitudes to antibiotic resistance (Butler, Rollnick, Kinnersley, 
Jones, & Stott, ͱ͹͹͸; Butler, Rollnick, Pill, Maggs-Rapport, & Stott, ͱ͹͹͸; Coenen, 
Michiels, Renard, Denekens, & Van Royen, ͲͰͰͶ; Hardy-Holbrook, Aristidi, 
Chandnani, DeWindt, & Dinh, ͲͰͱͳ; Kumar, Little, & Britten, ͲͰͰͳ; McDonnell 
Norms Group, ͲͰͰ͸; Teixeira Rodrigues et al., ͲͰͱͳ).  However, it is not known which 
of these barriers are more important, and therefore more critical to address in 
national programs promoting prudent use of antibiotics. 
 
The doctor-patient relationship 
It is undisputed that the doctor-patient relationship is core to the clinical 
consultation.  The nature of the doctor-patient encounter and its impact on antibiotic 
prescribing has been studied by Strandberg and colleagues (Strandberg, Brorsson, 
Hagstam, Troein, & Hedin, ͲͰͱͳ).  The interaction could be harmonious when both 
GP and patient expectations are aligned, or more akin to a fight involving either 
collaboration or negotiation, resulting in agreement, a compromise or disagreement.   
Important factors related to the encounter which enabled prudent prescribing of 
antibiotics include:  professional autonomy of the GP and continuity of the clinical 
relationship (patient is well known to the GP).  The latter encouraged the GP to 
invest time in educating the patient and explaining why antibiotics were not required 
in that instance, if indeed that was the case (Strandberg et al., ͲͰͱͳ).  
Several studies infer the centrality of prescribers wanting to preserve the doctor-
patient relationship over all other factors.  This is evidenced by GPs acquiescing to 
perceived or actual patient expectation for antibiotics (Coenen et al., ͲͰͱͳ; Lopez-
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Vazquez, Vazquez-Lago, & Figueiras, ͲͰͱͲ; Mangione-Smith, Stivers, Elliott, 
McDonald, & Heritage, ͲͰͰͳ; McDonnell Norms Group, ͲͰͰ͸; Tonkin-Crine, 
Yardley, & Little, ͲͰͱͱ).  Motivations for preserving the doctor-patient relationship 
varied from being able to draw upon a good relationship in the future to negotiate a 
more serious medical matter to concerns about loss of revenue to the clinic as many 
believed that the patient would seek antibiotics from another GP elsewhere (Butler, 
Rollnick, Pill, et al., ͱ͹͹͸).  In a recent survey of ͷͳͰ GPs in Australia, about ʹͰ% of 
respondents reported they would prescribe antibiotics to meet patient expectation 
(Hardy-Holbrook et al., ͲͰͱͳ).  While in another study more than half of the GPs 
surveyed self-reported that they would prescribe antibiotics for an upper respiratory 
tract infection to meet patient expectations (Fletcher-Lartey, Yee, Gaarslev, & Khan, 
ͲͰͱͶ).  However, GPs’ perception of which patients expected antibiotics were not 
strongly correlated with the patients’ actual view, although it resulted in antibiotics 
being more likely to be prescribed (Coenen et al., ͲͰͱͳ).  In contrast, GPs who 
withheld antibiotics where appropriate to do so, seemed confident that it would not 
jeopardise the doctor-patient relationship (Kumar et al., ͲͰͰͳ).  While preservation 
of the doctor-patient relationship is understandably desired, it is not unequivocal that 
it is the foremost factor impacting on prescribers’ decision. 
 
General Practitioners’ views on AMR and prescribing behaviours 
GPs’ views on AMR influenced how readily they prescribed antibiotics.  AMR is only 
one of many considerations GPs take into account when making prescribing decisions 
and is often not the most prominent factor (Simpson, Wood, & Butler, ͲͰͰͷ).  
Generally, GPs are aware of the increasing problem of AMR, and therefore of the need 
to conserve potent broad spectrum antibiotics, as well as reduce the volume of 
antibiotic used (Dallas, van Driel, van de Mortel, & Magin, ͲͰͱʹ; Simpson et al., ͲͰͰͷ; 
Wood et al., ͲͰͱͳ; Wood, Simpson, & Butler, ͲͰͰͷ).    However, how GPs conceived 
of AMR as an issue spatially (in the foreground, background or “elsewhere”) or 
temporally (immediate or future time), coloured prescribing decisions.   
GPs who held their concerns about AMR in the forefront when making decisions 
about antibiotic prescribing, were more mindful of selecting the narrowest spectrum 
antibiotic that would work.  In contrast, GPs who de-emphasised the issue of AMR 
tend to more readily prescribe potent broad spectrum antibiotics.  These findings 
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have been consistent throughout the UK and in Europe (Wood et al., ͲͰͱͳ; Wood et 
al., ͲͰͰͷ). 
GPs who saw AMR as an issue “in the future” were high volume prescribers of potent 
broad spectrum antibiotics, and justified their prescribing decisions as duty of care to 
the individual patient.  These GPs “wanted to be sure of a good result” i.e. to prevent 
serious decline especially of very ill or elderly patients (Wood et al., ͲͰͰͷ).    
A dichotomy is seen in GPs’ prescribing responses to AMR.  GPs who believed that 
most infections no longer respond to narrower spectrum or older antibiotics as a 
result of AMR, resorted to prescribing broad spectrum antibiotics for their patients’ 
benefit – a view found to be prevalent amongst GPs in Southern and Eastern 
European countries (Wood et al., ͲͰͱͳ).  In contrast, GPs who displayed more careful 
prescribing of these antibiotics were acting to conserve the utility of these antibiotics 
into future – a view held by GPs in Northern European countries (Wood et al., ͲͰͱͳ).  
Interestingly, in choosing either of these courses of actions, GPs perceived themselves 
as acting in a socially responsible way (Wood et al., ͲͰͰͷ).   
The conundrum in primary healthcare here and elsewhere, lies in the uncertainty of 
not only which patients would benefit from an antibiotic, but also which antibiotic to 
select.  Often GPs need to make a decision without means of being sure of the 
infecting micro-organism and its sensitivities to antibiotics.  It is not surprising 
therefore, that broad spectrum antibiotics comprise the largest volume of antibiotic 
usage in Australia (Department of Health, ͲͰͱͳ).  Research that brings about 
accurate, cost-effective and rapid point-of-care testing as incentivised by the 
Longitude Prize (Longitude Prize, ͲͰͱͶ), would be impactful in providing GPs with a 
microbiological basis for prescribing. 
Global investment to facilitate both the development and widespread uptake of rapid 
diagnostics is a promising circuit breaker for the overuse of antibiotics.  O’Neill 
makes a convincing case that rapid diagnostics could reduce unnecessary prescribing 
of antibiotics, reduce the use of broad spectrum antibiotics, improve selection of 
antibiotics, and reduce costs for hospitals, patients and healthcare systems (Review 
on Antimicrobial Resistance, ͲͰͱ͵).  The underlying assumption is that the rapid 
diagnostic test would be able to quickly and reliably show whether the organism is 
bacterial or viral, the type of bacteria including whether it is a resistant strain, and the 
bacteria’s susceptibility to available antibiotics (Review on Antimicrobial Resistance, 
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ͲͰͱ͵).  However, he is careful to point out that behaviour change is still needed “to 
alter long-established ways of using antibiotics” and recommends increasing public 
awareness of antimicrobial resistance globally (Review on Antimicrobial Resistance, 
ͲͰͱ͵). 
 
General Practitioners’ views of themselves and prescribing behaviours 
Social science research found that prescribing behaviour was related to GPs’ self-
perception (Henriksen & Hansen, ͲͰͰʹ).   GPs felt pressured by both extrinsic and 
intrinsic factors, and prescribed in a way that protected their personal and 
professional self (Henriksen & Hansen, ͲͰͰʹ).  To illustrate, when patients 
demanded or clearly expected an antibiotic, GPs were exposed to extrinsic pressure, 
and felt that their autonomy had been compromised or that the patient lacked 
respect for them.  Some GPs reported feeling used or abused (Butler, Rollnick, Pill, et 
al., ͱ͹͹͸; Henriksen & Hansen, ͲͰͰʹ).  Intrinsically, if GPs gave in to the pressure and 
prescribed antibiotics against evidence based medicine, they became disappointed 
with themselves.  This negative self-perception triggers the application of both 
preventative strategies (such as communication skills) and coping strategies (such as 
adhering more strictly to clinical guidelines) as a form of self-protection (Henriksen & 
Hansen, ͲͰͰʹ).   
 
How real is AMR?   
GPs’ views about the reality of AMR ranged from acknowledging that it is a significant 
issue to claiming they had not encountered this in their practice.  Some believe that 
AMR is an important problem in particular clinical areas only e.g. urinary tract 
infections but not in upper respiratory tract infections (Vazquez-Lago, Lopez-
Vazquez, Lopez-Duran, Taracido-Trunk, & Figueiras, ͲͰͱͲ).  GPs who think the 
problem of AMR is exaggerated require less evidence to prescribe antibiotics, than 
those who believe that AMR poses a real threat (Björnsdóttir, Kristinsson, & Hansen, 
ͲͰͱͰ).   
European GPs often attributed treatment failure to reasons other than AMR, i.e. 
patient’s non-adherence to antibiotics or to the viral aetiology of the infection (Wood 
et al., ͲͰͱͳ).  GPs in Northern Europe believe that the issue of AMR is more serious in 
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Southern Europe where antibiotics are available without a prescription in some 
jurisdictions (Wood et al., ͲͰͱͳ).   
In Australia, Britt, Harrison, and Miller (ͲͰͱͲ) caution against making a causal link 
between primary healthcare sector prescribing of antibiotics with the emergence of 
AMR due to limited evidence.  However, recent surveillance reports by the Australian 
Group on Antimicrobial Resistance, showed rising rates of multi-drug resistant 
organisms in the community (Australian Commission on Safety and Quality in Health 
Care, ͲͰͱͶ; Turnidge et al., ͲͰͱͳ).  In corroboration, a new meta-analysis of studies 
conducted in the US and Europe provided strong evidence of a positive relationship 
between antibiotic consumption and AMR in the community (Bell, Schellevis, 
Stobberingh, Goossens, & Pringle, ͲͰͱʹ).   
AMR at an individual level for up to ͱͲ months, has been shown to be associated with 
the prescribing of antibiotics in primary care, particularly for urinary tract, respiratory 
tract and skin infections (Costelloe, Metcalfe, Lovering, Mant, & Hay, ͲͰͱͰ).  
Costelloe et al appropriately concluded that residual resistance to antimicrobials 
detectable up to ͱͲ months is an important driver for endemic levels of antimicrobial 
resistance in the community (Costelloe et al., ͲͰͱͰ).  In other words, individual 
prescribers’ decisions to prescribe an antibiotic can contribute to an increase in AMR 
at the population level. 
 
Too little, too late? 
Some GPs remain optimistic about being able to collectively contain the problem of 
AMR with more careful prescribing, preventative action such as vaccinations and 
patient education, and development of new agents.  Others are pessimistic and 
believe it is too late for changes in prescribing practice to have a real impact on 
reducing AMR (Wood et al., ͲͰͱͳ).  This is perhaps not surprising given that some 
GPs interviewed felt that if antibiotics are inappropriately prescribed “once or twice a 
year for an upper respiratory tract infection or a little bronchitis”, no harm is done 
(Butler, Rollnick, Pill, et al., ͱ͹͹͸).  Other GPs have reported “throwing in the towel” 
as far as preventing inappropriate prescribing of antibiotics for upper respiratory tract 
infections were concerned (Butler, Rollnick, Pill, et al., ͱ͹͹͸). 
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2.2.2 Why we need to get it right:  Emerging prescribers 
The need to more fully understand the drivers influencing prescribing of antibiotics 
in the primary healthcare sector is critical as non-medical prescribers, apart from 
dentists, emerge.  In Australia, non-medical prescribers currently include nurse 
practitioners, midwives, optometrists, paramedics and podiatrists (Health Workforce 
Australia, ͲͰͱͳ).  It is imminent that physiotherapists and pharmacists will soon hold 
authorisations to prescribe (Pharmacy Board of Australia, ͲͰͱʹ; Physiotherapy Board 
of Australia, ͲͰͱʹ).   
Already a recent study of nurse practitioners in the UK point to similar challenges in 
antibiotic prescribing for the management of patients presenting with respiratory 
tract infections (Rowbotham et al., ͲͰͱͲ).  As such, findings from this research will 
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Table 2.  Factors influencing GPs from the literature 
Theoretical Domains 
Framework 




D1. Knowledge GPs were aware of AMR as a significant problem generally. (Dallas et al., 2014; 
Hardy-Holbrook et al., 
2013; McCullough, 
Rathbone, Parekh, 
Hoffman, & Del Mar, 
2015; Simpson et al., 
2007; Wood et al., 2013; 
Wood et al., 2007) 
Some GPs question the evidence linking their prescribing 
patterns to AMR and poorer patient outcomes. 
 
(Dallas et al., 2014; 
Fletcher-Lartey et al., 
2016; Simpson et al., 
2007) 
In antibiotic selection, GPs feel hampered by not having 
sensitivities available at the point of prescribing.  Results 
take too long to influence treatment decisions. 
(Wood et al., 2013; Wood 
et al., 2007) 
 
Prescribing narrow spectrum antibiotics as confident that 
most commonly encountered micro-organisms would 
respond. 
(Wood et al., 2007) 
A small number of GPs felt that having access to local 
resistance data would help in selecting narrower spectrum 
antibiotics. 
(Wood et al., 2013) 
Evidence that unnecessary antibiotics can harm individuals 
may change prescribing behaviour. 
(Butler, Rollnick, Pill, et 
al., 1998) 
D2. Skills Use of running commentary as a communication technique 
during consultation can reduce patient expectations for 
antibiotics. 
(Mangione-Smith et al., 
2003)  
D3. Social/ Professional 
role and identity 
Prescribing potent broad spectrum antibiotics due to a sense 
of duty to do their best for the patient in front of them. 
(Butler, Rollnick, Pill, et 
al., 1998; Wood et al., 
2007) 
Not prescribing potent broad spectrum antibiotics due to a 
sense of social responsibility to conserve potent broad 
spectrum antibiotics for the future, unless clearly indicated 
by microbiology. 
(Tonkin-Crine et al., 2011; 
Wood et al., 2007) 
D5. Optimism Antibiotics perceived to have a low incidence of side effects 
and an easy dosing regimen.   
(McDonnell Norms 
Group, 2008; Wood et al., 
2007) 
AMR can be contained with prudent use of antibiotics being 
one of the key strategies. 
(Wood et al., 2013) 
AMR is seen as a problem in the future. 
 
(McCullough, Rathbone, 
et al., 2015; Wood et al., 
2007) 
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Table 2 (continued) 
Theoretical Domains 
Framework 




D6. Beliefs about 
consequences 
Prescribing broad spectrum antibiotics seen as “effective 
early treatment” to prevent serious decline in very ill, 
elderly, or patients with co-morbidities. 
(Kumar et al., 2003; 
Teixeira Rodrigues et al., 
2013; Vazquez-Lago et al., 
2012; Wood et al., 2007) 
D6. Beliefs about 
consequences 
(continued) 
Belief that most infections are resistant to narrow spectrum 
antibiotics and therefore prescribe newer broad spectrum 
agents. 
(Wood et al., 2013) 
Have not encountered AMR in daily practice.  Attributed 
treatment failure to patient’s non-adherence to antibiotics 
or to infection being of viral origin, rather than to AMR. 
(Simpson et al., 2007; 
Wood et al., 2013) 
Belief that patients will seek antibiotics from another 
prescriber anyway (if not prescribed an antibiotic). 
(Butler, Rollnick, Pill, et 
al., 1998; Vazquez-Lago et 
al., 2012) 
Prescribing antibiotic as a way to shorten consultation. 
Trying to change patient’s beliefs and expectations 
perceived to be time consuming and unrewarding. 
(Butler, Rollnick, Pill, et 
al., 1998; Dallas et al., 
2014; Tonkin-Crine et al., 
2011) 
Too late to contain AMR with prudent use of antibiotics. 
 
(Wood et al., 2013) 
D7. Reinforcement Experience of frequent treatment failures with narrower 
spectrum antibiotics. 
 
(Wood et al., 2007) 
D9. Goals Prescribing a potent broad spectrum antibiotic to prevent a 
possible hospital admission. 
 
(Wood et al., 2007) 
D10. Memory, 
attention and decision 
processes 
Require a very good reason to prescribe a fluoroquinolone 
e.g. microbiology. 
 
(Wood et al., 2007) 
GPs justified non-adherence to clinical guidelines by arguing 
that this was in the best interest of the patient e.g. evidence 
base for clinical guidelines are flawed as clinical trial 
populations are unlike their patients. 
(Wood et al., 2007) 
Patient’s social situation e.g. perceived importance of 
patient’s job, perceived ability to afford a sick day, ability to 
return for reassessment. 
(Björnsdóttir et al., 2010; 
Teixeira Rodrigues et al., 
2013; Tonkin-Crine et al., 
2011) 
GPs used nationally recognised antibiotic guidelines when 
making prescribing decisions, as it provides a safety net 
should the treatment fail. 
(Dallas et al., 2014) 
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Table 2 (continued) 
Theoretical Domains 
Framework 





context and resources 
Prescribing potent broad spectrum antibiotics to reduce 
number of re-presentations, and hence workload. 
(Wood et al., 2007) 
 
Belief that AMR is less of/not a problem in primary 
healthcare, more a concern for hospital sector. 
(Fletcher-Lartey et al., 
2016; McCullough, 
Rathbone, et al., 2015; 
Teixeira Rodrigues et al., 
2013; Vazquez-Lago et al., 
2012; Wood et al., 2013) 
Concerns regarding loss of patients, hence loss of revenue. (Butler, Rollnick, Pill, et 
al., 1998; Teixeira 
Rodrigues et al., 2013) 
D12. Social influences Prescribing antibiotics due to perceived patient expectations 
and to preserve good doctor-patient relationship. 
(Butler, Rollnick, Pill, et 
al., 1998; Coenen et al., 
2006; Coenen, Van 
Royen, Vermeire, 
Hermann, & Denekens, 
2000; Fletcher-Lartey et 
al., 2016; McDonnell 
Norms Group, 2008; 
Teixeira Rodrigues et al., 
2013; Tonkin-Crine et al., 
2011; Vazquez-Lago et al., 
2012; Wood et al., 2007) 
Prescribing choices influenced by peers through meetings, 
training events and discussions, or shaped by senior medical 
colleagues/supervisors. 
 
(Dallas et al., 2014; Wood 
et al., 2007) 
D13. Emotion Feeling under pressure to prescribe antibiotic. 
 
(Kumar et al., 2003; 
Wood et al., 2007) 
Aware that antibiotics are not indicated for most upper 
respiratory tract infections and acute bronchitis, yet still 
prescribe them due to the desire to take the path of least 
(emotional) resistance. 
 
(Dallas et al., 2014) 
Uncertainty of diagnosis (viral or bacterial) contributing to 
fear or anxiety of missing a serious infection requiring 
antibiotic treatment (and consequences of not starting 
antibiotics).   
(Coenen et al., 2000; 
Kumar et al., 2003; 
McDonnell Norms Group, 
2008; Teixeira Rodrigues 
et al., 2013; Tonkin-Crine 
et al., 2011; Vazquez-Lago 
et al., 2012) 
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Table 2 (continued) 
Theoretical Domains 
Framework 






Distancing/ Externalisation:  Attributing the rise of AMR to 
over-prescribing of antibiotics for self-limiting infections, 
inappropriate use by patients e.g. self-prescribing of 
antibiotics or non-adherence, use in livestock, prescribing 
behaviour of dentists and hospital doctors; pharmacies 
giving out antibiotics without a prescription. 
(Hardy-Holbrook et al., 
2013; Vazquez-Lago et al., 
2012; Wood et al., 2013) 
Indifference/ apathy regarding the problem of inappropriate 
antibiotic prescribing. 
 
(Teixeira Rodrigues et al., 
2013) 
Feel unable to influence the problem of AMR. 
 
(Simpson et al., 2007) 
D14. Behavioural 
regulation 
Prescribing antibiotics to avoid an expensive hospital 
admission when funding arrangements for primary and 
tertiary healthcare are managed by the same body e.g. local 
health board, primary care trust. 
(Wood et al., 2007) 
Prescribing choices influenced by formulary. 
 
(Wood et al., 2007) 
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2.2.3 What influences consumers? 
Barriers related to consumers which prevent appropriate use of antibiotics include (a) 
confusion as to whether viruses or bacteria caused the infection, (b) belief that 
antibiotics will shorten illness duration, (c) seeking antibiotics despite being aware of 
the self-limiting nature of the illness, (d) not being aware of risks associated with 
antibiotic use, (e) needing a legitimate reason to be away from work, and (f) the 
perception that antibiotic resistance is a problem for hospitals only and caused by 
doctors who overprescribe antibiotics (Belongia, Naimi, Gale, & Besser, ͲͰͰͲ; Braun & 
Fowles, ͲͰͰͰ; Brooks, Shaw, Sharp, & Hay, ͲͰͰ͸; Cals et al., ͲͰͰͷ; Emslie & Bond, 
ͲͰͰͳ; Eng et al., ͲͰͰͳ; Gonzales, Wilson, Crane, & Barrett, ͲͰͰͰ; McCullough, Parekh, 
Rathbone, Del Mar, & Hoffman, ͲͰͱ͵; NPS MedicineWise, ͲͰͱʹb). 
 
Patient satisfaction 
Patient satisfaction levels with clinic visits were not necessarily related to getting 
antibiotics (Butler, Rollnick, Pill, et al., ͱ͹͹͸; Coenen et al., ͲͰͱͳ).  Many simply wanted 
reassurance, were seeking information or pain relief (Butler, Rollnick, Pill, et al., ͱ͹͹͸).  
Conversely, a Cochrane review by Spurling et al (ͲͰͱͳ) found patient satisfaction to be 
higher for immediate antibiotic prescriptions despite no difference in clinical outcomes 
for cough and the common cold.   
While research on the experiences and satisfaction levels of patients are informative, it 
would be more useful to investigate what consumers as patients really want from the 
visit to the GP for largely self-limiting conditions such as acute respiratory tract 
infections e.g. reassurance, medical certificate, before assuming consumers are seeking 
a prescription for antibiotics. 
 
Consumer views of AMR and antibiotic use 
Consumers were found to be generally aware of the link between antibiotic use and 
AMR in a European study (Brookes-Howell et al., ͲͰͱͲ).  However, the majority of 
patients interviewed misunderstood AMR to mean that the body becomes resistant 
rather than the micro-organism acquiring mechanisms of resistance to antibiotics 
(Brookes-Howell et al., ͲͰͱͲ; McCullough, Parekh, et al., ͲͰͱ͵; Wellcome Trust, ͲͰͱ͵).  
Patients’ interpretations of AMR being a property of the body included, the body being 
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incompatible with the antibiotic, the body “getting used” to the antibiotic, the immune 
system being damaged through taking unnecessary antibiotics, or AMR being 
hereditary (Brookes-Howell et al., ͲͰͱͲ; McCullough, Parekh, et al., ͲͰͱ͵; Wellcome 
Trust, ͲͰͱ͵).   
A significant proportion of consumers is still confused and incorrectly thinks that 
antibiotics are effective against viral infections (Cals et al., ͲͰͰͷ; NPS MedicineWise, 
ͲͰͱͳb), despite public health campaigns aimed at raising awareness of AMR (Huttner, 
Goossens, Verheij, & Harbarth, ͲͰͱͰ).  For example, ͵ͳ% of respondents in Europe 
thought that antibiotics kill viruses, while ʹͷ% believed antibiotics to be effective for 
the common cold (European Commission, ͲͰͱͰ).  In Australia, more than half of the 
respondents surveyed thought that antibiotics are effective against viruses (NPS 
MedicineWise, ͲͰͱͳb).  In addition, Ͷ͵% of Australian workers believed that taking 
antibiotics for the common cold would hasten recovery and enable an earlier return to 
work (NPS MedicineWise, ͲͰͱʹb).  Consistent confusion in consumers’ understanding 
of AMR and knowledge about antibiotics indicate that communication from GPs, 
community pharmacists and public health campaigns need to be clearer and more 
precise. 
 
Consumer behaviour and AMR 
Apart from seeking antibiotics for minor self-limiting illnesses such as an acute 
respiratory tract infection, two types of consumer behaviour contribute to AMR – self-
medication with antibiotics and non-adherence to prescribed antibiotics (Céspedes & 
Larson, ͲͰͰͶ; World Health Organization, ͲͰͱʹa).   
Consumers reported having antibiotics on hand “just in case” and demand antibiotics 
from pharmacists without a prescription, believing these medicines to be a panacea 
(Anghel & Craciun, ͲͰͱͳ; Roque et al., ͲͰͱͳ).  Self-medication with antibiotics is highly 
prevalent in Southern and Eastern Europe especially in countries where antibiotics are 
available without a prescription (Grigoryan et al., ͲͰͰ͸), and has been targeted in the 
ͲͰͱʹ European Antibiotic Awareness Day (Earnshaw et al., ͲͰͱʹ).  In Australia, where 
antibiotics are only available with a prescription, self-medication can occur when 
patients use antibiotics leftover from a previous illness, share another’s antibiotics or 
obtain them while overseas.  Little research has been done to understand the issue of 
self-medication with antibiotics in Australian consumers.  
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Non-adherence with antibiotics is common, with only about ͶͰ% of patients taking as 
prescribed (Kardas, Devine, Golembesky, & Roberts, ͲͰͰ͵).  Patients display a range of 
intentional and unintentional non-adherent behaviours (Hawkings, Butler, & Wood, 
ͲͰͰ͸).  Intentional non-adherent behaviours include stopping antibiotics early to save 
them for future use or stopping as soon as they feel better because antibiotics are 
“unnatural” (Hawkings et al., ͲͰͰ͸).  Unintentional non-adherence occurs due to 
missing doses because of work and social constraints or forgetfulness (Hawkings et al., 
ͲͰͰ͸).  While strategies for integrating medicine-taking into daily routines and a clear 
plan for managing missed doses can mitigate unintentional non-adherence, factors 
motivating intentional non-adherence will need to be addressed to bring about 
behaviour change.
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D1. Knowledge Past experience of antibiotics working for similar 
symptoms e.g. coloured sputum. 
(Butler, Rollnick, Pill, et al., 
1998) 
Most patients are aware of the link between antibiotic 
use and AMR. 
(Brookes-Howell et al., 
2012) 
Misconception of what AMR means e.g. the body 
becomes resistant. 
(Brookes-Howell et al., 
2012; McCullough, Parekh, 
et al., 2015; Wellcome 
Trust, 2015) 
Think that antibiotics are effective against viruses. (Cals et al., 2007; European 
Commission, 2010; NPS 
MedicineWise, 2013b) 
Think that antibiotics are effective against coughs and 
the common cold. 
(European Commission, 
2010) 
Unaware that most coughs and the common cold are 
caused by viruses. 
(NPS MedicineWise, 2013b) 
Big figures (financial cost, lives lost) are too abstract to 
have an impact on consumers.  Analogies to climate 
change or the term “superbugs” are not persuasive.  
Practical implications e.g. impact on surgery, side 
effects, are more persuasive. 
(Wellcome Trust, 2015) 
D4. Beliefs about 
capabilities 
Belief that they knew whether antibiotics were needed 
before consulting doctor. 
(Belongia et al., 2002; 
Wellcome Trust, 2015) 
Feel that solutions to AMR are outside their control. (Brooks et al., 2008; 
McCullough, Parekh, et al., 
2015) 
Confident about self-medication with antibiotics. (Anghel & Craciun, 2013; 
Grigoryan et al., 2008; 
Roque et al., 2013) 
D5. Optimism Belief that new drugs/solutions would be developed to 
solve AMR. 
(Brooks et al., 2008; 
Wellcome Trust, 2015) 
D6. Beliefs about 
consequences 
Faith in the efficacy of antibiotics. (Anghel & Craciun, 2013; 
Vazquez-Lago et al., 2012) 
Past experience or belief of quicker recovery with 
antibiotics.  
(Braun & Fowles, 2000; Eng 
et al., 2003; Gonzales et al., 
2000; NPS MedicineWise, 
2014b) 
Risk of taking antibiotics perceived to be small.  Benefits 
of taking antibiotics outweigh the risks. 
(Eng et al., 2003; 
McDonnell Norms Group, 
2008) 
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D6. Beliefs about 
consequences 
(continued) 
Most patients thought AMR would not affect them 
personally.  More a problem for society. 
(Brooks et al., 2008; 
McCullough, Parekh, et al., 
2015) 
 
Taking antibiotics for a cold prevented more severe 
illness. 
(Eng et al., 2003) 
D9. Goals 
 
Going to the doctor to get antibiotics due to symptoms 
e.g. coloured sputum, very sore throats. 
 
(Belongia et al., 2002; 
Braun & Fowles, 2000; 
Butler, Rollnick, Pill, et al., 
1998; Emslie & Bond, 2003; 
Eng et al., 2003) 
D10. Memory, 
attention and decision 
processes 
Concerns about AMR not a reason for modifying own 
behaviour. 
(Brooks et al., 2008) 
Stopping antibiotics early or as soon as feeling better – 
to save some for next illness or belief that antibiotics are 
“unnatural”. 
(Hawkings et al., 2008) 
D11. Environmental 
context and resources 
Cost of the antibiotic is less than the cost of follow up 
clinic visit (time and money). 
(McDonnell Norms Group, 
2008)  
D13. Emotion Going to the doctor for reassurance when concerned it 
may be something serious. 
(Butler, Rollnick, Kinnersley, 
et al., 1998) 
Attributes AMR to other people’s behaviours – i.e. other 
patients, doctors who over prescribe antibiotics.  
(Brooks et al., 2008; 
McCullough, Parekh, et al., 
2015) 
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2.2.4 What influences community pharmacists? 
Community pharmacists are accessible to consumers for advice and self-management 
of minor illnesses such as acute respiratory tract infections.  As such, community 
pharmacists are well placed to promote prudent use of antibiotics to consumers in 
three major ways (World Health Organization, ͲͰͱʹc).  First, advice on appropriate 
non-antibiotic self-care strategies, including preventative measures such as vaccination.  
Second, not providing antibiotics without both clinical justification (in the case of 
repeat prescriptions, or where over-the-counter antibiotics are legal) and legal 
requirements being met (where a prescription is required to access antibiotics).  Third, 
when antibiotics are prescribed, advice on appropriate use, management of side effects 
and return of leftover antibiotics for disposal (World Health Organization, ͲͰͱʹc).  A 
recent policy analysis on AMR by the World Health Organization concluded that 
community pharmacists have been underutilised and should be engaged by health 
authorities to be stewards of antibiotic use in collaboration with GPs (World Health 
Organization, ͲͰͱʹc).  
Globally, out of fourteen national campaigns to promote prudent use of antibiotics, 
only one (Canada) explicitly targeted community pharmacists (Huttner et al., ͲͰͱͰ).  
Community pharmacists justified their modest participation in public health 
campaigns to raise awareness of AMR by citing time constraints, a lack of support from 
managers, professional organisations and GPs, or a lack of suitable educational 
resources for themselves and for consumers (Coleman, ͲͰͰͳ).  Further, community 
pharmacists were reluctant to question GPs about the appropriateness of antibiotic 
prescriptions (Kotwani, Wattal, Joshi, & Holloway, ͲͰͱͲ).  Given the unwritten medical 
hierarchy, community pharmacists may be better utilised in the consumer-facing arm 
of national campaigns. 
What are the current attitudes and behaviours of community pharmacists with regard 
to the consumer interface and AMR?  Disconcertingly, some community pharmacists 
were observed to be willing to provide antibiotics without a prescription with little 
persuasion (Stoyanova, Dimova, & Raycheva, ͲͰͱͲ), others reported being pressured by 
consumers to do so (Roque et al., ͲͰͱͳ).  Community pharmacists identified the 
following reasons for consumers requesting or demanding antibiotics without a 
prescription:  past experience with and/or belief in the effectiveness of antibiotics, 
difficulty in accessing a GP, unable to afford a medical consultation, or unable to miss 
work without financial penalty being imposed (Roque et al., ͲͰͱͳ).  Other reasons cited 
Chapter Ͳ:  Literature Review  ͵Ͱ 
for providing antibiotics without a prescription include:  economic gain (Kotwani et al., 
ͲͰͱͲ; Stoyanova et al., ͲͰͱͲ), to clear near-expiry stock, to save poorer patients the cost 
of consulting a GP, or out of fear of losing customers (Kotwani et al., ͲͰͱͲ).  An attitude 
of complacency prevailed around provision of antibiotics, as many community 
pharmacists did not think that this practice contributed to AMR as they were “only 
giving antibiotics for a few days” (Kotwani et al., ͲͰͱͲ; Roque et al., ͲͰͱͳ).  Some of 
these factors coupled with knowledge of the consumer’s clinical history and/or 
confidence in obtaining a prescription retrospectively from the GP, may be powerful 
enough for community pharmacists to yield to consumer demand (Roque et al., ͲͰͱͳ). 
Like GPs and consumers, community pharmacists externalised the issue of 
inappropriate use of antibiotics – attributing responsibility to GPs and health 
authorities to lead on combating AMR, and also to consumers (Kotwani et al., ͲͰͱͲ; 
Roque et al., ͲͰͱͳ).  Taken together, from the perspectives of GPs, consumers and 
community pharmacists, the responsibility for mitigating AMR is attributed to 
“everyone else” and therefore, to no one.   
There is clearly a role for community pharmacists in the fight against AMR by virtue of 
their training and their placement as one of the key healthcare interfaces with 
consumers, apart from GPs.  However, little qualitative research has been done to 
understand how community pharmacists in Australia view the issue of AMR, their 
professional role in mitigating the rise of AMR and their perceptions of what influences 
use of antibiotics.  Understanding what motivates or de-motivates community 
pharmacists as active partners will be critical in empowering and engaging them as 
stewards of antibiotic use.  Knowing what enablers and barriers community 
pharmacists face in promoting prudent use of antibiotics will be critical in designing 
suitable healthcare interventions targeted at consumers. 
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Table 4.  Factors influencing community pharmacists from the literature 
Theoretical Domains 
Framework 




D1.  Knowledge Mixed level of awareness regarding inappropriate use of 
antibiotics and links to AMR – ranging from unaware to 
generally aware. 
(Coleman, 2003; Kotwani 
et al., 2012) 
D3.  Social/ 
Professional role and 
identity 
Providing antibiotics without a prescription out of a sense 
of compassion for patient’s social situation and duty of 
care. 
(Kotwani et al., 2012; 
Roque et al., 2013) 
D6.  Beliefs about 
consequences 
Providing antibiotics without a prescription for fear of 
losing customers. 
(Kotwani et al., 2012) 
Complacency around provision of antibiotics - did not 
think that this practice contributed to AMR. 
(Kotwani et al., 2012) 
D8.  Intentions Providing antibiotics without a prescription for economic 
gain. 
(Stoyanova et al., 2012) 
Providing antibiotics without a prescription to clear near-
expiry stock. 
(Kotwani et al., 2012) 
D12. Social influences Providing antibiotics without a prescription due to demand 
or pressure from patients, especially if patients have 
difficulty accessing a GP, unable to afford a medical 
consultation, or unable to miss work without financial 
penalty. 
(Roque et al., 2013) 
D13. Emotion Providing antibiotics without a prescription out of a sense 
of compassion for patient’s social situation and duty of 
care. 
(Roque et al., 2013) 
Distancing/ Externalisation:  Attributed responsibility of 
reducing mitigating AMR to GPs, health authorities and 
consumers. 
(Kotwani et al., 2012; 
Roque et al., 2013) 
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 BEHAVIOUR CHANGE FOR POLICY AND PRACTICE 
Behaviour change can occur at three different levels – individual, interpersonal and 
community.  The underlying behaviour change theory for public policy is the rational 
choice model where individuals seek to maximise benefits to self (Australian Public 
Service Commission, ͲͰͰͷ; Simon, ͱ͹͵͵).  This model takes into account individual and 
group choice, but arguably falls short when other important factors influencing 
behaviour such as social and environmental factors, come into play.  One of the 
constraints of the rational choice model is when what is perceived to be a personal 
benefit by an individual i.e. receiving antibiotics for a cough or cold, runs counter to 
societal benefit, as this behaviour increases antibiotic resistance in the community. 
Interventions aimed at influencing desired behaviour change in the use of antibiotics in 
the primary healthcare sector have largely been aimed at individuals – largely, GPs and 
consumers.  Taking a societal perspective, the desired behaviour change for prescribers 
is a reduction in unnecessary prescribing of antibiotics.  In the case of consumers, the 
desired behaviour change is greater health literacy, for example, coughs and colds are 
caused by viruses, and that antibiotics are not useful in treating viral infections – which 
lead consumers to not expect or demand antibiotics. 
The European Centre for Disease Control (ECDC) has led an annual Antibiotic 
Awareness Day (EAAD) targeted at both GPs and consumers across Europe to promote 
prudent use of antibiotics since ͲͰͰ͸ (Earnshaw et al., ͲͰͱʹ).  The effects of public 
campaigns on antibiotic consumption are mixed.  There appears to be no association 
between the number of years of participation in the EAAD with national antibiotic 
consumption (Earnshaw et al., ͲͰͱʹ; OECD, ͲͰͱͱ).  Campaigns that were formally 
evaluated reported a range of effects from a significant reduction in antibiotic 
consumption over a number of years to no measurable effect over time (Huttner et al., 
ͲͰͱͰ).  Strategies with the strongest evidence for success in reducing inappropriate 
antibiotic use include (a) delayed antibiotics – defined as a prescription provided with 
advice to delay using the prescription for more than ʹ͸ hours after initial consultation, 
(b) appropriate education for parents ideally prior to illness episode, (c) prescriber 
audit and feedback, and (d) educational meetings particularly using a social marketing 
approach (Andrews et al., ͲͰͱͲ; Arnold & Straus, ͲͰͰ͵; Spurling et al., ͲͰͱͳ).  
Campaigns which include multifaceted strategies are more likely to have a positive 
effect (Arnold & Straus, ͲͰͰ͵), especially if educational material for prescribers are 
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combined with educational meetings (van der Velden et al., ͲͰͱͲ).  The impact of such 
campaigns on curbing AMR is proving challenging to quantify, as is the potential 
adverse consequences of reduced antibiotic prescribing e.g. complications (Huttner et 
al., ͲͰͱͰ).  It remains unclear which messages, interventions or combination of 
interventions are most effective in reducing antibiotic consumption and AMR (Huttner 
et al., ͲͰͱͰ). 
 
A note about delayed prescribing 
Delayed prescribing has been recommended as a strategy for reducing inappropriate 
antibiotic prescribing by the National Institute for Health and Care Excellence 
(National Institute for Health and Care Excellence, ͲͰͰ͸) and has been used by some 
GPs (Butler, Rollnick, Pill, et al., ͱ͹͹͸).  GPs felt delayed prescribing to be useful in 
managing diagnostic uncertainty, preventing a return visit to the clinic, providing a 
measure of reassurance to the patient, and reducing consultation time (Kumar et al., 
ͲͰͰͳ).  However, recent studies including a Cochrane Review found no difference in 
clinical outcomes for cough and the common cold when patients were refused 
antibiotics (Coenen et al., ͲͰͱͳ; Spurling et al., ͲͰͱͳ), suggesting that delayed 
antibiotics should no longer be recommended practice.   
 
 APPLICATIONS TO MEDICAL DECISION-MAKING 
Decision-making implies an individual’s conscious application of cognitive processes 
such as gathering relevant information and reasoning or thinking, to select a course of 
action from a set of alternatives.  
Drawing from dual-processing theories in cognitive and social psychology (Evans, 
ͲͰͰ͸), Kahneman categorises thinking into fast thinking and slow thinking 
(Kahneman, ͲͰͱͱ).  Characteristics of fast thinking include it being automatic, 
instantaneous, intuitive, associated with emotion and perhaps a memory.  
Experientially, fast thinking “happens to you”.  In contrast, slow thinking is effortful 
and involves some control of attention.  Because slow thinking is closer to subjective 
experience, for example making a conscious decision, individuals are more conscious of 
this way of thinking.   
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These modes of thinking are fluid.  Slow thinking can move to become fast thinking 
when the task at hand has been mastered, for example driving a car in normal traffic 
conditions.  In addition, mental effort comes at a cost.  Kahneman establishes that slow 
thinking is guided by fast thinking, and that often, slow thinking is used to simply 
confirm decisions made from fast thinking alone (Kahneman, ͲͰͱͱ).   
Bate et al (ͲͰͱͲ) applies Kahneman’s findings to medical decision-making, where gaps 
are often seen between evidence base and actual practice.  Here, it seems that the 
doctor develops a pattern of knowledge which they then rely on for decision-making 
(fast thinking), rather than activating slow thinking – systematically working through 
available evidence to inform prescribing decisions (Bate et al., ͲͰͱͲ).  Conceivably, 
specialists or experts in the field may access fast and slow thinking in a different way – 
a decision has been made using fast thinking (accurate pattern of clinical features and 
presentation from years of experience), and slow thinking is applied to simply provide 
confirmation of their original decision. 
More usually in medical decision-making, apart from clinical considerations, GPs 
balanced clinical risks against patients’ social situation (Björnsdóttir et al., ͲͰͱͰ).  For 
example, in considering whether to prescribe an antibiotic for an infection, GPs may 
weigh up clinical risks such as the possible harm from an untreated infection against 
the development of AMR in the community.  Some GPs considered both types of risks, 
while others considered neither (Björnsdóttir et al., ͲͰͱͰ).  Clinical risks were balanced 
against patients’ social situation such as being able to return for a follow up visit 
(availability of time and money), their role in society (perceived importance of the 
patient’s job) and financial resources (patient’s need for earnings, ability to afford a sick 
day) (Björnsdóttir et al., ͲͰͱͰ).  The relative importance of clinical risks against other 
factors such as patients’ social situation, patients’ expectations, or societal risks of AMR 
to name a few, is not known. 
 
Physical and emotional state 
GPs’ emotional and physical state at the time of prescribing can potentially impact on 
their decision-making (Tonkin-Crine et al., ͲͰͱͱ).  The cognitive demand of multiple 
clinical decisions per day can result in decision fatigue – resulting in GPs being more 
vulnerable to making inappropriate prescribing choices (Linder et al., ͲͰͱʹ).  Linder et 
al (ͲͰͱʹ) showed that GPs were more likely to prescribe antibiotics for acute 
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respiratory infections in the latter half of both morning and afternoon ʹ-hour clinic 
sessions.  It remains to be seen if and how awareness of this tendency assists GPs in 
modulating their decision-making. 
 
Competing interests:  Individual vs Societal benefits  
The confluence of moral choice and medical decision-making occurs at the doctor-
patient interface, where patient well-being is likely to take precedent over all other 
entities.  The withholding of antibiotics for what could be self-limiting minor illnesses 
may therefore place GPs in an uncomfortable position — pitting patient well-being 
against public good.  
In moral decision-making, psychological distance either temporally or spatially from an 
event decreases deontological judgements and increases consequentialist choices 
(Gong, Iliev, & Sachdeva, ͲͰͱͲ).  That is, if the event (e.g. prescribing antibiotics) is far 
into the future or happens in a distant location, individuals are more likely to choose 
the course of action that will have the best anticipated outcome for most people 
(consequentialist).  In the case of antibiotic prescribing, this translates to choosing not 
to prescribe antibiotics for an acute respiratory tract infection to a patient (next year or 
in the UK) if this will lead to more people being protected from AMR.  The converse is 
true for deontological judgements, where duty of care to the patient is paramount.  The 
associations between consequentialist responses with deliberate, rational thinking, and 
deontological responses with emotion and intuition (Gong et al., ͲͰͱͲ), is reminiscent 
of Kahneman’s (ͲͰͱͱ) slow and fast thinking, respectively.     
This way of viewing moral decision-making may explain why GPs who prescribed 
potent broad spectrum antibiotics for their patients and those who chose to conserve 
these antibiotics for the future, both perceived their actions to be socially responsible. 
 
 SUMMARY AND IMPLICATIONS 
Every dose of antibiotic prescribed and used, increases the likelihood of AMR (Phelps, 
ͱ͹͸͹).  The greatest proportion of antibiotics is prescribed in the primary healthcare 
sector (Australian Commission on Safety and Quality in Health Care, ͲͰͱͶ), where its 
use is strongly correlated to antimicrobial resistance rates (Bell et al., ͲͰͱʹ; National 
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Institute for Health and Care Excellence, ͲͰͰ͸).  Hence, the primary healthcare sector 
is an important area for action. 
The literature highlights several research gaps, some of which will be addressed in this 
study.  Efforts to reduce inappropriate antibiotic use in the Australian primary 
healthcare sector have largely comprised clinical and educational interventions 
targeted at individual GPs and/or consumers.  Designing effective healthcare 
interventions to reduce the inappropriate use of antibiotics, be they clinical, 
educational or pertaining to policy, means identifying and addressing the barriers to 
appropriate antibiotic use that is pertinent to each individual involved.  Although some 
barriers and enablers to appropriate use of antibiotics affecting GPs and consumers are 
known, it is not clear which factors are most important or dominant that would impact 
on the decision.  In addition, research on GP prescribing behaviours and attitudes 
found in published literature were predominantly completed on those practising in the 
UK, Europe or the USA.  To date, limited research has been done with Australian GPs 
in this area.  The same can be said of consumers.  In the case of community 
pharmacists, little qualitative research has been done to understand how those 
practising in Australia view the issue of AMR, their professional role in mitigating the 
rise of AMR and their perceptions of what influences use of antibiotics.   
Another research gap identified which would add useful insight to efforts in mitigating 
AMR, is to investigate factors that are known to colour decision-making, such as 
discounting the future.  In addition, the analysis of barriers and enablers to behaviour 
change against a theoretical framework suited for knowledge translation is critical for 
informing existing national programs to bring about a reduction in inappropriate use of 
antibiotics.  Research findings can then (a) influence how key messages and public 
health campaigns are crafted to prompt desired behaviour change, and (b) inform 
clinical education and empowerment of GPs and community pharmacists to play a 
more responsive role as stewards of antibiotic use in the community.  Absence of such 
research compromises our collective ability to synergise multi-level intervention 
strategies to reduce antibiotic consumption in Australia. 
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 Research Design and Methods 
In this chapter I establish the argument for using a mixed methods research design, 
justify and describe the methods used, detail the development of research instruments, 
and describe the conduct of research.  The chapter is divided into three portions.  The 
first portion, Sections ͳ.ͱ to ͳ.ͳ, deals with the research design — description of the 
research paradigm used (pragmatism), and justification for the methodology (mixed 
methods) including the points of interface between each method i.e. how and where 
“mixing” will occur in the research.  The second, Section ͳ.ʹ, deals with the qualitative 
method selected — semi-structured interview.  Justification for the selection of semi-
structured interview is provided, along with the development of the interview guide, 
and a description of how research interviews were conducted.  A brief statement about 
me — the researcher — is provided in Appendix B, as per best practice reporting for 
qualitative research (Tong, Sainsbury, & Craig, ͲͰͰͷ).  The third portion, Section ͳ.͵, 
details the quantitative method selected — discrete choice experiment (DCE).  The 
rationale for DCE, the development, and the implementation of the DCE survey are 
detailed.  Strengths and limitations of both methods are discussed in their respective 
sections.  Research ethics and management of research data are stated in Sections ͳ.Ͷ 
and ͳ.ͷ, respectively.   
Descriptions of methods (this chapter) and reporting of results (Chapters ʹ and ͵) 
follow recognised best practice guidelines — the consolidated criteria for reporting 
qualitative research (COREQ) for the semi-structured interviews (Tong et al., ͲͰͰͷ), 
and the recommendations of the Good Research Practices for Conjoint Analysis Task 
Force of The International Society for Pharmacoeconomics and Outcomes Research 
(ISPOR) for the DCEs (Bridges et al., ͲͰͱͱ). 
 
 RESEARCH PARADIGM:  PRAGMATISM 
The substantive theory stance in mixed methods research states that the key driver for 
guiding inquiry decisions should be the substantive issues and conceptual theories 
relevant to the study being conducted, rather than philosophical paradigms in and of 
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themselves (Greene, ͲͰͰͷ, p. Ͷ͹).  However, there is value in adopting a paradigm if 
this lends further robustness to situate and frame the research and its findings. 
This research has been conducted using pragmatism as the underpinning philosophy, 
relying on Dewey’s pragmatism in particular, approaching inquiry as beginning with 
the problem and through inquiry transforming the “indeterminate situation” into one 
“that is so determinate in its constituent distinctions and relations as to convert the 
elements of the original situation into a unified whole” (Biesta, ͲͰͱͰ).  That is, 
pragmatism understood as a problem-driven approach, the overriding concern being 
the research question.  It is important to emphasise here that pragmatism as a 
philosophy does not equate to an “anything goes” approach.  Rather, I understand 
pragmatism to be a composite of the following core ideas:  that knowledge is based on 
practical outcomes and judged on its usefulness when applied to a “real world” 
problem, that there is no single or best method that can be used to elicit indisputable 
knowledge, that knowledge is provisional and contextual (what is true now for a 
particular cultural context, may not be so in the future) due to the way it is produced, 
and finally, that pragmatism as a philosophy is anti-dualistic (for example, that water-
tight distinctions between theory and practice is at best unhelpful).   
Given that the research aim was to establish the dominant factors influencing decisions 
to use antibiotics by GPs, community pharmacists and consumers in the Australian 
primary healthcare sector — currently an “indeterminate situation”, and that it points 
to a problem-driven approach, it seemed appropriate to underpin this work with 
pragmatism as a philosophy. 
 
 METHODOLOGY:  MIXED METHODS 
Research that involves the investigation of applied issues often requires both 
quantitative and qualitative methods. The use of mixed methods research, while not 
new, is one that is still evolving (Tashakkori & Teddlie, ͲͰͱͰ).  As such, there are 
currently several definitions of what constitutes mixed methods research (Teddlie & 
Tashakkori, ͲͰͱͰ).  The definition adopted for this research is the use of two or more 
methods in a single research project which yields both qualitative and quantitative data 
(Creswell & Plano Clark, ͲͰͱͱ; Teddlie & Tashakkori, ͲͰͰ͹).   
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While definitions of mixed methods may vary, several common characteristics hold 
true, which aligns with the investigative aim of this research.  These common 
characteristics of contemporary mixed methods research, which are at the same time 
useful and compelling, are outlined below.  Following a short introduction of each 
characteristic, a brief explanation of how it is relevant to this research is provided. 
The first characteristic — methodological eclecticism, allows the selection and 
synergistic integration of the most appropriate methods from quantitative, qualitative 
and mixed strategies to thoroughly investigate a phenomenon of interest (Teddlie & 
Tashakkori, ͲͰͱͰ, p. ͵).  For this research, which aimed to establish the dominant 
factors influencing decision-making on the part of general practitioners, community 
pharmacists and consumers whether to use an antibiotic, a qualitative component was 
required to explore what these factors may be in the Australian primary healthcare 
context.  The qualitative component alone, while yielding useful insights in answer to 
the first research question (RQͱ.  What influences antibiotic use from the perspectives 
of GPs, community pharmacists and consumers?), would not have fully addressed the 
research aim.  A quantitative component was also required so that factors identified 
from both the literature and the qualitative component could be measured or weighted 
relative to one another (RQͲ.  How do GPs and consumers trade-off on factors 
influencing antibiotic use?). 
From this we can know which factors have more weight in influencing decision-making 
on antibiotic use.  This in turn would inform the development and points of emphases 
of key messages in Australia’s public health campaigns, in order to produce a 
measurable reduction in antibiotic use nationally. 
The second characteristic — paradigm pluralism, asserts that more than one paradigm 
can serve as the underlying philosophy for mixed methods research, albeit only one 
paradigm can be used in a single study (Teddlie & Tashakkori, ͲͰͱͰ).  While 
pragmatism has often been touted as the only acceptable paradigm for mixed methods 
research, other plausible paradigms include dialectics (Greene & Hall, ͲͰͱͰ), critical 
theory (Hesse-Biber, ͲͰͱͰ) and critical realism (Maxwell & Mittapalli, ͲͰͱͰ).  Here, I 
have chosen to use pragmatism as the underlying philosophy given that (a) the 
research aim describes an “indeterminate situation”, (b) the research contributes 
provisional knowledge and potential solutions to a “real world” problem, and (c) the 
required combination of qualitative and quantitative methods to address the research 
aim, makes essential the anti-dualistic stance of pragmatism i.e. not preferring 
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positivism (quantitative methods) over interpretivism (qualitative methods) or vice 
versa. 
The third characteristic is an emphasis on diversity at all levels of the research, apart 
from methodological eclecticism and paradigm pluralism outlined above.  This 
emphasis on diversity means that a carefully designed mixed methods study can 
address both confirmatory and exploratory questions simultaneously (Teddlie & 
Tashakkori, ͲͰͱͰ).  Properly conducted mixed methods research also provides 
intellectual space to process divergent conclusions and inferences from research 
findings (i.e. data and subsequent analyses).  This third characteristic has served my 
research well, where the qualitative component has not only been exploratory 
(identifying factors), but also confirmatory (supporting the results from the 
quantitative component).  In mixing the findings from both the qualitative and 
qualitative components, synergy has been found in that the qualitative component lent 
useful explanations to the results from the quantitative component.  In short, applying 
this third characteristic of mixed method research has proven to be fruitful for this 
research in providing greater insight into the complex phenomenon of decision-making 
in a healthcare context, and exposed further gaps in what is currently understood about 
the issue. 
The fourth characteristic — an emphasis on continua rather than dichotomies, moves 
away from setting up binaries and replaces the either-or paradigm debates.  Continua 
allows for a range of options from across the methodological spectrum (Teddlie & 
Tashakkori, ͲͰͱͰ).  Hence, in my research, the inclusion of methods associated with 
interpretivist paradigms (qualitative), as well as methods associated with positivist 
paradigms (quantitative), was made possible.  
The fifth characteristic stipulates an iterative, cyclical approach to research, which 
includes both inductive and deductive logic in the same study (Teddlie & Tashakkori, 
ͲͰͱͰ).  Tashakkori & Teddlie (Teddlie & Tashakkori, ͲͰͱͰ) explains that the cycle of 
research may be seen as moving from results (facts/ observations) through inductive 
logic to general inference (or theory), then from those general inferences through 
deductive logic to tentative hypotheses or predictions of particular outcomes.  
Although research may start from any point in the cycle, all mixed methods research 
goes through a full cycle at least once.   
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In my research the literature review provided the starting point, in which deductive 
logic was applied using the selected theoretical lens — Theoretical Domains 
Framework (Section Ͳ.ͱ.ͱ), to inform the development of interview guides for the 
qualitative component.  Data from the semi-structured interviews were coded using a 
blend of deductive and inductive coding (Section ʹ.ͱ).  Inductive logic was then applied 
to identify realistic decision points, attribute and levels for the quantitative component 
— discrete choice experiments (DCEs).  Finally, deductive logic was applied to the 
findings of the DCEs, together with those from the semi-structured interviews, to arrive 
at tentative hypotheses in answer to the research aim and research questions.  This 
research cycle and design is represented in a schematic diagram in Section ͳ.ͳ.ͱ (Figure 
Ͳ). 
The sixth characteristic, a focus on the research question in determining the methods 
used in a study, is perhaps the characteristic that comes to mind most when thinking 
about mixed methods research (Teddlie & Tashakkori, ͲͰͱͰ, p. ͱͰ).  This problem-
driven approach serves to de-couple the methods employed from philosophical issues 
such as epistemology and ontology.  Indeed, good research on any important evidence-
based problem would very likely need to use a mix of methods (Gorard, ͲͰͱͰ).  In 
Sections ͳ.ʹ and ͳ.͵ justification is provided for the methods selected in order to 
investigate the research questions posed. 
The seventh characteristic is a set of fundamental research designs and analytical 
processes, commonly associated with and used in mixed methods research (Teddlie & 
Tashakkori, ͲͰͱͰ, p. ͱͰ).  There is as yet no universal terminology to describe these 
research designs and no consensus regarding the specific number and types of research 
designs admissible in the field of mixed methods research.  Section ͳ.ͳ contains a 
discussion on mixed methods research design generally, as well as the design used for 
this research. 
The eight characteristic — a tendency toward balance, drawing from appropriate 
methodologies where required rather than sitting at either end of the methodological 
spectrum (positivism vs. interpretivism), serves my research aim which cannot be 
adequately addressed by adopting either a positivist or interpretivist approach alone.   
Finally, the ninth characteristic — a reliance on visual representations (for example 
diagrams) and a common notation system for research design by Morse (Tashakkori & 
Teddlie, ͲͰͱͰ, p. ͱͲ), allows mixed method researchers to easily communicate their 
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research designs in shorthand — see Section ͳ.ͳ.ͱ for the Morse notation used in this 
study. 
In summary, the rationale for using mixed methods in this research is that firstly, a 
qualitative component was needed in order to elicit attitudes, behaviours and 
perspectives of Australian general practitioners, community pharmacists and 
consumers, on antibiotic use.  This was to better understand the Australian context, as 
much of the published research and grey literature in this area had been produced 
elsewhere — in countries with different levels of access to healthcare systems and 
models of funding.  Secondly, building on the literature, the findings from the 
qualitative component were not only used to develop the quantitative research 
instrument, but also to gain a more comprehensive understanding of the first research 
question (RQͱ).  Thirdly, while previous research has reported on factors that seem to 
influence prescribing patterns of doctors, both those working in primary care or in 
hospital settings, to the best of my knowledge there is as yet no better appreciation of 
which factors are dominant in doctors’ decision-making processes.  Hence, a 
quantitative component which would allow these factors to be measured or weighted 
relative to one another, would narrow this research gap.  The application of mixed 
methods, as described above, maximises the strengths of each approach and allows 
synergistic analyses of the findings to bear upon the research aim. 
 
 RESEARCH DESIGN  
There is as yet no consensus regarding the specific number and types of mixed methods 
designs.  Robust scholarly debates are still ongoing, which serve to further develop this 
field (Tashakkori & Teddlie, ͲͰͱͰ) while allowing newer researchers to contribute to 
the conversation.  Certainly the fact that mixed methods research is not yet “set in 
stone”, seems to have attracted its application in diverse disciplines, from sociology to 
psychology, and increasingly in health services research (Russo et al., ͲͰͱͶ; Wong, 
Norman, Dunning, Ashley, & Lorgelly, ͲͰͱʹ). 
Amidst the current lack of consensus in the field of mixed methods research, there are 
at least three different frameworks in use for planning and implementing such 
research, represented by the work of Janice Morse, Jennifer Greene, and Tashakkori and 
Teddlie, respectively. 
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In Morse’s framework, one method is dominant over another.  The dominant or core 
method is that part which can stand alone as its own completed study (and can be 
reported as such), while the non-dominant method cannot.  Morse determines that the 
dominant method sets the overall theoretical drive, either inductive or deductive, for 
that study.  She argues for the necessity of keeping the quantitative and qualitative 
components of a study as separate as possible, in order to realise the strengths of each 
component.  Hence, there is no mixing of theoretical drives (Tashakkori & Teddlie, 
ͲͰͱͰ).  Although a recognised pioneer of mixed methods research, Morse’s position on 
research design is different from what is now generally endorsed in the field, where a 
more thorough mixing of methods is expected.  
In line with contemporary mixed methods practice, Greene encourages the mixing of 
theoretical drives, as methods cannot be divorced from assumptive frameworks 
(Tashakkori & Teddlie, ͲͰͱͰ).  This advantageous stance serves five important purposes 
of research designs:  allowing triangulation, complementarity, development, initiation 
and expansion.  
Finally, Tashakkori and Teddlie lay out their typology based on research 
implementation processes of the qualitative and quantitative components.  They 
identified four families of designs:  parallel, sequential, conversion, and fully integrated 
(Teddlie & Tashakkori, ͲͰͱͰ, p. Ͳʹ).  Each of the first three designs can be further sub-
divided according to the data sources:  multiple samples (qualitative and quantitative 
data are from different individuals or are not linked), same or subsample (both types of 
data are available for some individuals and are linked), and multilevel samples (data are 
collected from different social 'hierarchies' of individuals i.e. qualitative data from 
parents and quantitative data from children, and linked during analysis) (Teddlie & 
Tashakkori, ͲͰͱͰ, p. Ͳʹ).  The fully integrated design can include combinations of these 
options — the three families of designs with the sub-divisions of data sources, in an 
iterative manner (Teddlie & Tashakkori, ͲͰͱͰ, p. Ͳʹ) 
  
3.3.1 Research design for this study 
The research design for this study was an exploratory sequential mixed methods design 
(Creswell, ͲͰͱʹ), and compatible with Greene's mixing of theoretical drives, although it 
is perhaps most closely aligned to Tashakkori and Teddlie's typology — a fully 
integrated design comprising sequential implementation of qualitative followed by 
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quantitative components, using multiple samples.  In Morse's notation, the research 
design is represented as QUAL  QUAN.  A substantial qualitative component 
(QUAL) designed to be conducted first, in order to answer the first research question 
(RQͱ), also informed the development of the quantitative research instrument — 
discrete choice experiments (QUAN).  The DCEs addressed the second research 
question (RQͲ).  Each component was of equal importance.   
The literature review provided the starting point, in which deductive logic was applied 
using the selected theoretical lens — Theoretical Domains Framework (Section Ͳ.ͱ.ͱ), 
which informed the development of interview guides for the semi-structured interviews 
(QUAL).  Findings from the semi-structured interviews were coded using a blend of 
deductive and inductive coding (Section ʹ.ͱ).  Inductive logic was then applied to 
identify realistic decision points, attributes and levels for the quantitative component 
— DCEs (QUAN).  This step is the first (Mixing ͱ) of two points of interface where the 
mixing of methods occurred.  Finally, deductive logic was applied to the findings of the 
DCEs, together with those from the semi-structured interviews (Mixing Ͳ) to arrive at 
tentative hypotheses in answer to the research aim and research questions.  This 
research cycle and design is represented in a schematic diagram (Figure Ͳ). 
The two methods selected for this research were (a) semi-structured interviews for the 
qualitative component, and (b) discrete choice experiments for the quantitative 
component.  Justification for the selection of each of these methods, development of 
research instruments, implementation of these methods, along with strengths and 
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 METHOD 1:  SEMI-STRUCTURED INTERVIEWS 
The qualitative component of this research comprised of semi-structured interviews in 
order to capture the lived meanings and views of GPs, community pharmacists and 
consumers (Kvale, ͲͰͰͷc).  This method was selected, rather than other types of 
interviews such as unstructured interviews, structured interviews, focus groups or 
group interviews, as it best served the exploratory nature of this phase of the research 
in the following ways: 
Firstly, semi-structured interviews allowed for the exploration of a main set of 
questions while enabling flexibility for follow-up questions, probing questions, 
questions that seek clarification, further explanation or examples, unlike fully 
structured or unstructured interviews.  In this research, the use of follow-up questions 
yielded interesting findings, which is reported in Chapter ʹ. 
Secondly, unlike structured interviews, the sequence of questions asked in semi-
structured interviews can be varied to take into account how the conversation unfolded 
with each participant.  This flexibility in question sequence, enabled me to lead and in 
turn, be led, by the participant, which not only facilitated a more natural flow of 
conversation, but also increased the efficacy of information gathering during the 
interview.   
Thirdly, for this research the semi-structured interviews were conducted one-on-one, 
rather than in a group setting.  This arrangement allowed each participant the freedom 
of expressing their views without fear of being judged by fellow participants, ample 
time to put forward their perspectives, and preserved anonymity.  It also greatly 
minimised the likelihood that participants were only disclosing what they deemed to 
be socially acceptable or desirable.  Focus groups were therefore ruled out as the 
method of choice. 
Finally, the intent of the qualitative component was to elicit a diverse range of views, 
attitudes and behaviours on antibiotic use — not participant consensus.  Given these 
considerations, the one-on-one semi-structured interview was selected as the method 
for the qualitative phase of this research. 
3.4.1 Development of interview guides 
Three interview guides were developed, one for each participant group i.e. GPs, 
community pharmacists and consumers.  Interview guides comprised of relevant 
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contextual questions pertaining to the personal context of participants, main interview 
questions, possible follow-up and probing questions, as well as prompts for interactions 
i.e. for starting and wrapping up the interview session.   
Each interview guide was piloted with at least two people of similar background as the 
intended participant groups i.e. two practicing GPs, two practicing community 
pharmacists, and three consumers.  Data from these pilot interviews were not included 
in the data analysis, as the purposes of these pilots were to (a) refine the draft interview 
guides prior to being used in the research i.e. check clarity of the questions, (b) test 
that the main questions would adequately elicit useful responses to the research 
question, (c) ascertain how long an interview session would last, (d) serve as a practice 
run, and (e) obtain constructive feedback regarding the way I conducted the interview 
session and how the research interview was experienced by the participant. 
Final versions of the interview guides for each of the participant groups are shown in 
Appendices C, D and E.  Briefly, for GPs the main questions in the interview elicited 
their (a) decision-making processes when considering whether to prescribe antibiotics, 
(b) challenges regarding antibiotic prescribing — including handling patients' demands 
for antibiotics, (c) views on antibiotic resistance, (d) mitigating strategies for antibiotic 
resistance, and (e) personal behaviours regarding antibiotic use.  Contextual 
information relevant to the research were elicited, such as the characteristics of (a) the 
GP — where they gained their qualifications, where they trained, number of years in 
practice, current working arrangements, and involvement in mentoring/supervising 
medical students or GP Registrars, and (b) the clinic — business structure and billing. 
The main questions in the interview guide for community pharmacists elicited their 
normal practice in (a) managing a cough or common cold in a consumer, (b) consumer 
requests for antibiotics including the handling of repeat antibiotic prescriptions, (c) 
pharmacist views on and understanding of antibiotic resistance, (d) mitigating 
strategies for antibiotic resistance, and (e) the pharmacist’s personal behaviours 
regarding antibiotic use.  Contextual information relevant to the research were elicited 
and included those that described the characteristics of (a) the community pharmacist 
— where the participant gained their pharmacy qualification/s, place of training, place 
of practice, number of years in practice, current working arrangements, and 
involvement in mentoring or supervising pharmacy students and interns, and (b) the 
pharmacy — type of pharmacy, range of services provided, and general profile of users 
of the pharmacy. 
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The main questions in the interview guide for consumers elicited (a) their self-care 
strategies in managing a respiratory tract infection, (b) when they would consult a GP, 
(c) their expectations of the GP consultation, (d) their views and responses to the GP 
who advised that an antibiotic was not needed, (e) their views and responses if the GP 
seemed unsure of the need for antibiotics but prescribed it as a contingent measure, 
and (f) their views on the risks and potential side effects of antibiotics.  The interview 
guide also included questions on consumer experience with antibiotics — both 
taking/adherence to antibiotics and the use of repeat prescriptions, and their views on 
antibiotic resistance.  Contextual information relevant to the research were elicited, 
such as (a) personal characteristics — age, highest education level achieved, 
place/country of origin, number of years residing in Australia, (b) whether they have a 
regular GP, and (c) whether they use a regular pharmacy. 
 
3.4.2 Sampling and recruitment for semi-structured interviews 
Eligible participants for semi-structured interviews, were as follows:  (a) GPs/GP 
Registrars and community pharmacists practising at a location within an hour's drive 
from the Brisbane Central Business District (CBD), and (b) consumers 
residing/working within an hour's drive from the Brisbane CBD and between the ages 
of ͱ͸ to ͵ʹ years old.  The stipulation of being within an hour's drive of the Brisbane 
CBD, was so that the interviews could be conducted face-to-face.  An age range of ͱ͸ to 
͵ʹ years old for consumers was specified for the following reasons:  (a) Australian data 
indicated a high rate of antibiotic usage in this age range for acute respiratory tract 
infections, coughs and sore throats6 (Australian Bureau of Statistics, ͱ͹͹͹), (b) a less 
than ͵% prevalence of chronic diseases such as Type Ͳ Diabetes and Chronic 
Obstructive Pulmonary Disease, which may require treatment with antibiotics, and 
hence minimising the likelihood of introducing a confounding factor (Australian 
Institute of Health and Welfare, ͲͰͱʹ), and (c) it represents the peak years of men and 
women in the Australian workforce (Australian Institute of Health and Welfare, ͲͰͱ͵).  
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6 Prior to the recent August ͲͰͱͶ release of linkable MBS and PBS data for research purposes, 
the Australian Bureau of Statistics report referenced here, was the best available data which 
linked antibiotic consumption, medical indication, and age groups. 
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A national survey of consumers found that some of the reasons people use or ask for 
antibiotics were because of the belief that antibiotics would help quicken recovery 
(NPS MedicineWise, ͲͰͱʹb). 
Constraints of time and budget were taken into account when planning the research.  It 
was anticipated that approximately ͵Ͱ interviews in total can be conducted, given that 
each hour of interview was estimated to generate at least ͸ hours of work, including 
transcription and coding.   
The exact number per participant type i.e. number of GPs, community pharmacists and 
consumers, was difficult to determine from the outset as the point of theme saturation 
where no further interviews are required, cannot be pre-determined.   Hence, 
indicative numbers per participant group were agreed upon a priori, with the split 
favouring consumers (see Table ͵ where possible options regarding the split in 
participant numbers are outlined in the column entitled “Estimated number of 
participants”). 
Table 5.  Participant type and sampling strategy 
Participants Sampling Estimated number of participants (n = 50) 




10 12 15 
Community Pharmacists 10 12 15 
Consumers  
(18 – 54 years old) 
30 26 20 
 Total 50 50 50 
 
Convenience and snowball7 sampling were used in the recruitment of all three 
participant groups.  Recruitment strategies for each participant group are outlined 
below.  Participants were recruited until no new relevant information was obtained — 
determined by reviewing documented post-interview reflections — or when the a priori 
sample size had been reached, whichever occurred sooner. 
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7 Snowball sampling — participants were asked to refer potential participants to the 
researcher. 
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GPs were recruited via community notices placed in electronic newsletters of two of the 
largest Primary Health Networks (PHNs) in Queensland in terms of population 
(Department of Health, ͲͰͱͶ) i.e. the Brisbane North PHN and Brisbane South PHN.  
GPs were also invited to participate via recruitment emails to professional networks 
and Twitter.  Tweets were sent from my Twitter account, reserved for professional use, 
which were retweeted by professional colleagues, CRE-RHAI, AusHSI, Brisbane North 
and Brisbane South PHNs.  These strategies yielded ͱͰ expressions of interest – ͷ GPs 
and ͳ GP Registrars, which were subsequently interviewed. 
Community pharmacists were invited to participate via a recruitment email sent by the 
School of Pharmacy, Queensland University of Technology, to ͳ͹Ͷ community 
pharmacies within an hour’s drive of Brisbane CBD — postcode ranges of ʹͰͰͰ to ʹͳͰ͵ 
and ʹ͵ͰͰ to ʹ͵ͱͱ.  Other avenues included advertorials in two consecutive issues of the 
Pharmaceutical Society of Australia’s Queensland Branch eNewsletter, emails to my 
professional network, and Twitter®.  Tweets regarding community pharmacist 
recruitment were retweeted by interested Twitter® followers i.e. pharmacy colleagues 
or affiliated research groups.  These recruitment avenues yielded ͱͳ community 
pharmacists expressing interest to participate.  One withdrew prior to the interview 
due to logistic issues related to the relocation of their Pharmacy to new premises.  
Therefore, ͱͲ community pharmacists were subsequently interviewed.   
Recruitment of consumers was via an email sent to staff and students by the Faculty of 
Health and the Institute of Health and Biomedical Innovation at QUT, as well as via 
Twitter®.  Due to consideration of recruitment costs e.g. advertising in the local paper, 
recruitment of consumers was limited to the university population.  While this 
population is not likely to be representative of the general population in terms of 
educational levels achieved, the university is a microcosm of diversity i.e. multi-ethnic, 
multi-cultural, people from rural/regional, as well as metropolitan areas.  Having such 
diversity would enrich the findings of this research.  These recruitment strategies 
yielded ʹ͹ expressions of interest — ͳ did not respond to follow up emails to book an 
interview time, ͱͳ were not included either due to over-representation of the younger 
age group or were later expressions of interest after saturation of concepts/themes had 
been reached.  Thirty-three consumers were booked for an interview, but one did not 
present.  Hence, ͳͲ consumers were interviewed. 
Overall, ͵ʹ semi-structured interviews were conducted — ͱͰ GPs/GP Registrars, ͱͲ 
community pharmacists, ͳͲ consumers. 
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3.4.3 How interviews were conducted  
The interviews were conducted one-on-one and face-to-face, rather than via telephonic 
or online technology, so that non-verbal communication from the participant could be 
observed and noted.  Careful observation of non-verbals e.g. hand gestures, 
posture/positioning, and gaze, helped to either corroborate or cast doubt on the 
participant’s response to particular questions.  As this research is not focussed on 
semiotics, the analysis and reporting of these non-verbals have not been included. 
Interviews were conducted in a conversational manner, following Rubin and Rubin’s 
responsive interviewing8 technique (Rubin & Rubin, ͲͰͱͲ).  During the interview 
paraphrasing was used to clarify and/or to confirm that the intended meaning had been 
interpreted accurately.  I kept a calm, interested and non-judgmental stance 
throughout the interview, using minimal encouragers (verbal sounds such as “uh-huh”, 
“yup”) and nods while listening, and to signal my continuing interest in what the 
participant was saying.  I found my previous training in educational visiting/academic 
detailing9 and active listening10 in a healthcare context, useful for the preparation and 
implementation of these interviews.  Practiced self-awareness and reflexivity honed 
over many years in clinical roles, enabled me to easily move between the interview 
questions and the participant’s experience when conducting the interviews. 
Taken as a whole, the nature of these interviews for each participant group was 
iterative, to allow exploration of new or interesting concepts/themes in subsequent 
interviews with other participants from the same group (Rubin & Rubin, ͲͰͱͲ).  For 
example, new concepts/themes which surfaced in an interview was introduced as part 
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8 Responsive interviewing:  A way of interviewing based on extended conversation.  The 
researcher and participant become conversation partners, allowing the co-creation of 
knowledge and meaning through the participant's words and experiences. 
9 Education visiting/academic detailing:  A one-on-one outreach education technique to 
support clinicians in providing better patient care, pioneered by Jerry Avorn.  Academic 
detailing delivers evidence-based syntheses of clinical practice that is accurate, balanced, and 
current, in an engaging and highly interactive format, tailored to the clinician.   
10 Active listening:  A way of listening deeply and responding appropriately, often used in 
counselling and training.  Characteristics of active listening include:  attending fully to the 
person speaking (focus of attention), empathetic para-phrasing and responding non-
judgmentally. 
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of the conversation in the next or subsequent interviews, in order to elicit another’s 
perspective — to discover if there is resonance or refutation, but also to lend richness 
to that concept.   
As a way of corroborating concepts/themes said about another participant group, I 
introduced these as additional questions to the relevant group.  For example, 
concepts/themes about GPs' prescribing behaviour mentioned by community 
pharmacists and/or consumers were added to GP interviews opportunistically. 
 
3.4.4 Interview logistics:  Time and sequence of interviews 
Interviews were conducted between late April and mid-October ͲͰͱ͵, in order to 
capture the pre and post winter months for Brisbane, Australia (where this research 
was being carried out) — typically the peak flu season.  This period was selected as it 
also coincided with the national public health awareness campaign in ͲͰͱ͵ — Winter is 
Coming.   The campaign included (a) the #savethescript short film competition in 
partnership with Tropfest, poster advertisements at bus stops and in buses (Antibiotics 
are losing their power), and TV advertisements (Antibiotics are losing their power, 
which aired during the commercial breaks for MasterChef Australia ͲͰͱ͵, a highly 
popular cooking program with a viewing audience of nearly ͱ.͵ million).  As part of the 
campaign, GPs would be sent a personalised report on their antibiotic prescribing 
patterns to coincide with Antibiotic Awareness Week, which included antibiotic type 
and volume prescribed, and de-identified comparative data of their peers.  Resources 
for patients such as a brochure entitled “Colds, Coughs and Flu: What you can do”, as 
well as symptom management checklists, were disseminated to GPs for use with 
patients.  Posters and brochures were also made available to community pharmacies.   
The expectation was that many consumers interviewed would be aware of these 
messages, either from the ͲͰͱ͵ or previous campaigns11, and that community 
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11 Since ͲͰͱͲ, NPS MedicineWise and the Australian Commission on Safety and Quality in 
Health Care have jointly conducted annual campaigns to reduce the consumption of 
antibiotics, targeting consumers and health professionals during Antibiotic Awareness 
Week.  Previously, NPS MedicineWise (then known as the National Prescribing Service) had 
conducted similar campaigns from ͱ͹͹͹ to ͲͰͰ͵. 
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pharmacists and GPs would have had recent interactions with consumers regarding the 
management of coughs and the common cold.   
Specifically, community pharmacist interviews commenced first (Ͳͳrd April ͲͰͱ͵ to Ͳͱst 
May ͲͰͱ͵), followed by consumer interviews (Ͳ͹th May to ͲͶth June ͲͰͱ͵).  GP 
interviews were conducted last, from ͱͶth September to ͱͳth October ͲͰͱ͵. 
Sequencing of interviews for each participant group was carefully considered and the 
decision to interview community pharmacists, consumers and GPs, in that order, was 
based on the following rationale: 
 Community pharmacists are often the first port of call for consumers seeking 
advice from a healthcare professional and/or seeking self-care solutions for a 
cough or cold.  Hence, it was prudent to begin the interviews with community 
pharmacists. 
 My professional background in pharmacy was conducive to building rapport 
quickly with community pharmacist participants.  This allowed me to focus on 
the responsive interviewing technique to produce fruitful, data-rich 
conversations, both for the community pharmacist participant group and 
subsequent groups. 
 Consumers were interviewed next, as some interview questions explored their 
awareness of public health campaigns which typically emerge in June, as 
outlined above, at the start of the southern hemisphere’s winter months. 
 GPs were interviewed in the months immediately post winter, so that 
conversations included their most recent experience with clinic consultations 
for upper respiratory tract infections. 
 
3.4.5 Interview logistics:  Participant related 
Each potential participant was contacted upon receipt of their expression of interest.  A 
standard procedure for interview bookings and confirmation (Appendix G) developed 
for this research was followed.  The procedure included (a) negotiation of an interview 
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timeslot and venue which was convenient for the participant12, (b) ascertaining or 
confirming the participant’s preferred contact details i.e. email and phone number, and 
(c) email confirmation of the agreed timeslot which included the Participant 
Information and Consent Form, as well as my contact details.  Participants who chose 
to be interviewed at the Queensland University of Technology (QUT) Kelvin Grove 
campus were emailed a campus map, parking and transport options, if they were 
unfamiliar with the campus. 
One interview was conducted with each participant, who was given the choice of being 
interviewed either at their place of practice/workplace or at QUT.  Interviews which 
occurred at participants’ place of practice i.e. GP clinic or pharmacy, were conducted in 
a private area within the practice.  For example, the GP’s office, the patient counselling 
room or the office area at the back of the pharmacy.  There were four exceptions — 
three were community pharmacists who preferred to be interviewed at a café near the 
pharmacy, and one was a consumer who preferred to be interviewed at a café close to 
their workplace.  Interviews held at QUT were conducted in a meeting room at the 
Institute of Health and Biomedical Innovation (IHBI). 
Each participant completed and returned their signed consent form prior to the 
commencement of the interview.  As part of good research practice and participant 
care at the beginning of each interview, I briefly reiterated the purpose of the interview, 
the conversational nature of the session, the approximate length of time that the 
interview would take (using this as an opportunity to re-confirm the availability of the 
participant as their schedules could have changed since the interview was booked), and 
to invite any questions they may have about the research.  Assurance was provided that 
participants could choose to skip any questions asked — which signalled that they have 
some measure of control over the interview.  Notwithstanding the signed consent form, 
I asked each participant whether they were willing to be audio-recorded, before 
switching on the digital recorder.  All participants consented to be audio-recorded.  At 
the end of each interview I invited participants to add any further comments they 
wished to make about the topic.  The digital recorder was turned off after any 
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12 Particular care was taken to ensure interview timeslots for GPs did not encroach into their 
clinical time.  For example, offering timeslots before or after clinics, or during their breaks. 
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additional remarks were made by the participant.  To conclude the interview, I thanked 
the participant for their time and insights, and enquired whether they knew of others 
who would be interested to be interviewed. 
The length of GP interviews took between ͲͲ and ͳ͵ minutes, with an average of Ͳ͹ 
minutes.  Community pharmacist interviews took longer – between ͳͲ and ͶͲ minutes, 
with an average of ͵Ͱ minutes.  Consumer interviews were between ͳͰ and ͵͹ minutes, 
averaging ʹͳ minutes.  These interviews yielded over ͹ͰͰ pages of transcripts (ͱͱ font 
type, single-spaced). 
Participants volunteered their time and were not remunerated.  In line with university 
guidelines, appropriate participant incentives were offered.  Each participant was given 
two movie vouchers or a movie gift card with the total value of $ͳͰ.  In addition, 
participants were offered a summary report of the research interviews.  Interested 
participants were sent a short report in April ͲͰͱͶ, after all interviews had been 
conducted and preliminary data analysis was completed (Appendix I). Five GPs, ͱͱ 
community pharmacists, and Ͳ͵ consumer participants received the short report. 
Self-reflections were documented immediately after each interview using a template 
adapted from Miles, Huberman and Saldana (Appendix J, template adapted from 
(Miles, Huberman, & Saldana, ͲͰͱʹ, p. ͱͲ͵)) regarding the interview process, 
observations of participants’ non-verbal communication, and any new concepts/themes 
that could be explored in subsequent interviews. 
 
3.4.6 Trustworthiness of qualitative research 
Unlike quantitative work where research quality and rigour is determined by how well 
the study has demonstrated internal validity, generalisability, reliability and objectivity 
of its findings, qualitative research speaks of trustworthiness — whether others can 
trust that the research accurately reflects the situation being described.  Guba’s four 
criteria for ensuring and demonstrating trustworthiness — credibility, transferability, 
dependability and confirmability (Lincoln & Guba, ͱ͹͸͵, p. ͳͰͰ), have been deemed the 
qualitative counterpart of quantitative research quality and rigour, and is widely used 
by researchers.   
Credibility is gained through establishing a high level of confidence in the findings — 
in terms of (a) what was communicated by participants matched what was reported, 
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and (b) the appropriate procedural conduct of research (Lincoln & Guba, ͱ͹͸͵, p. ͳͰͱ).  
In my research, the following strategies were used to demonstrate credibility:  member-
checking was done in-process via regular para-phrasing, and a short report 
summarising the interviews were sent to all interested participants, to ensure their 
views were adequately captured.  In addition, pertinent quotes from participants have 
been included in Chapter ʹ, to show how inductive codes were derived, and to 
demonstrate data-driven hypotheses.  Where appropriate, competing/alternative 
explanations were offered and participant quotes that do not seem to “fit” the 
hypotheses have been surfaced.  As a way to corroborate findings between the three 
participant groups, selected concepts gleaned from the community pharmacist 
interviews were introduced into the conversations with consumers.  In turn, selected 
concepts from community pharmacist and consumer interviews were introduced into 
the conversations with GPs (the last participant group to be interviewed). 
Transferability is the applicability of the research findings to other contexts (Lincoln & 
Guba, ͱ͹͸͵, p. ͳͱͶ).  While findings of qualitative research cannot be said to be 
generalizable, often due to non-representation of the population and/or the relatively 
small sample size when compared to quantitative research, they may be transferable to 
other situations or settings.  The findings from these semi-structured interviews are 
transferable to metropolitan areas of other Australian states and territories, as they 
share similar diversity of population, primary health infrastructure and governance 
arrangements for training and for practice.  For example, GP and pharmacist training 
for those trained in Australia are governed by the same national and accreditation 
standards set by the respective Boards — Medical Board or Pharmacy Board, and 
Councils — the Australian Medical Council and the Australian Pharmacy Council.  
Professional registration to practice as a GP or as a pharmacist, whether trained here or 
overseas, is nationally governed by the Australian Health Practitioner Regulation 
Agency (AHPRA).   
Dependability or consistency of research processes, is demonstrated through a clear 
audit trail — a carefully conceived study, with clear research processes that are well 
documented and well conducted (Lincoln & Guba, ͱ͹͸͵, p. ͳͱͷ).  In my research, 
dependability was demonstrated through having standard procedures for key stages 
such as, recruitment (communication templates), interviews (booking and preparing 
for interviews, interview guides), and post-interview tasks (structured self-reflection 
notes, filing consent forms, transcription log).  An adapted Jeffersonian Transcription 
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Notation (Appendix K) was used to ensure consistency during the transcription stage 
(Jefferson, ͱ͹͸ʹ).  A codebook was developed and used, to ensure consistency during 
deductive and inductive coding.  Overall, a data management plan which was audited 
annually for compliance, was implemented.   
Confirmability is the extent to which the research findings accurately reflect participant 
experiences and views, rather than researcher bias (Lincoln & Guba, ͱ͹͸͵, p. ͳͱ͸).  The 
findings of this research from the semi-structured interviews were coded according to a 
codebook.  One percent of transcripts from each participant group was randomly 
selected for validation of coding by a second researcher (process detailed at the end of 
Section ʹ.ͱ.ͱ).  Subsequent data analysis adhered to Fereday and Muir-Cochrane's 
clearly articulated steps to arrive at hypotheses (Fereday & Muir-Cochrane, ͲͰͰͶ).  
Finally, a decision log was kept throughout the research to capture key decisions points 
and rationale for each decision. 
 
3.4.7 Preparation of data for analysis 
Interviews were fully transcribed verbatim from the audio recording.  In order to better 
capture nuances of meaning, I used a naturalistic approach when transcribing where 
speech mannerisms such as emphases in intonation and hesitancy were noted, along 
with pauses, emotional expression such as laughter, sighs, as well as other non-verbal 
observations (Kvale, ͲͰͰͷe; Rubin & Rubin, ͲͰͱͲ).  An adaptation of the Jeffersonian 
Transcription Notation for transcribing was used (Jefferson, ͱ͹͸ʹ).  Notations used are 
shown in Appendix K. 
Transcripts, and hence participants, were de-identified and labelled with a participant 
code.  To preserve the anonymity of participants in research reports, only the 
participant code along with pertinent personal and practice characteristics were used.  
For example, GPͰͲ, GP for Ͷ years; or CSͰ͹, female, ͳͱ years old.  All transcripts were 
prepared in MS Word® format and uploaded into an information management software 
for qualitative research – NVivo® (Version ͱͱ.ͳ.ͱ.ͷͷͷ; (ͲͰͱͶ)) for the purposes of coding 
and analysis.  Contextual and demographic information for each participant (as 
described in Section ͳ.ʹ.ͱ Development of interview guides) e.g. consumer age, gender, 
and highest education level achieved, were captured in an Excel® table and imported 
into NVivo® as a Source Classification Attributes matrix, enabling data queries for 
comparison between participants and analytic induction.   
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Details of coding and analysis are given in Chapter ʹ (Section ʹ.ͱ) along with how 
findings from the qualitative phase were used to inform the development of DCEs for 
the quantitative phase of the study (Section ʹ.Ͷ). 
   
3.4.8 Strengths, limitations, and mitigating strategies 
Strengths 
Semi-structured interviews enabled the capture of participants’ knowledge, lived 
experience and views, in their own words.  Pre-determined outcomes were avoided, as 
these interactions, resulted in the co-creation of knowledge (Kvale, ͲͰͰͷb; Rubin & 
Rubin, ͲͰͱͲ).  The interviews were conducted one-on-one, which allowed participants 
to engage in unfettered commentary, to express their views openly and removed the 
social/professional need to conform to what other people/colleagues were saying.  
The exclusivity of the interview session in its one-on-one, face-to-face format not only 
allowed follow up questions to be asked — in order to probe and explore with greater 
precision — but also afforded the opportunity to observe non-verbal communication 
from the participants.     
 
Limitations and mitigating strategies 
Positivists would deem limitations of semi-structured interviews as those inherent in 
its execution, in that each interview is unique and cannot be replicated by another 
researcher, or even the same researcher, with the same result.  However, interpretivists 
would view non-replicability to be the nature of such research methods and hence, not 
a limitation per se.  Non-replicability does not mean that the research was not well 
carried out or that the results were unreliable.  Ways to ensure and demonstrate rigour 
and trustworthiness in qualitative research were well documented by Lincoln and Guba 
(ͱ͹͸͵) and applied in this research as previously described in Section ͳ.ʹ.Ͷ.   
The quality of the co-created knowledge in an interview is contingent on the skill of the 
researcher (Kvale, ͲͰͰͷd).  My skills and experience in educational visiting/social 
marketing and active listening, served me well in the preparation and execution of 
these interviews.  Conducting several pilot interviews prior to the actual interviews 
further enhanced my interviewing skills.  In addition, the post-interview self-reflections 
documented immediately after each interview not only enabled me to improve in 
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interview technique with each subsequent interview, but also to identify new questions 
for further exploration. 
Scholars hold differing views regarding what constitutes an acceptable percentage of 
interview transcripts coded by a second or multiple coders to ensure reliability of codes 
(Barbour, ͲͰͰͱ; Campbell, Quincy, Osserman, & Pedersen, ͲͰͱͳ).  Cited percentages of 
transcripts coded by more than one coder ranged from Ͱ% (the argument being that 
even the same coder may be unable to perfectly code the transcript in the same way 
twice due to the complexity and nature of such qualitative analysis), to ͱͰͰ% (Barbour, 
ͲͰͰͱ; Campbell et al., ͲͰͱͳ; Glaser & Laudel, ͲͰͱͳ).  In order to balance resource 
constraints and code reliability, one percent of interview transcripts were coded by two 
researchers (outlined at the end of Section ʹ.ͱ.ͱ).  Perhaps if all transcripts were coded 
by multiple coders a different number of codes or different descriptors for codes may 
have emerged due to the variety of backgrounds and worldviews of coders. 
 
 METHOD 2:  DISCRETE CHOICE EXPERIMENTS 
Discrete choice experiments (DCEs) have mainly been used in the field of health 
economics, such as in health technology priority setting from a societal perspective 
(Whitty, Ratcliffe, Chen, & Scuffham, ͲͰͱʹ), for valuing health programs ranging from 
consumer to third-party payer perspectives (M. Ryan & Gerard, ͲͰͰͳ), and for valuing 
SF-ͶD health states (Norman et al., ͲͰͱͳ).  Increasingly DCEs have been used in health 
services research(M Ryan, Gerard, & Amaya-Amaya, ͲͰͰ͸), for example, to elicit 
patient preferences for health services (Gerard, Tinelli, Latter, Blenkinsopp, & Smith, 
ͲͰͱͲ; Hall, Kenny, Hossain, Street, & Knox, ͲͰͱͳ; M. Ryan, Bate, Eastmond, & 
Ludbrook, ͲͰͰͱ; Wong et al., ͲͰͱʹ) and health provider preferences for healthcare 
programs (Russo et al., ͲͰͱͶ). 
DCEs are based on an integrated behavioural theory of decision-making and choice 
behaviour — random utility theory — which states that utility can be described by a 
systematic (explainable) component and a random (unobservable) component 
(McFadden, ͱ͹ͷʹ; M. Ryan & Gerard, ͲͰͰͳ; M Ryan et al., ͲͰͰ͸).  DCEs also draw upon 
Lancaster’s economic theory of value (Lancaster, ͱ͹ͶͶ), which assumes that individuals 
derive utility not from the goods/service itself but from the characteristics (attributes) 
of the goods/service.  When presented with choices, an individual would choose the 
Chapter ͳ:  Research Design and Methods  ͸Ͱ 
alternative which maximises utility for themselves (Lancaster, ͱ͹ͶͶ; McFadden, ͱ͹ͷʹ; M 
Ryan et al., ͲͰͰ͸).  The results of DCEs are used to model preferences within a random 
utility maximisation (RUM) framework, represented by the following equation 
(McFadden, ͱ͹ͷʹ; M Ryan et al., ͲͰͰ͸): 
 
where, 
௜ܷ௧௝ is the utility individual i derives from choosing alternative j, in choice set t;  ݔ௜௧௝ 
is the vector of observed attributes; ߚ௜ is the vector of coefficients reflecting the 
desirability of the attributes; and ߝ௜௧௝ is the random error (unobservable). 
Plainly stated, DCEs are structured surveys designed to elicit preferences from 
individuals in a way that can be quantified.  It is a method for valuing different 
attributes that influence decision-making.  The questions are framed to force a choice, 
to enable trade-offs to be quantified in making that choice, so as to understand the 
relative importance of the different attributes of interest (Lancsar & Louviere, ͲͰͰ͸).  
In other words, the DCE is a way of finding out the strength of preference for attributes 
of goods or services.   
DCEs use hypothetical scenarios where participants are asked to choose between two 
or more options.  An example adapted from the WHO is shown in Figure ͳ (World 
Health Organization, ͲͰͱͲb) where participants are asked to choose between Job A and 
Job B.  In this example, there are four attributes that influence decision-making i.e. 
location, pay, housing and workload.  Each attribute has two levels i.e. the location is 
urban or rural, pay per year is either $ͱͶͰ,ͰͰͰ or $ͲʹͰ,ͰͰͰ, housing is provided or not, 
and the workload is either heavy or normal.  The two jobs differ in a number of 
attributes.  In making a choice between Job A and Job B, the participant is essentially 
trading off on these attributes. 
It is worth pointing out that the attributes can be hypothetical, in that the salary for Job 
B in the example may be hypothetical and not reflective of the current market rates.  
This is useful for investigating and quantifying the probability of choice uptake, even 
when the attributes of goods or services described in the survey does not yet exist at 
that point in time (World Health Organization, ͲͰͱͲb). 
 
ܷ݅ݐ݆ =  ݔ݅ݐ݆ ߚ݅ +  ߝ݅ݐ݆  
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Figure 3.  Example of a choice set with four attributes and two levels from a DCE 
 
 
Continuing with the example in Figure ͳ, the participant has selected Job B.  A series of 
such choice sets is posed to participants, with the levels of the attributes being varied 
each time to cover all possible permutations and combinations.  Regression analysis is 
then used to uncover which attributes are more important in job selection.  
The DCE was considered as the quantitative method for this study, as at the time, real-
time patient level data was not available in the public domain for use by researchers.13   
In the future, the NPS MedicineWise’s MedicineInsight pilot currently underway will 
have de-identified real-time data for an estimated Ͳ.͵ million patients from GP 
desktops, to inform clinical practice improvement, discerning changes in prescribing 
behaviour and to inform policy making (NPS MedicineWise, ͲͰͱͳa).   
At the time of planning this research in ͲͰͱʹ, there were two sources of national data 
on antibiotic prescribing in the Australian primary healthcare sector: 
 Family Medicine Research Centre at the University of Sydney — the Bettering 
the Evaluation and Care of Health (BEACH) reports (Britt et al., ͲͰͱʹ, ͲͰͱ͵), 
which collates general practice activity annually, from about ͱͰͰͰ GPs for ͱͰͰ 
consecutive patients seen within a stipulated time period.  However, the 
Australian government ceased funding the BEACH program from ͳͰ June ͲͰͱͶ, 
resulting in its closure after ͱ͸ consecutive years of what was a unique national 
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13 It was only in August ͲͰͱͶ, that the Australian government released a de-identified subset 
of linkable Medicare Benefits Schedule (MBS) and Pharmaceutical Benefits Scheme (PBS) 
data for use by researchers.  
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study of GP prescribing practices involving over ͱͱ,ͰͰͰ GPs (Family Medicine 
Research Centre, ͲͰͱͶ)  
 Australian  Statistics on Medicines (Department of Health, ͲͰͱͳ), which consists 
of data on costs and volume from (a) subsidised prescriptions under the 
Pharmaceutical Benefits Scheme (PBS) and Repatriation Pharmaceutical 
Benefits Scheme (RPBS), and (b) a representative sample of community 
pharmacies to provide an estimate of the non-subsidised prescriptions i.e. 
private prescriptions and PBS prescriptions priced under the general patient co-
payment 
While these reports provided useful information on the conditions for which 
antibiotics were prescribed and the volume of antibiotics prescribed, they shed little 
light on key drivers influencing GPs to prescribe antibiotics, and none on how 
consumers use these antibiotic prescriptions.   
As explained at the beginning of this section, DCEs have usually been used to reveal 
factors that drive selection of goods or services, and/or to test a hypothesis.  However, 
DCEs can conceivably be used as an exploratory method to tease out trade-offs 
between given factors, rather than to test a hypothesis.14  This research selected DCE as 
an exploratory method for the quantitative phase for the following reasons:  (a) to build 
on the findings of the semi-structured interviews, (b) to elicit how GPs trade-off 
between factors that influence their prescribing behaviour, and (c) to elicit how 
consumers trade-off between factors that drive their antibiotic prescription-filling 
behaviour.   
The use of DCEs as an exploratory method required adaptation, in that the attributes 
and levels were not characteristics of a product/good or service/test, but rather of the 
relevant personal and external circumstances related to the hypothetical scenario in the 
DCE.  The trade-offs observed between factors, given the same hypothetical scenario, 
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14 Academic consultations during research design phase in ͲͰͱʹ with the following DCE 
experts: (a) Prof Jennifer Whitty — Professor of Health Economics, Norwich Medical School, 
University of East Anglia, UK (formerly at the School of Pharmacy, The University of 
Queensland, Australia), and (b) Prof Julie Ratcliffe — Professor in Health Economics, School 
of Medicine, Flinders University, Australia. 
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yielded valuable and useful applications for practice and for policy, discussed in Section 
Ͷ.ͳ.ͳ.  
 
3.5.1 Development of DCEs 
Two DCEs were developed, one for GPs and another for consumers.  A DCE was not 
developed for community pharmacists.  Evidence from the literature (Chapter Ͳ) and 
results from the semi-structured interviews (Chapter ʹ, Section ʹ.ͳ) confirmed that 
community pharmacists in Australia have no direct influence on and are excluded from 
the decision-making process of when to use an antibiotic — unlike in countries where 
antibiotics are unregulated and available over-the-counter from community 
pharmacists.  Therefore, a realistic scenario which was also relevant to policy and 
practice, could not be created for a community pharmacist DCE.  This is established 
and discussed more fully in Chapter ʹ, Section ʹ.Ͷ.Ͳ. 
There are several stages in developing, conducting and analysing DCEs (Bridges et al., 
ͲͰͱͱ; Lancsar & Louviere, ͲͰͰ͸; World Health Organization, ͲͰͱͲb).  These are: 
 Identification of attributes and levels; 
 Deciding what choices to present to participants and experimental design (i.e. 
whether blocking is used); 
 Development of the DCE survey; 
 Administration of the refined DCE survey; 
 Data entry and cleaning (i.e. preparation of data for analysis) 
 Data analysis and interpretation 
Expertise from Professor Jennifer Whitty, Professor of Health Economics at the 
University of East Anglia, UK, who is an established authority on DCEs, was sought in 
the development of both the consumer and GP DCEs. 
 
3.5.2 Identification of attributes and levels  
Prior to identifying attributes and levels for the DCEs, it was necessary to first clarify 
the decision points which would not only be realistic for participants, but also useful 
for policy and practice.  Findings from the semi-structured interviews informed the 
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identification of these decision points.  The semi-structured interviews highlighted that 
there were several antibiotic “reservoirs” in the community — unused antibiotics, 
unused antibiotic prescriptions, delayed prescriptions15, and repeat prescriptions16, 
which provide consumers with opportunities for decision-making on whether, when 
and how they use antibiotics.  For example, plausible decision points for consumers 
would be whether they chose to fill the antibiotic prescription and their behaviours 
thereafter in using the antibiotics.  For GPs, a clear decision point would be in their 
decision-making of whether to prescribe an antibiotic, which in turn, contributes to the 
consumption of antibiotics in the Australian community.   
Aspiring to an elegant design, a single hypothetical scenario was used for both the GP 
and consumer DCEs, which could incorporate the relevant decision points each would 
have to make.  The hypothetical scenario was adapted from one used by Hardy-
Holbrook et al. (Hardy-Holbrook et al., ͲͰͱͳ), featuring an adult patient presenting 
with symptoms of a respiratory tract infection.  The scenario for GPs included some 
clinical information, to more closely mimic reality.   
The framing of the question for decision-making differentiates each DCE.  Consumers 
were asked to choose between two situations where they would be more likely to fill a 
delayed prescription for antibiotics.  This was to elicit trade-offs between attributes and 
levels influencing consumers' decision to fill — with intention to take, a delayed 
prescription for antibiotics.  GPs were asked to choose between two situations where 
they would be more likely to prescribe antibiotics for a respiratory tract infection, 
which would reveal trade-offs between attributes influencing their decisions in this 
case.  A secondary question was included in the GP DCE to ascertain the nature of the 
prescription — whether it was for immediate use or a delayed prescription (Figure Ͷ 
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15 Delayed antibiotic prescription — a prescription given to a patient with instructions to use 
it only if their symptoms worsen or do not improve in a few days.  The delayed prescription 
is usually given to the patient during the initial consultation, although some GPs prefer to 
leave the prescription with clinic reception for the patient to collect at a later date. 
16 Repeat prescriptions enable a regular re-supply of the prescribed medicine without the 
patient having to see the GP each time.  The number of repeats is authorised by the GP on 
the original prescription.  The Pharmaceutical Benefits Scheme (PBS) Schedule lists 
medicines and the maximum number of repeats subsidised under the scheme.  Time 
intervals between supplies must meet PBS criteria. 
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shows the secondary question in one of the choice sets).  Boxes ͱ and Ͳ, show the 
hypothetical scenario and question for decision-making, developed for the consumer 
and GP DCEs. 
Box 1.  Hypothetical scenario and question for decision-making — Consumer DCE 
Imagine you have a runny nose, sneezing, a sore throat and a dry cough.  You have 
managed these symptoms in your usual way, which may include a combination of rest, 
home remedies, vitamin supplements, commercial immune boosters, and cold/flu/cough 
products.  As you are still feeling unwell, you decide to consult a doctor.   
After examining you, the doctor gives you a prescription for antibiotics because you can’t 
come back for a reassessment in 2 days. 
Question 
Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would 
you be more likely to fill the antibiotic prescription (go to the pharmacy to get the 
antibiotics)? 
 
Box 2.  Hypothetical scenario and question for decision-making — GP DCE 
An adult patient presents with a runny nose, sneezing, a sore throat and dry cough.  They 
have managed these symptoms in their usual way, which may include a combination of 
rest, home remedies, vitamin supplements, commercial immune boosters, and 
cold/flu/cough products.  As they are still feeling unwell, they decided to consult a doctor 
(you).   
The patient has no significant past medical history.  On examination, their temperature 
(tympanic) is 37.8°C, throat appears slightly red and there is no exudate or cervical 
lymphadenopathy.  Chest is clear. 
Question 
Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 
DCE attributes and levels relevant to these decision points were then identified from 
the TDF mapping of the literature review (Chapter Ͳ) as well as those that emerged 
from the semi-structured interviews.  Section ʹ.Ͷ steps through the process in detail 
(Coast & Horrocks, ͲͰͰͷ; Wong et al., ͲͰͱʹ). 
Five attributes of either two or three levels each, were identified for both the consumer 
and the GP DCEs.  The two sets of attributes and levels, together with respective a 
priori assumptions, are shown in Tables Ͷ and ͷ. 
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Table 6.  Attributes and Levels — Consumer DCE 
Attributes Attribute text Levels Design 
Coding  




You have had 
symptoms for 







In general, a positive 
preference for filling the 
script, the longer the duration 
of symptoms.  
Life event Life event: 
You have an 
important event 






In general, a positive 
preference for filling the 
script, if an important life 
event was coming up.  
Time off Time off:   
You are able to 







In general, a positive 
preference for filling the 
script, if not able to take time 
off to recover from symptoms. 
Doctor’s 
advice  
Doctor’s advice Says it’s probably a 
viral infection and 
antibiotics won’t 
help 
Says you decide 
whether to take 
the antibiotics or 
not 
Says to start 
antibiotic 
treatment if you 
feel worse or no 









In general, a positive 
preference for filling the 
script, if the doctor says to 
start antibiotic treatment if no 
better in 2 days. 
Past 
experience 
Past experience:  









In general, a positive 
preference for filling the 
script, if the consumer had 
taken antibiotics for similar 
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Table 7.  Attributes and Levels — GP DCE 
Attributes Attribute text Levels Design 
Coding  
A priori assumptions 
Duration of symptoms Duration:  








In general, a positive 
preference for prescribing 
antibiotics, the longer the 
patient’s duration of 
symptoms.  
Life event Life event: 
Patient has an 
important event 






In general, a positive 
preference for prescribing 
antibiotics (if indicated), if 
patient has an important life 













In general, a negative 
preference for prescribing 
antibiotics if patient is able 
to return for reassessment. 











In general, a negative 
preference for prescribing 
antibiotics if this is a regular 
patient (assumption: the 
doctor had “trained” the 
patient that antibiotics are 
not always needed to get 
better.  So time had already 
been invested to explain this 
previously). 
Patient’s expectations Patient’s 
expectations 
Says they want 
antibiotics 
Says they don’t 
want antibiotics 
unless necessary 








In general, a negative 
preference for prescribing 
antibiotics if patient 
indicates they want 
reassurance (or that they 
don’t want antibiotics unless 
necessary). 
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3.5.3 Choices to present and experimental design 
In this section, I explain the processes and substantiate the decisions made concerning 
the experimental design, according to recognised research practices stated in the 
ISPOR Task Force Report (Johnson et al., ͲͰͱͳ).  The consumer DCE is first discussed in 
detail.  The GP DCE follows much of the same rationale — exceptions or differences 
will be pointed out.  
 
Consumer DCE 
The consumer DCE contained a total of ͵ attributes — ͳ attributes of Ͳ levels each, and 
Ͳ attributes of ͳ levels each.  The number of attributes is in line with other DCE studies.  
Marshall et al. reports that ͷͰ% of conjoint analysis studies include between ͳ and ͷ 
attributes (Marshall et al., ͲͰͱͰ).  Given the number of attributes and levels for the 
consumer DCE, there were ͷͲ choice profiles, as  
Number of choice profiles = Ͳͳ x ͳͲ = ͷͲ 
 
The consumer DCE presented a pair of choice profiles per choice set, and participants 
would choose between the two choice profiles.  Hence, for a full factorial experimental 
design, there would be Ͳ͵͵Ͷ choice sets, as  
Number of choice sets = (ͷͲ x ͷͱ) / Ͳ = Ͳ͵͵Ͷ for full factorial design 
 
While desirable from a data modelling perspective, a full factorial design presenting 
Ͳ͵͵Ͷ choice sets would be too burdensome for any one participant to complete.  
Instead, a fractional factorial design was selected, so as to reduce cognitive and time 
burdens for participants.  In the fractional factorial design each participant would only 
be presented with a subset — a small block, of choice sets. 
A D-optimal design — the optimal orthogonal in the differences design (OOD), was 
decided upon to estimate main effects (Choice Metrics, ͲͰͱʹ).  As indicated by its 
name, the OOD is orthogonal and optimally efficient.  It assumes zero priors, which 
was appropriate for this research.  The OOD is also optimised for estimation using 
either multinomial logit (MNL) or mixed logit (MXL) models (Choice Metrics, ͲͰͱʹ).  
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Effects coding was used due to the largely qualitative nature of the attribute levels 
(Choice Metrics, ͲͰͱʹ; M Ryan et al., ͲͰͰ͸). 
The syntax17 created for input into the NGENE® software (Version ͱ.ͱ.Ͳ; (ͲͰͱʹ))to 
generate an experimental design with two blocks and effects coding, was: 
Box ͳ.  Syntax — Consumer DCE 
Design 
; alts = sitA, sitB 
; rows = 24 
; block = 2 
; orth = ood 
; model: 
U(sitA) = b1 +  
b2[0|0].effects*A[0,1,2] +  
b3[0].effects*B[0,1] +  
b4[0].effects*C[0,1] +  
b5[0|0].effects*D[0,1,2] +  
b6[0].effects*E[0,1] 
/ 
U(sitB) = b2*A + b3*B + b4*C + b5*D + b6*E 
$ 
 
NGENE® returned an experimental design with ͳͶ rows (as one with Ͳʹ rows could not 
be found), a desirable D-optimality of ͱͰͰ% — indicating efficiency, and a correlation 
matrix of zero (C matrix).  The experimental design was manually checked for level 
balance and minimal overlap — which were achieved. 
An experimental design with ͳͶ rows meant that each block would consist of ͱ͸ choice 
sets.  Of these, one choice set per block was duplicated, so that participant consistency 
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17 The number of rows for DCEs must be (a) at least ͱͰ, (b) greater than the number of 
parameters being estimated, and (c) divisible by the number of levels per attribute — Ͳ and ͳ 
in this case (Prof Jennifer Whitty, academic consultation, June ͲͰͱͶ).  As the choice sets 
would be presented in Ͳ blocks, Ͳʹ rows would yield a design with Ͳ blocks of ͱͲ choice sets 
each. 
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in trade-offs could be checked — bringing the total number of choice sets per block to 
ͱ͹.  Nineteen choice sets is well within the range of Ͳ to ͳ͵ in published conjoint 
analysis studies, where the majority (͹ͳ%) presented ͲͰ or less choice sets (Marshall et 
al., ͲͰͱͰ).  
The choice sets selected (one in Block ͱ, the other in Block Ͳ) for intra-participant 
consistency checks were those in which one of the choice profiles was most aligned to 
the a priori assumptions outlined previously.  Hence, from the original set of ͱ͸ choice 
sets, choice set #ͱ͸ (NGENE® design output row ͳͲ) was duplicated for Block ͱ, while 
choice set #ͳ (NGENE® design output row ͱͳ) was duplicated for Block Ͳ.  To be useful 
as a consistency check, the duplicate choice sets must not be obvious to the participant 
i.e. presented consecutively or too close together in the DCE survey sequence.  The 
ISPOR Task Force Report is silent on best practice in the selection and placement of 
duplicate choice sets within the DCE survey (Johnson et al., ͲͰͱͳ).  Published studies 
have duplicated the first or second choice set, as the final or penultimate choice set.  
For the consumer DCE comprising of ͱ͹ choice sets per block (including the duplicate), 
the selected choice sets to duplicate were placed as choice set #ͳ and choice set #ͱ͸, in 
the survey sequence. 
 
GP DCE 
The GP DCE comprised a total of ͵ attributes — Ͳ attributes of ͳ levels each, and ͳ 
attributes of Ͳ levels each.  Hence, ͷͲ choice profiles were available (Choice Metrics, 
ͲͰͱʹ), as  
Number of choice profiles = ͳͲ x Ͳͳ= ͷͲ 
 
Similar to the consumer DCE, the GP DCE presented a pair of choice profiles per choice 
set, and participants would choose between the two choice profiles.  Hence, for a full 
factorial experimental design, there would be Ͳ͵͵Ͷ choice sets (Choice Metrics, ͲͰͱʹ), 
as  
Number of choice sets = (ͷͲ x ͷͱ) / Ͳ = Ͳ͵͵Ͷ for full factorial design 
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The decisions and rationale for the experimental design are the same as that for the 
consumers.  The syntax created for input into the NGENE® software (Version ͱ.ͱ.Ͳ; 
(ͲͰͱʹ)) to generate an experimental design with two blocks and effects coding, was: 
Box ʹ.  Syntax — GP DCE 
Design 
; alts = sitA, sitB 
; rows = 24 
; block = 2 
; orth = ood 
; model: 
U(sitA) = b1 +  
b2[0|0].effects*A[0,1,2] +  
b3[0].effects*B[0,1] +  
b4[0].effects*C[0,1] +  
b5[0].effects*D[0,1] +  
b6[0|0].effects*E[0,1,2] 
/ 
U(sitB) = b2*A + b3*B + b4*C + b5*D + b6*E 
$ 
 
NGENE® returned an experimental design with ͳͶ rows (as one with Ͳʹ rows could not 
be found), a desirable D-optimality of ͱͰͰ% — indicating efficiency, and a correlation 
matrix of zero (C matrix).  The experimental design was manually checked for level 
balance and minimal overlap — which were achieved. 
The choice sets selected (one in Block ͱ, the other in Block Ͳ) for intra-participant 
consistency checks were those in which one of the choice profiles was most aligned to 
the a priori assumptions outlined previously.  Hence, from the original set of ͱ͸ choice 
sets, choice set #ͱͶ (NGENE® design output row ͳͲ) was duplicated for Block ͱ, while 
choice set #ͷ (NGENE® design output row ͱͱ) was duplicated for Block Ͳ.  For the GP 
DCE comprising of ͱ͹ choice sets per block (including the duplicate), the selected 
choice sets to duplicate were placed as choice set #ͳ and choice set #ͱ͸, in the survey 
sequence. 
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Forced choice 
In both the consumer and GP DCEs, the participants were asked to choose one of two 
choice profiles i.e. select either Situation A or Situation B.  During the development 
phase of both DCEs, a “neither” option (opt-out) was considered, but not offered for 
the following reasons: 
 A “neither” option would offer participants a choice which is likely to be deemed 
socially desirable.  Hence, there was a high risk that trade-offs would not be 
observed, if participants often or always selected the “neither” option; 
 Not offering the “neither” option would force a choice to be made between 
Situation A and Situation B; 
 The intent of the DCEs were not to estimate or predict the demand for 
antibiotics, but in identifying the factors most likely to influence the decision to 
fill an antibiotic prescription — in the case of consumers, or to prescribe an 
antibiotic — in the case of GPs.  Understanding how trade-offs in these DCEs 
are made will inform the creation of more precise key messages for public health 
campaigns, appropriate healthcare interventions, and healthcare/training 
resources to support GPs as stewards of antibiotic use 
In order to mitigate the fact that a “neither” option was not offered, the decision 
questions posed to participants were deliberately worded to reflect the constraints 
of the DCE survey — stating what they say they may do, rather than what they 
would actually do.  For example, in the consumer DCE, the decision question was:  
"Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) 
would you be more likely to fill the antibiotic prescription?", rather than the more 
definitive, "… in which situation (A or B) would you fill the antibiotic prescription?"  
Similarly, the decision question for the GP DCE was:  "Based on the scenario, in 
which situation (A or B) would you be more likely to prescribe an antibiotic for 
the patient?", rather than the more definitive, "… in which situation (A or B) would 
you prescribe …?" 
The use of “nested” choice sets was also considered in the development phase of the 
DCEs.  “Nested” choice sets first present a forced choice i.e. choose between 
Situation A and Situation B, then ask "What would you really do?" — presenting the 
participant with the additional “neither” option (Figure ʹ).  A draft DCE presented 
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as an adaptation of “nested” choice sets was piloted using the same hypothetical 
scenarios outlined previously in Section ͳ.͵.Ͳ.  However, feedback from pilot 
participants indicated that (a) the “nested” choice sets were confusing, (b) it 
undermined the DCE and their decisions, as they had already chosen either 
Situation A or B with the intention to take the antibiotic, (c) it changed how they 
responded to subsequent choice sets after completing the first “nested” choice set.  
Given these considerations, “nested” choice sets were not used in the consumer and 
GP DCEs. 
Figure 4.  An example from the pilot of “nested” choice sets 
Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more likely 
to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
1 week 2 weeks 
Life event: 
You've an important event or a 
deadline coming up 
Yes No 
Time off: 
You're able to take time off from 
work/study to recover 
No Yes 
Doctor’s advice: Says to start antibiotic 
treatment if you feel worse or 
no better in 2 days 
Says it’s probably a viral 
infection and antibiotics won’t 
help 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
Yes No 
I would be more likely to fill the 
antibiotic prescription in …  





In reality, what would you have done? 
 Filled the antibiotic script in the situation I have chosen above, and taken it 
 Filled the antibiotic script in the situation I have chosen above, but may not take it  
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3.5.4 Development of the DCE survey 
Following the identification of attributes and levels, as well as experimental designs for 
both the consumer and GP DCEs, the DCE surveys were developed.  Each survey 
comprised of three parts: 
 Section A — selected demographics (ͱͱ questions); 
 Section B — DCE choice sets (ͱ͹ choice sets); and 
 Section C — questions pertaining to attribute attendance/non-attendance, 
multi-choice question/s using the same hypothetical scenario, questions to 
gauge participant perception of the survey (consumer survey:  ͵ questions plus a 
free-text box for additional comments, GP survey: ʹ questions plus a free-text 
box for additional comments) 
Each DCE survey18 was preceded by screening questions to ensure that only 
participants meeting the inclusion criteria, participated.  Consumers were eligible to 
participate if they were at least ͱ͸ years old and residing in Australia.  Consumers who 
were adamantly against any use of antibiotics were not eligible to participate.  GPs were 
eligible to participate if they were practising in Australia.  GPs who worked primarily 
for an after-hours medical deputising service were not eligible to participate, as this 
research focussed on those practising in primary healthcare clinics.  The GP DCE 
survey was open to both GPs and GP Registrars. 
Each DCE survey was piloted to ensure appropriateness of the framing, attributes and 
levels, and clarity of instructions.  The consumer DCE survey was piloted in two 
iterative cycles with two different consumers each time.  Feedback from pilot 
participants indicated that the framing, attributes and levels were relevant and realistic.  
Suggestions for layout and instructions were used to further refine the survey after each 
pilot.  Likewise, the GP DCE survey was piloted with a GP and GP Registrar and refined 
after each pilot. 
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18 DCE survey — refers to the whole research instrument comprising of Sections A, B and C 
as outlined in Section ͳ.͵.ʹ above.  DCE e.g. consumer DCE or GP DCE refers to Section B 
only — DCE choice sets. 
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Appendices J and K show the final version of the consumer and GP DCE surveys, prior 
to being html coded for upload onto the QUT approved online survey platform — Key 
Survey® (Version ͸.ͷ.͵; (ͲͰͱͶ)).  Figures ͵ and Ͷ shows a choice set from the consumer 
and GP DCE surveys, respectively. 
 
Figure 5.  Consumer DCE Survey — Block 1 Choice Set 5 
Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more likely to fill 
the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
1 week 2 weeks 
Life event: 
You've an important event or a 
deadline coming up 
No Yes 
Time off: 
You're able to take time off from 
work/study to recover 
No Yes 
Doctor’s advice: Says it’s probably a viral infection 
and antibiotics won’t help 
Says you decide whether to take 
the antibiotics or not 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
No Yes 
I would be more likely to fill the 
antibiotic prescription in …  
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Figure 6.  GP DCE Survey — Block 2 Choice Set 17 
Based on the scenario, in which situation (A or B) would you be more likely to prescribe an antibiotic for the 
patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
2 weeks 3 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
No Yes 
Reassessment:  Patient is able to 
return for reassessment 
Yes No 
Familiarity with patient New patient Regular patient 
Patient’s expectations Says they want reassurance Says they want antibiotics 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐ For immediate use 
☐ A delayed prescription 
 
 
For both the consumer and GP DCE surveys, survey logic was encoded to: (a) link the 
surveys, and (b) allow the following workflow on the Key Survey® online platform.   
 
Put another way, each DCE survey comprised of three linked surveys in Key Survey®.  
Each DCE survey was tested to ensure that (a) the workflow was functional, and (b) 
participants would be randomly presented with choice sets from either Block ͱ or Block 
Ͳ for Section B of the DCE surveys.  The tested surveys were then approved and 
activated for public release, as per the QUT Key Survey® protocol (Gee, ͲͰͱ͵, pp. ͷʹ-
ͷ͵). 
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3.5.5 Sample size 
Currently there is no formal consensus on what constitutes an appropriate sample size 
for conjoint analysis studies, nor is there a definitive statistical formula for calculating 
sample size (Marshall et al., ͲͰͱͰ).  Therefore, an accepted rule of thumb within the 




 ≥ 500 
  
where, n is the number of respondents, t is the number of tasks (or choice sets), ܽ is the 
number of alternatives per task, and c is the number of analysis cells (the largest 
number of levels for any one attribute in the case of main effects) (Marshall et al., 
ͲͰͱͰ).  Solving for n, gives this equation: 





Given the following values (Box ͷ) for the consumer and GP DCEs, the minimum 
sample size per block was calculated to be ʹͲ.  Therefore, the minimum sample size for 
each DCE survey was ͸ʹ, as it comprised of Ͳ blocks. 
݊ ≥  
500 ×3
18 ×2
 = 41.67 
rounding up, 
݊ ≥ 42 
 
Box 7.  Values to calculate minimum sample size 




t (number of tasks or choice sets) 18* 18* 
ܽ (number of alternatives per task) 2 2 
c (number of analysis cells) 3 3 
*The duplicated choice set is not included in this number.  Hence, t is 18. 
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3.5.6 Administration of the DCE surveys 
Both DCE surveys on the Key Survey® platform (Version ͸.ͷ.͵; (ͲͰͱͶ)) were publicly 
released on Ͳ͵th July ͲͰͱͶ for two months, with survey closure initially set at ͳͰth 
September ͲͰͱͶ.  The closure date for both surveys was extended by a month to ͳͱst 
October ͲͰͱͶ due to: (a) low participation of the GP DCE survey evident by week ʹ of 
the public release, (b) inclusion of the RACGP and ACRRM national conferences for GP 
DCE recruitment, and (c) inclusion of SONA — the QUT Psychology Research 
Management System for consumer DCE recruitment.  Approval by the QUT Human 
Research Ethics Committee was obtained prior to the extension of the closure date and 
the inclusion of additional avenues for participant recruitment. 
 
Participant recruitment for consumer DCE 
The recruitment strategy used for the consumer DCE survey was via the university, 
consumer organisations and social media, as follows:  (a) dissemination via the QUT 
Institute of Health and Biomedical Innovation (IHBI) email list, and IHBI social media 
avenues such as Yammer posts and IHBI LinkedIn page, (b) posting on the IHBI 
research webpage, (c) posting on SONA — the QUT Psychology Research Management 
System, (d) advertising in QUT Classifieds via the Student Guild, (e) flyers at all six 
QUT Health Clinics, (f) approaches to Consumers Health Forum (CHF) Australia — the 
national peak body for consumers in healthcare, (g) approaches to five state-based 
consumer organisations — Health Consumers NSW, Health Care Consumers' 
Association of the ACT, Health Consumers Alliance of South Australia, Health 
Consumers Queensland, Health Consumers' Council WA, (h) eNews of the Primary 
Health Care Research and Information Service (PHCRIS), and (i) posting on social 
media such as Facebook® and Twitter® at intervals, and to coincide with dissemination 
by some of the state-based consumer organisations e.g. Health Consumers Queensland, 
Health Consumers NSW.   
At the research planning stage additional avenues for recruitment of consumers were 
explored, such as online consumer panels and “piggy-backing” on other researchers' 
consumer groups i.e. sending the survey to a consumer cohort already engaged in 
another study.  Online consumer panels for DCEs were estimated to cost about 
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$ͲͰ,ͰͰͰ19 and were therefore beyond the budget allocated for a PhD study.  Piggy-
backing on other researchers' consumer group was explored20 and deemed unsuitable.  
The issues which surfaced were: (a) additional burden to the consumer group, (b) 
careful timing of the survey was required so as not to jeopardise the aims of the original 
research, (c) often these groups were part of ongoing research and consent to 
participate had already been obtained.  More importantly, the approved research ethics 
for the original work was unlikely to have included a clause to enable the addition of 
surveys from another researcher or research group. 
 
Participant recruitment for GP DCE 
The recruitment strategy for the GP DCE survey included dissemination via 
professional networks, professional colleges/bodies, Primary Health Networks (PHNs), 
GP Registrar regional training organisations, GP conferences and social media.  In other 
words, the recruitment was via the following:  (a) Primary Health Care Research and 
Information Service (PHCRIS) eNews, and approaches to (b) General Practice 
Registrars Australia (GPRA) — the peak body representing Ͳ͵,ͰͰͰ medical students, 
pre-vocational doctors and GP Registrars, (c) all eleven GP Registrar Regional Training 
Organisations nationally, (d) all thirty-one Primary Health Networks (PHNs) 
nationally, (e) The Royal Australian College of General Practitioners (RACGP), (f) the 
Australian Rural and Remote College of Medicine (ACRRM), (g) national conferences 
of the RACGP and ACRRM, and (h) posting on social media such as Twitter® at 
intervals, and to coincide with dissemination by RACGP and some of the PHNs e.g. 
Gold Coast PHN, Murrumbidgee PHN. 
 
xcix                                                     
 
19 Academic consultations with DCE experts, Prof Julie Ratcliffe (ͲͰͱʹ) and Prof Jennifer 
Whitty (ͲͰͱʹ). 
20 Academic consultation with Prof Philip Baker in his role as Faculty Research Advisor 
(ͲͰͱʹ), Prof Nicholas Graves in his role as Associate Supervisor (ͲͰͱʹ), and the QUT Office 
of Research, Ethics and Integrity (ͲͰͱʹ). 
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3.5.7 Preparation of data for analysis 
No data entry was required for the consumer and GP DCE surveys which were 
completed online through Key Survey®.  Survey data collected via Key Survey® were 
displayed in spreadsheets which were re-formatted and cleaned as part of the process 
of preparing data for analysis.  Completed surveys which contained unmatched 
duplicated choice sets were excluded from data analysis, as this may indicate that the 
respondent was not attending sufficiently to the choice sets.  However, for 
completeness, model estimates for full datasets — matched and unmatched duplicated 
choice sets — are presented in Appendix N. 
For DCE surveys that passed the consistency checks (matched duplicated choice sets), 
the responses to the repeated choice sets were excluded from data analysis i.e. only 
responses to choice set #ͳ were included and not responses to choice set #ͱ͸, as #ͱ͸ is a 
duplicate of #ͳ.  Data analysis was done using NLOGIT® (Version Ͷ; (ͲͰͱͶ)) software 
(see Chapter ͵, Section ͵.ͱ.ͱ).   
Data entry onto a spreadsheet was not required for hardcopies of GP DCE surveys 
disseminated at the RACGP and ACRRM national conferences, as no surveys were 
returned. 
 
3.5.8 Strengths and limitations 
DCEs allow preferences to be quantified, and hence, compared.  Attributes that could 
potentially influence choice which may or may not currently exist, not exist 
consistently, or not made explicit, can be created and included.  Further, multiple 
regression techniques allow an understanding of how participants trade-off on these 
attributes and levels, which can then be interpreted to inform policy and practice.   
As a method DCEs are limited in that participants are asked to make decisions based 
on hypothetical scenarios.  Hence, the findings of a DCE would need to be validated by 
other means e.g. real-time data if available.  Additionally, DCEs rely on what 
participants say they would do (stated preference), not what they actually do (revealed 
preference).  As such, comparison of the findings of the GP DCE against data from 
MedicineInsight when available in the future, will yield valuable information. 
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 HUMAN RESEARCH ETHICS 
An ethics application for low/negligible risk research in line with the National 
Statement on Ethical Conduct in Human Research was submitted to the QUT Human 
Research Ethics Committee (HREC) for consideration (The National Health and 
Medical Research Council, Australian Research Council, & Australian Vice-Chancellors' 
Committee, ͲͰͰͷ).  Ethics approval was originally granted on ͸th April ͲͰͱ͵ — HREC 
approval number: ͱ͵ͰͰͰͰͰͱ͹Ͱ (Appendix O).   
The QUT HREC subsequently approved all variations to the original application as 
follows: (a) Ͳʹth September ͲͰͱ͵ — addition of GP Registrars as part of GP cohort, and 
(b) ͵th September ͲͰͱͶ — addition of the QUT Psychology Research Management 
System (SONA) as an avenue for recruitment for consumer DCE surveys, and 
distribution of hardcopies of GP DCE surveys at the national RACGP and ACRRM 
conferences. 
 
 DATA MANAGEMENT  
A data management plan was prepared and adhered to, in line with the university's 
requirements, to ensure appropriate and secure handling of research data.  An annual 




This chapter began with a brief discussion and justification of pragmatism as the 
research paradigm and the mixed methods research design selected.  A schematic 
diagram illustrated the research design, research cycle and the points at which “mixing” 
occurred — and clearly showed how these elements taken together, addressed the 
research aim and research questions.  Justification of the selected qualitative method — 
semi-structured interview, the development of the interview guides, sampling and 
recruitment, the conduct of interviews, and the preparation of data for analysis, were 
detailed.  The justification of the selected quantitative method — DCE, the 
development of the research instruments — the DCE surveys, sampling and 
recruitment, the conduct of the DCE surveys, and the preparation of data for analysis, 
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were then discussed.   Research issues such as the low uptake of GP DCEs were flagged, 
along with mitigating steps — extension of survey closure date and hardcopies of the 
survey disseminated at two national GP conferences.  The strengths and limitations of 
both methods were detailed in their respective sections. 
In the next two chapters, the results from the semi-structured interviews (Chapter ʹ) 
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 What influences antibiotic use from 
the perspectives of GPs, community 
pharmacists and consumers? — Data 
analysis and results of semi-
structured interviews 
In this chapter, data analysis and results of the qualitative component — semi-
structured interviews, are presented in answer to Research Question ͱ:  What 
influences antibiotic use from the perspective of GPs, community pharmacists and 
consumers?  The chapter begins with a description of the data analysis — from coding 
and categorisation, to the development of main concepts and themes.  Next, research 
findings from each of the participant groups are reported separately, before being 
drawn together into a cohesive whole which elucidates how these concepts/themes 
could be linked across participant groups, using a model developed from the data — 
the Enabling Antibiotic Eupraxis (EABE) model.  This is followed by a bridging section 
at the end of the chapter (Section ʹ.Ͷ), which briefly describes how selected 
concepts/themes were then used to shape the development of the quantitative research 
instrument — the discrete choice experiments (detailed development of the discrete 
choice experiments has been provided in Chapter ͳ, Section ͳ.͵.ʹ).   
Sampling and recruitment, and the determination of sample size, were dealt with in 
Chapter ͳ, Section ͳ.ʹ.Ͳ.  Time and sequencing of interviews were detailed in Chapter 
ͳ, Section ͳ.ʹ.ʹ.  Justification for trustworthiness of findings was given in Chapter ͳ, 
Section ͳ.ʹ.Ͷ, while verification of coding is explained in this chapter, at the end of 
Section ʹ.ͱ.ͱ. 
Parts of this chapter have been presented at the ͹th Health Services and Research Policy 
Conference, Melbourne, Australia, December ͷ – ͹, ͲͰͱ͵, under the auspices of the 
Health Service Research Association Australia and New Zealand (HSRAANZ).  An 
abstract was published in the conference proceedings (Lum, Page, Nissen, Doust, & 
Graves, ͲͰͱ͵). 
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 DATA ANALYSIS 
The transcripts were coded to identify categories and themes, where the analysis was 
focused on meaning rather than on linguistic form (Kvale, ͲͰͰͷa).  A blend of 
deductive and inductive coding was used (Fereday & Muir-Cochrane, ͲͰͰͶ).  For 
deductive coding, a codebook was developed a priori, based on both the main interview 
questions and the Theoretical Domains Framework (TDF).  Data-driven inductive 
coding was done using an eclectic combination of coding methods i.e. descriptive, 
initial, In Vivo, and theming the data (outlined under Inductive coding in Section ʹ.ͱ.ͱ) 
(Saldana, ͲͰͱͳ).  Following first cycle coding, code mapping was used as a transition 
method to surface categories.  Three iterations of code mapping were completed to 
theme the data into higher order concepts/themes (Fereday & Muir-Cochrane, ͲͰͰͶ; 
Saldana, ͲͰͱͳ).  A model arose out of the third iteration, both to explain the 
phenomenon of what influences antibiotic use, as well as to enable a theory-informed 
practice of mitigating antibiotic resistance. 
Though the coding and analysis are described in a linear way, the actual processes were 
iterative in nature, particularly for inductive coding.  For example, refining inductive 
codes as coding progressed, checking refined codes against earlier transcripts coded, 
and making any necessary adjustments to ensure consistency in interpretation. 
 
4.1.1 Coding — First cycle 
Deductive coding 
Deductive coding was based on the codebook developed a priori from the TDF and 
main interview questions.  A total of ͳʹ codes were defined and described, as shown in 
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Table 8.  Codes developed a priori for deductive coding from the Theoretical Domains 
Framework and main interview questions 
Label Definition/Description 
TDF D1 Knowledge An awareness of the existence of something.  For example, GP's 
knowledge of clinical features, sequelae and treatment of bacterial and 
viral infections.  For example, consumer's knowledge of management 
of common side effects of antibiotics. 
TDF D2 Skills An ability or proficiency acquired through practice.  For example, more 
experienced GPs have well established strategies for dealing with 
patients wanting antibiotics.   
TDF D3 Social/Professional role 
and identity 
A coherent set of behaviours and displayed personal qualities of an 
individual in a social or work setting.  For example, GP's role and 
responsibility to manage diagnostic uncertainty.  For example, 
consumer's role as a parent/carer. 
TDF D4 Beliefs about 
capabilities 
Acceptance of the truth, reality or validity about an ability, talent or 
facility that a person can put to constructive use.  For example, 
pharmacist's or consumer's view that GPs are better placed to make 
the decision whether an antibiotic is needed or not. 
TDF D5 Optimism The confidence that things will happen for the best or that desired 
goals will be attained.  For example, the view that medical technologies 
will help to overcome antibiotic resistance. 
TDF D6 Beliefs about 
consequences 
Acceptance of the truth, reality or validity about outcomes of a 
behaviour in a given situation.  For example, GP's or pharmacist's view 
of the potential adverse impact of getting the management of a patient 
wrong.  For example, consumer's view of how antibiotics affect their 
body. 
TDF D7 Reinforcement Increasing the probability of a response by arranging a dependent 
relationship, or contingency, between the response and a given 
stimulus.  For example, consumer's strategy for remembering to take 
antibiotics as prescribed by using visual cues or apps. 
TDF D8 Intentions A conscious decision to perform a behaviour or a resolve to act in a 
certain way.  For example, GP's intention to prescribe antibiotics 
according to Therapeutic Guidelines (which are accepted as best 
practice nationally in Australia). 
TDF D9 Goals Mental representations of outcomes or end states that an individual 
wants to achieve.  For example, consumer's practice of keeping healthy 
in order to avoid falling ill. 
TDF D10 Memory, Attention 
and Decision processes 
The ability to retain information, focus selectively on aspects of the 
environment and choose between two or more alternatives.  For 
example, GP's processes for making treatment decisions.  For example, 
pharmacist's processes for making self-care recommendations to 
consumers.  
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TDF D11 Environmental context 
and resources 
Any circumstance of a person's situation or environment that 
discourages or encourages the development of skills and abilities, 
independence, social competence, and adaptive behaviour.  For 
example, time constraints for GPs to educate the patient on why an 
antibiotic is not needed to treat their current illness. 
TDF D12 Social influences Those interpersonal processes that can cause individuals to change 
their thoughts, feelings or behaviours.  For example, consumer being 
positively influenced by their GP due to good doctor-patient 
relationship established.  For example, influence on the consumer from 
friends, family or life partner, regarding attitudes toward or behaviours 
around antibiotic use. 
TDF D13 Emotion A complex reaction pattern, involving experiential, behavioural and 
physiological elements, by which the individual attempts to deal with a 
personal matter or event [definition adapted from the TDF].  For 
example, feelings of frustration, fear of being negatively evaluated by 
another person, and so forth. 
TDF D14 Behavioural regulation Anything aimed at managing or changing objectively observed or 
measured actions.  For example, GPs receiving personalised feedback 
reports on their antibiotic prescribing patterns from NPS MedicineWise 
via the Federal Department of Health.  For example, GP explaining to 
patient why antibiotics have to be used in a certain way, in order to 
increase adherence to prescribed antibiotics. 
AB behaviours Behaviours related to antibiotic use, including disposal.  For example, 
adherence and handling missed doses. 
AB side effects experienced Side effects experienced due to taking antibiotics, and how consumers 
managed them. 
AB prescribing challenges Challenges experienced by GPs regarding antibiotic prescribing.  For 
example, when the patient expects or demands antibiotics. 
ABR affect health Views from multiple sources i.e. consumers, pharmacists, GPs, on the 
extent antibiotic resistance could affect their personal health or 
family's health.   
ABR and prescribing decisions Whether GPs think about antibiotic resistance when making 
prescribing decisions 
ABR community and timeframe Views on whether antibiotic resistance is an issue that would affect the 
community, and how far into the future i.e. is this an issue now or 
some (stated) time in the future? 
ABR meaning The meaning attributed to the phrase “antibiotic resistance”, by people 
i.e. consumers, pharmacists, GP.  For example, what comes to mind 
when you hear the phrase “antibiotic resistance”? 
ABR What consumers can do Views from multiple sources i.e. consumers, pharmacists, GPs, on what 
consumers can do to help address antibiotic resistance.   
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ABR What GPs can do Views from multiple sources i.e. consumers, pharmacists, GPs, on what 
GPs can do to help address antibiotic resistance. 
ABR What pharmacists can do Views from multiple sources i.e. consumers, pharmacists, GPs, on what 
pharmacists can do to help address antibiotic resistance. 
Addressing AB expectations How GPs address patient expectations or demands for antibiotics. 
Approach to AB use Their personal approach to antibiotic use as a private individual i.e. 
consumers, pharmacists and GPs in their personal life. 
Clinical approach and DM GP's clinical approach and decision-making processes when thinking 
through whether the patient needs antibiotics for respiratory tract 
infections. 
Consumer responses AB not 
prescribed 
Consumer's responses to GP's decision not to prescribe an antibiotic 
(antibiotic not needed) or the doctor said no antibiotics were needed. 
Delayed AB Views on the use of delayed antibiotic prescriptions.  For example, 
consumer's views and responses if the GP prescribed delayed 
antibiotics as a contingent measure.  For example, GP's views on the 
usefulness (and place, if any) for delayed antibiotic prescriptions. 
Patient expectations Consumer's expectations regarding the GP consultation. 
Perspective risk of AB Views on the risks of using antibiotics.  For example, GP's perspective 
on the risk of prescribing antibiotics; consumer's perspective on the 
risk of taking antibiotics. 
Repeat scripts Views on the use of repeat antibiotic prescriptions.  For example, 
pharmacist's handling of repeat antibiotic prescriptions presented for 
dispensing by the consumer, months after the original prescription was 
dispensed.  For example, GP's views on the usefulness/need for repeat 
antibiotic prescriptions. 
Self-management strategies CC Self-management strategies for the common cold:  what the 
pharmacist would usually advice consumers to try; what self-
management strategies consumers would usually use. 
Time lag seeking GP consult How long people would wait before seeking a GP consult.  For example, 
how long consumers would wait before seeking a GP consult.  
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Inductive coding 
Inductive coding was data-driven — additional codes not previously defined in the 
codebook — were created for segments of meaningful data found in the interview 
transcripts.  The following eclectic combination of coding methods were used:  
descriptive, initial, In Vivo, and theming the data (Saldana, ͲͰͱͳ).  Each coding method 
is briefly explained below and illustrated with a code from the research interviews. 
Descriptive coding captures in a word — usually a noun — or short phrase, the topic of 
a passage (Saldana, ͲͰͱͳ, p. ͸͸).  An example of a descriptive code from the consumer 
interviews is "Leftovers" — which describes what people do with leftover antibiotics. 
Initial coding, sometimes referred to as open coding, is where qualitative data is broken 
down into discrete parts and closely examined, after which a comparison is made 
regarding similarities and differences (Saldana, ͲͰͱͳ, p. ͱͰͰ).  Categories, including 
those in development, can be coded (Saldana, ͲͰͱͳ, p. ͱͰͰ).  An example from the 
interview transcripts is "Information needs" — which is what consumers wanted to 
know, regardless of whether or not they asked the GP or pharmacist during a 
consultation. 
In Vivo coding or verbatim coding, uses words or short phrases from the research 
participants themselves, thereby surfacing more clearly the participant's voice (Saldana, 
ͲͰͱͳ, p. ͹ͱ).  Working with interview transcripts, In Vivo coding was used for iconic 
phrases, metaphors and evocative word choices.  For example, the "dark arts of 
selecting antibiotics" (GPͰͷ, line ͱ͵ͱ). 
Although themes are usually thought of as outcomes of coding, Saldana proposes that 
it can be useful to label and analyse portions of data i.e. "theme the data", as part of 
first-cycle coding (Saldana, ͲͰͱͳ, p. ͱͷ͵).  Theming the data, is the use of an extended 
phrase or sentence to either (a) capture the essence of a segment of data, or (b) 
organise a group of repeating ideas (Saldana, ͲͰͱͳ, pp. ͱͷ͵-ͱͷͶ), in order to summarise 
what is going on (the phenomenon), to provide an explanation, and/or to suggest a 
rationale for why something is done (Rubin & Rubin, ͲͰͱͲ, p. ͱ͹ʹ).  An example of a 
theme from the research interviews is "Knowledge-Practice dissonance", where 
knowledge about antibiotic resistance does not translate into practice for a proportion 
of people — whether GPs, pharmacists or consumers.  Using these first-cycle coding 
methods, ͱ͸ͷ codes were additionally defined, as shown in Table ͹. 
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Table 9.  Inductive codes which emerged from interview transcripts 
Label Definition/Description 
AB choice rationale Consumers want to know the GP's rationale for choosing that 
particular antibiotic over another one, or why different 
infections seem to be treated by the same antibiotic. 
AB colours Consumers curious about the symbolism of the different colours 
of antibiotic tablets/capsules.  For example, do the colours 
mean anything? 
AB counselling Counselling provided by the pharmacist or GP to a patient when 
dispensing/prescribing an antibiotic.  Information received by 
the consumer about the antibiotics. 
Abdicating responsibility GPs act to absolve themselves from being responsible for the 
patient's health outcome by giving patients a delayed antibiotic 
prescription, thereby delegating the final decision to the patient. 
AB lost effectiveness The antibiotic has lost its effectiveness; no longer effective. 
AB prescribing behaviours Antibiotic prescribing behaviours observed by consumers and/or 
pharmacists*. 
AB prescribed on reassessment Antibiotics were only prescribed on second visit or reassessment 
visit, as symptoms had progressed further. 
AB script as validation The prescribing/receipt of antibiotics validates the patient's 
concerns about their symptoms. 
AB treatment Consumer seeks antibiotic treatment, if bacterial infection. 
ABR not forefront issue Antibiotic resistance is not an issue that is forefront in people's 
consciousness. 
ABR synergy Tackling antibiotic resistance needs to involve all parties — GPs, 
pharmacists and consumers. 
Active engagement in 
campaigns 
The extent to which pharmacy staff is promoting/advocating the 
campaign when interacting with consumers. 
Access without script Ability to access medicines such as antibiotics without a 
prescription, from community pharmacies. 
Adherence Adherence to prescribed antibiotic regimen. 
Advising in context Advice shaped by knowledge of patient's medical history e.g. 
the pharmacist is familiar with the regular patient's medical 
history or has access to this information. 
Affecting work Being unwell starts affecting work. 
Alcohol and AB Consumers wanted to know if they can drink while on 
antibiotics. 
Allergy check Whether the GP and/or pharmacist checked on allergies when 
prescribing/dispensing antibiotics. 
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Ascertain AB warranted Pharmacists determining if antibiotics are clinically warranted 
(late presentation of an antibiotic prescription, whether original 
or a repeat prescription). 
Audio-visual media Raise awareness of antibiotic resistance using TV, cinema ads, 
movie script, podcasts. 
Avoid falling sick Self-care strategies to avoid falling sick in the first place. 
Bacteria resistant Bacteria is resistant to the antibiotic. 
Bad experiences of delaying GP 
consult 
Adverse consequences e.g. deterioration, pneumonia, 
previously experienced due to delaying a GP consult. 
Barriers education Barriers to educating patients. 
Barriers to GP consult Barriers to seeking GP consult e.g. may be difficult to book an 
appointment, time, cost, effort to get there, delay in getting 
seen (clinic running late). 
Battle metaphors Explaining antibiotic resistance using battle or war metaphors. 
Better safe than sorry GPs who feel that the safer option is to prescribe antibiotics if 
there is a chance it could be bacterial. 
Body resistant Body is resistant to the antibiotic. 
Brand substitution The need for pharmacists to reinforce/re-clarify medication 
name during counselling when generics are dispensed to avoid 
confusion. 
Bulk-billing Whether bulk-billing was a factor in choosing their regular GP. 
Cheap treatment Cheaper to fill antibiotic prescription than to buy products for 
symptom management. 
Choice of pharmacy The consumer's choice of pharmacy to use e.g. for advice, to fill 
a prescription. 
Clinic billing affects 
appointment duration and cost 
to patient 
The type of clinic billing affects how much time a GP can spend 
with a patient and also how much the patient is charged. 
Clinic billing affects GP 
remuneration 
Clinic billing and contractual arrangements with GP will affect 
GP's remuneration.  For example, salaried vs. contracted GP; 
percentage of billing revenue in GP's contract. 
Co-morbidities Patient's co-morbidities e.g. chronic obstructive pulmonary 
disease or asthma, makes the issuing of a delayed antibiotic 
prescription a reasonable course of action. 
Communication difficulties Language difficulties giving rise to communication difficulties, 
either on the part of the GP or the consumer. 
Concerned despite AB 
warranted 
Consumers who are concerned about taking antibiotics even 
when the need for it is warranted. 
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Conditioning Experiential or cultural conditioning or assumptions, impacting 
how a person uses antibiotics. 
Confidence in new solutions Confidence (or otherwise) that medical technology, science, 
innovations — would be able to fight or resolve antibiotic 
resistance. 
Conflation of concepts Conflation of concepts pertaining to antibiotic resistance in the 
community, with antibiotic resistance in an individual. 
Conflict of interest Pharmacists' conflict of interest (perceived or otherwise).  For 
example, there is no incentive for refusing to fill an antibiotic 
prescription. 
Constrained by travel The issuing of delayed antibiotic prescriptions in the 
circumstance where the patient is unable to travel back to clinic, 
or will only have access to a pharmacy later. 
Consumer response refusal to 
fill repeat 
Consumer's response to the pharmacist not filling the repeat 
antibiotic prescription, mitigated with patient education. 
Continuity of care Ensuring GP has access to relevant information in order to 
provide care. 
Convenient location Pharmacy is convenient to either where the consumer works, 
where they happen to be, what they happen to be doing e.g. 
shopping centre. 
Dark arts of selecting antibiotics GP speaking about rationale of antibiotic selection (GP07, line 
151). 
Debate Current debate about whether you need to finish the course of 
antibiotics. 
Decision-making cognition and 
intuition 
The cognitive and intuitive weighing up of information in order 
to arrive at a course of action.  For example, the process 
undertaken by GPs when making a decision whether or not to 
prescribe an antibiotic. 
Definitive instructions Consumer wants to be given definitive/specific instructions 
about what to do e.g. whether to take the antibiotics, 
when/whether to use the repeat antibiotic prescription. 
Delegation of decision Decision of when/whether to use antibiotics is essentially 
delegated to the patient, when GPs do not/are not able to 
provide definitive instructions. 




Many do not have the ability to discern between good medical 
practices and potentially harmful ones e.g. that the prescribing 
of an antibiotic may not be in the consumer's best interest. 
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Dispensing instructions GP's annotation on the antibiotic prescription instructing 
pharmacists either not to dispense before a certain date, or not 
to dispense after a certain date. 
Disease immune The disease/infection becomes immune to antibiotics. 
Disposal How people dispose of antibiotics. 
Doctor-Patient relationship The doctor-patient relationship.  For example, preserving an 
existing good relationship, building a relationship, or not 
aggravating a new or existing relationship. 
Dose rationale Consumers want to know the GP's rationale for the dose chosen 
e.g. do men and women get different doses, do their bodies 
process antibiotics differently. 
Doubts about GP's decision to 
prescribed 
Things that led the consumer to doubt the GP's decision to 
prescribe an antibiotic e.g. quick consultation, not thorough but 
then prescribes antibiotics. 
Doubts about pharmacist's role Consumer doubts pharmacist's role in diagnosing and 
recommending treatments (for minor ailments). 
Duration Counselling patient about duration of treatment (GP and/or 
pharmacist); pharmacist finding out what the GP has told the 
patient.  Information received by the consumer about the 
duration of treatment. 
Duration rationale Consumers want to know the GP's rationale for duration of 
treatment. 
Enable appropriate AB access Where there is a genuine clinical need, to have ways of enabling 
access to repeat or longer courses of antibiotics. 
Evidence-free zone GP speaking about negotiating clinical uncertainty (GP07, line 
161) and/or where there is relatively weak evidence base for 
treatment of respiratory tract infections. 
Experience outweigh EBM GP's clinical experience could sometimes outweigh EBM, 
especially if there had been adverse consequences for the 
patient. 
Experience of GP consult A description of the consumer's experience of the GP 
consultation. 
Expired repeats Repeat antibiotic prescriptions are kept on file in the pharmacy 
or at home, which are never used and expires. 
Explain AB unwarranted GP explains why antibiotics are not immediately warranted i.e. 
rationale for not prescribing antibiotics right away. 
Explaining ABR How the GP or pharmacist conveys the concept of antibiotic 
resistance to patients 
Extent of issue and practical 
consequences 
Unaware of the extent of antibiotic resistance in the community 
and the specific consequences (practical consequences). 
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Farmed animals Antibiotic resistance in food-producing animals possibly 
affecting human health. 
Fighting an enemy with 
weapons that aren't good 
enough 
Consumer (CS15, line 331) describing how they would explain 
antibiotic resistance to others. 
Gamification Use principles of gamification to create/raise 
awareness/educate on antibiotic resistance. 
Generic vs Brand names Consumers not aware of which antibiotic due to medicines 
having both generic and brand names, unless they looked 
carefully/intentionally. 
Good GP Description of what a good GP is. 
Government Government sponsored or sanctioned ads/campaigns. 
GP's advice What the GP says about the need, or otherwise, for antibiotics; 
or about treatment decisions. 
GP Registrars' patient base A description of GP Registrars' patient base and lag time to build 
patient base. 
Green mucous That green mucous indicates a bacterial infection and that 
antibiotics are needed. 
Handling delayed presentation How the pharmacist handles a request to dispense a repeat 
prescription for antibiotics, presented months later. 
Handling missed doses What people do if they have missed doses of antibiotics.  
How common Pharmacists' views on how often they see repeat antibiotic 
prescriptions. 
Hyperbole Perception that the Media hyped up the issue of antibiotic 
resistance beyond what it is. 
I don’t want to have to deal with 
that in the next 20 years 
GP (GP04, line 201-202) speaking about dealing with antibiotic 
resistant infections in the community. 
IMG Possibility that International Medical Graduates (IMGs) or 
Overseas Trained Doctors (OTDs) from countries with a strong 
medical hierarchy, would communicate selectively with patients 
based on socio-economic status of the patient. 
Important life events The need to get well quickly due to pressing or important life 
events prompted the visit to the GP, perhaps sooner than what 
would have normally been the case. 
I'm not going to give you 
antibiotics 
Consumer (CS04, line 259) recounting visit to a GP.  GP 
recounting what happened or what would happen if they said 
this. 
Inaction Inaction due to being unsure of the extent of the antibiotic 
resistance issue and specific consequences. 
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Incentives Incentives for behaviour change.  For example, provision of 
financial assistance if the behaviour change will cost people 
more money. 
Inference Inferred that antibiotic resistance is an issue due to seeing many 
campaigns or mentioned in the media. 
Influence of specialists Refers to exposure of GP Registrars to prescribing preferences 
of hospital specialists and/or consulting specialists regarding 
what to prescribe. 
Information leaflet Consumer Medicines Information (CMI) for antibiotics. 
Information needs What consumers wanted to know, regardless of whether they 
asked the GP or pharmacist during the consultation. 
Issue specific Consumers may use a different GP for different issues e.g. for 
sexual health consumers would see a female GP; for minor 
issues may see any GP rather than regular GP. 
Instructions from GP Whether the GP had given specific instructions on when or 
whether to use the repeat prescription. 
Invisible Consumer speaking about antibiotic resistance (CS16, line 718) 
i.e. people cannot see antibiotic resistance, unlike car crashes 
(speed kills).  Antibiotic resistance is a harder message to sell. 
It doesn’t look like you're trying 
to scam them 
GP01, line 161-163, regarding why they would issue a delayed 
antibiotic prescription rather than insist on another visit for 
reassessment. 
Just in case Consumer given an antibiotic prescription by the doctor "just in 
case". 
Knowledge-Practice dissonance Knowledge about antibiotic resistance does not translate into 
practice for a proportion of people — whether GPs, pharmacists 
or consumers. 
Leftovers What people do with leftover antibiotics. 
Low meds user Consumers who are not on much medication or do not take 
much medication. 
Make a judgment call GP07, line 102, speaking about negotiating clinical uncertainty. 
Makes my job harder GP05, line 207, speaking about the first thing that comes to 
mind regarding antibiotic resistance. 
Making deposits in relationship 
bank 
An example of how GPs and/or patients invest/make deposits in 
the doctor-patient relationship. 
Media and campaigns Consumer exposure to public health campaigns about prudent 
antibiotic use and/or accompanying media messages promoting 
such, and/or sensational headlines. 
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Medical certificate Seeing the GP to obtain a medical certificate for some time off 
work/study. 
Medical treatment overseas Consumers seeking medical treatment overseas e.g. in home 
country or medical tourism. 
Misinformation Incorrect, incomplete or misleading information. 
More serious health concerns 
takes precedence 
More serious and immediate health concerns e.g. chronic 
illness, cancer, takes precedence over antibiotic resistance, as 
currently not being affected. 
Negotiating clinical uncertainty The GP's ability to deal with and/or manage clinical uncertainty 
e.g. diagnostic uncertainty, 
No definitive trigger There is no single symptom which, if it gets worse, would 
indicate that is when the antibiotic should be taken. 
Patient education Patient education by pharmacist or GP. 
Past experience with AB People's previous experience with taking antibiotics, including 
consequences such as side effects. 
Permissible circumstances Circumstances in which GPs feel that issuing a delayed 
prescription for antibiotics is permissible. 
Perspective CC complications Consumer perspectives on complications from the common 
cold. 
Pharmacist's advice What the pharmacist said (to the consumer). 
Pharmacist uncertain Situations where the patient's condition cannot be identified by 
the pharmacist with certainty. 
Pharmacist underlying concerns Underlying concerns that lead pharmacists to refer the patient 
to a GP. 
Prefer reassessment Consumers preferred to have a reassessment to determine if 
another course of antibiotics is needed rather than be given a 
delayed prescription or repeat prescription for antibiotics.  GPs 
preferred to reassess rather than write delayed or repeat 
prescriptions for antibiotics. 
Preparing the ground The GP conducts the consultation in such a way that the patient 
feels valued and listened to, which leads to increased trust.  
Patient perceives the GP is on their side and acting in their best 
interest. 
Prescribing antibiotics How GPs prescribe antibiotics — the practicalities i.e. guidelines 
used, dose considerations and so forth. 
Prescribing habits formed early Prescribing habits usually formed early in GP's career and may 
not have changed.   
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Prescribing practice of other GPs Prescribing practices of other GPs e.g. prescribing antibiotics 
when not required, makes it hard for GPs who want to do the 
right thing (conserve antibiotics). 
Price Would choose a cheaper pharmacy. 
Print media Raise awareness of antibiotic resistance through newspapers, 
magazines, bus stop posters, bus ads, posters, flyers. 
Prioritise own health Would put aside broader concerns about how the use of 
antibiotics affect the community, in order to treat themselves 
first.  Competing priorities — own health and health of loved 
ones over the community. 
Professional etiquette Various ways GPs extend professional etiquette to other GPs 
e.g. GP acceding to patient demand for antibiotics as their 
regular GP "always prescribes" antibiotics for them; not critically 
questioning prescribing decisions; not seen to be negatively 
evaluating the abilities of their colleagues. 
Propagated myths Popular beliefs or assumptions about antibiotics or antibiotic 
use. 
Proposed PBS changes Views on Drug Utilisation Sub Committee (DUSC) proposed 
Pharmaceutical Benefit Scheme changes i.e. remove repeats for 
antibiotic prescriptions on PBS; shorten the period of validity for 
antibiotic prescriptions. 
Proxy decision maker Making a decision whether to use antibiotics on behalf of others 
e.g. dependents who are very young or very elderly. 
Quarantine Quarantine restrictions at Australian airports, including of 
people who are ill e.g. traveller screening at airports during 
pandemics. 
Quick consult The GP conducted the consultation quickly and perceived by the 
patient as not thorough. 
Raising awareness Ideas on how to raise public awareness of antibiotic resistance. 
Reassessment motives Motives for reassessment of a patient.  For example, GPs prefer 
to reassess rather than prescribe delayed antibiotics.  For 
example, some consumers suspect reassessment is for 
monetary gain. 
Reassurance Consumer wants or is seeking reassurance from GP. 
Reduce validity period Reduce the period of validity for oral antibiotic prescriptions. 
Referral to GP Pharmacists would refer the patient to a GP given these 
symptoms/patient's condition.  Consumers would self-refer to a 
GP given these symptoms/conditions. 
Regular GP Whether the consumer has a regular GP. 
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Regulatory changes Regulatory and systemic changes regarding the access to and 
supply of antibiotics. 
Reinforcing wrong beliefs GP's prescribing practices inadvertently reinforces consumer's 
wrong beliefs about the need for antibiotics. 
Reliance on AB Consumer resorts to antibiotics as first line treatment, as these 
have worked in the past. 
Remove repeats Removal of repeats for oral antibiotics from the PBS. 
Resources for consumers Resources to raise consumer awareness of antibiotic resistance 
which may or may not be mediated via the pharmacist e.g. 
patient education, podcasts. 
Resources for GPs Resources for GPs.  For example, to educate consumers/patients 
about antibiotic resistance or to explain that an antibiotic is not 
needed.  For example, resources to equip GPs for addressing 
patient expectations for antibiotics. 
Resources for pharmacists Training and other resources for pharmacists to upskill or be 
familiarised with the issue of antibiotic resistance. 
Respecting patient's time GP respecting patient's time by issuing a delayed antibiotic 
prescription as an option, rather than insisting they return for a 
reassessment. 
Reticence about seeking 
clarification 
Consumer's reticence about seeking clarification from GPs about 
when to use delayed antibiotic prescription. 
Review asthma management Review of asthma management. 
Requests AB OTC Consumers asking to purchase antibiotics over-the-counter i.e. 
without a prescription. 
RUM Program Return of Unwanted Medicines (RUM) Program:  whether the 
pharmacy offers this service and if people bring in antibiotics for 
destruction. 
Script used for next illness Consumers use existing repeat prescription for antibiotics the 
next time they become ill. 
Seek GP's expertise Consumer is seeking GP's expertise in diagnosing their health 
issue and suggesting a course of action/treatment. 
Seeks immediate solution CC Consumer seeks immediate solution to get rid of common cold 
e.g. products to ameliorate symptoms. 
Seeks second opinion Consumer seeks another healthcare professional's opinion 
regarding prescribed antibiotics or treatment decision.  For 
example, going to another GP, or going to the pharmacy and 
queries the need for the prescribed antibiotics. 
Self-assessment of severity Self-assessment of severity of symptoms prior to seeking GP 
consult. 
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Self-management SE Self-management of antibiotic side effects experienced. 
Shared expectations Shared expectations and goals for health management, between 
GP and consumer/ patient. 
Sharing Sharing antibiotics with others or accepting shared antibiotics. 
Side effects Pharmacist and/or GP counselling the patient about antibiotic 
side effects and its management.  Information received by the 
consumer about side effects of antibiotics and its management. 
Social media and internet Raise awareness of antibiotic resistance using social media 
and/or the internet. 
Society immune The society becomes immune to antibiotics. 
Solution without seeing GP Consumers seeking solution (any) that does not involve going to 
the GP. 
Specific referral for AB Pharmacists would refer the patient to a GP for antibiotics given 
these symptoms/patient's condition. 
Staffing Lack of staff making it difficult for pharmacists to spend time 
educating patients. 
Standing firm GP standing firm on their decision not to prescribe antibiotics 
despite patient expectations or demand. 
States expectations Consumer states expectations regarding the GP consult and/or 
antibiotics. 
Tests not feasible Tests to determine if antibiotic treatment is required may not be 
available or may take a long time for results to be returned. 
Time Lack of time brought about by high workload and/or staffing 
pressures to educate patients. 
Time pressure on GPs Time pressure on GPs.  For example, to keep consultation within 
allotted time and/or to get through the patients in the waiting 
room. 
Took antibiotics despite doubts Consumer took the antibiotics despite doubts about GP's 
decision to prescribe antibiotics. 
Trust Trust has been established with the GP. 
Trustworthy GP Consumer felt that the GP was trustworthy, even though not 
their regular GP. 
Unable to present Patient is unable to return to clinic for reassessment if condition 
worsens. 
Unaware of duration Patient is not aware of duration of antibiotic treatment, with 
consequences impacting adherence. 
Unconvinced of rationale Consumer does not seem convinced of GP’s rationale for the 
treatment decision.  
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Used a previous script for next 
illness 
Consumer used old/previous script (whether unused original 
script or a repeat script) to self-medicate the next time they 
became ill. 
User experience of Australian 
healthcare 
A description of the participant's experience of the Australian 
healthcare system, whether in primary care or hospital care, 
which came up in the interview. 
User experience of Overseas 
healthcare 
A description of the participant's experience of healthcare 
systems Overseas, whether in primary care or hospital care, 
which came up in the interview. 
Validation Consumer feels validated that they are not bringing a non-
existent problem to the GP. 
Wary of AB Consumers who are more mindful of what medicines they take 
and/or those who are aware of antibiotic resistance, may limit 
their use of antibiotics as much as possible. 
Want quick recovery People want to get better quickly and believe they need 
antibiotics to do so.   
Weak evidence base GP’s knowledge of weak evidence base for delayed antibiotic 
prescriptions led to avoidance of issuing such prescriptions. 
What people do with repeats Descriptions of what people do with their antibiotic repeat 
prescriptions. 
Why people seek AB GP, pharmacist and consumer views on why/what drives 
consumers to seek antibiotics. 
Wise advocate Denotes GP as wise advocate for patient's health.  For example, 
not prescribing antibiotics when not needed, and the ability to 
gently convince the patient that this is in their best interest. 
Workload Workload barriers to spending time educating patients. 
You get the patients you 
deserve 
GP08, line 168-173 and GP06, line 391-400, speaking about the 
need to adequately address patient expectations. 
You're going to run out of 
antibiotics 
GP09, line 205, speaking about antibiotic resistance when 
making prescribing decisions. 
*Note:  All references to pharmacists in this table refers to community pharmacists. 
 
To test the reliability of the codes, while being mindful of the constraints of doctoral 
research — time, budget and human resources — and the volume of interview data 
collected, one percent of interview transcripts was randomly selected for coding 
confirmation by another researcher.  The Microsoft Excel® random number function 
was used to select ͵ interview transcripts for coding — one each from GP and 
community pharmacist interviews and three from consumer interviews.  Deductive and 
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inductive coding were done simultaneously for each transcript.  The coded transcripts 
were then given to another researcher (my principal supervisor) for coding 
confirmation. 
The level of agreement between both researchers was high for deductive coding, as was 
the level of agreement for segments of data that were coded inductively.  However, 
some labels for inductive coding needed to be refined and adjusted collaboratively.  
Remaining disagreements on codes or coding were resolved via discussion to reach a 
consensus.   
The rest of the interview transcripts were then coded, using the same deductive codes 
and the refined inductive codes, with expectations for the addition of new inductive 
codes as these emerged from subsequent interview transcripts.  Table ͹ shows the final 
list of inductive codes after first cycle coding.   
Coding saturation — the point where no new codes emerged from the data being coded 
— was reached after Ͷ GP interviews, Ͷ community pharmacist interviews and ͱͰ 
consumer interviews (Hennink, Kaiser, & Marconi, ͲͰͱͶ). 
  
4.1.2 Code mapping — Transition 
Code mapping was used as a transition method following first cycle coding, to surface 
categories — not only those elicited by the main interview questions, but also relevant 
emergent topics from the interviews.  Several iterations of code mapping were 
undertaken. The first iteration simply grouped first cycle codes under each category — 
main interview question or emergent topic.  Some codes were grouped under more 
than one category, where appropriate.  For example, the TDF Domain code — "TDF Dͱ 
Knowledge" — is relevant to most categories, and "Script used for next illness" is 
relevant to categories ͵, Ͷ, and ͹.  Table ͱͰ shows the list of categories, followed by the 
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Table 10.  List of categories for each participant group 
Categories GPs Community 
Pharmacists 
Consumers 
1. Process for clinical decision-making    
2. Prescribing challenges    
3. Patient education vs. Information needs    
4. Patient expectations    
5. Delayed antibiotic prescriptions    
6. Repeat antibiotic prescriptions    
7. Views on antibiotic resistance    
8. Mitigating antibiotic resistance    
9. Antibiotic use behaviours    
10. Self-care strategies for respiratory tract 
infections 
   
11. Views on risks of taking antibiotics    
 
 
Code mapping:  First iteration 
The first iteration of code mapping for each of the eleven categories are given below. 
 
CATEGORY ͱ.  PROCESS FOR CLINICAL DECISION-MAKING 
 Related codes: 
 Clinical approach and DM 
 Decision-making cognition and intuition 
 Experience outweigh EBM 
 Good GP 
Negotiating clinical uncertainty 
  Make a judgment call 
 TDF Dͱ Knowledge 
TDF DͲ Skills 
TDF Dͳ Social, Professional role and identity 
 TDF DͱͰ Memory, Attention and Decision processes 
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CATEGORY Ͳ.  PRESCRIBING CHALLENGES 
Related codes: 
AB prescribing behaviours 
 Prefer reassessment 
 AB prescribed on reassessment 
Clinic billing affects appointment duration and cost to patient 
Clinic billing affects GP remuneration 
Evidence-free zone 
GP Registrars' patient base 
Influence of specialists 
Knowledge-Practice dissonance 
Patient expectations (large category mapped separately as Category ʹ) 
Prescribing antibiotics 
Better safe than sorry 
Dark arts of selecting antibiotics 
Prescribing practices of other GPs 
Prescribing habits formed early 
Professional etiquette 
Tests not feasible 
Time pressure on GPs 
TDF Dͱ Knowledge 
TDF DͲ Skills 
TDF Dͳ Social, Professional role and identity 
TDF Dʹ Beliefs about capabilities 
TDF DͶ Beliefs about consequences 
TDF DͱͰ Memory, Attention and Decision processes 
TDF Dͱͱ Environmental context and resources 
TDF DͱͲ Social influences 
TDF Dͱͳ Emotion 
 
CATEGORY ͳ.  PATIENT EDUCATION VS. INFORMATION NEEDS 
Related codes for Patient education: 
 AB counselling 
  Brand substitution 
  Duration 
   Debate 
  Side effects 
 Active engagement in campaigns 
 Advising in context 
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 Allergy check 
 Barriers education 
  Staffing 
  Time 
  Workload 
 Conflation of concepts 
Explaining ABR 
 IMG 
 Propagated myths 
  Green mucous 
  Misinformation 
 Raising awareness 
  Audio-visual media 
  Gamification 
  Government 
  Print media 
  Social media and internet 
 TDF Dͱ Knowledge 
 TDF DͲ Skills 
 TDF Dͳ Social, Professional role and identity 
 TDF Dʹ Belief about capabilities 
 TDF Dͷ Reinforcement 
 TDF D͸ Intentions 
 TDF D͹ Goals 
 TDF DͱͲ Social influences 
 TDF Dͱʹ Behavioural regulation 
 
 Related codes for Information needs: 
 AB choice rationale 
 AB colours 
 Alcohol and AB 
 Definitive instructions 
 Dose rationale 
 Duration rationale 
  Unaware of duration 
 Generic vs. Brand names 
 Information leaflet 
 Media and campaigns 
  Hyperbole 
 TDF Dͱ Knowledge 
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 TDF Dͳ Social, Professional role and identity 
 TDF Dʹ Belief about capabilities 
 TDF Dͷ Reinforcement 
 TDF D͸ Intentions 
 TDF D͹ Goals 
 TDF DͱͲ Social influences 
 TDF Dͱʹ Behavioural regulation 
 
CATEGORY ʹ. PATIENT EXPECTATIONS 
 Related codes: 
 Addressing AB expectations 
  Explain AB unwarranted 
  Preparing the ground 
  Shared expectations 
  Caving in 
  Reassurance 
  Standing firm 
  Validation  
   AB script as validation 
  Wise advocate 
  You get the patients you deserve 
 Bad experiences of delaying GP consult 
Consumer responses: AB not prescribed  
Discerning-Undiscerning consumer 
Doctor-patient relationship 
Making deposits in relationship bank 
Doubts about GP's decision to prescribe 
 Quick consult 
 Seeks second opinion 
 Took AB despite doubts 
 Unconvinced of rationale 
Good GP 
GP's advice 
I'm not going to give you antibiotics 
Knowledge-Practice dissonance 
Proxy decision maker 
Regular GP 
 Bulk billing 
 Continuity of care 
 Issue specific 
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 Trust 
Seek GP's expertise 
  AB treatment 
  Review asthma management 
 States expectations 
 User experience of Australian healthcare 
  Experience of GP consult  
   AB prescribed on reassessment 
   Communication difficulties 
   Trustworthy GP  
Pharmacy 
  Choice of pharmacy 
   Convenient location 
   Price 
  Conflict of interest 
  Doubts about pharmacists' role 
User experience of overseas healthcare 
  Access without script 
 TDF Dͱ Knowledge 
 TDF DͲ Skills 
 TDF Dͳ Social, Professional role and identity 
 TDF Dʹ Beliefs about capabilities 
 TDF DͶ Beliefs about consequences 
 TDF Dͷ Reinforcement 
 TDF D͸ Intentions 
 TDF D͹ Goals 
 TDF Dͱͱ Environmental context and resources 
TDF DͱͲ Social influences 
 TDF Dͱͳ Emotion 
 TDF Dͱʹ Behavioural regulation 
  
CATEGORY ͵. DELAYED ANTIBIOTIC PRESCRIPTIONS 
 Related codes: 
 Abdicating responsibility 
Delegation of decision 
 Doctor-patient relationship 
Making deposits in relationship bank 
 Dispensing instructions  
It doesn't look like you're trying to scam them 
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 Just in case 
 No definitive trigger 
 Permissible circumstances 
  Co-morbidities 
  Constrained by travel 
  Unable to re-present 
 Proxy decision maker 
Reassessment motives 
 Reinforcing wrong beliefs 
 Respecting patient's time 
 Reticence about seeking clarification 
Script used for next illness 
Time lag seeking GP consult 
Weak evidence base 
TDF Dͱ Knowledge 
TDF Dͳ Social, Professional role and identity 
TDF Dʹ Beliefs about capabilities 
TDF D͵ Optimism 
TDF DͶ Beliefs about consequences 
TDF DͱͰ Memory, Attention and Decision processes 
TDF Dͱͳ Emotion 
TDF Dͱʹ Behavioural regulation    
 
CATEGORY Ͷ.  REPEAT ANTIBIOTIC PRESCRIPTIONS 
 Related codes: 
 Ascertain AB warranted 
 Consumer response: refusal to fill repeat 
Handling delayed presentation 
How common 
Instructions from GP 
What people do with repeats 
 Discard 
 Expired repeats 
 Script used for next illness 
Time lag seeking GP consult 
Unaware of duration 
TDF Dͱ Knowledge 
TDF D͸ Intentions 
TDF DͱͰ Memory, Attention and Decision processes  
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CATEGORY ͷ.  VIEWS ON ANTIBIOTIC RESISTANCE 
 Related codes: 
 ABR affect health 
  Medical treatment overseas 
 ABR and prescribing decisions 
  I don't want to have to deal with that in the next Ͷʹ years 
  You're going to run out of antibiotics 
 ABR community and timeframe 
  Confidence in new solutions  
  Farmed animals 
  Quarantine 
 ABR meaning 
  AB lost effectiveness 
  Bacteria resistant 
  Battle metaphors 
   Fighting an enemy with weapons that aren't good enough 
  Body resistant 
  Disease immune 
  Makes my job harder 
  Society immune 
 ABR not forefront issue 
  Extent of issue and practical consequences 
  Inaction 
  Inference 
  Invisible 
  More serious health concerns takes precedence 
  Prioritise own health 
 TDF Dͱ Knowledge 
 TDF Dʹ Beliefs about capabilities 
 TDF D͵ Optimism 
 TDF DͶ Beliefs about consequences 
 TDF Dͱͱ Environmental context and resources 
 TDF DͱͲ Social influences 
 TDF Dͱͳ Emotion 
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CATEGORY ͸.  MITIGATING ANTIBIOTIC RESISTANCE 
Related codes: 
 ABR Synergy 
 ABR what consumers can do 
 ABR what GPs can do  
 ABR what pharmacists can do 
 Patient education (large category mapped separately in Category ͳ) 
Resources for consumers 
 Resources for GPs  
Resources for pharmacists 
Regulatory changes 
 Incentives 
 Proposed PBS changes 
  Enable appropriate AB access 
  Reduce validity period 
  Remove repeats 
Confidence in new solutions 
TDF Dͱ Knowledge 
TDF DͲ Skills 
TDF Dʹ Beliefs about capabilities 
TDF D͵ Optimism 
TDF DͶ Beliefs about consequences 
TDF Dͷ Reinforcement 
TDF D͸ Intentions 
TDF D͹ Goals 
TDF DͱͲ Social influences 
TDF Dͱʹ Behavioural regulation   
 
CATEGORY ͹.  ANTIBIOTIC USE BEHAVIOURS 
 Related codes: 




  RUM program 
 Handling missed doses 
 Leftovers 
Requests AB OTC 
Sharing 
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Script used for next illness 
Self-prescribing  
Solution without seeing GP 
Took AB despite doubts 
Why people seek AB 
 Cheap treatment 
 Reliance on AB 
 Want quick recovery 
TDF Dͱ Knowledge 
TDF Dʹ Beliefs about capabilities 
TDF D͹ Goals 
TDF Dͱͱ Environmental context and resources 
TDF DͱͲ Social influences 
 
CATEGORY ͱͰ.  SELF-CARE STRATEGIES FOR RESPIRATORY TRACT INFECTIONS 
 Related codes: 
 Avoid falling sick 
 Barriers to GP consult 
 Perspective CC complications 
 Referral to GP 
  Medical certificate 
  Pharmacist uncertain 
  Pharmacist underlying concerns 
  Self-assessment of severity 
  Specific referral for AB 
Seeks immediate solution CC 
 Self-management strategies CC 
 Time lag seeking GP consult 
  Affecting work 
  Important life events 
 TDF Dͱ Knowledge 
 TDF DͲ Skills 
 TDF Dͳ Social, Professional role and identity 
 TDF Dʹ Beliefs about capabilities 
 TDF D͵ Optimism 
 TDF DͶ Beliefs about consequences 
 TDF D͸ Intentions 
 TDF D͹ Goals 
 TDF DͱͰ Memory, Attention and Decision processes 
 TDF Dͱͱ Environmental context and resources 
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 TDF DͱͲ Social influences   
 
CATEGORY ͱͱ.  VIEWS ON RISKS OF TAKING ANTIBIOTICS 
 Related codes: 
 Approach to antibiotic use 
 Past experience with AB 
  AB side effects experienced 
  Self-management SE 
 Perspective: risk of AB  
Wary of AB 
  Concerned despite AB warranted 
  Low meds user 
TDF Dʹ Beliefs about capabilities  
TDF DͶ Beliefs about consequences 
 
 
Code mapping:  Second iteration 
The second iteration further reduced first cycle codes into concepts and/or themes, as 
shown below, while retaining the categories used in the first iteration of code mapping.   
 
CATEGORY ͱ.  PROCESS FOR CLINICAL DECISION-MAKING 
 Cognition and clinical examination 
 Experience and intuition 
  
CATEGORY Ͳ.  PRESCRIBING CHALLENGES 
 Practical and time constraints 
 Knowledge-Practice dissonance in antibiotic prescribing behaviours 
 Prescribing practices of medical colleagues 
 
CATEGORY ͳ.  PATIENT EDUCATION VS. INFORMATION NEEDS 
 Health professional mediated patient education vs. Consumer information needs 
 Public campaigns vs. Consumer awareness 
  
CATEGORY ʹ.  PATIENT EXPECTATIONS 
 Establishing and addressing patient expectations for the consultation 
 Managing relationships 
 Discerning-Undiscerning consumer  
Chapter ʹ:  What influences antibiotic use from the perspectives of GPs, community 
pharmacists and consumers? — Data analysis and results of semi-structured interviews
  ͱͳͱ 
CATEGORY ͵.  DELAYED ANTIBIOTIC PRESCRIPTIONS 
 Integrity and responsibility 
Support for issuing delayed antibiotic prescriptions 
Opposition to issuing delayed antibiotic prescriptions 
 
CATEGORY Ͷ.  REPEAT ANTIBIOTIC PRESCRIPTIONS 
 Intentional vs. Unintentional 
 Problematic sequelae 
 
CATEGORY ͷ.  VIEWS ON ANTIBIOTIC RESISTANCE 
 Meaning of antibiotic resistance  
Pessimism vs. Optimism 
 Impact of antibiotic resistance:  Professional, Personal, Societal    
 
CATEGORY ͸.  MITIGATING ANTIBIOTIC RESISTANCE 
 Individual initiatives:  Professional and Personal 
 Government and Commonwealth funded initiatives 
 
CATEGORY ͹.  ANTIBIOTIC USE BEHAVIOURS 
 Consumer behaviours   
 Health professional behaviours as consumers 
 Motivations for seeking antibiotics 
 
CATEGORY ͱͰ.  SELF-CARE STRATEGIES FOR RESPIRATORY TRACT INFECTIONS 
 Self-care and self-management of respiratory tract infections 
 Triggers for self-referral to GP 
 
CATEGORY ͱͱ.  VIEWS ON RISKS OF TAKING ANTIBIOTICS 
 Past experience with using antibiotics:  Non-event vs. Negative event 
 Safe to use vs. Concerned 
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Code mapping:  Third iteration 
The third iteration further reduced the categories from eleven to three — categorising 
the categories using new labels (Saldana, ͲͰͱͳ, p. ͱ͹͸).  The three meta-categories are: 
(a) clinical processes and challenges, (b) consumer attitudes, behaviours, skills and 
knowledge, and (c) engaging with antibiotic resistance.  These meta-categories with the 
eleven categories — now displayed as subcategories — are shown in Figure ͷ.  
 
Figure 7.  Meta-categories of what influences antibiotic use from the perspectives of GPs, 
community pharmacists and consumers 
 
CATEGORY A.  CLINICAL PROCESSES AND CHALLENGES 
Subcategories: 
Processes for clinical decision-making 
Prescribing challenges (overlaps with Category C) 
Delayed antibiotic prescriptions 
Repeat antibiotic prescriptions 
 
CATEGORY B.  CONSUMER ATTITUDES, BEHAVIOURS, SKILLS AND 
KNOWLEDGE 
 Subcategories: 
 Patient expectations (overlaps with Category A) 
 Antibiotic use behaviours 
 Self-care strategies for respiratory tract infections 
 Views on risks of taking antibiotics 
 
CATEGORY C.  ENGAGING WITH ANTIBIOTIC RESISTANCE 
 Subcategories: 
 Views on antibiotic resistance 
 Mitigating antibiotic resistance 
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Overlaps and linkages between the three meta-categories i.e. related concepts and/or 
themes across the three participant groups are illustrated in Figure ͸.  This became the 
Enabling Antibiotic Eupraxis (EABE) Model, which is discussed in Section ʹ.͵. 
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 GENERAL PRACTITIONERS:  INTERVIEW FINDINGS 
4.2.1 About the participants 
A total of ͱͰ GPs, of which ͳ were GP Registrars in their final year of training, were 
interviewed in the Brisbane or Greater Brisbane Area.  There was an equal number of 
male and female GPs interviewed in this participant group — ͵ men and ͵ women.  All 
were trained in Australia.  Their number of years of practice as a GP, including as a GP 
Registrar, ranged from ʹ to Ͳʹ years — ʹ were early career GPs (in practice for ͵ years 
or less), ʹ were mid-career (Ͷ to ͱ͵ years), and Ͳ had practiced for more than ͱ͵ years.   
Eight GPs/GP Registrars worked ͳͰ or more clinical hours per week.  Two GPs/GP 
Registrars identified as being part-time, working less than ͳͰ clinical hours per week.  
The characteristics of the clinic where these GPs practiced is summarised in Figure ͹. 
Figure 9.  Characteristics of clinics in which GPs interviewed worked 
Clinic type:   1 worked in a Corporate clinic; 3 in Sole-owner Multi-GP clinics; 2 in 
Multi-GP clinics; 4 in Government Health Service clinics. 
AGPAL Accreditation:   8 worked in AGPAL accredited clinics; 2 did not. 
Billing: 3 worked in a mixed billing clinic; 1 in a private billing clinic; 6 in bulk-
billing clinics. 
Location: All clinics were located in the suburbs. 
Socio-economic status 
(SES)21 of community 
served: 
4 were serving lower SES communities; 4 were serving mixed SES 
communities; 2 were serving higher SES communities. 
 
There were nine main concepts/themes which emerged out of the GP interviews — 
previously shown in Table ͱͰ:  process for clinical decision-making, prescribing 
challenges, delayed antibiotic prescription, repeat antibiotic prescription, patient 
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21 Socio-economic status by postal area code were taken as a guide to relative disadvantage as 
per the Socio-Economic Indexes for Areas (SEIFA) by the Australian Bureau of Statistics 
(Australian Bureau of Statistics, ͲͰͱͳ).  SEIFA ranking within State or Territory as deciles 
were used, with deciles ͱ and Ͳ representing the most disadvantaged, deciles ͹ and ͱͰ being 
the least disadvantaged.  For the purposes of describing the characteristics of the population 
which the GPs interviewed served, lower SES was represented by deciles ͱ to ͳ, mixed SES by 
deciles ʹ to ͸, and higher SES by deciles ͹ and ͱͰ. 
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expectations, antibiotic use behaviours, patient education, views on antibiotic 
resistance and mitigating antibiotic resistance.  These concepts/themes mirror the 
main interview questions asked of this participant group, as well as those which 
emerged from the GP interviews.  Each concept/theme is discussed in turn below, 
beginning with those pertaining to the participants' professional role as a GP, before 
exploring concepts related to personal views and behaviours.   
Quotations from the interviews are included where relevant, to provide evidentiary 
warrant or to illustrate a point.  Quotations are presented in the format in which the 
transcripts were done i.e. using an adaptation of the Jeffersonian Transcription 
Notation (Appendix K).   
Reporting of interview results for community pharmacists (Section ʹ.ͳ) and consumers 
(Section ʹ.ʹ), follow the same presentation format. 
 
4.2.2 Process for clinical decision-making 
Cognition and clinical examination 
GPs described the complex process of medical decision-making — in this case, when 
considering whether antibiotics are warranted for a respiratory tract infection — as 
working through a mental algorithm comprising several elements (Box ͸).  Key 
elements named by GPs included:  symptoms and clinical features of the patient's 
presentation of illness, patient's age and general health, length of illness, additional 
information upon clinical examination, medical history including co-morbidities, the 
likelihood of a bacterial infection, predisposition to certain bacterial infections due to 
being indigenous Australians or geographical location, the patient's concerns and 
experience of the illness (e.g. how unwell the patient feels).  As part of the mental 
algorithm, GPs also sifted through differentiating features indicative of a list of 
common respiratory infections which require treatment with antibiotics e.g. 
pneumonia, bacterial sinusitis, streptococcal infection of the throat (Box ͹) (Antibiotic 
Expert Groups, ͲͰͱʹ).  Decisions as to whether further investigations are warranted e.g. 
throat swab, chest x-ray, are also made at this point. 
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Box ͸. 
"So there’s a whole variety of algorithms that are going on at the same time!  
((smiles))  So keeping in mind that most respiratory infections are not going to be 
bacterial, so antibiotics are actually not indicated, they’re going to do nothing.  
Um, so trying to figure out whether it’s more likely to be a viral or bacterial 
infection; um, the severity of the infection."  (GPͰͲ, GP for Ͷ years, line ͸͵-͸͹) 
 
Box ͹. 
"It’s my job to filter in my head, is this actually one of those few conditions where 
there is evidence for antibiotics?"  (GPͰͷ, GP for ʹ years, line ͸Ͳ-͸ͳ) 
 
Procedurally, the medical decision-making process described for respiratory tract 
infections is not dissimilar to GPs weighing up treatment or management options for 
other types of illnesses — perhaps differing only in the details of diagnostic tests used, 
criteria for diagnosis, methods of assessment and monitoring, and frequency of review, 
taking into account the need for involvement of other medical (e.g. specialists) or allied 
health colleagues (e.g. dietitian, podiatrist, speech therapist, physiotherapist, 
occupational therapist, clinical nurse, clinical pharmacist).  However, uncertainty of 
diagnosis for respiratory tract infections (whether the pathogen is viral or bacterial) 
compounded with the element of patient expectations for antibiotics — whether actual 
or perceived by the GP — exerts a measure of prescribing pressure on the GP.  This 
pressure to prescribe antibiotics for a respiratory tract infection, was felt more acutely 
by early career GPs — GP Registrars and newly qualified GPs — who may not yet have 
well-practiced strategies and professional confidence to holistically address the 
patient's expectations for antibiotics: 
"… and I guess I could just say:  No, I’m absolutely a hundred percent not 
giving it [antibiotics] to you.  But maybe that’s where clinical experience 
comes in to hand, because I feel like well, I haven’t been doing this for 
twenty years.  So, maybe they [patients] actually do know better than 
me, and then you kind of- I guess then: “Well, I don’t want you to 
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suddenly get sick because I haven’t given you something [antibiotics], so 
here you go."  (GPͰʹ, GP Registrar final year, line ͱͶ͵-ͱͷͰ). 
The concept of patient expectations and its impact on prescribing decisions and 
prescribing behaviours, is discussed more fully in Section ʹ.Ͳ.Ͷ. 
 
Experience and intuition 
It is evident that medical decision-making processes involves cognitive processes, given 
that clinical reasoning relies heavily on knowledge, the ability to retain information 
(memory), attention, and the ability to differentiate and choose between two or more 
alternatives.  Given this reliance on cognition, it is perhaps surprising that GPs also 
recognised that medical decision-making necessitates the involvement of intuition, as 
evidenced by the following quote. 
"… you have to do it fairly quickly and intuitively, it’s quite a lot of 
information to sort of try to pack into your ratio of whether you should 
prescribe or not."  (GPͰ͸, GP for ͲͰ years, line ͱͳ͹-ͱʹͰ) 
The intuition spoken of here is arguably that of a practiced intuition, in that it is a 
heuristic or pattern recognition that is refined through clinical experience.   
An early career GP used a related but different term — "gut instinct" or "instinct" — as 
shown in the following quotes. 
"… but it’s a- it’s tough- you know, it’s kind of gut instinct you know, do 
they look sick, do they look well…"; and 
"… and try and treat each patient, but um, on our instincts and our 
clinical knowledge."  (GPͱͰ, GP Registrar final year, line ͱͷͱ-ͱͷͲ and line 
ͳ͵͵-ͳ͵ͷ) 
 
The choice of words by this GP Registrar, using "instinct" rather than "intuition", 
signals their self-awareness that they currently lacked the depth and breadth of clinical 
experience, which was corroborated in other parts of the interview (see quote from 
GPͱͰ in the discussion on negotiating clinical uncertainty in this section). 
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Conversations during the interviews on processes for clinical decision-making and 
patient expectations, led to an emergent concept — the notion of what it means to be a 
good GP (Box ͱͰ shows a representative quote).  As part of their social/professional role 
and identity, a good GP is someone who (a) has the skills to deal with uncertainty i.e. 
the ability to weigh up risks and benefits when making treatment decisions and the 
ability to ascertain likelihoods and consequences of risks, (b) practices evidence-based 
medicine when evidence for a particular course of action is available, (c) has good 
communication skills, and (d) is able to establish rapport with the patient to build good 
doctor-patient relationships.  A good GP is also a wise advocate for the patient, in that 
he/she makes treatment decisions in the best interest of the patient.  Hence, when 
antibiotics are not warranted, "… good GPs talk to you about not using antibiotics." 
(GPͰ͹, GP for Ͳʹ years, line ͳ͵ʹ-ͳ͵͵) 
Box ͱͰ.  Description of a "good GP" 
"… the skill of being a good GP is to deal with risk, deal with uncertainty, deal 
with likelihoods and I think um, that is what I spend a lot of time talking about 
and thinking about.  And so, … so to me it’s all a matter of weighing up the harms 
and benefits…"  
(GPͰ͸, GP for ͲͰ years, line ͱͲ͸-ͱͳͰ) 
 
Negotiating clinical uncertainty — deciding on a course of action when there is 
ambiguity either in the patient's presentation, in clinical guidelines or in the evidence 
(or lack of evidence) — is part and parcel of GPs' work.  When making decisions in 
these situations, GPs weigh up risks and benefits in at least two ways for each course of 
action being considered: (a) the likelihood of the pathogen i.e. whether bacterial or 
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viral, (b) the impact on the patient's health outcomes if the GP gets it wrong.  The 
figure below illustrates this in a Ͳ x Ͳ matrix22: 
 
 Impact on patient's health 
(bacterial infection requiring 
antibiotics) 





1. Desirable impact — GP 
prescribes antibiotics and 
the patient needs 
antibiotics. 
2. Adverse impact — exposing 
patient to side effects of 
antibiotics and antibiotic 
resistance:  GP prescribes 
antibiotics and the patient 
does not need antibiotics. 
GP does not 
prescribe 
antibiotics 
3. Adverse impact — 
patient's health 
deteriorates:  GP does not 
prescribe antibiotics and 
the patient needs 
antibiotics. 
4. Desirable impact — GP does 
not prescribe antibiotics and 




Quadrants ͱ and ʹ are desirable, in that in both cases the GP's decision is aligned with 
the patient's need or otherwise, for antibiotics.  Quadrants Ͳ and ͳ illustrate cases 
where, retrospectively, the GP has made the wrong decision to the detriment of the 
patient. 
"So, you also have the potential impact if you get it wrong, and it’s on 
both sides.  So there’s also potential impact on giving an antibiotic and it 
being viral and you get side effects from the antibiotic and resistance; all 
that sort of stuff [Quadrant Ͳ].  There’s [sic] impacts the other way 
round, where you’re pretty sure it’s viral but once in a while you know 
you’ll be wrong [Quadrant ͳ], and if that person has lots of co-
morbidities or perhaps is very health illiterate or has no transport or is 
cxxxix                                                     
 
22 Adapted from related work I conducted as a Research Assistant to my Principal Supervisor, 
Dr. Katie Page, investigating how consumers value the different consequences using the 
Value of Consequences method. 
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likely- going out bush or something like that, impacts of that could be 
worse."  (GPͰ͸, GP for ͲͰ years, line ͱͳͲ-ͱͳ͸) 
 
The ability to negotiate diagnostic uncertainty, which then impacts on the course of 
treatment, is a challenge and can be a source of frustration especially for early career 
GPs. 
"… well, I feel like it’s a grey area anyway.  … we try and explain to 
patients, but … whether it’s because I’m a GP Registrar or whatever, I 
feel it’s pretty grey anyway.  So I feel frustrated in myself.  Sometimes 
I’m like, what should I do, you know" and "… it’s a bit better as a GP 
Registrar, but I’m aware I’m about to leave that public protection and so, 
you feel a bit on your own and you- I mean you read guidelines but no 
one can kind of really hold your hand and tell you exactly when you 
should give it [antibiotics].  So I still struggle with that a lot."  (GPͱͰ, GP 
Registrar final year, line Ͳ͹ͱ-Ͳ͹ͳ and ͳͷ͵-ͳͷ͸)   
 
All things being equal, the willingness to take a wait-and-see approach differs between 
GPs, perhaps due to different tolerance levels for uncertainty.  The two quotes that 
follow demonstrate this difference, and that being cautious takes on different meanings 
and expressed as different behaviours for each GP.   
"I usually err on the side of caution and not prescribe, and say uh:  'Look 
it might get a bit worse, we’ll see how you go, if you’re any worse 
tomorrow, come back and we’ll have another look at you.' "  (GPͰͲ, GP 
for Ͷ years, line ͲͰ͹-Ͳͱͱ)  
"Sometimes there, there is an area of grey in medicine.  Um, and it’s not 
apparent, you know, this definitely is the diagnosis requiring antibiotics.  
And sometimes you err on the side of caution, because the potential 
benefit outweighs the risk.  OK.  And then you find out subsequently [in 
actual] fact that probably was an URTI, and I probably didn’t need to 
prescribe antibiotics in that situation.  … but, yeah, so the grey area can 
be difficult."  (GPͰͳ, GP for ͱͳ years, line Ͳͳ͹-Ͳʹʹ) 
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The use of shared decision-making was mentioned as a strategy for managing clinical 
uncertainty collaboratively with the patient: 
"So there are some situations where it’s uncertain.  If it’s been going on 
for a long time you know, a couple of weeks; that makes it trickier.  
Sometimes with bronchitis, you’re not sure if it’s mycoplasma.  
Sometimes if there’s otitis media there is some evidence of benefit, you 
know [to use antibiotics].  You would then … negotiate it with the 
patient.  So you know what the harms and benefits are, and you discuss 
them [with the patient] and you present them.  And see which way 
they’re landing; and then in that situation it’s not unreasonable to 
prescribe antibiotics, in my view."  (GPͰͶ, GP for ͱͱ years, line ͳͲʹ-ͳͳͰ) 
 
However, in dealing with grey areas in medicine e.g. where there is a lack of evidence, 
GPs will often have to make a judgment call.  GPͰͷ gives the example of managing a 
chronic cough as a grey area:   
"So when someone comes to me and they’ve had a productive cough for 
ͳ weeks, my interpretation is their- I know it’s acute bronchitis and I 
know it’s- a lot of those is still viral or they still resolve without 
antibiotics.  But … I sometimes feel they haven’t done studies on that 
sample population and … I make a judgment call in that group, in that 
grey area."  (GPͰͷ, GP for ʹ years, line ͹͸-ͱͰͲ) 
 
4.2.3 Prescribing challenges 
Practical and time constraints 
The need to keep consultations within (or as close as possible to) the allotted 
appointment duration means that GPs need to be efficacious with their use of time.  
One of the common challenges cited by GPs is the lack of time to properly educate 
patients who demand or expect antibiotics when it is not clinically warranted.  In order 
to adequately address these patient expectations, experienced GPs have well-honed 
consultation processes which persuade the patient that they are acting in the patient's 
best interest.  Even so, these processes take time.  For less experienced/early career 
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GPs, time constraints may be felt more acutely, especially for those working in non-
bulk-billing clinics where the cost to patients is significant for longer appointments.  
GPs who work in bulk-billing or mixed billing clinics report the contrary: 
"… ͱ͵-minute [appointments], as a rule.  This practice is very good on 
encouraging patients to book long, if they’ve got more than one 
problem.  And from what I hear, it’s a lot better than other practices ...  
… and because it’s bulk billing, well the Registrars are all bulk billing.  ... 
To book a private patient a long appointment is a big deal.  I mean 
privately, I think it’s about $ͱͲͰ or $͹Ͱ or something.  So I think private 
clinics probably don’t book as many patients but they book them all 
short.  Whereas … I guess I have a freedom ‘coz I’m bulk billing.  If I 
want to spend longer with the patient I can and it doesn’t affect the 
patient’s billing."  (GPͱͰ, GP Registrar final year, line ͱͲͱ-ͱͳͲ) 
A practical consideration which may influence prescribing patterns and which 
reinforces the problem of time constraints, is the contractual arrangement between the 
clinic and the GP.  For example, some GPs are remunerated with a pre-negotiated 
percentage of clinic billings in addition to base pay.  Others have a percentage of 
billings attributed to their caseload being taken by the clinic as payment for the use of 
facilities and clinic staff.  In either case, there is a financial imperative, arguably more 
so for early career GPs, to build up a regular patient base and/or to see as many 
patients as possible as evidenced by the following quotes. 
"… and a lot of patients too, they come here expecting a certain service, 
so I might give it [antibiotics] to them because of their expectations, but 
not encourage them to take it, and explain to them about resistance and 
why.  But still patient expectation does come into it."  (GPͰͱ, GP for ͱ 
year, line ͹Ͷ-͹͹) 
"… and some will do very short, very brief appointments.  So I remember 
working in another practice, where sometimes a Ͳ-minute appointment 
— all you have time [for] is a script and my colleague sometimes 
wouldn’t shut the door, there’s no time, you just get them through … 
that’s a very different way of practising."  (GPͰͲ, GP for Ͷ years, line 
ʹ͹ͷ-͵Ͱͱ) 
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Other challenges when deciding whether or not antibiotics are needed are when tests 
to assist in diagnosis (to ascertain whether the pathogen is viral or bacterial) are not 
available or not feasible (Box ͱͱ) i.e. will take too long for results to be returned, for 
timely treatment.  Making a decision in an "evidence-free zone" (Box ͱͲ) is another 
challenge which was discussed under negotiating clinical uncertainty in Section ʹ.Ͳ.Ͳ 
above. 
 
Box ͱͱ.  Prescribing antibiotics — better safe than sorry 
"… situations dictate that they can’t have those investigations, the safe option I 
feel would be then to cover them with antibiotics, in case of that chance that it is 
bacterial" and "… so if I’m concerned, … so in this situation where I’m unclear 
whether it’s more likely viral or bacterial, if I’m fence-sitting, and I can’t get them 
to have investigations … then yeah, I’d give it [antibiotics] to them and say start 
them."  (GPͰ͵, GP Registrar final year, line ͷͳ-ͷ͵ and line ͷ͹-͸ͱ) 
 
Box ͱͲ.  Making decisions in an "evidence-free zone" 
"… a lot of the time we make decisions … in an evidence free zone.  For instance, 
someone comes in and they’ve got acute bronchitis and they’re coughing a bit of 
green- a bit of phlegm, but it’s been there for more than a week, it’s not especially 
productive, they’re young.  And then you’ve got the decision, do I need antibiotics 
at all?  Probably not.  Um, if I do use antibiotics, do I use a typical one like 
Amoxycillin or do I think:  could it be mycoplasma, one of those atypical 
infections in a young person; and should I use Rulide® or doxycycline or 
erythromycin?"  (GPͰͷ, GP for ʹ years, line ͱͶͱ-ͱͶͷ) 
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Knowledge-Practice dissonance in antibiotic prescribing behaviours 
The dissonance between knowledge and prescribing practices was apparent from the 
interviews.  Sometimes, despite GPs discerning that the presenting infection is highly 
likely to be viral and the knowledge that unnecessary use of antibiotics causes 
antibiotic resistance — antibiotics are still prescribed.  GPs are aware that in doing so, a 
breach of best practice has occurred.  Self-acknowledgement of this dissonant 
behaviour resulted in a range of emotions described in the interviews — frustration or 
disappointment in themselves, a sense of guilt, feelings of having been manipulated, 
and exhaustion. 
GPs spoke of "caving in" to patient expectations to prescribe antibiotics, due to 
exhaustion.  The quote below conveys a sense of futility in trying to persuade the 
patient otherwise, resulting in the GP taking the "path of least resistance": 
"I admit there’s been times I’ve prescribed antibiotics that I actually 
don’t think is appropriate.  Um, but the person is so::: adamant about it 
or difficult to deal with or just completely insistent about it, that … 
sometimes it’s exhausting actually trying to convince them that they 
don’t need them [antibiotics], so the path of least resistance is just to 
write a script, and like — There! Get out of my room."  (GPͰʹ, GP 
Registrar final year, line ͱͲ͵-ͱͳͰ) 
GPs are especially vulnerable to knowledge-practice dissonance, if they have not 
previously thought through (and practiced) strategies — both processual and verbal — 
in dealing with patient expectations for antibiotics.  Retrospective rationalisation may 
ensue, to assuage the GP's conscience, and to keep their professional role and identity 
as a good/caring GP intact. 
"But if you haven’t really thought about it [antibiotic resistance] or it’s 
not a number one issue for you, and there are lots of competing 
demands for GPs; then yeah, you’ll find it very difficult to resist the 
patient who’s asking for it in front of you.  You’ll tell yourself all sorts of 
stories about how it’s really not that dangerous for them, which it 
probably isn’t; and … it’s just one script and … this is an easy, quick end 
to a consult."  (GPͰͶ, GP for ͱͱ years, line ͳ͵ͱ-ͳ͵Ͷ) 
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A subtler form of knowledge-dissonance ("soft option" in quote below) was displayed in 
relation to prescribing delayed antibiotics, when GPs held views and knowledge of the 
weak evidence base to support such prescribing behaviours, but yet decided to do so.  
In these instances, caveats were used to delineate the circumstances under which 
issuing delayed antibiotic prescriptions is permissible.  
"I know the evidence is not for it.  I sometimes, sometimes I do it as my 
soft option.  I know I’m not supposed to, I know it actually would- my 
understanding of the evidence is that the patients would be happier to 
come back and see me, um, if they’re worried about it getting worse.  
Um, but I know I do.  I do delayed antibiotics, particularly for workers or 
for people who are- live a certain distance from the clinics.  Some of our 
people live out past [name of suburb], so that’s ͳͰ or ʹͰ minutes’ drive 
from here.  … but I know it’s not the best evidence, the best practice."  
(GPͰͷ, GP for ʹ years, line ͱͲ͸-ͱͳʹ) 
Patient expectations, addressed in Section ʹ.Ͳ.Ͷ, is a key prescribing challenge reported 
by GPs.   
 
Prescribing practices of medical colleagues 
The selection of antibiotics, whimsically referred to as "the dark arts" by a GP (GPͰͷ, 
GP for ʹ years, line ͱ͵ͱ), is influenced by senior medical colleagues such as GPs or 
hospital specialists — who sometimes recommend inappropriate antibiotics for the 
primary healthcare sector, either in terms of not being funded on the Pharmaceutical 
Benefits Scheme (PBS), having too broad a spectrum for common bacteria found in the 
community setting, or both.    
"… specifically, I’m thinking about … one of my GP Registrar colleagues 
when I was training … and their supervisor’s a bit weird.  And absolutely 
told the patients they needed this different special antibiotic … 
clarithromycin or something …   he [the supervisor] was chastising her, 
the Registrar … for picking a standard amoxicillin."; and  
"… I remember in Emergency when I was doing my training up in 
[hospital name], they had a lot of moxifloxacin, a very broad spectrum 
antibiotic, um, which is there on the guideline but it’s not funded [on 
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the PBS]. … they [hospital doctors] … just felt that that’s the strongest 
antibiotic, we’ll give it to every patient.  When they ran out, they started 
writing scripts for moxifloxacin, not realising that they were expensive 
private scripts for patients, … so yeah, they were telling- writing letters 
to GPs saying please prescribe moxifloxacin if this recurs.  And of course 
we can’t access that under PBS."  (GPͰͷ, GP for ʹ years, line ͱ͵ͱ-ͱͷ͹) 
 
GP Registrars are perhaps more susceptible to the influence of hospital specialists, due 
to the recency of being under an inherent medical hierarchy while on hospital rotation 
for training.  However, more experienced GPs have also reflected on the fact that their 
prescribing had been somewhat shaped by specialist medical colleagues such as Ear, 
Nose and Throat specialists, Respiratory physicians and Cardiologists.  To further 
compound the issue, hospital specialists often treat a different type of patient 
compared to those who present to general practice, in that the suspected pathogens are 
often different and perhaps more virulent — requiring stronger antibiotics. 
"… and also Ear, Nose and Throat specialists and Respiratory physicians 
are seeing a different population.  … they wouldn’t see, you know, ͹͵% 
of the people I see.  They’re just going to see a subset … this kind of 
specific subset which isn’t reflective of the community thing.  So in 
actual fact … Ear, Nose and Throat specialists should be working with us 
… not telling us this is the right antibiotic to use."  (GPͰ͹, GP for Ͳʹ 
years, line ͱͷͷ-ͱ͸Ͳ) 
 
Undesirable prescribing practices of other GPs present another dilemma and a source 
of frustration for GPs who are conserving antibiotics.  At best, the patient is confused 
with the mixed messages regarding the use of antibiotics from different GPs (Box ͱͳ).  
At worst, patients are perversely encouraged to seek GPs whom they know habitually 
prescribe antibiotics, even when not required. 
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Box ͱͳ.  A source of frustration for prudent GPs 
"I’m hoping my colleagues will stop prescribing antibiotics to my patients when 
they’ve got a cold ((laughs)).  It’s very frustrating.  They [other GPs] don’t talk 
about it, they just give it.  And then my patients come back and say, 'Oh, we went 
over there we got antibiotics, great.  But they didn’t even listen to my chest, they 
didn’t check my temperature, they didn’t do anything, they just said, Oh, you’ve 
got a terrible infection you must take this [antibiotic].'  Uhhhh::: ((frustrated soft 
sigh)) ((laughs)) Little bit frustrating!   
Again I don’t mean to sound like I’m being disrespectful to my colleagues and 
things like that.  But I know there’s just a few people who’re like that, it’s not 
everyone. [Speaking about GPs pulling together in the same direction] Yes. ‘Coz 
then there’s no confusion amongst patients as to why you did not prescribe when 
this other doctor said I needed to have it.  So everyone gets confused."  (GPͰͲ, GP 
for Ͷ years, line ʹͷͱ-ʹ͸Ͳ) 
 
The phenomenon of extending professional etiquette was observed when interview 
conversations with GPs veered into critique or comment about prescribing practices of 
other GPs (as seen in Box ͱͳ previously).  While there is a level of frustration that not all 
GPs are pulling in the same direction — hence somewhat undoing the patient 
education prudent GPs have done — GPs were largely careful not to negatively evaluate 
the decisions and abilities of their colleagues.  Instead, GPs extended professional 
courtesy by suggesting or speculating on reasons why other GPs could have prescribed 
antibiotics: (a) the patient changed their story, (b) the GP started their career when 
antibiotic resistance was not such an issue and that prescribing habits formed early are 
not easy to change, and (c) the GP did not have the benefit of hospital rotations unlike 
current GP training programs, where the reality of the consequences of antibiotic 
overuse is evident daily. 
GPs may also extend professional etiquette to other GPs through the following ways — 
especially if they are simply filling in e.g. as a locum GP or the patient could not get an 
appointment with their regular GP:  by (a) acceding to patient demand for antibiotics 
Chapter ʹ:  What influences antibiotic use from the perspectives of GPs, community 
pharmacists and consumers? — Data analysis and results of semi-structured interviews
  ͱʹ͸ 
as their regular GP "always prescribes" antibiotics for their presenting condition, and/or 
(b) not critically evaluating previous prescribing decisions. 
 
4.2.4 Delayed antibiotic prescriptions 
Integrity and responsibility 
The question of whether to issue a delayed antibiotic prescription for a respiratory tract 
infection, is a contentious one.  While there are reasonable grounds for such 
prescriptions, such as (a) the inability of the patient to present for reassessment should 
their health deteriorate due to finances, time and/or travel constraints, and (b) co-
morbidities e.g. chronic obstructive pulmonary disease, delayed antibiotic prescriptions 
can also represent an abdication of responsibility on the GP's part.  Essentially, in the 
case of respiratory tract infections when there is uncertainty as to whether the 
pathogen is viral or bacterial (and the delayed prescription was issued under these 
circumstances), the patient makes the final decision on when and whether to start 
antibiotics.   
GPs who do not subscribe to this practice, think that it is unfair to delegate the 
decision on when and whether to use antibiotics to the patient — perhaps reflecting a 
view that GPs should take more responsibility for treatment decisions (Box ͱʹ).  To 
complicate matters, often in these cases there is no single, definitive symptom that 
would trigger the warrant for antibiotics.  Thus, it is difficult for GPs to provide 
meaningful advice to guide the patient to a course of action, apart from general 
statements such as "… and in ͳ or ʹ days if you’re not any better, then you could try the 
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Box ͱʹ.  Unfair to delegate treatment decision to patient 
"I think to some extent it’s placing an onus on the patient themselves … [it] is 
already a very difficult decision for a highly trained, experienced health 
professional to make …  It’s fairly unfair I think.  And it’s very hard to, in 
most cases, for respiratory things for example, to describe the circumstance 
in which you would like them to take it.  Because you know, we know that all 
the symptoms, things like fever and cough and production of cough and that 
sort of thing, aren’t all that discriminatory anyway.  And in fact, that’s why 
we, in our heads use them as a bit of an algorithm, there’s no single 
symptom which if it gets worse that’s when you take the antibiotic.  So it’s 
very hard to, I think, explain that to a patient and expect them to make a 
rational decision."  (GPͰ͸, GP for ͲͰ years, line Ͳͱͱ-ͲͲͱ) 
 
On the other hand, some GPs seem comfortable with letting the patient decide 
(discussed in subsection:  Support for issuing delayed antibiotic prescriptions), and 
may view the refusal to prescribe delayed antibiotics to be an overly paternalistic 
approach. 
Prescribing delayed antibiotics also calls into question the problem of professional 
integrity, especially if GPs capitulate to patient demands or expectations.  Experienced 
GPs make the distinction between having consciously made a medical decision — 
"Does this person need antibiotics or not?" — and dealing with patient expectations for 
antibiotics.  Failure to separate the two acts can lead to using a delayed antibiotic 
prescription as a means of assuaging the patient, which in turn compromises the GP's 
professional integrity and chips away at their professional identity. 
"Does this person need antibiotics or not?  … if there were no other 
societal pressure, what would I do here?  What is the right thing to do?  
And so I think it’s really critical to make that decision."; and 
"…because if you … decide that they don’t need antibiotics, which almost 
always they don’t, or frequently they don’t, um, then you’ve got a bit of 
an integrity issue … if you go and prescribe them."  (GPͰͶ, GP for ͱͱ 
years, line ͲͲ͵-ͲͲ͸ and line ͲͲ͸-ͲͳͰ) 
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Support for issuing delayed antibiotic prescriptions 
GPs who are open to the practice of issuing delayed antibiotic prescriptions seem to do 
so for the following reasons: (a) as a way of investing in the doctor-patient relationship, 
(b) as a way of respecting and involving the patient in collaborative management of 
their health — respecting the patient's time and ability to judge if antibiotics are 
needed, as demonstrated by the two quotes that follow: 
"… but I think you sometimes need to do that [give delayed antibiotic 
prescriptions] to maintain the relationship with the patient.  And then, 
if they've got trust in you, you can then educate them.  And then they 
won't necessarily expect them [antibiotics] in the future."  (GPͰͱ, GP for 
ͱ year, line ͱͱ͹-ͱͲͱ) 
"… and I’ll often say to them, 'if it was me, I’d most probably take this 
home and sit on it, and not use it and just see if my own body would 
handle this, even though you are sick, your own body could still fight 
this; but this is how I’d approach it …' So trying to give them that option 
and stuff like that.  I think it’s really hard when people [GPs] say, no, no 
look, you know, you’ve got to come back and see me.  … if it’s right on 
the cusp, and you’re dealing with adults, I do think that you can respect 
the adult and say [that], because the other thing is people have had to 
take time off work to come in and see you."  (GPͰ͹, GP for Ͳʹ years, line 
͸͹-͹Ͷ) 
 
In each of these instances, there is also an element of optimism and trust on the GP's 
part — both in the patient's capabilities to judge for themselves and that the patient 
would make the right decision. 
"I feel that the patients [of] this particular clinic are very reasonable 
people and make sensible decisions."  (GPͰͱ, GP for ͱ year, line ͱ͵͹-ͱͶͰ) 
Another concern of some GPs is to avoid being negatively evaluated by patients and 
being accused of harbouring questionable motives.  By withholding the prescribing of 
antibiotics and insisting that they return for a reassessment in the event their 
symptoms worsen, patients may think that the GP is financially motivated: 
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"… [by writing a delayed antibiotic script] it doesn't look like you're 
trying to scam them into another appointment if they don't get better or 
anything like that.  So you keep the relationship."  (GPͰͱ, GP for ͱ year, 
line ͱͶͱ-ͱͶͳ) 
 
Opposition to issuing delayed antibiotic prescriptions 
Apart from the issues of compromised integrity and abdication of responsibility 
discussed previously, prescribing delayed antibiotics potentially confuses patients by 
giving them a mixed message.  As one GP puts it: "… it sends a mixed message.  I don’t 
think you need antibiotics, but here’s a script."23 
GPs who prefer decisive action argue that by putting off the treatment decision, the 
benefits of antibiotics would be lost to the patient:   
"If they [antibiotics] were going to have any benefits you should give 
them straightaway, rather than delaying a couple of days.  … you get a 
ͱͶ-hour benefit on- for sore throat and otitis media, and it’s within a 
couple of days.  So if you wait a couple of days you’re missing out [on the 
benefits of treating with antibiotics]." (GPͰͶ, GP for ͱͱ years, line ͲͶ͹-
ͲͷͲ) 
GPs who oppose or rarely prescribe delayed antibiotics prefer that patients return for a 
reassessment of treatment needs.  In instances where there is uncertainty of diagnosis 
(between viral and bacterial) and the GP has made a judgment call that antibiotics are 
not needed at that point, rather than issuing a delayed antibiotic prescription the 
patient is given a range of signs and symptoms which, should they occur, would 
warrant a return to the clinic for reassessment. 
cli                                                     
 
23 A systematic review (Spurling et al., ͲͰͱͳ) not surprisingly showed that a strategy of no 
antibiotics for respiratory infections reduced antibiotic use by a larger percentage as 
compared to a strategy of delayed antibiotics.  Hence, assuming the no antibiotic approach 
was reasonable clinically, avoiding the prescription of delayed antibiotics would both help to 
reduce antibiotic use and maintain the GPs’ professional integrity. 
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"I mean that situation occurs commonly [uncertainty of diagnosis].  … … 
so I provide the patient with safety net information.  So for example, if I 
send them away with a diagnosis of a viral URTI, I will say to them, … 'if 
you find that in, you know, Ͳ or ͳ days’ time you’ve still got 
temperatures above this level, … or if you’re finding that you’re getting 
short of breath or getting pain in your chest especially if you take a deep 
breath in, or you’re just finding that you’re generally deteriorating, then 
please come back and see me.'  … essentially saying I’ve got an open door 
and if you’re feeling worse, come back."  (GPͰͳ, GP for ͱͳ years, line ͱͷͳ-
ͱ͸Ͳ) 
 
Having said that, even GPs who adamantly avoid prescribing delayed antibiotics 
conceded that they would do so, if the patient was unable to present for reassessment 
should their health deteriorate due to finances, time and/or travel constraints. 
 
4.2.5 Repeat antibiotic prescriptions 
Intentional vs. Unintentional 
Repeat antibiotic prescriptions are stipulated by the GP when issuing the original 
antibiotic prescription.  A repeat prescription enables a patient to obtain another 
course of antibiotics without having to consult a GP.  Hence, these prescriptions are 
usually only issued if (a) the GP intentionally prescribes a duration of treatment which 
requires more than one course of antibiotics, (b) when the dosage required means a 
repeat prescription is needed to obtain the correct quantity of tablets/capsules for a 
course of treatment, or (c) when a standby antibiotic prescription is needed in the 
event of an acute relapse/exacerbation e.g. patients suffering from chronic obstructive 
pulmonary disease.   
However, since the advent of computer generated prescriptions, GPs may inadvertently 
include a repeat prescription where none was intended, due to prescribing software 
defaults.  Unless these defaults are inactivated by the GP, the prescription generated 
would usually indicate the maximum number of repeats allowed under the PBS.  This is 
perhaps desirable for prescription medication used to treat chronic illnesses e.g. 
hypertension, diabetes (but even then, it can be argued that a medication review at 
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least every ͳ months would not be amiss), but creates a situation that tempts 
inappropriate usage of antibiotics.  Some GPs may not be aware that these software 
defaults are in place or they may not remember to deactivate it when generating an 
antibiotic prescription. 
"… but I find it horrendous, the thought that it happens a lot, 
particularly junior doctors coming to practice will not even realise 
there’s such a thing as a default tick box.  Virtually not realising that 
they’re prescribing repeats, or if they are [realising it], just think, oh 
well, everyone else must be doing it, so I’ll do it as well."  (GPͰ͸, GP for 
ͲͰ years, line Ͳͳ͵-Ͳͳ͹) 
 
Problematic sequelae 
Repeat antibiotic prescriptions — both intentional and unintentional repeats — can 
create subsequent problems for the patient and the GP.  A patient with a repeat 
antibiotic prescription in hand, may choose to self-medicate the next time they became 
ill, regardless of whether they think it is the same infection or a different one.  GPs 
could then be faced with problematic sequelae such as having to deal with late 
presentation of the patient (having unsuccessfully tried to self-medicate with 
antibiotics), perhaps more resistant bacteria, or inability to perform necessary tests for 
verification of the pathogen due to the patient being exposed to antibiotics.  The quote 
that follow is from a GP who is now against "just in case" antibiotic prescriptions, due 
to adverse sequelae, which is applicable to repeat antibiotic prescriptions: 
"… I used to do that, but then what happened would be, they’d come 
back ͸ months later with an entirely different infection and they go, 'Oh, 
I’ve had this script that you gave me just in case back then, I thought 
that would be good for my bladder infection.  So I just started taking it.'  
And now, I’ve got this problem that I haven’t had a urine test done 
before they started taking this random antibiotic, which is not the right 
one anyway for their bladder infection, or miscellaneous other 
infections.  So I prefer patients not to have their hands on ((laughs)), 
um, boxes of antibiotics or spare scripts, when they could do silly things 
with it."  (GPͰͲ, GP for Ͷ years, line ͲͳͶ-Ͳʹͳ) 
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4.2.6 Patient expectations 
Establishing and addressing patient expectations for the consultation 
It is important for GPs to discern and establish the patient's agenda for the 
consultation, preferably at the beginning of the session, rather than assume that the 
patient expects antibiotics (Box ͱ͵).  Some patients, but not all, state their expectations 
clearly and at the outset.  GPs interpret the following statements by patients to be 
veiled requests for antibiotics:  "I just want to nip it in the bud", "I just want something 
to stop it in its tracks" (GPͰʹ, GP Registrar final year, line ͱͲͰ-ͱͲͱ).  Other patients are 
more explicit: "… got a sore throat and runny nose, I want antibiotics before it goes to 
my chest” (GPͰ͵, GP Registrar final year, line ͹Ͷ-͹ͷ). 
Box ͱ͵.  Establishing the patient's agenda 
"… finding out what the patient wants to start with, is a good start.  Because they 
might not actually be wanting antibiotics; they want reassurance or just a check-
up.  But in the back of our mind, we might be thinking, 'Oh, they want 
antibiotics', what are we going to do; and that puts stress on us.  But getting their 
reason for attending is important.  … if they really want antibiotics, try to assess 
why they want those antibiotics …"  (GPͰͲ, GP for Ͷ years, line ͱͱͶ-ͱͲͲ) 
 
GPs also reported that some patients are clear about not wanting antibiotics if not 
required, and are simply seeking confirmation and assurance:  "I want to check up, but 
I'm hoping not to have antibiotics" (GPͰͲ, GP for Ͷ years, line Ͳͳͱ). 
The rest of Section ʹ.Ͳ.Ͷ, will focus on patient expectations for antibiotics. 
 
When addressing patient expectations for antibiotics, experienced GPs have well-
honed strategies to do so efficaciously.  One GP describes it as "preparing the ground" 
which comprises at least these components: (a) taking a thorough medical history, (b) 
conducting a thorough clinical examination, (c) consciously making a clinical decision 
for treatment and management i.e. whether antibiotics are required, (d) 
communicating the decision to the patient with confidence, empathy, and in a manner 
which conveys that the GP has made the decision in the patient's best interest.  GPs 
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emphasised that as part of managing patient expectations and maintaining the GP's 
autonomy of the prescribing decision, it is important to have explicitly/consciously 
made a decision about the need or otherwise for antibiotics, prior to communicating 
this decision to the patient in an appropriate manner. 
"…what you need to do then though, is take a thorough history, take a 
thorough examination, if::: well you obviously don’t want to miss things 
but also to indicate to the patient that the decision you’re about to tell 
them you’ve made, is based on your thorough history and examination 
of them.  It’s not of uh, some ideology, public health ideology, or some 
other thing that’s determining whether or not you give them antibiotics.  
It’s all got to be about them.  And part of the reason for that is they’re 
sick, you know.  They’re feeling really unwell and they want to know 
that you’ve got their best interest at heart.  And so once you’ve done 
that, you have to then decide whether they need antibiotics or not in 
your head.  OK, so do they really need antibiotics or do they not?  I 
think that’s a crucial step that a lot of doctors don’t take."  (GPͰͶ, GP for 
ͱͱ years, line Ͳͱʹ-ͲͲͳ) 
 
According to the GPs interviewed, GPs suffer from a lack of confidence in terms of 
refusing to prescribe antibiotics when it is not indicated.  Reframing the consultation 
and instituting "preparing the ground" processes as described previously, will help GPs 
demonstrate that they are an advocate for the patient and that they are not simply 
refusing to prescribe antibiotics due to a strongly held public health ideology.  These 
strategies also help to establish and build trust in the doctor-patient relationship — the 
GP comes across as a wise advocate for the patient, standing firm in their conviction 
that an antibiotic is not required and doing so in a manner which validates the patient's 
concerns without capitulating to inappropriate patient demands.  GPͰͶ offers an 
example of how a wise advocate would communicate to the patient, their decision not 
to prescribe an antibiotic: 
"So I frame it in terms of … 'I’ve looked at you very carefully.  And it’s 
really clear to me that this is an infection that is not going to benefit 
from antibiotics.'  In fact I would be running pretty much all the risks 
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and the harms of antibiotics, and none of the benefits, you know 'the 
harms of antibiotics being diarrhoea and vomiting and rash, I wouldn’t 
want to give you any of those [side effects].'  … and the other thing I say 
to them is, 'if I thought I could help you with antibiotics, I would give 
them to you in a second.' "  (GPͰͶ, GP for ͱͱ years, line Ͳʹͱ-Ͳʹ͸) 
On the contrary, GPͰͷ points out how not to communicate i.e. minimising the 
patient's concerns undermines the patient advocacy message: 
"I see with student doctors and junior doctors … the biggest problem is 
when they say [to the patient/parent] it’s just a cold, [signalling to the 
patient/parent] go away, this child is not sick enough for treatment.  … 
[instead] you want to say, yes this child is sick and unwell … and I’m 
doing everything in my power to get them better; antibiotics is just not 
part of that."  (GPͰͷ, GP for ʹ years, line ͱͲͲ-ͱͲ͵)  
 
GPs found that patients were responsive to the wise advocate approaches outlined 
above as they feel heard and validated, and were appreciative of the GPs' expertise:   
"… a patient does accept if you’ve done all those things before.  Because 
they think 'I’ve been listened to, and he’s you know, making this 
decision in my interest.' "  (GPͰ͸, GP for ͲͰ years, line ͱ͹ͱ-ͱ͹Ͳ) 
 
GPs reflected on the fact that "you get the patients you deserve", in that over time, 
patients come to understand the GP's clinical approach and stance.  The fact that the 
patient returns and/or considers the GP their regular doctor indicates that they 
appreciate the approach taken by the GP.  The following quote illustrates this point: 
"… there’s an adage in general practice that you … get the patients you 
deserve.  But I think what that means is, patients tend to gravitate 
towards you if they are comfortable with your style.  And um, so of the 
more regular patients I have, I mean I’ve sort of been practicing pretty 
much the same way all my career; and there is a choice, luckily, of 
various doctors.  So the patients I have tend to … have heard my spiel a 
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few times and ((chuckles)) know what I think …"  (GPͰ͸, GP for ͲͰ 
years, line ͱͶ͸-ͱͷʹ) 
 
Capitulating to patient expectations for antibiotics may have other practice 
ramifications for GPs.  For example, it calls into question how they would deal with 
patient demands/expectations for other types of medicines, such as those with 
potential for abuse:   
"You get the patient population who[m] you deserve.  If you’re always 
capitulating then you’ll get a whole pile of patients who demand things 
of you.  I mean, would you do that with Valium® [a common 
benzodiazepine which can be addictive]?  Some doctors do, you know.  
They just accede to those demands.  Would you do it with MS Contin® 
[an opioid]?  Maybe some doctors would and then you get a whole pile 
of patients who are demanding MS Contin® and antibiotics for colds, 
and is that the patient population you want?  Whereas … you decide … 
what you think is right medically, and stick to it and explain it clearly, 
then your patients will respect you for that … and you’ll have a patient 
cohort who come back and see you because of your integrity and maybe 
they’re the sort who[m] you want as your patients."  (GPͰͶ, GP for ͱͱ 
years, line ͳ͹ͱ-ʹͰͰ) 
 
Managing relationships 
An essential part of appropriately addressing patient expectations for antibiotics is the 
GP's ability to establish rapport with the patient, and to build and maintain (or at least 
not aggravate) an existing doctor-patient relationship.  However, dealing with regular 
patients could be a two-edged sword — on one hand, regular patients would have 
shared expectations with the GP regarding the use of antibiotics (see also Consumer 
findings, Section ʹ.ʹ.ʹ), on the other hand there could be other dynamics at play given 
the familiarity of the patient with the GP.  GPͱͰ speaks about dealing with regular 
patients who present with respiratory tract infections: 
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"So … it doesn’t affect my clinical approach to them and whether I think 
they’re sick or not, but it does affect all those other, you know, just 
emotional things … the manipulation that the patient ((grins)) gives 
you."  (GPͱͰ, GP Registrar final year, line ͱ͹ͳ-ͱ͹Ͷ) 
 
Discerning-Undiscerning consumer 
What does the practice of good medicine look like to the consumer?  It depends.  
Consumers who are aware of antibiotic resistance and their role in conserving 
antibiotics (e.g. not demanding antibiotics for coughs and colds) will appreciate GPs 
who are prudent with antibiotics — the discerning consumer (see also Consumer 
Section ʹ.ʹ.ʹ).  Consumers who are less aware, may interpret the same circumstances 
otherwise — the undiscerning consumer.  GPs who are wise advocates would probably 
be able to educate these less aware consumers.  However, GPs who capitulate to patient 
expectations are inadvertently reinforcing the incorrect belief that antibiotics are 
effective for coughs and colds: 
"I’m thinking of this particular patient, and I said, you know, 'I 
remember seeing you last time and I gave you that script; and do you 
think it helped?'  And she said, 'Oh::: well yeah, I think it did.'  So 
((scrunches face)) yeah, that particular one, she’s not going to- she’s just 
so set in her beliefs."  (GPͱͰ, GP Registrar final year, line ͲͲ͵-ͲͲ͸) 
 
The undiscerning consumer may take the prescribing of antibiotics as: (a) validation of 
their concerns, and (b) an indication that they had been heard. 
"…the “unknowing” ((makes quotation marks with fingers of both 
hands)) patient then thinks, 'Ah right, the doctor must have been 
listening to what I said because, here, I’ve got a script to prove it.'  But in 
that sense you can get away with far less of a history, far less of an 
examination and just sort of plonk your stethoscope on the shirt and 
say, gosh I think you need an antibiotic.  And the patient … particularly 
the less educated patient, won’t actually have the capacity to realise that 
that’s actually not good medicine.  … So I think it’s a bit of a trap GPs 
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can fall into, particularly if they’re very pressured for time."  (GPͰ͸, GP 
for ͲͰ years, line ͱ͹͵-ͲͰʹ) 
 
4.2.7 Antibiotic use behaviours 
Consumer behaviours 
Consumer behaviours observed by GPs such as self-medicating with a previous 
antibiotic script without having consulted the GP anew, was discussed in Section ʹ.Ͳ.͵ 
(Repeat antibiotic prescriptions).  Addressing consumer behaviours such as sharing 
antibiotics with others, need to be handled skilfully by GPs when disclosed, so that 
patient-doctor trust is maintained or enhanced.  GPͰ͹ raised the often overlooked 
positive intentions of the patient, and how to sensitively handle the disclosure of 
sharing antibiotics: 
"Well, I say, well, thanks for coming in and talking to me about it, you 
know.  And like, I would try to say, be careful sharing things and stuff.  
But in certain populations that sharing is considered like an act of love.  
And so, so you have to raise it with that in mind."  (GPͰ͹, GP for Ͳʹ 
years, line Ͳ͵͸-ͲͶͰ). 
Antibiotic use behaviours from the perspective of consumers are detailed in Section 
ʹ.ʹ.͵. 
 
Health professional behaviours as consumers 
As private individuals, GPs reported being low or very low users of antibiotics 
themselves — using antibiotics mainly for pneumonia, tonsillitis, skin and/or dental 
infections — and only when clinically warranted.  A few avoided antibiotics with 
detrimental consequences to their health.  The aversion to antibiotic use was led by 
their desire to avoid adverse consequences of taking antibiotics, and perhaps also 
optimism that their immune system would be able to overcome the infection without 
medical intervention.  Thus, unduly delaying seeking medical attention, despite being 
aware that the manifestation of clinical features indicated a bacterial infection: 
"I’m aware of the side effects of antibiotics.  Um, and I’m aware that um, 
there are lasting effects for months afterwards taking a course of 
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antibiotics, and I am aware of resistance.  So I was hoping I wouldn’t 
need that [antibiotics].  But I waited too long.  So if I had seen myself as 
a patient, I would have prescribed antibiotics in that situation because I 
was systemically severely unwell.  Fevers in the ʹͰs the whole time, and 
classic bacterial pneumonia."  (GPͰͲ, GP for Ͷ years, line ͳ͸͸-ͳ͹ͳ) 
An interesting question to pose is:  to what extent does the GP's own approach to 
antibiotic use personally, affect their prescribing practice?  Although this research was 
not designed to answer the question, the following preliminary observations from the 
data are offered.  Many GPs in this interview sample identified as low prescribers of 
antibiotics — with objective data to substantiate their claim e.g. GPs received a 
personalised report in ͲͰͱ͵ generated by NPS MedicineWise and sent via the 
Department of Health on antibiotics prescribed.  These GPs were also low users of 
antibiotics themselves.  Perhaps a strongly held ideology, whether acknowledged or 
implicit, to conserve antibiotics pervades both the personal and professional, so that 
GPs who are low (personal) users of antibiotics would also be low prescribers of 
antibiotics, compared to their peers.  Divergent cases would need to be found in order 
to assess the credibility and validity of this observation, so as to develop the hypothesis 
further.  The following quote illustrates the proto-hypothesis: 
"I hate taking them [antibiotics].  I don’t take them if I can avoid it.  So, I 
was actually talking to some friends about this recently.  And may- and I 
think probably my own personal opinion does actually skew my GP hat.  
… I know for me, that most years if I get a bad cold, I will get a bit of 
bronchitis from it and end up with a pretty hacking impressive sounding 
cough for a couple of weeks.  But I don’t feel clinically unwell with it, I 
know it will get better."  (GPͰʹ, GP Registrar final year, line ͳͶͱ-ͳͶ͵) 
 
In the same vein, favourable personal experience with antibiotics seem to shift GPs 
toward being more sympathetic to prescribing antibiotics: 
"One of them was my personal illness, where … I had a fever and 
productive cough for a long time and I got significantly better after 
some- I felt I got better in myself after antibiotics.  And um, that 
probably was it, probably was it.  I realised that I was a mantra of no 
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antibiotics at all for URTIs, and then I, I kind of realise well, some 
prolonged URTIs they might, you know, there may be indications or 
there may be a grey area where we can consider it.  Yeah."  (GPͰͷ, GP 
for ʹ years, line ͲͳͲ-Ͳͳͷ) 
 
Finally, it is perhaps reassuring to find that GPs as individuals, also behave like 
consumers in these ways: (a) more likely to seek GP consult for a course of antibiotics if 
there is an important life event coming up e.g. medical school exams (although 
arguably, this was prior to becoming qualified as a GP), and (b) imperfect adherence to 
prescribed antibiotics e.g. missing doses and taking longer to finish the course of 
antibiotics. 
 
4.2.8 Patient education vs. Information needs 
Health professional mediated patient education vs. Consumer information needs 
GPs mediated at least two types of patient education: (a) when an antibiotic was 
warranted — how to use the antibiotics prescribed e.g. dosage, frequency and 
important side effects to note, (b) when an antibiotic was not warranted — educating 
the patient on why an antibiotic was not required for treatment of their presenting 
illness and would not be in their best interest.   
GPs view the importance of properly addressing patient expectations for antibiotics as a 
way to disrupt the vicious pathway of:  patient expectations leading to pressure on GPs 
to prescribe antibiotics, which in turn leads to antibiotic resistance in the community.  
Although some GPs are yet to be convinced that prescribing patterns in primary 
healthcare contribute directly to antibiotic resistance in the community, many GPs 
acknowledge the profession's role in creating the problem of patient expectations for 
antibiotics. 
"I think … a lot of GPs cop out and say, oh::: the patient demands it and I 
feel like I should give it.  My point is that, I think doctors have created 
this problem.  We were the ones that were over prescribing antibiotics 
to start with and have, um, created a generation of people who expect 
antibiotics.  So it’s up to doctors to re-educate … … I don’t think it needs 
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to get to a confrontation.  If you educate, you put up enough barriers 
and explain it’s in the patient’s best interest … people usually would be 
happy with safe prescribing patterns, yeah."  (GPͰͷ, GP for ʹ years, line 
ͲͰͶ-Ͳͱ͵) 
 
GPs explain the concept of antibiotic resistance to patients in the following ways: (a) 
using the returned pathology results which shows cultures and sensitivities for various 
antibiotics, and (b) in plain language describing the consequences of inappropriate use 
of antibiotics.  In these explanations, there can be a conflation of concepts — resistance 
to antibiotics at the societal level is conflated with resistance to antibiotics at the 
individual patient level.  While the two are inter-related, in that resistance to 
antibiotics at the personal level contributes to resistant bacteria at the societal level, 
patients are usually more concerned with the former. 
Consumer information needs is discussed in Section ʹ.ʹ.ͱͰ. 
 
Public campaigns vs. Consumer awareness 
Public campaigns by governmental or Commonwealth funded agencies such as NPS 
MedicineWise and the Australian Commission on Safety and Quality in Health Care, 
should be continued.  GPs value the public awareness created through these national 
campaigns, and pointed out the importance of conveying accurate information to the 
general public to curtail propagated myths e.g. green/coloured mucous is an indication 
that antibiotics are needed (they are not).   
GPs also mentioned the resources for GP-mediated patient education during these 
campaigns have been helpful e.g. NPS MedicineWise brochures on "Colds, Coughs and 
Flu:  What you can do", "Common colds need common sense:  Not antibiotics", 
symptom management pad with checklist for GPs to prescribe a customised plan for 
the patient, and Antibiotic Resistance Fighter posters.  One GP was also aware of the 
social media campaign by NPS MedicineWise for consumers. 
There was cautious hope that patient education through these national campaigns 
would reduce or resolve inappropriate patient demand and/or expectations for 
antibiotics:   
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"… the public need to be better educated and stop coming and asking for 
them … and then it [antibiotic resistance] would probably be solved.  … 
it would be nice, you know, … ads on TV where this is- you have the 
common cold, antibiotics are not for the common cold.  That would be 
nice, and I think that would go a long way in stemming antibiotic 
resistance.  Um, people are coming in with gastro, you don’t need 
antibiotics for gastro.  Just watch and wait, it will get better with time, 
very unlikely you need antibiotics.  But people come in [asking for 
antibiotics] and then, lo and behold they’ll get Clostridium difficile and 
they’d be multi-resistant, and then they’ll be in hospital, and then we 
have all kinds of problems.  Now that’s a big issue…"  (GPͰ͵, GP 
Registrar final year, line ͳ͵ͱ-ͳ͵ͷ) 
Linked to public campaigns was the suggestion of spreading the message of what 
constitutes a good GP.  Essentially, educating the public that a good GP would act in 
your best interest and would not prescribe antibiotics unnecessarily nor would they do 
so on demand. 
"… good GPs talk to you about not using antibiotics [when not required].  
You know, we need a message like that.  Yeah.  A good GP tells you not 
to smoke, lose weight ((chuckles)), and you know, you don’t need 
antibiotics…"  (GPͰ͹, GP for Ͳʹ years, line ͳ͵ʹ-ͳ͵͸) 
GPs reported noticing a shift in consumers i.e. moving away from seeking antibiotics, 
perhaps due to increased awareness generated by these campaigns, but also a move 
towards seeking alternative/natural remedies and self-care solutions: 
"I’ve only been practising since ͲͰͱͰ but I’ve noticed even in that time 
the public is a lot more aware of the fact that antibiotics aren’t these 
fantastic, life-saving happy pills that we should take all the time 
((chuckles))"; and 
"… we’re having a bit of a turn away from western medicine to start with, 
and people prefer natural therapies, or go to the health food shop and 
get something — echinacea, garlic-based for their cold.  They’re happy 
with that, which is good.  It makes my job a bit easier.  Obviously not 
poisoning themselves with anything ((laughs)).  But we do have a few 
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groups of people who really don’t want antibiotics and they’re clear 
about that."  (GPͰͲ, GP for Ͷ years, line ͲͲͱ-ͲͲͳ and line ͲͲ͵-ͲͲ͹). 
Consumer awareness is discussed in Section ʹ.ʹ.ͱͰ. 
 
4.2.9 Views on antibiotic resistance 
Meaning of antibiotic resistance 
When asked about what comes to mind when they hear the phrase "antibiotic 
resistance", most GPs associated it with making their job more difficult.  The 
overarching emotion was one of worry, resignation, helplessness and frustration. 
"((sighs)) That I’m going to get a pathology result that says resistant to 
everything and I won’t know what to give them.  Oh, it’s just frustrating.  
It’s just frustrating.  Um, it just makes the job harder… the other thing I 
guess comes to mind is that, that knowledge that you’re giving this 
antibiotic that you’re pretty confident it will work, and then now, we 
have to think, maybe it won’t work, and if they come back and they have 
ongoing symptoms, is it because the bug was resistant or is it because I 
got the diagnosis wrong?"  (GPͰ͵, GP Registrar final year, line ͲͰʹ-ͲͱͲ) 
 
Pessimism vs. Optimism 
GPs expressed anxiety about having to deal with an increasingly intractable problem 
using a dwindling armamentarium of antibiotics.  Interestingly, despite widely reported 
efforts in national and global media about tackling antibiotic resistance via a multi-
pronged approach — rapid diagnostics, new medical technologies and discoveries in 
reducing virulence of resistant bacteria, reduction of antibiotics in veterinary and 
agricultural industries — GPs did not seem to be optimistic about these advances.  
Perhaps, the significant time lag between discovery to marketable product is too great 
to offer much hope for the practicable future.  In addition, GPs recognise that unless 
the fundamental problem of human behaviour is addressed, the success of new 
solutions may only be short-lived and could introduce new, unforeseen problems. 
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Impact of antibiotic resistance:  Professional, Personal, Societal 
By far, GPs are most concerned about the impact of antibiotic resistance in their 
professional role as doctors, and thus, the societal fallout as well.  As discussed in 
"Meaning of antibiotic resistance" above, there is a sense of inevitability in having to 
deal with an increasingly difficult problem.  This anxiety was seen equally in those just 
beginning their career as GPs, as well as those with decades of experience.  The 
following quotes are from both ends of the experience spectrum, with each having 
consulted on cases of resistant bacteria in their clinical practice: 
"I am genuinely worried about antibiotic resistance.  I saw someone this 
year who had just a UTI, didn’t even get them that frequently.  And her 
E.coli was resistant to every form of oral antibiotic.  … it was resistant to 
multiple of the IV antibiotics as well.  And you know, this is just 
someone walking around in the community, she hadn’t even been in 
hospital or anything like that …… and so we had to … give her IV 
Ceftriaxone every day for ͵ days.  And you just kind of like, well that 
stuff is scary, and I don’t want to have to deal with that in the next ͲͰ 
years."  (GPͰʹ, GP Registrar final year, line ͱ͹ʹ-ͲͰͲ) 
 
"Well, I hope I don’t see it in my- you know, I’ve got another ͱͰ or ͱ͵ 
years of career to go.  I hope it isn’t in my ͱͰ or ͱ͵ years, but it could be.  
There’s gonorrhoea resistant [to] antibiotics … antibiotic resistant 
gonorrhoea floating around the place in Thailand.  We’ve got a lot of 
antibiotic resistance there.  If that gets into some of our communities, 
we’re going to be in trouble."  (GPͰ͹, GP for Ͳʹ years, line ͳͱ͵-ͳͱ͹) 
 
4.2.10 Mitigating antibiotic resistance 
Individual initiatives:  Professional and Personal 
GPs identified various ways in which they can help mitigate antibiotic resistance in the 
community.  These are everyday actions that any GP can take.  Examples include: (a) 
writing a "do not dispense after this date <insert date>" to reduce the likelihood of 
patients using the prescription at a later date inappropriately for a different illness, (b) 
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having a well-practiced procedure for addressing patient expectations, (c) being able to 
confidently communicate the medical decision that an antibiotic was not warranted, 
and (d) providing a written symptom management plan as a way to end the consult. 
"Now, they often are very disappointed they’re not getting antibiotics, so 
I do like to give written materials like the NPS um … symptomatic 
management pad.  Yes, so you rip one of them out [each sheet has a 
checklist for symptom management which can be tailored for the 
patient by the GP], and on the back it helpfully says, most of the time 
antibiotics aren’t required.  So it’s not just me being a crap nasty GP 
((laughs)) actually."  (GPͰͲ, GP for Ͷ years, line ͱͳͱ-ͱͳ͵) 
 
Some GPs interviewed were also educators — trainers of GP Registrars and/or teach 
medical students.  They observed that it was important to include sample verbal scripts 
in their training, to give trainees an idea of how to skilfully communicate the medical 
decision that an antibiotic was not warranted.  A quote showing a sample 
communication script was included in Section ʹ.Ͳ.Ͷ (Establishing and addressing 
patient expectations for the consultation). 
"And then you’ve got to give the students or doctors the tools and the 
scripts [what to say] the thing to say, to help them get through the next 
couple of minutes when they’re explaining to the patient why they don’t 
need antibiotics."  (GPͰͶ, GP for ͱͱ years, line Ͳͳʹ-ͲͳͶ) 
 
GPs would like better/more evidence-based guidelines, especially in areas where there 
are gaps in research, not only to provide a measure of confidence for prescribing 
decisions or for clinical guidance, but also as a strategy to address patient expectations 
for antibiotics: 
"…that would also empower you to say no [to the patient expecting 
antibiotics] as well … because you can say, I’ve made this decision based 
on this evidence, um, using them appropriately, like appropriate 
antibiotics for appropriate infections like the Therapeutic Guidelines."  
(GPͰͱ, GP for ͱ year, line Ͳʹ͹-Ͳ͵Ͳ) 
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On a personal level as a private individual, GPs use antibiotics judiciously, as discussed 
in Section ʹ.Ͳ.ͷ Health professional behaviours as consumers. 
 
Government and Commonwealth funded initiatives 
Public campaigns were discussed in Section ʹ.Ͳ.͸.  Other government initiatives are 
regulatory in nature, such as proposed changes to the PBS regarding antibiotics, by the 
Drug Utilisation Sub Committee (DUSC).  Two proposals pertaining to the subsidy of 
oral antibiotics on the PBS were mentioned:  (a) removing repeat prescriptions from 
the PBS for oral antibiotics, and (b) reducing the validity period of antibiotic 
prescriptions (Department of Health & Pharmaceutical Benefits Advisory Committee, 
ͲͰͱ͵; Drug Utilisation Sub Committee, ͲͰͱ͵).   
GPs were in largely in favour of both these proposals (Box ͱͶ), with the caveat that 
steps be in place to enable appropriate access to antibiotics for patients who need 
longer term or repeat treatment e.g. patients with cystic fibrosis, chronic obstructive 
pulmonary disease, recurrent urinary tract infections, osteomyelitis.  A reasonable 
period of prescription validity would be one month for most patients, and up to six 
months for those requiring longer term treatment. 
Box ͱͶ. 
"… so I think … the repeat and all those rules, need to reflect best practice, 
especially in this area given the enormous consequences of antibiotic resistance.  I 
mean, you would think that in ͲͰ years’ time if we look back and people are dying 
of … sepsis, because we can’t treat it, we’ll go why on earth didn’t we implement 
these changes.  It doesn’t make any sense at all.  … so, yeah, I would totally 
support those measures."  (GPͰͶ, GP for ͱͱ years, line ʹͲͱ-ʹͲ͵) 
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 COMMUNITY PHARMACISTS:  INTERVIEW FINDINGS 
4.3.1 About the participants 
Thirteen community pharmacists expressed interest to participate in the interviews.  
One cancellation was received prior to the appointed interview timeslot, due to 
unforeseen issues with the scheduled relocation of the pharmacy.  Therefore, a total of 
ͱͲ community pharmacists were interviewed in the Brisbane and Greater Brisbane Area 
– ͵ men and ͷ women.  All were trained in Queensland, Australia, with most trained in 
metropolitan universities (i.e. The University of Queensland, Griffith University, and 
Queensland University of Technology) and one from a regional university (James Cook 
University).  Their years of practice as a pharmacist excluding the ͱ-year pharmacy 
internship ranged from Ͳ to ͳͱ years — ͳ were early career pharmacists (͵ years or less 
in practice), Ͷ were mid-career (Ͷ toͱ͵ years), and ͳ had more than ͱ͵ years of 
experience.  Eight pharmacists identified as working full-time or approximately ͳ͸ 
hours per week.  Five were employed as staff pharmacists, with the remainder holding 
both clinical and management roles — being either the proprietor or manager of the 
pharmacy.   The box below shows the characteristics of the pharmacies in which the 
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Figure ͱͰ.  Characteristics of Pharmacies 
Pharmacy type: 
 
3 multi-practitioner independent pharmacies, 9 multi-
practitioner chain or banner group pharmacies. 
Location: 9 located in the suburbs, 3 located in Brisbane CBD. 
Socio-economic status (SES)24 
of community served:   
1 was serving lower SES communities, 4 were serving 
mixed SES communities, 7* were serving higher SES 
communities. 
*These pharmacists also had previous experience working in pharmacies serving lower and/or 
mixed SES communities. 
 
There were six main concepts/themes which emerged out of the community 
pharmacist interviews — previously shown in Table ͱͰ:  process for clinical decision-
making, repeat antibiotic prescriptions, antibiotic use behaviours, views on antibiotic 
resistance, mitigating antibiotic resistance, and patient education.  These 
concepts/themes mirror the main interview questions asked of this participant group, 
as well as those which emerged from the community pharmacist interviews.  Each 
concept/theme is discussed in turn below, beginning with those pertaining to the 
participants' professional role as a community pharmacist, before exploring concepts 
related to personal views and behaviours.   
 
4.3.2 Process for clinical decision-making 
Cognition 
Consumers access community pharmacies as a first port of call for minor illnesses.  
Community pharmacists often provide advice to consumers on symptomatic 
clxix                                                     
 
24 Socio-economic status by postal area code were taken as a guide to relative disadvantage as 
per the Socio-Economic Indexes for Areas (SEIFA) by the Australian Bureau of Statistics 
(Australian Bureau of Statistics, ͲͰͱͳ).  SEIFA ranking within State or Territory as deciles 
were used, with deciles ͱ and Ͳ representing the most disadvantaged, deciles ͹ and ͱͰ being 
the least disadvantaged.  For the purposes of describing the characteristics of the population 
which the pharmacists interviewed served, lower SES was represented by deciles ͱ to ͳ, mixed 
SES by deciles ʹ to ͸, and higher SES by deciles ͹ and ͱͰ. 
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management of respiratory tract infections — advice for self-care as well as 
recommendations for products which may assist in the alleviation of symptoms.   
Clinical decision-making processes relevant to the role of community pharmacists are: 
(a) when discerning whether the symptoms reported by the consumer match the 
provisional diagnosis, for example, of a common cold or cough, (b) when deciding on 
appropriate advice for self-care, (c) when deciding on appropriate products to 
recommend for alleviation of symptoms, and (d) when deciding on whether a referral 
to a GP is required.  All of these decision-making processes are largely based on 
information provided by the consumer and the pharmacist's clinical knowledge and 
experience, with perhaps a measure of practiced intuition — although not explicitly 
mentioned by the pharmacists interviewed.   
Community pharmacists would refer consumers to GPs in the following circumstances: 
(a) the signs/symptoms reported by the consumer constitute red flags for more serious 
illness, (b) there is ambiguity/uncertainty in the diagnosis, (c) any other underlying 
concerns of the pharmacist. 
 
4.3.3 Repeat antibiotic prescriptions 
Intentional vs. Unintentional 
Community pharmacists interviewed reported that repeat antibiotic prescriptions were 
becoming less common — as an estimate, about ͵Ͱ% of original antibiotic 
prescriptions dispensed in their pharmacies included a repeat prescription. It is often 
opaque to community pharmacists whether repeat antibiotic prescriptions were 
intentionally prescribed by GPs or were generated by the prescription software due to a 
default setting — where GPs have not inactivated this function, as discussed in General 
Practitioners:  Interview Findings, Section ʹ.Ͳ.͵.  As such, if the dosage and treatment 
duration were both in line with prescribing guidelines, such as the Therapeutic 
Guidelines, community pharmacists deemed the repeat prescription to have been 
intentionally prescribed by the GP.   
As a way to confirm intentionality of the GP, pharmacists would often flag with 
consumers that a repeat prescription was available, as part of the patient counselling 
process.  Consumers who had been given (or perhaps, remembered that they had been 
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given) instructions by the GP as to the need for/use of the repeat prescription would 
indicate their awareness of the arrangement.  However, many consumers seemed to be 
unaware that the GP had ordered a repeat antibiotic prescription, and were also 
unclear as to the intended duration of their treatment (see also General Practitioners:  
Interview Findings, Section ʹ.Ͳ.͵, for reasons GPs order repeat prescriptions).  The 
quote below illustrates the issues outlined above, caused by the information vacuum 
between GP and pharmacist regarding repeat antibiotic prescriptions:   
"So we would say, you know [to the consumer], 'Did your doctor explain 
to you?  Did he [or she] want you to continue … the full course, did he 
give any instructions there?'.  And nine times out of ten I would say, 
they [consumers] would say 'No'.  They weren’t given instructions about 
the repeat, whether it was important to take it or not.  … … I felt it was, 
and I think it got worse when the computer generated scripts came up, 
because when the doctor had to write 'repeat x ͱ', that was presumably … 
they would either explain to the patient a bit more so, or they were 
saying 'and you’ll need this repeat … .'  But when it just happens 
automatically and they [GPs] you know, might not have really, 
necessarily intended the patient to have the repeat."  (CPͰͱ, pharmacist 
for ͳͰ years, line Ͳ͸͵-Ͳ͹Ͷ) 
 
Problematic sequelae 
In the case of community pharmacists, the problematic sequelae arising from repeat 
antibiotic prescriptions pertain to the handling of delayed presentation of the 
prescription.  Consumer requests to dispense these prescriptions months after the 
original prescription, put pharmacists in the untenable position of having to ascertain 
that the antibiotic was still warranted.  Pharmacists observed that many consumers 
who present repeat prescriptions after a long time lag were intending to self-medicate 
and avoid the cost and/or the inconvenience of seeking a GP consult. 
The strategies used by community pharmacists when handling consumer requests to 
dispense repeat antibiotic prescriptions after a lag time of many months post-initial 
infection, fall into two broad categories: (a) strategies to ascertain whether they can 
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clinically justify dispensing the prescription, and (b) strategies to persuade the 
consumer to contact or return to their GP for a review.   
The pharmacist would carefully probe the consumer as to their reason for filling the 
repeat prescription and would query the consumer regarding symptoms experienced.  
The repeat prescription would be dispensed if the clinical warrant was clear, for 
example, an exacerbation of chronic obstructive pulmonary disease or a recurrent 
urinary tract infection.  Occasionally, careful probing reveals the consumer's intentions 
to use the antibiotic inappropriately, and the pharmacist was able to prevent misuse by 
recommending a referral to a GP, as reported by CPͱͰ:  
"….. antibiotic repeats we are careful; we are careful with that.  … It was 
an old repeat [but still within ͱͲ months of the original date of 
prescribing].  And, uh, I can’t remember what the antibiotic was for, but 
the moment it’s like old, meaning even beyond a couple of months, ͳ or 
ʹ months, I would query that.  So, she brought the prescription in … to 
me, and … apparently it was her husband’s prescription …  That was 
really tricky, how that happened.  ‘Coz I wouldn’t have known.  She was 
not going to tell me that [she was going to use it herself].  So, 
apparently, there was a repeat left, uh, an antibiotic repeat left for the 
husband, and then this is the … what I call, using your partner’s 
medication.  Happens; quite common [using partner's medication — all 
types of medications], let me tell you ((laughs)).  Surprisingly." (CPͱͰ, 
pharmacist for ͳͰ years, line ͲͱͲ-ͲͲͲ) 
 
If the clinical warrant was not clear after querying the consumer, the pharmacist would 
try to convince the consumer to return to their GP for a review.  The following quotes 
provide sample verbal scripts that pharmacists would use to communicate this advice 
to consumers: 
"Normally I will tell them, 'Look you know, unless it’s exactly the same 
symptoms, there’s a possibility of them [antibiotics] not working.  Even 
if it is the same symptoms, doesn’t necessarily mean exactly the same 
bug that’s caused it.  At the very least, give the doctor a call.'  That 
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doesn’t cost them anything obviously, and they can touch base with the 
doctor.  And the doctor might want to get them in."; and 
"… And I normally explain that, 'Look if it’s not the right one, it’s going 
to get worse and then you’re going to waste money on the antibiotics.'  
That sort of thing."  (CPͰͷ, pharmacist for ͵ years, line ͲͶͷ – Ͳͷͱ and 
line Ͳ͸ͳ-Ͳ͸ʹ) 
 
4.3.4 Antibiotic use behaviours 
Motivations for seeking antibiotics 
From the perspective of community pharmacists, consumers who seek antibiotics as 
their first recourse for a respiratory tract infection do so due to: (a) the belief that 
antibiotics will hasten their recovery, (b) past experience with antibiotics were 
generally positive i.e. recovered from illness and had no troublesome side effects from 
antibiotics, leading to an over-reliance on antibiotics, (c) the cheaper cost of procuring 
antibiotics due to being subsidised under the Pharmaceutical Benefits Scheme for 
concession card holders, compared to over-the-counter products for symptom 
management.  Pharmacists who served (or previously served) in the lower socio-
economic areas observed that the latter is especially true amongst the consumers who 
use their pharmacy, compared with consumers from higher socio-economic areas.  
Consumers who are concession card holders are generally bulk-billed by GPs, so there 
would be no out-of-pocket expenses for seeing a doctor to obtain an antibiotic 
prescription.  Lower health literacy could also be a potential contributor to the 
consumer behaviour of seeking antibiotics.  CPͱͰ has worked in both types of socio-
economic settings and offers the following observations: 
"…And I think people, overall like I said, when we give them cold and flu 
medicine [over-the-counter products for symptom alleviation], they’re 
not asking me about antibiotics.  Uh, we don’t even go there.  It seems 
to me also that, they don’t want to take antibiotics, if they don’t have to.  
As opposed to … and that’s to do with the demographic …  Because my 
experience with [name of a lower socio-economic suburb] pharmacies, … 
a high pension/ concession area, [larger proportion of] lower socio-
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economic group of people — they’ll want antibiotics.  And that would be 
a cost factor as well."  (CPͱͰ, pharmacist for ͳͰ years, line ͳ͸ͷ-ͳ͹ͳ) 
 
Health professional behaviours as consumers 
Community pharmacists as private individuals generally take antibiotics only when 
prescribed by a dentist or GP — citing dental infections and travel related antibiotic 
prophylaxis e.g. malaria prophylaxis, respectively.  Most identify as low users of 
antibiotics themselves, with those who have young children being conscious of 
avoiding antibiotics as proxy decision-maker on their behalf, when not clinically 
required.   
"I’ve got .. [an] ͸-month old now, day care, who’s just coming home with 
everything you know, all the bugs.  And she’s already been on antibiotics 
once, which I’m not pleased about.  But it’s yeah, you know, as a [parent] 
have gone to the doctor and said to them, 'I don’t really want to have 
antibiotics [for the child], but if you think that she needs them, then I’ll 
give them to her.'  Um, … in my mind it only makes things worse, unless 
it’s really severe; especially with the littlies, it just knocks their immune 
system around."  (CPͰͶ, pharmacist for ʹ years, line ʹͳ͸-ʹʹʹ) 
 
Some pharmacists interviewed lament the fact that they were unable to inculcate 
prudence with antibiotics amongst older family members, such as their parents who 
have entrenched beliefs in antibiotics as a panacea for common ailments. 
"For me, I don’t like taking antibiotics personally.  I rather my body fight 
it off as it should.  But there are people like, for example my [mum] as 
soon as she’s sick, she’s like ((snaps fingers)), 'Oh, antibiotics.' ((laughs)) 
…And you know, she normally gets the Augmentin Duo Forte® [a broad 
spectrum antibiotic], all that sort of stuff.  And it takes weeks before she 
gets better. … we’ve sort of told her … And this is … it’s pretty ironic 
right?"; and   
"… but for mum’s mentality I think she just, as long as she gets better, 
she doesn’t care what it is.  She just wants to get better.  So yeah, I think 
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maybe for the older generation if I can put it that way; the older 
generation they saw it worked when they were younger.  And so 
therefore, they stick to that."  (CPͰͳ, pharmacist for ͱͲ years, line ʹͳͶ-
ʹʹͳ and line ʹʹͷ-ʹ͵Ͱ) 
  
On the topic of adherence to prescribed antibiotics, some pharmacists confessed that 
they do not personally practice what they counsel consumers to do: 
"…It's really embarrassing!  I'm the worst antibiotic user in the world 
((chuckles)).  I know, pharmacist in reality [are] very, very different; and 
I think you'll get that with every pharmacist you talk to.  All my friends 
are exactly the same, all the pharmacists.  So what we tell patients is very 
different to what we do ((laughs)). … I never finish my course of 
antibiotics; because I forget every time.  So the first two days I would 
take them … and then I'll forget, ((laughs)) and that's it, because I feel 
great.  So I don't [remember to] take them."  (CPͱͱ, pharmacist for Ͷ 
years, line ͵Ͷͱ-͵ͷͰ) 
 
4.3.5 Views on antibiotic resistance 
Meaning of antibiotic resistance 
The phrase "antibiotic resistance" evoked the following from community pharmacists 
interviewed:  (a) that the bacteria has acquired resistance to the antibiotic and 
therefore  the antibiotic will no longer work, (b) "superbugs" in hospitals such as 
Methicillin- or multidrug-resistant Staphylococcus aureus (MRSA) and Vancomycin-
resistant Enterococci (VRE), (c) the  anticipation of adverse societal impact, and (d) the 
global emergence of antibiotic resistance and its association with low and middle 
income countries where misuse is perceived to be more rampant. 
"… that the antibiotics that we have are not working well against the 
bacteria, and that we’re running out of options to treat people 
effectively."  (CPͰͶ, pharmacist for ʹ years, line ͳͳʹ-ͳͳͶ) 
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Pessimism vs. Optimism 
Although concerned about the issue of antibiotic resistance, community pharmacists 
seemed to be neither pessimistic nor optimistic about our collective ability to mitigate 
or address antibiotic resistance in Australia and the world.  Limited beliefs about their 
capabilities to be an active part of the solution — powerlessness — gave rise to a sense 
of ambivalence about the situation in some pharmacists.   
A difference in attitude was observed in pharmacist participants who worked in 
community pharmacies which offered a vaccination service.  These pharmacists 
identified the vaccination service as one of the mitigation strategies for antibiotic 
resistance, and saw themselves as an essential part of the solution — especially those 
who were trained to vaccinate against the influenza virus as part of the Queensland 
Government Pharmacists Immunisation Pilot (QPIP)25, rather than simply offering 
pharmacy premises as a venue for nurse-administered vaccinations.  CPͰʹ spoke about 
other benefits of offering these vaccinations in a community pharmacy setting: 
"…the main comment I get from people [consumers] is that it's so much 
more accessible and affordable.  … that would [help] achieve the two 
main goals … more people get vaccinated; and the other would be to 
save the government money.  … we're not billing Medicare like the GPs 
are [for vaccinations]."  (CPͰʹ, pharmacist for ͸ years, line ͷͱ-ͷ͵) 
 
Impact of antibiotic resistance:  Professional, Personal, Societal 
Some community pharmacists were aware of antibiotic resistance as an issue, while 
others inferred that it was so from the public health campaigns they had observed 
clxxvi                                                     
 
25At the time of the community pharmacist interviews, the QPIP was ongoing.  The QPIP ran 
in selected Queensland community pharmacies from January ͲͰͱʹ to March ͲͰͱͶ, with 
appropriately trained pharmacists administering immunisations to adults, against influenza 
(Phase ͱ of the pilot), measles and whooping cough (Phase Ͳ).  A total of ͳ͵,ͰͰͰ 
immunisations were given during the trial period.  Subsequently, the State of Queensland 
legislated the administration of these vaccines by appropriately trained pharmacists from Ͳʹ 
March ͲͰͱͶ following the success of the QPIP, via an amendment to Section ͱͷͱ of the Health 
(Drugs and Poisons) Regulation ͱ͹͹Ͷ (State of Queensland, ͲͰͱͶ, p. ͱͶͳ). 
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recently.  Many were unclear as to the extent of the problem and the practical 
consequences of antibiotic resistance — which did not seem to be a forefront issue for 
community pharmacists.   Perhaps, a lack of clarity about the issue of antibiotic 
resistance and their role in mitigating it contributes to inaction and/or apathy. 
"I don’t know the extent of what it [antibiotic resistance] will cause.  If I 
did read about it, or if I were informed of what the consequence would 
be, then I guess I’d be a bit more aware of it, concerned, and start 
advocating if it’s like a really big issue." (CPͰͲ, pharmacist for Ͳ years, 
line ͳ͸Ͳ-ͳ͸͵) 
 
Pharmacists who were aware of antibiotic resistance, spoke of this being a current issue 
in Australian hospitals, and were concerned about eventual societal impacts and for 
those who are immunocompromised.  When asked, pharmacists estimated a timeframe 
of less than twenty years' lag time before antibiotic resistance would be more of an 
issue in the primary healthcare sector, if not actively addressed now. 
"I think it’s affecting the community now; but more so in hospital 
settings though.  Less in the community.  But if … we’re not active about 
it [mitigating antibiotic resistance], it could definitely become a bigger 
problem ͵, ͱͰ years from now I think, in the community.  I know in the 
hospital it’s a big problem already."  (CPͰʹ, pharmacist for ͸ years, line 
ͳͳͶ-ͳͳ͹) 
Pharmacists who were attuned to the issue of antibiotic resistance are occasionally 
seeing early signs in their community practice.  For example, consumers bringing in 
prescriptions for different types of antibiotics consecutively, to treat the same infection 
or consumers bringing in their pathology results which shows more instances of 
resistant bacterial being cultured.  
Personally, community pharmacists were not unduly concerned for their own health or 
their family's health being adversely affected by antibiotic resistance — with the 
assumption that their current good health continues.  Most associated their 
vulnerability to adverse impacts from antibiotic resistant bacteria with healthcare 
interventions such as major surgery or hospitalisation, should these be required. 
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4.3.6 Mitigating antibiotic resistance 
Individual initiatives:  Professional and Personal 
Community pharmacists spoke about the need for — not just GPs, but consumers and 
other health professionals as well — acting together to reduce the overuse of 
antibiotics, as part of fighting antibiotic resistance.  When reflecting on what 
community pharmacists can do as part of their day-to-day practice, the following were 
elicited: (a) being consistent or continuing with patient education — to raise consumer 
awareness of antibiotic resistance and to steer consumers away from seeking antibiotics 
as a first recourse to minor illnesses such as the common cold and coughs, and (b) 
getting pharmacy staff engaged and involved in public campaigns such as the 
Antibiotic Awareness Week held annually.  
Pharmacists' personal approaches to antibiotic use as private individuals would also 
contribute to either mitigation or otherwise, of antibiotic resistance.  This was 
discussed under the subsection Health professional behaviours as consumers in Section 
ʹ.ͳ.ʹ.  
 
Government and Commonwealth funded initiatives 
In line with GPs, most pharmacists interviewed were supportive of the proposed 
Pharmaceutical Benefit Scheme (PBS) changes, namely — removing repeat antibiotic 
prescriptions from the PBS for oral antibiotics and reducing the validity period of 
antibiotic prescriptions.  The period of one month was also suggested as a reasonable 
period for the validity of antibiotic prescriptions. 
Only one pharmacist interviewed expressed doubts about these measures, in that it 
may cost the Medicare Benefits Schedule (MBS) more, as was seen with another 
medication: 
"I think … it’ll cost the government a lot of money. …They will need 
possibly more GP visits, and overload the health system in general which 
is already pretty you know, under stress already.  So, yeah.  And 
obviously GPs only have a maximum number of MBS claims … 
interventions or patients that they can see per day anyway.  So might be 
maxing that out.  Obviously that’ll cost- like their GP visit will cost the 
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government a lot more than the PBS, $ͱͰ for an antibiotic or something 
like that.  And you already see it with things like Nexium® ʹͰmg."; and 
"… Nexium ʹͰmg is only approved on the PBS for one repeat.  So it’s 
supposed to be initial therapy for GORD [gastro-oesophageal reflux 
disorder] or reflux.  And then after that they’re supposed to go down on 
to the ͲͰmg, which is available as ͵ repeats.  But there’re still plenty of 
patients on ʹͰmg long term.  … so that’s with one repeat, every Ͳ 
months you have to go see the doc, when your other conditions might 
be well managed." (CPͰͷ, pharmacist for ͵ years, line Ͳ͹͹-ͳͰͶ and line 
ͳͰ͸-ͳͱͲ) 
However, it can be argued that unlike Nexium®, antibiotics are usually meant for short-
term treatments only and as flagged by the GPs, the government would need to 
institute other pathways to ensure appropriate access of antibiotics for consumers 
requiring longer term treatments, such as for osteomyelitis (see also Section ʹ.Ͳ.ͱͰ). 
Public campaigns will be discussed in Section ʹ.ͳ.ͷ below.   
 
4.3.7 Patient education vs. Information needs 
Health professional mediated patient education vs. Consumer information needs 
When consumers are prescribed antibiotics, community pharmacists would usually 
provide the following information as part of patient counselling: (a) how to use the 
antibiotic — dosage, frequency, timing in relation to food, and a reminder to complete 
the course, (b) common side effects and how to manage these, (c) major side effects 
which would warrant urgent medical attention, (d) additional advice regarding timing 
of antibiotics and/or precautions if the consumer was also taking other medications 
which could be affected by antibiotics e.g. oral contraceptives, and (e) whether there 
was a repeat antibiotic prescription available.  Pharmacists would also check with the 
consumer regarding their allergies to medication prior to dispensing the antibiotic. 
Pharmacists cite the following barriers to providing patient education and engaging 
patients in conversations about prudent use of antibiotics: (a) time constraints, (b) 
inadequate staffing of some pharmacies, (c) high workload, and (d) disinterested 
consumers.   
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"… most patients there’s not the time, they’re thinking of other things, 
um, I’m trying to make sure they understand that they’ve got to take this 
with food and finish the whole lot. … I’ve got if you like, an agenda there 
to [accomplish] … the scope of them taking this properly and 
understanding what they’ve got to do and to check that they’re not 
allergic to macrolides or penicillin or whatever it is they’re taking.  So 
I’m very you know, fixed on that [counselling on the essentials].  And 
they’re fixed on when the next bus comes and so there’s not always long 
conversations about antibiotic resistance."  (CPͰ͸, pharmacist for Ͳͳ 
years, line ͷͱͶ-ͷͲͳ) 
 
When explaining the concept of antibiotic resistance to consumers, not surprisingly, 
pharmacists usually expressed it as avoiding antibiotic resistance at an individual level, 
rather than at a societal level, with some using creative everyday metaphors to get the 
explanation across: 
" 'Look bacteria can get like weeds and that sort of thing, you know.  
Certain weeds are resistant to certain pesticides.  Bacteria’s the same 
with antibiotics.  So you start off with a hundred bacteria, maybe one or 
two of them might be resistant to this antibiotic. … normally if you take 
a full course of antibiotics, the idea there is to get rid of all of a hundred 
of them.  If you don’t use the antibiotic properly, if you only take let’s 
say half your course or something like that, you might kill the weak 
seventy-five, then those twenty-five still hanging around.  And you 
might feel better, but you’ve still got those little twenty-five bacteria 
hanging around.  And when you get another infection, those twenty-five 
which are stronger or more resistant to that antibiotic, when you treat it 
with that again [the same antibiotic], you might not kill any of them at 
all, or very little.'  I find putting it into- as simple as possible; that’s still 
pretty complicated for a layman to understand."  (CPͰͷ, pharmacist for 
͵ years, line ʹ͹Ͷ-͵ͰͶ) 
The information needs of consumers is discussed in Section ʹ.ʹ.ͱͰ. 
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Public campaigns 
Not unlike GPs, many community pharmacists were aware and supportive of public 
campaigns to raise consumer awareness regarding prudent use of antibiotics, such as 
those run by NPS MedicineWise.  Some pharmacists interviewed were actively involved 
during the annual Antibiotic Awareness Week or seasonal campaigns (e.g. Winter is 
Coming campaign by NPS MedicineWise in ͲͰͱ͵), and used NPS provided print and 
social media material to engage their client base and walk-in consumers.  Pharmacists 
pointed out that pharmacy staff needed to engage with consumers on the topic for 
these pharmacy-mediated public campaigns to be noticed.  Simply putting the 
campaign poster up on the wall or having flyers in the pharmacy would not be as 
effective. 
Pharmacists noted a level of complacency amongst some consumers, and suggested the 
need for this aspect to be addressed through public campaigns:   
"So consumers also need to take that [antibiotic resistance] seriously, 
rather than, 'Oh, it’s not our problem, it’s a developing countries’ 
problem.'  It’s actually our problem as well."  (CPͰͳ, pharmacist for ͱͲ 
years, line ͵ͶͶ-͵Ͷ͸) 
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 CONSUMERS:  INTERVIEW FINDINGS 
4.4.1 About the participants 
Forty-nine consumers expressed interest to participate in the interviews, out of which 
ͳͲ were selected.  The rationale for selecting a sample to interview from those who 
expressed interest were: (a) given the limited timeframe for this research, it was not 
feasible to interview all ʹ͹ consumers especially when factoring in transcription time 
(for each hour of interview recorded, transcription took another ʹ to ͵ hours), (b) to 
obtain a spread of ages from ͱ͸ – ͵ʹ years old, (c) to have as much diversity as possible 
i.e. place of origin and lived experience (rural, regional and metropolitan) and 
ethnicity.  
A total of ͳͲ consumers were interviewed ― ͹ men and Ͳͳ women.  Their ages ranged 
from Ͳͳ to ͵ͳ years old (mean:  ͳͳ years old), with the majority (͸ʹ%) in the age band 
between Ͳͱ to ʹͰ years old.  Participants originated from ͱͷ countries including 
Australia.  Years of residency in Australia ranged from ʹ months to ͵ͳ years, with ͶͶ% 
having lived in Australia for ͵ years or more.  Thirteen participants were originally from 
Australia, out of which ʹ were from or had lived in rural/regional towns.  The achieved 
education level was high — all participants held at least a bachelor’s degree.  About 
two-thirds (Ͳͱ participants) also held either a Masters or a Doctorate degree.  
There were nine main concepts/themes which emerged from the consumer interviews 
— previously shown in Table ͱͰ (List of categories for each participant group):  delayed 
antibiotic prescriptions, repeat antibiotic prescriptions, patient expectations, antibiotic 
use behaviours, self-care strategies for respiratory tract infections, views on the risks of 
taking antibiotics, views on antibiotic resistance, mitigating antibiotic resistance and 
information needs.  These concepts/themes mirror the main interview questions asked 
of this participant group, as well as those which emerged from the consumer 
interviews.  Each concept/theme is discussed in turn below, beginning with those 
largely pertaining to health professionals, before moving on to those focussing on 
consumers.   
 
Chapter ʹ:  What influences antibiotic use from the perspectives of GPs, community 
pharmacists and consumers? — Data analysis and results of semi-structured interviews
  ͱ͸ͳ 
4.4.2 Delayed antibiotic prescriptions 
Integrity and responsibility 
Consumers were split on the issue of delayed antibiotics — on whether this was a 
preferable course of action for GPs to take in instances where there was uncertainty in 
the diagnosis (i.e. whether the pathogen was viral or bacterial) and therefore ambiguity 
in the need for antibiotics.  Many consumers had actual experiences of being given a 
delayed antibiotic prescription under the circumstances just described, and hence, 
were able to provide their perspectives on this issue.   
Those in favour of the delayed antibiotic prescription cited personal convenience as the 
over-riding factor, in that they would not have to return to the GP for a reassessment if 
their symptoms worsened.  Their preference for a delayed antibiotic prescription was 
particularly evident when the consumer either had an important upcoming event e.g. 
university exams, a wedding, or when they were about to travel interstate or overseas.  
One consumer mentioned that they would prefer a delayed antibiotic prescription if 
the weekend was coming up, as GP clinics may not be open throughout the weekend 
should they need to return for a review. 
Consumers not in favour of a delayed antibiotic prescription, were overwhelmingly 
uncomfortable with the fact that they had to make the final decision, rather than the 
GP.  Although highly educated and sophisticated, these consumers did not want the 
responsibility of deciding whether to use the antibiotic prescription or not.  
Nevertheless, these consumers were appreciative of the fact that the GP was being 
honest in expressing their uncertainty regarding the diagnosis and course of treatment.   
"… a bit confused, because I think when you go to the doctor you do 
want someone to be quite definitive.  Whether they’re right or wrong, 
you need that confidence that their decision is right.  But I thought 
they’re being honest to say they’re not sure.  But it was … I didn’t really 
like having that sort of choice in my hands."  (CSͰͳ, female, Ͳͷ years old, 
line ͳ͸Ͱ-ͳ͸ͳ)  
 
Another concern was that GPs did not or were not able to provide precise and 
definitive instructions on when to use the delayed antibiotic prescription (see also 
General Practitioners:  Interview Findings, Section ʹ.Ͳ.ʹ Delayed antibiotic 
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prescriptions).  This consumer expressed their reticence in asking the GP for more 
specific instructions, perhaps for fear of being negatively evaluated: 
"… sometimes they’re [GP] just like, 'Oh just keep it in case you need it.'  
I’m like, what- ((makes an incredulous face)) … Well, how will I know if I 
need it?  Like I actually- I just said, I don’t think I do. … And so I have a 
script sitting at home for that 'in case'.  But then I don’t want to just take 
them because things might have changed since they prescribed it 
anyway."; and 
"… feel sort of embarrassed if they’re [GP] sort of assuming that you 
must know [when to take] or something.  Like, I’m like, well maybe I 
should know [so did not ask for clarification] and … so look a bit stupid."  
(CSͰͶ, female, ͳ͸ years old, line ͱ͵Ͳ-ͱ͵ͷ and line ͱͶͳ-ͱͶ͵) 
 
Another way in which the delayed antibiotic prescription is a double-edged sword is 
how consumers interpret this act.  By virtue of having been provided with a delayed 
antibiotic prescription, some consumers interpreted this to mean that the GP was 
leaning towards the judgment that antibiotics were warranted.  In such cases, the 
consumer would fill the prescription immediately and commence treatment without 
delay.  The exception would be, if the GP had given explicit instructions not to start 
treatment until after another Ͳ days of self-care and self-management.  Hence, GPs' 
instructions need to be unambiguous in order to avoid misuse of antibiotics. 
"I’d probably get it filled, yep.  … and then I would see if after Ͳʹ hours 
or ʹ͸ hours if I was actually starting to make a recovery."; and  
"I would still have that thought in the back of my head that, well the 
doctor’s got you know, reasonable thought that they have prescribed the 
[delayed] antibiotic, so they reasonably think- like I trust they 
reasonably think that this- it really could be a bacterial infection that is 
best treated with antibiotics."  (CSͱ͹, female, ͳͱ years old, line ͳͰͱ-ͳͰͲ 
and line ͳͱʹ-ͳͱͷ) 
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How consumers handled delayed antibiotic prescriptions seemed also to be shaped by 
their experience of primary healthcare systems overseas.  Consumers who had 
lived/worked in countries where GPs tend to prescribe multiple medications — 
perhaps due to fear of litigation for a missed diagnosis or perverse financial incentives 
— were more likely to not use the delayed antibiotic prescription. 
 
4.4.3 Repeat antibiotic prescriptions 
Intentional vs. Unintentional 
When GPs do not explicitly discuss what to do with repeat antibiotic prescriptions 
(assuming one was given intentionally, let alone those issued unintentionally), 
consumers are left to decide for themselves with varying outcomes, some of which 
could contribute to antibiotic resistance.  Proactive consumers may contact the clinic 
to enquire, while others would simply ignore the repeat prescription especially if they 
feel sufficiently recovered.  The quote below was from a consumer expressing their 
frustration regarding the lack of discussion about the repeat prescription at the point of 
prescribing.  This consumer subsequently rang the clinic to enquire about the need for 
the repeat antibiotic prescription: 
"I finish[ed] one [prescription] and I thought that’s all over you know, 
but I see that I’ve got a repeat.  And so, you know, 'Oh wait, do I need to 
do this?' [fill the repeat prescription and take the antibiotics].  And then 
you call up [the clinic] and then by the time you get to the pharmacy 
again, sometimes you’ve lost time.  To me, that was kind of annoying 
when that happened."; and   
"I ended up getting the repeat.  But it wasn’t until about three days 
[later], so there was a three-day gap.  So I was quite annoyed about that, 
‘coz I felt like that even though the doctor assured me that it wouldn’t 
be a problem, I sort of felt … from my small amount of knowledge, that 
it would be a problem.  ‘Coz … I know that you’re supposed to always 
take your antibiotics at the same time regularly, because that affects it.  
So I felt like having that three-day gap between the two sets might have 
made my whole set completely irrelevant or something."  (CSͰͲ, female, 
Ͳͷ years old, line ͱ͸Ͷ-ͱ͹Ͱ and line ͲͲͶ-ͲͳͲ) 
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Problematic sequelae 
Unused repeat antibiotic prescriptions contribute to the potential "reservoir" of 
antibiotics accessible to consumers, much like unused delayed antibiotic prescriptions.  
Many consumers retain these prescriptions only to use them for another illness with 
similar symptoms, discarding them only when the prescription has expired and can no 
longer be dispensed (currently set at ͱͲ months from date of prescribing).    
 
4.4.4 Patient expectations 
Establishing and addressing patient expectations for the consultation 
Consumers who have regular GPs tend to have shared expectations regarding overall 
management of their health and health outcomes.  Informed consumers with 
established doctor-patient relationships reported having had pre-emptive 
conversations regarding their preference to avoid antibiotic use where possible.  
Although it was not apparent whether these conversations were GP or consumer 
initiated, it provided a basis for future GP consultations whenever the need for 
antibiotic use came into question. 
"But if you’re going to miss more than ͱ day [of work] then I’ll go and see 
a doctor to get a medical certificate.  But you know, like, I’ll say to them 
to make clear that I don’t want antibiotics or anything.  I don’t need to 
say that if I see my GP.  Because she knows that."  (CSͰͶ, female, ͳ͸ 
years old, line Ͷͷ-ͷͰ) 
 
Overwhelmingly, when describing what they expected from a GP consult should the 
consumer decide to see a GP for a respiratory tract infection, consumers said that they 
wanted to be listened to.  Consumers also expected the GP to conduct a thorough 
clinical examination, explain their findings, treatment options, and decisions, and to 
answer any questions.  These elements of the consultation taken together, seemed to 
increase consumer confidence in the professionalism, competence and trustworthiness 
of the GP.  The first quote below illustrates a positive experience, while the quick 
consultation described in the second quote led the consumer to doubt the medical 
decision of the GP: 
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" … she [the GP] really … listen[ed] to me … really attentive towards me.  
… I really trusted her.  … Very professional … she was very clear with me, 
… she answered all the questions.  But at the end, I can feel that she was 
really concerned about all the things.  So I really trusted what the doctor 
said."  (CSͱͲ, male, Ͳ͵ years old, line ͳͳͷ-ͳʹ͵) 
"… I mean, you sort of just feel as if you’ve been palmed off a little bit= … 
they’re [GP] just prescribing you the antibiotic just to get you out the 
door.  Yeah.  I didn’t really- ‘coz they didn’t really do a thorough 
examination.  They listen [to] your chest with the stethoscope and they 
do your blood pressure, but um, it sort of felt like they were just trying 
to get through the people in the waiting room a little bit."  (CSͰ͹, 
female, ͳͱ years old, line ͱ͵͵-ͱͶͰ) 
 
Consumers sometimes seek a GP consult, not so much hoping, wanting or expecting 
antibiotics, but to seek their expertise in discerning whether there were more serious 
underlying health issues, for ascertaining whether the pathogen was viral or bacterial 
(and hence, whether treatment with antibiotics was warranted), and for reassurance.  
The GP advised this consumer to rest rather than resort to using antibiotics for a sore 
throat and fever: 
"[I was] not surprised.  It was as expected.  I thought, oh that’s good, I 
haven’t you know- not going to get worse.  I’d only gone in [to see the 
GP] because I was going to Sydney on the weekend and I just wanted to 
make sure … I … was going to be OK.  So it was more just to check."  
(CSͰͳ, female, Ͳͷ years old, line ͱʹ͹-ͱ͵Ͳ) 
 
Most if not all consumers interviewed would accept the GP's decision not to prescribe 
an antibiotic if this was clearly explained.  Only a few expressed disappointment: 
"I’d be disappointed that it couldn’t be treated [with antibiotics].  But I 
also understand that there’s no point in treating some things with 
antibiotics.  …  So if that was clearly explained, I think I’d be less 
disappointed in the care that I receive from the doctor.  But of course, I 
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would always be disappointed in the fact that you just have to like, 
tough it out through a sickness, because there’s no easy fix."  (CSͰ͵, 
female, Ͳ͹ years old, line ͱͷ͹-ͱ͸ʹ) 
 
4.4.5 Antibiotic use behaviours 
Consumer behaviours 
Consumers acknowledged that it was difficult to have perfect adherence to prescribed 
antibiotics.  The most common behaviour was not completing the course of antibiotics, 
either due to a conscious decision to cease taking (Box ͱͷ), or forgetting to take when 
they felt better and hence, lost the main driver (feeling ill) to encourage adherence.   
Box ͱͷ. 
"I might have taken it for ͳ or ʹ days and then I stopped it, because I thought this 
was not a very serious situation.  I thought I could [fight it] by my own body."  
(CSͰ͸, male, Ͳ͸ years old, line Ͳ͵͵-Ͳ͵ͷ) 
 
Given that most consumers rely on GPs' instructions to guide them on appropriate use 
of antibiotics, GPs who omit to provide clear advice may inadvertently contribute to 
misuse.  For example, omission to provide advice on the duration of treatment led this 
consumer to misinterpret the GP's intent, and led to non-completion of the prescribed 
course of antibiotics:   
"… [the] doctor doesn’t comment much about when you stop it ((taps 
table twice with palm of hand for emphasis)).  So, the assumption is, you 
stop [taking antibiotics] when you feel good."  (CSͱͶ, male, ͲͶ years old, 
line ͳͶͰ-ͳͶͱ) 
 
Consumers found it challenging to remember to take the middle-of-the-day dose for 
antibiotics which has to be taken three or more times a day.  Some consumers handled 
missed doses by working it in within the same Ͳʹ-hour period.  Others simply skipped 
the missed dose — either because that was easiest to do or because they were unsure 
how to handle missed doses — which resulted in taking longer to complete the course.  
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One consumer reported taking twice the antibiotic dose for their next dose, to make up 
for the missed dose earlier in the day. 
"I’ll remember in the morning and then I’ll remember at night, but that 
middle of the day- and often I can do middle of the day ((raps table)) for 
you know, a few days, but then, no, I end up- you get to the end and 
you’re like, oh it’s taken me ͷ days to take a ͵-day course or something.  
… I have no idea what effect that has, but I figured- I guess it’s better to 
finish it."  (CSͰͶ, female, ͳ͸ years old, line Ͳ͵ʹ-Ͳ͵͸)  
 
Some consumers were proactive in anticipating the likelihood of forgetting doses and 
implemented strategies, such as using phone apps as reminder systems: 
"I found it [adherence] so much of an issue that I actually downloaded 
an app on my phone ((grins)) that would beep and remind me to take 
them [antibiotics] three times a day.  Because otherwise, yeah, I will 
forget."  (CSͱͰ, female, Ͳͳ years old, line Ͳͳ͸-ͲʹͰ) 
 
Consumers reported using leftover antibiotics from the last unfinished course the next 
time they were unwell with similar symptoms, sharing it with other people, and/or 
disposing unused leftover antibiotics as part of household waste when it expired.  The 
following quotes illustrate these views.  
"Just keep [the leftovers].  Like next time somebody gets sick you start 
with that, you don’t even go to the doctor ((chuckles))."  (CSͱͶ, male, ͲͶ 
years old, line ͳͶͶ-ͳͶͷ) 
" … like when I was taking them [antibiotics] all the time, I would keep 
them [leftovers] because I would expect to take them very soon.  … and 
then they run out of date … and I just had a big clean out last year 
((chuckles)) and I just chucked them all out.  And I probably should 
have taken them to the pharmacy but I didn’t, I just chucked it."  (CSͰʹ, 
female, ͳͱ years old, line ͳ͵Ͱ-ͳ͵ͳ) 
Most consumers were not aware of the Return of Unwanted Medicines (RUM) program 
for safe destruction of medicines, which is offered at no charge by community 
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pharmacies.  Methods of disposal reported by consumers interviewed were frequently 
via household waste or tipped down the sink (for liquids e.g. antibiotic 
mixtures/syrups). 
 
Social influences were important in shaping consumer approach and behaviours in 
antibiotic use.  Influences from family — parents (while growing up), friends and 
partner/spouse, were cited (Boxͱ͸).  The GP was another important influence, 
particularly for consumers who had established good doctor-patient relationship with a 
regular GP.  For example, consumers reported that they were more likely to complete 
the course of antibiotics if the GP had explicitly instructed them to do so.  Another 
consumer recounted that patient education from her GP previously, enabled her to 
recognise and resist inappropriate antibiotic use behaviours i.e. not accepting shared 
antibiotics from her twin sister and not using her own leftover antibiotics. 
Box ͱ͸.  Behaviour change due to spousal influence 
"He [husband] would just say- ‘coz I guess he’s very against all the antibiotics and 
everything, and I think that’s probably another influence on me that I have shifted 
from that, because … I would come back from [name of country, visiting family 
overseas] with a big sack of medication ((smiles)).  And he said, 'Oh you shouldn’t 
be doing this you know, you have to go and see the doctor' … and he said, 'you 
know the more you take [antibiotics], it’s not going to work anymore…' "  (CSͰʹ, 
female, ͳͱ years old, line ʹ͹Ͳ-ʹ͹ͷ) 
 
Motivations for seeking antibiotics 
The relatively higher cost of products for symptomatic management of coughs and the 
common cold may motivate some consumers to seek antibiotic treatment, which costs 
less.  This was true of consumers for whom costs of healthcare was a key concern.  
These consumers would also prefer to use bulk-billing clinics as far as possible in order 
to reduce out-of-pocket costs.  
"Because often I guess, those types of remedies like nasal sprays and … 
you know all those other types, they can … be a lot of them and they can 
be expensive [to purchase].  So whereas, antibiotics can just be quite 
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affordable, in terms of treatment options. … those alternatives aren’t 
always that affordable.  Like even just like cold and flu tablets are more 
expensive than antibiotics themselves."  (CSͰ͵, female, Ͳ͹ years old, line 
ͱ͹ʹ-ͲͰͳ) 
 
4.4.6 Self-care strategies for respiratory tract infections 
Self-care and self-management of respiratory tract infections 
Strategies used by consumers to manage the symptoms of a respiratory tract infection 
fell into these categories: (a) home remedies, (b) commercially available natural 
remedies, (c) immune boosters, (d) over-the-counter cough and cold products, and (e) 
increased rest and fluids.  Popular home remedies included, fruit and vegetable juices, 
hot drinks made from single-ingredient or a combination of garlic, ginger, lemon, 
and/or honey, tea, and traditional remedies such as green bean soup or herbal soup.  
Commercially available natural remedies used by consumers which were procured 
either from pharmacies, supermarkets or health food stores included echinaceae (with 
or without Vitamin C and Zinc) tablets/capsules, garlic tablets/capsules, and olive leaf 
extract.  Immune boosters used were a variety of vitamins and/or minerals e.g. 
multivitamins, Vitamin B, Vitamin C, and Zinc.  Over-the-counter cough and cold 
products used were those commonly available in pharmacies and/or supermarkets, 
such as Codral® Cold & Flu tablets, Lemsip®, Panadol® and lozenges, to name a few.  
Consumers with underlying long-term respiratory conditions such as asthma, were 
especially mindful of following their asthma management plan during periods of 
intercurrent illness. 
Consumers' self-care behaviours were also shaped by their workplace culture.  Some 
workplaces expect staff to "power through" minor infectious illnesses such as coughs 
and the common cold, whereas other organisations deem it acceptable (and even 
desirable) for staff to take a few days off work to recuperate at home, and to minimise 
the spread of infectious pathogens to other colleagues.  One consumer noted from their 
past experience that the doctors in the army seemed to prescribe antibiotics more 
freely, perhaps to prevent or minimise disruptions to soldiers' training schedule which 
can cause major logistical difficulties. 
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Triggers for self-referral to GP 
Consumers were realistic about feeling miserable and unwell during a common cold or 
cough, and would tolerate their symptoms for up to ͳ weeks (i.e. between ͱ to ͳ weeks) 
before seeking a GP consult.  Self-care and self-management strategies were used in the 
meantime to alleviate these symptoms. 
However, consumers are more likely to seek a GP consult if: (a) they were unable to 
take time off work/study to recover, (b) they had to maintain a high level of 
functionality — usually women with both work and family commitments, (c) an 
important upcoming event e.g. university exams, a wedding, (d) they need a medical 
certificate to take time off work to recover, and (e) persistence or worsening of 
symptoms.  The consumer quoted below would usually self-manage for up to a week 
before seeking a GP consult, but could self-refer earlier if there were important 
upcoming life events: 
"… so it would depend on my symptoms, but also what I have to do [life 
context].  So if I’m going through a period where I don’t have a lot on, 
then I wouldn’t mind so much suffering through symptoms.  But if I 
have something that I need to do like a run or something important job-
wise or something [like that], then I might seek out healthcare earlier. … 
I’ll just say persistence of the symptoms."  (CSͰ͵, female, Ͳ͹ years old, 
line ͱ͵Ͳ-ͱ͵Ͷ) 
 
4.4.7 Views on risks of taking antibiotics 
Past experience with using antibiotics:  Non-event vs. Negative event 
Consumers who had negative experiences with taking antibiotics reported side effects 
such as: (a) adverse impact to digestive system for a prolonged period, (b) feeling 
physically tired, and (c) vaginal thrush.  These consumers were more reluctant to use 
antibiotics, unless absolutely necessary.  The following quote was from a consumer who 
estimated that it took between Ͷ months to a year for the recovery of his digestive 
system following a prolonged course of antibiotics for tonsillitis: 
"Yes, from the roxithromycin [antibiotic] I got stomach discomfort.  Just 
don’t feel very comfortable.  Digestion was not very good and I was so 
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worried … after taking two months of antibiotics, the whole body [was] 
… very weak at that time; my digestion system.  And I got diarrhoea very 
easily.  So I think it might be related to the long term antibiotics …"  
(CSͰ͸, male, Ͳ͸ years old, line ͵ͱͳ-͵ͱͷ)   
 
Consumers who had neutral experiences with taking antibiotics e.g. those with no 
troublesome side effects and recovered with the treatment, were open to using 
antibiotics.  Although, many were mindful of not using antibiotics unless clinically 
warranted as advised by the GP. 
Those who had either life-saving experiences with antibiotics or close brushes with 
antibiotic resistance — of either themselves or close family members — were very 
attuned to the benefits of these medications and also very aware of the need to protect 
the remaining armamentarium of antibiotics.  For example, one participant had the 
traumatic experience of being told by hospital doctors that there was no antibiotic they 
could give her then ͱͰ-month old daughter for a post-surgical infection.  The child 
survived with supportive treatment.   
 
Safe to use vs. Concerned 
Many consumers generally perceive that antibiotics are a safe medication to take.  For 
example, some consumers knowing that there was uncertainty as to whether their 
infection was viral or bacterial, would choose to use their delayed antibiotic 
prescription immediately.  The rationale given seems to be a win-win for the consumer, 
in that — they are aware that the antibiotic would not work if the infection was viral, 
but they believe that antibiotics would not do any harm to their body; on the other 
hand, the antibiotic would be effective if the infection turned out to be bacterial. 
However, many consumers expressed their preference to avoid antibiotics where 
possible.  Their reasons ranged from being unsure as to how the antibiotics actually 
worked and the effects it could have on the body, to being concerned about becoming 
"resistant".  Many of these consumers also considered themselves low users of 
medications overall. 
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"I’m pretty hesitant to take them [antibiotics], only because of the lack 
of information that I have received about what they actually do.  And I 
prefer to find an alternative method to fixing what ails me ((chuckles))."  
(CSͰ͹, female, ͳͱ years old, line ͳ͹Ͱ-ͳ͹Ͳ) 
"…no, not going to take them because I don’t want to get resistant."  
(CSͰͲ, female, Ͳͷ years old, line ͳͶͶ-ͳͶͷ) 
Cultivating a healthy immune system was another reason cited by consumers who were 
mindful of using antibiotics only when required: 
"… from a while ago I got the idea in my head that in order to build up 
your immune system well, you need to give it a chance to fight things on 
its own.  It’s only if it’s clearly going to lose the battle that you should 
really help it with medication." (CSͱͰ, female, Ͳͳ years old, line ͳͷʹ-ͳͷͷ) 
 
4.4.8 Views on antibiotic resistance 
Meaning of antibiotic resistance 
Consumer understanding of antibiotic resistance was conceptualised in four ways: (a) 
as a property of the body — body becomes resistant to antibiotics, (b) as a property of 
the medication — antibiotic is no longer effective, (c) as a property of the bacteria — 
bacteria is resistant to the antibiotic, and (d) as a property of a collective — society is 
immune to antibiotics.  The quotes below illustrate the different ways consumers 
described antibiotic resistance. 
"… it’s [the antibiotic] just not effective for the body anymore.  That’s 
obviously, you know, it’s like the body’s built up this immunity to it [the 
antibiotic] actually working."  (CSͰͳ, female, Ͳͷ years old, line ͳͲͷ-ͳͲ͹ 
— expressing antibiotic resistance as both a property of the body and of 
the antibiotic) 
"… bacteria … is getting stronger. … People don’t finish the doses … so … 
the first part of the treatment there are more weak bacteria [that] died, 
and then the stronger ones live and as you don’t finish [the course of 
antibiotics], only the stronger ones [survive] and genetically would be 
the best bacteria, and that’s what’s happened."  (CSͱͲ, male, Ͳ͵ years old, 
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line ͵Ͱ͸-͵ͱ͵ — expressing antibiotic resistance as a property of the 
bacteria) 
"… if it’s [antibiotics] prescribed for reasons which aren’t very serious, 
then as a society we get immune to the effects of those drugs 
[antibiotics]." (CSͱͰ, female, Ͳͳ years old, line ͱ͹͹-ͲͰͱ — expressing 
antibiotic resistance as a property of a collective) 
Some consumers use battle metaphors in describing antibiotic resistance.  The 
following quote is an example: 
"… it’s like fighting an enemy with weapons that are not good enough."  
(CSͱ͵, female, Ͳ͸ years old, line ͳͳͱ-ͳͳͲ)   
 
Pessimism vs. Optimism 
Consumers were not necessarily pessimistic, but were concerned as to whether 
antibiotic resistance could be adequately addressed in a timely manner.  Many 
commented that "prevention is better than cure" — finding ways to prevent or 
minimise antibiotic resistance is preferable to having to find ways to resolve it.  A few 
consumers interviewed were very concerned about the issue (Box ͱ͹).  Perhaps, these 
consumers are more aware than most of the significant lag time between discovery and 
marketable product or technology.  Even promising new solutions take about ͵ to ͱͰ 
years to get to human trials. 
Box ͱ͹. 
"I’m actually quite worried.  ‘Coz even healthy people, when you travel 
around, one of the main reasons for spread of all these drug resistant 
strains has been human movement.  … people can carry them [resistant 
strains of bacteria] with them, and not- [be sick], just be a carrier.  And 
then, you know, you go to a region that’s endemic for … these drug 
resistant bacteria, pick them up and you come back, and you disseminate 
it.  And that’s how it spreads.  So, yeah, I’m, I’m quite worried.  And I hope 
if I do get a bacterial infection, it’s not drug resistant."  (CSͱ͵, female, Ͳ͸ 
years old, line ʹͳͷ-ʹʹͳ) 
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On the other hand, some consumers were optimistic and confident that medical 
technologies to address or overcome resistant bacteria would be found in the not too 
distant future. 
"I guess medicine and technology is advancing so quickly that they may 
be able to stamp them [resistant bacteria] all out …"  (CSͰ͹, female, ͳͱ 
years old, line ͳͰͳ-ͳͰʹ) 
"Scientists out there will come up with something and they’re really 
clever, so I don’t worry too much because I think somebody’s solving the 
problem."  (CSͲͳ, female, Ͳ͸ years old) 
 
Optimism was also found in consumers who had lived and/or worked overseas — due 
to their country of origin, furthering their studies, work opportunities or for extended 
travel — who felt that Australia had been managing the issue of antibiotic resistance 
rather well.  They note that antibiotics are regulated medicines in Australia and can 
only be accessed via a prescription.  These consumers surmised and were optimistic 
that GPs acted as good gatekeepers for antibiotic use in the community.  There was also 
a sense of complacency and/or a feeling of safety of being in a "first-world" country, 
conferring a false sense of impermeability to issues such as antibiotic resistance. 
"But here [Australia], you need to have a prescription.  So I would be less 
concerned here, because it’s regulated by the GP."  (CSͱͲ, male, Ͳ͵ years 
old, line ͵͹͹-ͶͰͰ) 
 
Impact of antibiotic resistance:  Personal and Societal 
Consumers were aware that antibiotic resistance is currently an issue in hospitals.  
Hence, the association was made that avoidance of hospitalisation would mean 
avoidance of antibiotic resistance for the individual. 
Consumers largely did not think antibiotic resistance would affect their health or their 
family's health.  Although a few mentioned the more vulnerable in society may be 
affected adversely e.g. people suffering from cystic fibrosis who usually need antibiotics 
as part of their management plan.  Many consumers commented that their health was 
good and saw this as insurance against being adversely affected by antibiotic resistance.  
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Most consumers, even those who were aware of antibiotic resistance and its 
consequences, were of the opinion that antibiotic resistance would only have societal 
impacts in a generation's time — citing a timeline between ͵ to ʹͰ years into the 
future. 
"Probably a generation.  So about ʹͰ years or so, I imagine."  (CSͰͲ, 
female, Ͳͷ years old, line ͳʹͰ) 
 
A few consumers who had personal or close family with health issues, were more 
concerned about the possibility that they could be adversely impacted.  For example, 
someone with allergies to some antibiotics now, would have a faster rate of diminishing 
options for treatment.  One consumer who seemed to rely considerably on antibiotics 
for minor ailments expressed their concerns about being able to continue to access 
antibiotics easily, should there be strong action by the government to address 
antibiotic resistance. 
It was interesting to find that despite the high education level of the consumers 
interviewed, many were not aware that antibiotic resistance could occur at both an 
individual and societal level.  These consumers had assumed it was one or the other.  A 
few were also not aware that using antibiotics inappropriately for the common cold 
and/or coughs can contribute to antibiotic resistance, and in time cause these 
antibiotics to be ineffective for other more serious infections.  Similarly, most 
consumers were not aware that resistant bacteria could be transferred from person to 
person or from food-producing animals to people. 
 
4.4.9 Mitigating antibiotic resistance 
Individual initiatives 
Consumers were thoughtful as to what they can do as individuals to help mitigate 
antibiotic resistance.  Although many felt that health professionals such as GPs should 
play a more proactive role — prescribe less antibiotics, educating patients when 
antibiotics are not required, and not succumbing to patient demands for antibiotics —  
they acknowledged that consumers need to be part of the solution.   
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Consumers reflected on their role in two ways: (a) what they can do personally as 
individuals, and (b) what consumers should/can do collectively.  At the 
personal/individual level, consumers felt that their general approach of avoiding 
unnecessary antibiotics meant that they were not worsening the problem of antibiotic 
resistance.  On occasions when antibiotics were prescribed, consumers recognised that 
socially responsible behaviour on their part would constitute completing the course of 
antibiotics, so as not to encourage the growth of resistant bacteria.  At the societal 
level, consumers reported attempts at influencing their social and familial circle — 
albeit with mixed results. 
Consumers also maintained a realistic view of having to tackle antibiotic resistance 
from multiple angles, highlighting the need for conservation of antibiotics now through 
individual efforts, while at the same time pursuing innovative approaches: 
"I certainly think we make a lot of medical breakthroughs.  But I think 
it’s often better to prevent than cure.  So … if we’ve got this thing 
[antibiotics], yes we should continue to develop medical technologies 
and continue to try and find new antibiotics and we should continue all 
of that, but we shouldn’t just forget about [the] potential looming 
problem.  So I think we need to do both, does that make sense?  … So we 
need to look after what we have [antibiotics], and not just hope that the 
next breakthrough is just around the corner.  I certainly hope that it is.  
But … where does it stop?  You might find a new antibiotic, well that one 
becomes resistant … so I think it’s a continual thing."  (CSͱ͹, female, ͳͱ 
years old, line ͵ʹͶ-͵͵ͷ) 
 
4.4.10 Patient education vs. Information needs 
Consumer information needs 
Consumers may or may not ask their GP or the community pharmacist for information 
about the antibiotics prescribed, as they expect to either see an information leaflet 
included in the medication pack or that the information could be easily found online.  
When asked, only a few consumers reported being given a leaflet with information 
about the prescribed antibiotics or that a leaflet had been included in the medication 
pack.  This could be due to the shift by pharmaceutical companies from paper leaflets 
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to providing Consumer Medicines Information online and/or via the Therapeutic 
Goods Administration website (Therapeutic Goods Administration, ͲͰͱʹ). 
Consumers interviewed wanted the following types of information, even though more 
often than not, they did not ask — or perhaps did not have the presence of mind to ask 
— the GP during the consultation or at the point of prescribing: (a) how the antibiotic 
worked, (b) the rationale for selection of a particular antibiotic, (c) the duration of 
treatment, including when or whether the repeat antibiotic prescription (if issued) 
should be used, (d) whether they can have alcohol while on antibiotics, and (e) the 
rationale for finishing the course of antibiotics (or the consequences of not doing so), 
so as to encourage adherence to the treatment.   
The quote below was from a consumer who would have liked either their GP or the 
community pharmacist to have discussed the possible interaction between alcohol and 
the prescribed antibiotics more thoroughly: 
"So the doctor just said, don’t drink alcohol when you take this 
antibiotic, which I’ve been told for most antibiotics I think.  And then … 
‘coz I was going out for my friend’s ͳͰth [birthday] while I was taking 
that [antibiotics].  And she said, 'Oh, no, you can drink alcohol while 
you’re taking antibiotics, I’ve done it loads of times.'  And so I looked it 
up because I have heard competing information.  … and all of the 
information that I could find said, most antibiotics, doesn’t really do 
anything when you drink alcohol [not necessary to avoid alcohol], but 
these particular like, maybe two strains or something … stop you from 
processing alcohol properly … So … you only need to have one drink or 
less, and you can start vomiting and fainting and be really sick 
((chuckles)).  So the doctor didn’t tell me that much detail.  He just said, 
don’t drink alcohol."  (CSͱ͸ female, Ͳ͹ years old, line ͱͶͲ-ͱͷʹ) 
 
Consumers noted that the types of information listed above were not voluntarily given 
by GPs or community pharmacists.  The quote below was from a consumer who 
wondered about the rationale for the selection of antibiotics, which seemed to be the 
same one given for another type of infection previously.   
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"But it seems to be the same one that’s prescribed.  So it would just be 
good if they [the GP] could provide the information of how that actually 
helps an ear infection and chest infection.  You know … because they’re 
completely different.  To me they’re completely different areas [the 
infections]." CSͰ͹, female, ͳͱ years old, line ʹͰͲ-ʹͰͶ)  
 
In the case of a delayed prescription for antibiotics, consumers wanted definitive 




Consumers interviewed were largely not aware of the public campaigns run by 
Government or Commonwealth funded agencies.  When asked, no consumer 
remembered having seen any of the recent campaign materials, whether current or 
from the past year — in the form of print media (posters in clinics or pharmacies, at 
bus stops, in buses), television advertisements, or social media.  This was an 
unexpected finding as the consumer interviews were conducted when the Winter is 
Coming ͲͰͱ͵ public health campaign was active26 (see Section ͳ.ʹ.ʹ for details of the 
campaign), coupled with the fact that the annual Antibiotic Awareness Week ͲͰͱʹ 
national campaign had occurred just six months prior.  A few consumers reported 
noticing articles related to antibiotic awareness in professional journals and online 
news, such as The Conversation.27  Interestingly, some consumers were generally 
cc                                                     
 
26 Incidentally, the bus stops outside the university where many of these consumer 
participants were based, did have the Winter is Coming posters.  Selected buses plying the 
university route also carried these poster advertisements, both inside the bus and on the 
external façade.  
27 The Conversation is a free online news site produced as a collaboration between editors 
and academics, which provides informed analyses and commentaries on important national 
and global events. 
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sceptical about news reported in the media, and would have assumed that the issue of 
antibiotic resistance had been sensationalised or that it was hyperbole. 
Some consumers interviewed offered ideas or perspectives for future public campaigns.  
Perspectives include: (a) avoiding visually shocking and/or overtly graphic television 
advertisements about the consequences of antibiotic resistance, which would be 
detrimental to the public health message, (b) using short video clips of ͵ to ͱͰ-minute 
talks about the topic of antibiotic resistance delivered in an engaging and entertaining 
manner, which could be easily shared on social media, (c) using infographics instead of 
text-heavy messages, and (d) using cartoon animation to tell the story of how resistant 
bacteria are caused and what can be done about it. 
There was a general consensus that antibiotic resistance is a difficult topic with which 
to engage consumers, as it is "invisible" (Box ͲͰ) and inconsequential for most people 
currently.  A few were concerned about the misinformation on social media or online 
about health-related topics, for example the use of alcohol while taking antibiotics.   
Box ͲͰ.  Antibiotic resistance is an invisible problem 
"Because it’s not something that you can see, antibiotic resistance.  … I don’t know 
if you can measure it. … You can’t even see it — look at you and then say like [you 
have it]. … it’s tough to convince people about that [the importance of addressing 
antibiotic resistance].  It’s invisible … And it is real, but it’s invisible.  So it’s very 
difficult to push the message across, people don’t see it you know.  They think 
like, it doesn’t matter, I’m better today, that’s all that matters to me."  (CSͱͶ, male, 
ͲͶ years old, line ͷͱͰ-ͷͲͰ) 
 
4.4.11 Other findings 
Other related findings from the consumer interviews are the use of more than one GP.  
Some consumers consult multiple GPs due to not having a regular GP.  This is 
especially so for consumers who have relocated to Brisbane — from another country, 
interstate, rural or regional Queensland town — or a change of residence locally (e.g. 
moving to another suburb which can be a considerable distance from the previous GP).  
Even those who reported having a regular GP acknowledged that they may see another 
GP for other types of issues — usually specialty issues e.g. skin checks, or minor issues.  
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For example, consumers who are managing long-term conditions tend to consult their 
regular GP for review and follow-up regarding these conditions, but may use another 
GP's service for minor conditions, in part due to difficulty in booking an unplanned 
appointment. 
 
 THE ENABLING ANTIBIOTIC EUPRAXIS (EABE) MODEL 
 
 
The Enabling Antibiotic Eupraxis (EABE) Model shown above, emerged from the third 
iteration of code mapping through studying the meta-categories of the coded semi-
structured interviews of all three participant groups (Section ʹ.ͱ.Ͳ).  The model 
comprises of three intersecting circles — each one representing a meta-category: (a) 
clinical processes and challenges, (b) consumer attitudes, behaviours, skills and 
knowledge, and (c) engaging with antibiotic resistance.   
The intersections between two circles represent shared or common subcategories 
between the two meta-categories concerned, and relevant to the third.  For example, 
the subcategory of Patient Expectations is shared between the meta-categories of 
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Clinical Processes & Challenges and Consumer Attitudes, Behaviours, Skills & 
Knowledge, while being relevant to Engaging with Antibiotic Resistance.  The same 
interpretation of the diagram applies to the sub-categories of Patient Education vs. 
Information Needs and Prescribing Challenges. 
The area where all three meta-categories intersect is represented by the letter "E" — 
eupraxis, defined here to mean good/right theoretically-informed practice.  This model 
can be used in two ways: (a) to explain the phenomenon of what influences antibiotic 
use from the perspectives of GPs, community pharmacists and consumers (Section 
ʹ.͵.ͱ), and (b) to inform individual and collective action on how to enable wise use of 
antibiotics (Section ʹ.͵.Ͳ).  In other words, antibiotic eupraxis is possible when 
prescribing challenges and patient expectations are made transparent between GPs and 
consumers, through skilful communication embedded in patient education that meets 
consumers' information needs. 
 
4.5.1 Explaining the phenomenon 
From the perspective of GPs, clinical processes which inform decision-making (TDF 
DͱͰ Memory, Attention and Decision processes) are relatively straightforward, relying 
mainly on cognition and clinical examination (TDF Dͱ Knowledge, TDF DͲ Skills), and 
experience and intuition, as reported in Section ʹ.Ͳ.Ͳ.  The challenges to prudent 
antibiotic prescribing for GPs lie predominantly in the undercurrents of covert pressure 
to acquiesce to (a) prescribing practices of other medical colleagues i.e. other GPs and 
specialists — perhaps to a lesser extent, and (b) patient expectations — perhaps to a 
larger extent due to immediacy of the encounter.  Referring to the EABE model to 
explain the doctor-patient encounter, when patient expectations for antibiotics coupled 
with prescribing challenges such as uncertainty of diagnosis or the prescribing 
practices of other medical colleagues (for example, when the patient claims that their 
usual GP “always” prescribes antibiotics for the same presentation), this exerts pressure 
on the GP to prescribe antibiotics.  If the situation is not diffused by the GP through 
actions that show they are the patient's wise advocate (detailed in Section ʹ.Ͳ.Ͳ) and by 
clearly explaining the rationale for the decision (patient education that meets 
consumer information needs), the dynamic is one of “pulling” away from eupraxis 
(Figure ͱͱ). 
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Figure 11.  Distortion A:  Illustration of the tension between patient expectations and 
prescribing challenges resulting in "pulling" away from eupraxis 
 
 
Figure ͱͲ illustrates the situation where patient expectations for antibiotics are not 
properly addressed by GPs through skilful patient education that meets patient 
information needs, resulting in eupraxis being lost. 
 
Figure 12.  Distortion B:  Illustration of the tension between patient expectations and patient 
education vs. information needs resulting in "pulling" away from eupraxis 
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Finally, Figure ͱͳ shows eupraxis being lost when GPs capitulate by prescribing delayed 
antibiotics and consumer information needs are not met when given this type of script.  
As a result, consumers may inadvertently engage in inappropriate antibiotic use 
behaviours.   
Figure 13.  Distortion C:  Illustration of the tension between prescribing challenges and 
patient education vs. information needs resulting in "pulling" away from eupraxis 
 
 
In other words, antibiotic eupraxis is possible when prescribing challenges and patient 
expectations are aligned between GPs and consumers, through skilful communication 
embedded in patient education that meets consumer information needs. 
 
4.5.2 Enabling theory-informed practice 
The EABE model assumes an interdependence between the three meta-categories.  
Behaviour (e.g. how we use antibiotics) is influenced and cannot be separated from 
contextual influences, temporal factors, and physical and psychological characteristics.  
Hence, a person's context is continually shifting.  As context changes, the behaviour 
necessary to accomplish a goal also changes.  Understanding how these meta-
categories lie in tension and what actions can defuse these tensions, bring or restore 
harmony, assists in creating or trouble-shooting individual and collective action to 
mitigate antibiotic resistance. 
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 THE BRIDGE:  FROM SEMI-STRUCTURED INTERVIEWS TO DISCRETE CHOICE 
EXPERIMENTS 
This section represents the first point of interface between methods (Mixing ͱ), as it 
bridges selective aspects of the qualitative phase with the quantitative phase of the 
research — from semi-structured interviews to discrete choice experiments.   
To recapitulate, the second research question aimed to investigate which factors are 
dominant in influencing the use of antibiotics in the primary healthcare sector, so that 
we can better understand which factors to target in order to reduce inappropriate 
antibiotic use.  To address this research question, the DCE was selected as the method 
of choice — justified in Chapter ͳ, Section ͳ.͵.  In order to be useful for informing 
policy or practice, DCEs must present relevant scenarios for which the participant is 
the actual or potential decision maker in real life.  This section describes how selected 
findings from the semi-structured interviews were used to develop the DCE research 
instrument — DCE scenarios, attributes and levels. 
4.6.1 Selection of concepts/themes for DCEs 
Findings from the semi-structured interviews highlighted that there were several 
antibiotic “reservoirs” in the community — unused antibiotics, unused antibiotic 
prescriptions, delayed prescriptions28, and repeat prescriptions29, which provide 
consumers with opportunities for decision-making on whether, when and how they use 
antibiotics (previously mentioned in Section ͳ.͵.Ͳ Identification of attributes and 
levels, and further explained in Sections ʹ.ʹ.Ͳ, ʹ.ʹ.ͳ and ʹ.ʹ.͵).  Scrutiny of research 
interviews revealed that GPs, community pharmacists and consumers placed less 
ccvi                                                     
 
28 Delayed antibiotic prescription – a prescription given to a patient with instructions to use 
it only if their symptoms worsen or do not improve in a few days.  The delayed prescription 
is usually given to the patient during the initial consultation, although some GPs prefer to 
leave the prescription with clinic reception for the patient to collect at a later date. 
29 Repeat prescriptions enable a regular re-supply of the prescribed medicine without the 
patient having to see the GP each time.  The number of repeats is authorised by the GP on 
the original prescription.  The Pharmaceutical Benefits Scheme (PBS) Schedule lists 
medicines and the maximum number of repeats subsidised under the scheme.  Time 
intervals between supplies must meet PBS criteria. 
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emphasis on unused antibiotics, unused antibiotic prescriptions and repeat antibiotic 
prescriptions being sources of frustration as compared to delayed antibiotic 
prescriptions.  This discovery led to delayed antibiotic prescription being the focus of 
the DCE scenario for consumers, and to a lesser extent, for GPs.   
With the research question, the purpose of the DCEs, and the focus of the DCE 
scenarios in mind, the salient decision points which would have an impact on 
antibiotic consumption are: (a) for the GPs — at the point of considering whether to 
prescribe an antibiotic (including a delayed antibiotic prescription), and (b) for the 
consumers — at the point of considering whether to fill a delayed antibiotic 
prescription.   
Given these two decision points, the relevant codes from the interview transcripts 
which signify events (e.g. seek GP's expertise), examples, topical markers (e.g. delayed 
prescription), concepts and/or themes from the research interviews, were examined for 
the development of the DCE scenarios and possible attributes and levels.  These codes 
— a mix of deductive and inductive codes — are listed in Figure ͱʹ. 
Figure 14.  Codes which were examined for DCE development 
Abdicating responsibility 
Affecting work 
Approach to AB use 
Bad experiences of delaying GP consult 
Barriers to GP consult 
Constrained by travel 
Definitive instructions 
Delayed AB 
Delegation of decision 
GP's advice 
Important life event 
Just in case 
Past experience with AB 
Perspective CC complications 
Referral to GP 
Seek GP's expertise 
Self-assessment of severity 
Self-management strategies CC 
Time lag seeking GP consult 
Better safe than sorry 
Clinical approach and DM 
Decision-making cognition and intuition 
Doctor-Patient relationship 
It doesn’t look like you’re trying to scam them 
Negotiating clinical uncertainty 
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A single hypothetical scenario was developed for both the GP and consumer DCEs, 
which could incorporate the relevant decision points each would have to make.  A 
scenario used by Hardy-Holbrook et al. (Hardy-Holbrook et al., ͲͰͱͳ) featuring an 
adult patient presenting with symptoms of a respiratory tract infection, served as the 
starting point.  Figure ͱ͵ shows the original scenario from Hardy-Holbrook et al. 
(Hardy-Holbrook et al., ͲͰͱͳ). 
Figure 15.  Base scenario 
A Ͳͷ-year-old male with no significant past medical history who attends with a ͳ-
day history of dry cough and sore throat. He has stayed home for ͳ days and 
requires a medical certificate for any further time off work. On examination, his 
temperature (tympanic) is ͳͷ.͸°C, his throat appears slightly red and there is no 
exudate or cervical lymphadenopathy. His chest is clear. 
 
The base scenario was further developed with information gleaned from the following 
codes:  approach to AB use, constrained by travel, referral to GP, seek GP's expertise, 
permissible circumstances, self-assessment of severity, and self-management strategies 
CC.  Figure ͱͶ shows the final versions of the hypothetical scenarios for both the 
consumer and GP DCEs.  The scenario for GPs retained the clinical information found 
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Figure 16.  Final versions of scenarios for consumer and GP DCEs 
Consumer DCE scenario 
Imagine you have a runny nose, sneezing, a sore throat and a dry cough.  You have 
managed these symptoms in your usual way, which may include a combination of rest, 
home remedies, vitamin supplements, commercial immune boosters, and cold/flu/cough 
products.  As you are still feeling unwell, you decide to consult a doctor.   
After examining you, the doctor gives you a prescription for antibiotics because you can’t 
come back for a reassessment in 2 days. 
GP DCE scenario 
An adult patient presents with a runny nose, sneezing, a sore throat and dry cough.  They 
have managed these symptoms in their usual way, which may include a combination of 
rest, home remedies, vitamin supplements, commercial immune boosters, and 
cold/flu/cough products.  As they are still feeling unwell, they decided to consult a doctor 
(you).   
The patient has no significant past medical history.  On examination, their temperature 
(tympanic) is 37.8°C, throat appears slightly red and there is no exudate or cervical 
lymphadenopathy.  Chest is clear. 
 
The framing of the DCE questions was discussed in Chapter ͳ, Section ͳ.͵.Ͳ.  For the 
consumer DCE, the question was:  "Based on the scenario, as you leave the doctor’s 
clinic, in which situation (A or B) would you be more likely to fill the antibiotic 
prescription (go to the pharmacy to get the antibiotics)?"  For the GP DCE, the 
question was:  "Based on the scenario, in which situation (A or B) would you be more 
likely to prescribe an antibiotic for the patient?", followed by "And this antibiotic 
prescription would be?" (two choices are then presented — one for immediate 
treatment, the other as a delayed prescription).   
The attributes and levels for the consumer and GP DCEs were presented in Chapter ͳ, 
Section ͳ.͵.Ͳ.  These were gleaned from the codes in Figure ͱʹ. 
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4.6.2 Rationale for not conducting a DCE for community pharmacists 
As alluded to in Chapter ͳ, a DCE for community pharmacists was not conducted as 
from the literature and the interviews, there was no real decision point where 
community pharmacists were able to exercise a decision which would contribute 
directly to the reduction of antibiotic use.  The Australian primary healthcare sector as 
it is currently structured, leaves community pharmacists out of the prescribing loop.  
This may change as more non-dispensing pharmacists work within a GP clinic as part 
of the healthcare team. 
The three most relevant points where community pharmacists interact with a 
consumer regarding the possible use of antibiotics are: (a) consumer seeking a solution 
to resolve symptoms of respiratory tract infection prior to consulting a GP, (b) 
consumer seeking to fill an original antibiotic prescription, (c) consumer seeking to fill 
a repeat antibiotic prescription.  For point (a), community pharmacists would exercise 
clinical judgment whether to recommend self-care products and provide advice for the 
self-management of symptoms, or to recommend a referral to the GP.  Hence, possibly 
averting potential antibiotic-seeking behaviour of consumers.  However, it can be 
argued that consumers who seek pharmacist advice first, have decided not to (or are 
less likely to) seek antibiotics in the first place.  For point (b), it is highly likely that the 
community pharmacist would fill the original antibiotic prescription, as long as the 
prescription is valid (legal), the dose was appropriate for the consumer and the 
indication as disclosed by the consumer seemed reasonable.  If the prescription was 
dated more than a month ago or if a repeat prescription was presented more than a 
month after the original was dispensed (point (c)), the pharmacist may question the 
consumer further to determine if they could clinically justify dispensing the antibiotic.  
As most community pharmacists currently do not have access to the medical records of 
the consumer — an issue which a robust and well-used national electronic health 
record would solve — they rely on the information provided by the consumer.  In 
practice, it is deemed impractical to ring the GP clinic for every occasion an antibiotic 
prescription was presented, unless there was an obvious patient safety issue, such as a 
contraindication e.g. consumer is allergic to the antibiotic, an interaction with another 
medicine the consumer is taking, or a dosage issue e.g. inappropriate dose.  For both 
points (b) and (c), the current remuneration model for pharmacies acts as a 
disincentive to refuse dispensing.  Currently, pharmacies are largely remunerated based 
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on prescriptions dispensed, although cognitive services are included in the Sixth 
Community Pharmacy Agreement (Australian Government & Department of Health, 
ͲͰͱ͵).  Some community pharmacists (particularly those who are practitioner-owners 
or in managerial roles) and a few consumers who participated in the semi-structured 
interviews, noted that there are currently no incentives for pharmacies or community 
pharmacists to be stewards of antibiotics. 
 
4.6.3 Summary  
In this chapter, results from the semi-structured interviews for GPs, community 
pharmacists and consumers were reported and then used to develop the Enabling 
Antibiotic Eupraxis (EABE) Model in answer to Research Question ͱ.  The EABE model 
comprise of three intersecting circles — each one representing a meta-category: (a) 
clinical processes and challenges, (b) consumer attitudes, behaviours, skills and 
knowledge, and (c) engaging with antibiotic resistance.  This model can be used in two 
ways: (a) to explain the phenomenon of what influences antibiotic use from the 
perspectives of GPs, community pharmacists and consumers (Section ʹ.͵.ͱ), and (b) to 
inform individual and collective action on how to enable wise use of antibiotics 
(Section ʹ.͵.Ͳ).  Plainly stated, antibiotic eupraxis is possible when prescribing 
challenges and patient expectations are made transparent between GPs and consumers, 
through skilful communication embedded in patient education that meets consumers' 
information needs. 
Together with the literature, these results sharpened the focus of decision points 
constructed for the discrete choice experiments (discussed in Section ʹ.Ͷ.ͱ).  Selected 
concepts from the semi-structured interviews were used to develop the attributes and 
levels of DCEs for GPs and consumers.  The results from these DCEs are reported next 
in Chapter ͵. 
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 How do GPs and consumers trade-off 
on factors influencing antibiotic use?  
— Data analysis and results of DCEs 
In Chapter ͵, data analysis and results of the quantitative component — discrete choice 
experiments, are presented in answer to Research Question Ͳ:  How do GPs and 
consumers trade-off on factors influencing antibiotic use?30 The chapter begins with a 
description of the Mixed Logit Model (MXL) in Section ͵.ͱ.  Next, results from the two 
DCEs — one each for GPs and consumers — are reported in Sections ͵.Ͳ and ͵.ͳ, 
respectively.  These sections conclude with comparisons of the relative importance of 
coefficients estimated for each attribute level within a DCE, and a relative order of 
attribute importance which influenced decision-making for each of the hypothetical 
scenarios.  
Development of the DCEs were dealt with in Chapter ͳ, Sections ͳ.͵.ͱ to ͳ.͵.ʹ, with 
additional information provided in Chapter ʹ, Section ʹ.Ͷ (The Bridge:  From Semi-
Structured Interviews to Discrete Choice Experiments).  Sampling and recruitment 
were addressed in Chapter ͳ in Sections ͳ.͵.͵ and ͳ.͵.Ͷ, respectively. 
 
 
 THE MIXED LOGIT MODEL (MXL) 
The Mixed Logit Model (MXL), also known as the Random-Parameters Logit (RPL), 
was used as it allows for potential preference heterogeneity amongst respondents and 
does not assume equal competition between choices unlike other multinomial logit 
model variants (M Ryan et al., ͲͰͰ͸).  The MXL is a model that is highly flexible and 
compatible to the random utility model, outlined in Chapter ͳ, Section ͳ.͵.  It is 
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was provided in Chapter ʹ, Section ʹ.Ͷ.Ͳ. 
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essentially the multinomial logit (MNL) mixed with the multivariate distribution of the 
random parameters (M Ryan et al., ͲͰͰ͸).  The MXL is represented by the following 
equation:  







( ௡ܸ௦௝) = ߚ௡ᇱ ݔ௡௦௝ 
and  ߚ௡ =  ߚ +  ∆ݖ௡ +  Γݒ௡ 
ݔ௡௦௝ is the K attributes of alternatives j in choice situation s faced by individual n; 
ݖ௡ is a set of M characteristics of individuals n that influence the mean of the taste 
parameters; and ݒ௡ is a vector of K random variables with zero means, known variances 
and zero covariances.  ∆ݖ௡ is the observed heterogeneity, while Γݒ௡ represents the 
unobserved heterogeneity (Hensher, Rose, & Greene, ͲͰͱ͵). 
 
5.1.1 Data analysis 
Completed surveys which contained unmatched duplicated choice sets were excluded 
from data analysis31, as explained in Chapter ͳ, Section ͳ.͵.ͷ.  Responses to the 
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31 However, for completeness, model estimates for the full dataset from the consumer 
DCE — matched and unmatched duplicated choice sets — are presented in Appendix 
N.  The model estimates for the full dataset (n = ͲͰ͵) were fundamentally similar to 
that presented in this chapter, Section ͵.ͳ.ʹ (n = ͱ͸Ͷ) apart from the attribute level 
coefficient for “Time off – No” in the full dataset which did not reach statistical 
significance indicating that the “Time off” attribute was not observed to be important 
in influencing decision-making.  All completed GP DCE surveys passed the consistency 
checks.  Hence, model estimates for the full dataset are presented in this chapter in 
Section ͵.Ͳ.ʹ. 
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duplicate choice sets were excluded from model estimates presented in Sections ͵.Ͳ.ʹ 
and ͵.ͳ.ʹ, as these were simply for respondent consistency checks to ensure data 
quality (i.e. in each DCE survey that passed the consistency check, only responses to 
choice set #ͳ and not #ͱ͸ were included, as #ͱ͸ is a repeat of #ͳ). 
Model estimation was done using NLOGIT® (Version Ͷ; (ͲͰͱͶ)).  All attribute levels 
were effects coded — allowing the estimation of effect size for each attribute level 
(Bridges et al., ͲͰͱͱ).  All coefficients of attribute levels were specified as random 
parameters with a normal distribution.  For the estimation of these random 
parameters, ͱ ͰͰͰ Halton (Standard Halton Sequence) draws were used. 
Results of both DCEs were assessed for significance of statistical tests used.  Statistical 
tests were accepted as significant if p < Ͱ.Ͱ͵ as per convention.  Seven coefficients were 
estimated for each DCE using NLOGIT® (Version Ͷ; (ͲͰͱͶ)).  The coefficients for the 
attribute levels which acted as reference levels — the omitted categories — were 
calculated from the estimated coefficients as their negative sum (Bech & Gyrd-Hansen, 
ͲͰͰ͵). 
 
 GENERAL PRACTITIONERS:  DCE RESULTS 
5.2.1 Completion rate 
Despite the comprehensive recruitment strategy detailed in Chapter ͳ, Section ͳ.͵.Ͷ at 
both a state/territory and national level, and the extension of survey closure date for an 
additional ʹ weeks, the recruitment of GPs proved to be difficult.  Participation was 
extremely low.  Forty-three GPs entered the online DCE survey and of these, Ͳͳ 
completed the survey — yielding a completion rate of ͵ͳ.͵%, over a ͳ-month period. 
As explained in Chapter ͳ, Section ͳ.͵.ʹ, respondents were randomly presented by Key 
Survey® with choice sets from either Block ͱ or Block Ͳ in the DCE survey.  Nine GPs 
completed a DCE Block ͱ survey, while the remaining ͱʹ completed a DCE Block Ͳ 
survey.   
The targeted sample size of ʹͲ completed surveys per block for a total of ͸ʹ completed 
surveys, was not reached (see Chapter ͳ, Section ͳ.͵.͵, for sample size calculation).  
However, given that there were ʹͱʹ choice observations generated from these 
responses (see Section ͵.Ͳ.ͳ) data analysis proceeded as described in Section ͵.ͱ.ͱ. 
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5.2.2 Respondent characteristics 
Table ͱͱ provides a summary of respondent demographics and characteristics (n = Ͳͳ).  
Nineteen GPs (͸Ͳ.Ͷ%) and ʹ GP Registrars (ͱͷ.ʹ%) completed the DCE survey.  Women 
comprised two-thirds (Ͷ͵.Ͳ%) of the respondents.  Most respondents had trained as a 
GP in Australia, with ͵ who received their training elsewhere — UK, New Zealand, Iran, 
South Africa and Pakistan.  Of these, ͱ was an early career GP (≤ ͵ years in practice), ͳ 
were mid-career (Ͷ to ͱ͵ years) and ͱ had been in practice for over ͳͰ years.  Four of the 
overseas trained GPs had practiced in Australia for ͳ years or less, with the exception of 
ͱ GP (Ͳͳ years).  The respondent sample showed GPs in various stages of their careers 
— early, mid- and late-career — with most being in the time-bands for Ͷ to ͱ͵ and ͱͶ to 
Ͳ͵ years of experience. 
More than half the respondents (͵Ͷ.͵%) were GPs practicing in Queensland, with the 
other ͱͰ practicing in either Victoria, Western Australia or South Australia.  There were 
no respondents from New South Wales, Tasmania, the Australian Capital Territory, and 
the Northern Territory.  Most of these GPs were located in metropolitan areas (ͷͳ.͹%), 
followed by Provincial/Regional (ͱͷ.ʹ%) and Rural/Remote (͸.ͷ%) areas.  Over forty 
percent (ʹͳ.͵%) of GPs worked in a multi-GP owned clinic, usually as a contractor or a 
staff GP, ͲͶ.ͱ% worked in a government or health service owned clinic, ͱͷ.ʹ% in a 
corporate practice, and ʹ.ͳ% in a sole GP practice.  The remainder (Ͳ, ͸.ͷ%) either 
worked in more than one type of practice or in a superclinic.  The majority of the multi-
GP owned clinics (i.e. Ͷ of the ͱͰ) offered mixed billing.  The other ͳ were bulk-billing 
clinics and ͱ offered private billing only.   
Self-reporting from respondents showed that a little more than half the sample (͵Ͷ.͵%) 
claimed that they prescribed about the same amount of antibiotics as their peers, while 
ʹͳ.͵% claimed that they prescribed less antibiotics than other GPs.  No respondent felt 
that they prescribed more antibiotics than their peers. 
Respondent characteristics were generally comparable to Australian GPs32 in terms of 
place of practice:  Ͷͷ.ʹ% of Australian GPs practiced in metropolitan areas, Ͳ͸.ʹ% in 
Provincial/Regional, and ʹ.Ͳ% in Rural/Remote areas (Department of Health, ͲͰͱ͵).  
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However, the proportion of female respondents (Ͷ͵.Ͳ%) was higher than the 
proportion of female GPs in Australia (ʹʹ.Ͳ%) (Department of Health, ͲͰͱ͵).  There 
were also more GPs who had trained in Australia amongst respondents (ͷ͸.ͳ%) 
compared to Australian GPs (ͶͰ.ͳ%) (Department of Health, ͲͰͱ͵). 
Table 11.  Respondent characteristics — GPs 
Characteristics Number (Percent)* 















Years of practice as a GP (including as a GP Registrar): 
≤5 years 
6 – 15 years 
16 – 25 years 








Years of practice as a GP in Australia (including as a GP Registrar): 
≤5 years 
6 – 15 years 
16 – 25 years 













There were no respondents from New South Wales, Tasmania, 
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Sole GP owned clinic 
Multi-GP owned clinic 
Corporate 
















Antibiotic prescribing patterns — self declared: 
Prescribe more than other GPs 
About the same as other GPs 





*Rounding to one decimal point means that some cells approach, but do not yield, a total of 
100%. 
 
5.2.3 Responses to choice sets 
A total of ʹͱʹ choice observations were possible from the completed surveys — ͱͶͲ 
from DCE Block ͱ surveys (i.e. ͹ x ͱ͸ choice sets) and Ͳ͵Ͳ from DCE Block Ͳ surveys 
(i.e. ͱʹ x ͱ͸ choice sets).  Of these, none were removed from the analysis as the 
duplicated choice sets inserted as an intra-participant consistency check — choice sets 
#ͳ and #ͱ͸ in each block — matched in all returned surveys.  This meant that there 
were a total of ʹͱʹ valid choice observations. 
 
5.2.4 MXL estimates 
The computation for MXL estimates converged after ͳͲ iterations, with a normal exit.  
Results of the MXL estimates are presented in Table ͱͲ.     The Log Likelihood (LL) was 
-ͱͶͱ.Ͷͱ and the Akaike Information Criteria (AIC) was Ͱ.͸͵.  McFadden's pseudo R-
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squared which provides a relative measure of model fit was Ͱ.ʹʹ.  A value between Ͱ.Ͳ 
and Ͱ.ʹ indicates a good model fit (Hauber et al., ͲͰͱͶ). 
Statistical significance was reached for all but two — Ͳ weeks and new patient — of the 
estimated coefficients of the attribute levels, confirming the importance of all 
attributes in influencing GP preferences, apart from the “Familiarity with patient” 
attribute.  Standard deviations were statistically significant for Ͷ of the ͷ estimated 
coefficients, confirming the presence of preference heterogeneity for these attribute 
levels amongst respondents. 
 
Table 12.  Mixed Logit estimates for GP DCE survey with effects coding (n = 23) 
Attribute Level Coefficient SE Prob. 
|z|>Z 




1 week -3.09**    0.93 0.0009 2.63** 0.85 0.0019 
2 weeks 0.16 0.21 0.4424 0.54 0.38 0.1548 
3 weeks^ 2.93#  -3.17#  
Life event  No -0.94** 0.32 0.0038 0.94** 0.28 0.0010 





No 0.85** 0.25 0.0006 0.86** 0.27 0.0012 
Yes^ -0.85#  -0.86#  
Familiarity with 
patient 
New patient -0.23 0.16 0.1444 0.53* 0.21 0.0123 
Regular patient^ 0.23#  -0.53#  
Patient's 
expectations 
Says they want 
antibiotics 
2.35** 0.74 0.0014 2.58** 0.93 0.0057 
Says they don't 
want antibiotics 
unless necessary 
-0.61* 0.29 0.0356 1.17* 0.55 0.0325 
Says they want 
reassurance^ 
-1.74#  -3.75#  
**p < 0.01 and *p < 0.05 
^ Omitted category/ reference level 
# Calculated as the negative sum of the estimated coefficients or SDs 
SE: Standard error 
SD: Standard deviation for estimated coefficients 
Prob. |z|>Z :  p-value for the Wald test 
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The attribute level coefficients both estimated and calculated, proved that a priori 
assumptions were correct for all attributes but one (see Section ͳ.͵.Ͳ, Table ͷ) i.e. 
“Familiarity with patient”.  Figure ͱͷ illustrates the interpretation of the estimated and 
calculated attribute level coefficients from Table ͱͲ.  In other words, GPs were more 
likely to prescribe antibiotics in the DCE scenario if: (a) the patient's duration of 
symptoms was ͳ weeks, (b) if the patient demanded antibiotics, (c) the patient had an 
important life event coming up, and (d) they could not return for a reassessment 
should their health deteriorate. 
In contrast, GPs were less likely to prescribe antibiotics if: (a) the patient’s duration of 
symptoms was ͱ week, (b) the patient said they did not want antibiotics unless 
necessary or that they want reassurance, (c) the patient did not have an important life 
event coming up, and (d) the patient could return for reassessment. 
Trending against a priori assumptions for the “Familiarity with patient” attribute, GPs 
may be more likely to prescribe antibiotics for a regular patient (with whom they are 
familiar in terms of medical history and an established rapport), compared to a new 
patient — this coefficient did not reach statistical significance.   
 
Figure 17. GP DCE:  Estimated and calculated coefficients for attribute levels (effects coded) 
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Figure ͱ͸ shows the relative importance of attribute levels (when compared against the 
respective reference level for each attribute) in influencing GP decision-making.  GP 
preferences for whether or not to prescribe antibiotics were more strongly influenced 
by: 
 “Duration of symptoms – ͱ week” (followed by “Duration of symptoms – Ͳ 
weeks”) when compared against the reference level for that attribute “Duration 
of symptoms – ͳ weeks”;  
 “Patient expectations – Says they want antibiotics” (followed by “Patient 
expectations – Says they don’t want antibiotics unless necessary”) when 
compared against the reference level “Patient expectations – Says they want 
reassurance”; 
 “Life event – No” (the patient did not have an important event or deadline 
coming up) when compared against “Life event – Yes”; and 
 “Reassessment – No” (the patient is unable to return for reassessment) when 
compared against the reference level “Reassessment – Yes” 
The attribute “Familiarity with patient” did not reach statistical significance, which 
means that this attribute was not important in influencing GP decision-making.   
 
Figure 18.  GP DCE:  Relative importance of attribute levels compared against its reference 
level 
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In order to quantify the relative importance of each attribute in influencing decision-
making, two steps were taken.  First, preference weights for each attribute were 
calculated as the difference between the highest and lowest attribute level coefficients 
from the MXL model within that attribute.  Second, an importance score expressed as a 
percentage (%) for each attribute was generated using its preference weight as the 
numerator and the total preference weight as the denominator, as shown in Table ͱͳ. 
Preference weights are not absolute numbers and can only be interpreted relative to 
each other i.e. not interpreted against a standard or benchmark.  For example, a 
preference weight of Ͷ.ͰͲ for “Duration of symptoms” signifies that this attribute is 
more important than “Patient expectations” which has a lower preference weight.  
Preference weights are unbounded values with no set minimum or maximum scores. 
Table 13.  GP DCE — Preference weights and importance scores for attributes 
Attribute Preference weight Importance score (%) 
Duration of symptoms 6.02 42.5 
Patient expectations 4.09 28.9 
Life event 1.88 13.3 
Reassessment 1.7 12.0 
Familiarity with patient 0.46 3.3 
Total 14.15 100 
 
Figure 19.  Relative importance of attributes influencing GP antibiotic prescribing  
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The importance scores indicate the relative importance of each attribute in influencing 
GP preferences — illustrated in Figure ͱ͹.  Beginning with the attribute which exerted 
the most influence on GPs' likelihood of prescribing antibiotics, these are: 
ͱ. Duration of symptoms 
Ͳ. Patient expectations  
ͳ. Life event  
ʹ. Reassessment 
The “Familiarity with patient” attribute did not reach statistical significance, indicating 
that it was not important in influencing GP decision-making. 
The "Duration of symptoms" and "Patient expectations" attributes were by far the two 
most influential factors for the prescribing of antibiotics by GPs (Figure ͱ͹).  “Life 
event” — whether the patient has an important life event or a deadline coming up — 
and “Reassessment” — whether the patient is able to return for reassessment should 
their symptoms worsen, exerted less influence on the propensity of GPs to prescribe 
antibiotics.  “Familiarity with the patient” i.e. whether the presenting patient was new 
to the GP or a regular patient seemed to be of negligible importance. 
Of the ʹͱʹ valid observations, GPs indicated in ͳͰ͸ observations (ͷʹ.ʹ%) that the 
prescription given would have been a delayed antibiotic prescription.  In the final 
section of the survey (Section C) GPs were asked about which they considered the most 
important and the least important attribute when weighing up between the two 
alternatives (Situation A and Situation B) presented in each choice set.  Most GPs 
reported that the “Duration of symptoms” was the most important attribute, while 
others chose (from most votes to least votes): “Patient expectations”, “Reassessment”, 
“Life event” and “Familiarity with patient”, which closely align with that of the DCE 
component.  Conversely, GPs found "Familiarity with patient" to be the least important 
attribute, which supports their preference elicited from the DCE component.   
When asked to choose a course of action for the same DCE scenario without a forced 
choice to prescribe (Box Ͳͱ, attribute levels in bold), ͱͰ GPs would not prescribe 
antibiotics, ͸ would prescribe a delayed course of antibiotics, ʹ would prescribe 
antibiotics for immediate use, and ͱ would seek more information such as co-
morbidities and smoking status. 
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Box Ͳͱ. 
A new patient (adult) presents with a runny nose, sneezing, a sore throat and dry 
cough, which they’ve had for Ͳ weeks.  They have managed these symptoms in 
their usual way, which may include a combination of rest, home remedies, 
vitamin supplements, commercial immune boosters, and cold/flu/cough 
products.  As they are still feeling unwell and they have an important event 
coming up, they decided to consult a doctor (you).  The patient says they want 
antibiotics. 
The patient has no significant past medical history.  On examination, their 
temperature (tympanic) is ͳͷ.͸c, throat appears slightly red and there is no 
exudate or cervical lymphadenopathy.  Chest is clear.  The patient can’t come 
back for a reassessment if they are not better or feel worse. 
Cͳ.  Which response best describes what you would do? 
☐Prescribe an antibiotic for immediate treatment 
☐Prescribe a delayed course of antibiotics 
☐Not prescribe an antibiotic 
☐Other response (please tell us) ________________________________ 
 
The complexity of the DCE seemed acceptable as more respondents found it to be 
easy/very easy (ʹͳ.͵%) or neutral (ͳʹ.͸%), compared to difficult/very difficult (Ͳͱ.ͷ%).   
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 CONSUMERS:  DCE RESULTS  
5.3.1 Completion rate 
The state and national recruitment strategy for consumer DCE surveys was detailed in 
Chapter ͳ, Section ͳ.͵.Ͷ.  Two hundred and ninety-six consumers entered the online 
DCE survey and of these, ͲͰ͵ completed the survey — yielding a completion rate of 
Ͷ͹.ͳ%, over a ͳ-month period. 
As explained in Chapter ͳ, Section ͳ.͵.ʹ (Developing the DCE survey) the online survey 
platform — Key Survey® — randomly assigned a DCE survey containing choice sets 
from either Block ͱ or Block Ͳ to each participant.  As such, ͹ʹ consumers completed a 
DCE Block ͱ survey, while ͱͱͱ completed a DCE Block Ͳ survey.  The targeted sample 
size of ʹͲ completed surveys per block, or a total of ͸ʹ completed surveys was exceeded 
(see Chapter ͳ, Section ͳ.͵.͵, for sample size calculation). 
 
5.3.2 Respondent characteristics 
Respondent demographics and characteristics are reported for the ͱ͸Ͷ respondents 
(after ͱ͹ DCE surveys with unmatched consistency checks were removed from the ͲͰ͵ 
surveys submitted).  A summary of respondent demographics and characteristics is 
shown in Table ͱͳ.   
Respondent demographics and characteristics for the full dataset (n = ͲͰ͵) were not 
significantly different to that of the dataset which passed consistency checks (n = ͱ͸Ͷ).   
The majority of respondents were women, who comprised ͸ͳ.ͳ% of the sample.  Ages 
ranged from ͱ͸ to ͶͶ years old, with the majority in the ͱ͸ to ʹʹ age bands i.e. ͱ͸ – Ͳʹ 
age band (ͳ͹.͸%), Ͳ͵ – ͳʹ age band (Ͳ͵.ͳ%) and ͳ͵ – ʹʹ age band (ͱ͹.ʹ%).  The mean 
age was ͳͰ.͵ years old while the median age was Ͳͷ years old.  Just under two-thirds of 
the respondents (ͶͰ.Ͳ%) had achieved at least a Bachelor's degree, and ͶͶ (ͳ͵.͵%) 
finished Year ͱͲ.  The majority of the respondents lived in Queensland, comprising 
͹ͷ.ͳ% of the sample.  The rest lived in New South Wales, Victoria, Western Australia 
and South Australia.  There were no respondents from Tasmania, the Australian Capital 
Territory or the Northern Territory.  Over ͹Ͱ% of respondents were located in 
metropolitan areas, with a small percentage located in Provincial/Regional (ͷ%) or 
Rural/Remote areas (Ͳ.ͷ%).  The majority of respondents were in good health, selecting 
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either excellent, very good or good health in the survey.  The sample comprised mainly 
of low users of antibiotics, with only ͱ͸ (͹.ͷ%) respondents using antibiotics three or 
four times in the past year, while ʹ (Ͳ.Ͳ%) had antibiotics five or more times in the 
same period.  Forty-nine (ͲͶ.ͳ%) respondents currently held a healthcare or concession 
card, allowing access to subsidised medicines and to bulk-billing clinics. 
Respondent characteristics were generally not comparable with the Australian 
population, in the following ways: 
 A higher proportion of respondents were female (͸ͳ.ͳ%) compared to that 
found in the general population (͵Ͱ.Ͷ%) (Australian Bureau of Statistics, ͲͰͱͶa);  
 The median age of the respondents was younger (Ͳͷ years old) compared to the 
median age of ͳͷ years old in the general population (Australian Bureau of 
Statistics, ͲͰͱͶa); 
 A higher proportion of respondents had achieved at least a bachelor’s degree 
(ͶͰ.Ͳ%) compared to the Australian population (ʹʹ% of those aged ͱ͵ to ͷʹ 
years old) (Australian Bureau of Statistics, ͲͰͱͶb); and 
 A higher proportion of respondents lived in metropolitan areas (͹Ͱ.ͳ%) 
compared to the Australian population (Ͷ͹%), while a lower proportion of 
respondents lived in regional areas (ͷ.Ͱ%) compared to the Australian 
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Table 14.  Respondent Characteristics — Consumers 






18 – 24 
25 – 34 
35 – 44 








Highest level of education achieved: 
Postgraduate degree 










Place of residence, State/Territory: 
Queensland  
























Number of antibiotic courses in past 12 months: 
None 
One or two 
Three or four 






Concession card holder 
Non-concession card holder 
49 (26.3) 
137 (73.7) 
*Rounding to one decimal point means that some cells approach, but do not yield, a total of 100%. 
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5.3.3 Responses to choice sets 
A total of ͳͶ͹Ͱ choice observations were possible from the ͲͰ͵ completed surveys — 
ͱͶ͹Ͳ from DCE Block ͱ surveys (i.e. ͹ʹ x ͱ͸ choice sets) and ͱ͹͹͸ from DCE Block Ͳ 
surveys (i.e. ͱͱͱ x ͱ͸ choice sets).  Of these, ͱ͹ surveys (or ͳʹͲ choice observations) were 
removed from the analysis as the duplicated choice sets inserted as an intra-participant 
consistency check — choice sets #ͳ and #ͱ͸ in each block — did not match in these 
surveys.  This meant that there were a total of ͱ͸Ͷ valid surveys for analysis — ͳͳʹ͸ 
valid choice observations — comprising ͱ͵ͶͶ choice observations from DCE Block ͱ 
surveys (i.e. ͸ͷ x ͱ͸ choice sets) and ͱͷ͸Ͳ from DCE Block Ͳ surveys (i.e. ͹͹ x ͱ͸). 
 
5.3.4 MXL estimates 
The computation for MXL estimates converged after Ͳ͵ iterations, with a normal exit.  
Results of the MXL estimates are presented in Table ͱʹ.     The Log Likelihood (LL) was 
-ͱͲͱͲ.ͳͳ and the Akaike Information Criteria (AIC) was Ͱ.ͷͳͳ.  McFadden's pseudo R-
squared which provides a relative measure of model fit was Ͱ.ʹ͸.  A value between Ͱ.Ͳ 
and Ͱ.ʹ indicates a good model fit (Hauber et al., ͲͰͱͶ). 
Statistical significance was reached for all but duration of symptoms of Ͳ weeks, of the 
estimated coefficients of the attribute levels, confirming the importance of all 
attributes in influencing consumer preferences.  Standard deviations were statistically 
significant for Ͷ of the ͷ estimated coefficients, confirming the presence of preference 
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Table 15.  Mixed Logit estimates for Consumer DCE survey with effects coding (n = 186) 
Attribute Level Coefficient SE Prob. 
|z|>Z 




1 week -0.72** 0.93 0.0000 0.81** 0.10 0.0000 
2 weeks 0.01 0.06 0.83 0.15 0.10 0.1377 
3 weeks^ 0.71#  -0.96#  
Life event  No -0.49** 0.06 0.0000 0.50** 0.07 0.0000 
Yes^ 0.49#  -0.50#  
Time off No 0.16** 0.05 0.0005 0.39** 0.06 0.0000 
Yes^ -0.16#  -0.39#  
Doctor's advice Says it's probably a 
viral infection and 
antibiotics won't help 
-2.78** 0.19 0.0000 1.62** 0.16 0.0000 
Says you decide 
whether to take the 
antibiotics or not 
0.57** 0.08 0.0000 0.69** 0.09 0.0000 
Says to start 
antibiotic treatment 
if you feel worse or 
no better in 2 days^ 
2.21#  -2.31#  
Past experience No -0.17** 0.04 0.0001 0.31** 0.06 0.0000 
Yes^ 0.17#  -0.31#  
**p < 0.01 and *p < 0.05 
^ Omitted category/ reference level 
# Calculated as the negative sum of the estimated coefficients or SDs 
SE: Standard error 
SD: Standard deviation for estimated coefficients 
Prob. |z|>Z :  p-value for the Wald test 
 
The attribute level coefficients both estimated and calculated, proved that a priori 
assumptions were correct for all attributes (see Section ͳ.͵.Ͳ, Table Ͷ).  Figure ͲͰ 
illustrates the interpretation of the estimated and calculated attribute level coefficients 
from Table ͱʹ.  In other words, consumers were more likely to fill the antibiotic 
prescription in the DCE scenario if: (a) the doctor’s advice was either “… you decide 
whether to take the antibiotics or not” or “… start antibiotic treatment if you feel worse 
or no better in Ͳ days”, (b) the duration of symptoms was ͳ weeks, (c) they had an 
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important event or deadline coming up (life event), (d) they had taken antibiotics for 
similar symptoms in the past, and (e) they were not able to take time off to recover. 
In contrast, consumers were less likely to fill the antibiotic prescription if: (a) the 
duration of symptoms was ͱ week, (b) the doctor’s advice was “…it’s probably a viral 
infection and antibiotics won’t help”, (c) they had no important life events coming up, 
(d) they had not taken antibiotics for similar symptoms in the past, and (e) they could 
take time off to recover.   
The attribute level “Duration of symptoms – Ͳ weeks” did not reach statistical 
significance (Ͱ.Ͱͱ, p=Ͱ.͸ͳ), although it trended towards the consumer being more 
likely to fill the antibiotic prescription. 
For completeness, model estimates for (a) the full dataset (n = ͲͰ͵) including surveys 
that did not pass the consistency check, and (b) the dataset (n = ͱ͸ͱ) comprising 
surveys that passed the consistency check for respondents ͱ͸ – ͵ʹ years old, are 
presented in Appendix N.  The attribute level coefficient for “Time off – No” did not 
reach statistical significance in the parameter estimates for the full dataset (n = ͲͰ͵) 
indicating that the ‘Time off” attribute was not observed to be important in influencing 
consumer decision-making.  The importance of all other attributes as well as the 
relative importance of the attribute levels in influencing preferences, did not change. 
Figure 20.  Consumer DCE:  Estimated and calculated coefficients for attribute levels (effects 
coded) 
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Figure Ͳͱ shows the relative importance of attribute levels (when compared against the 
respective reference level for each attribute) in influencing consumer decision-making.  
Consumer preferences in whether to fill a delayed antibiotic prescription were more 
strongly influenced by:  
 “Doctor’s advice – Says it’s probably a viral infection and antibiotics won’t help” 
(followed by “Doctor’s advice – Says you decide whether to take the antibiotics 
or not”);  
 “Duration of symptoms – ͱ week” (followed by “Duration of symptoms – Ͳ 
weeks”) when compared against the reference level for that attribute “Duration 
of symptoms – ͳ weeks”;  
 “Life event – No” (the consumer did not have an important event or a deadline 
coming up) when compared against “Life event – Yes”; 
 “Past experience – No” (the consumer had not taken antibiotics for similar 
symptoms in the past) when compared against “Past experience – Yes”; and 
 “Time off – No” (the consumer is unable to take time off from work/study to 
recover) when compared against “Time off – Yes” 
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The intent of the DCE for consumers was also to investigate the relative dominance of 
factors that had the most bearing on consumer decision-making i.e. in deciding 
whether to fill a delayed prescription for antibiotics.  Preference weights for each 
attribute were calculated as the difference between the highest and lowest attribute 
level coefficients within that attribute.  An importance score (%) for each attribute was 
generated using its preference weight as the numerator and the total preference weight 
as the denominator, as shown in the following table. 
Table 16.  Consumer DCE — Preference weights and importance scores for attributes 
Attribute Preference weight Importance score (%) 
Doctor's advice 4.99 61.9 
Duration of symptoms 1.43 17.7 
Life event 0.98 12.2 
Past experience 0.34 4.2 
Time off 0.32 4.0 
Total 8.06 100.0 
 
The importance scores indicate the relative importance of each attribute in influencing 
consumer preferences.  Figure ͲͲ presents the relative importance of attributes in this 
regard and shows not surprisingly, that GP advice regarding the use of the delayed 
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Figure 22.  Relative importance of attributes influencing consumer decision to fill a delayed 
antibiotic prescription 
 
In the final section of the survey (Section C), consumers were asked what they 
considered to be the most important and the least important attribute when weighing 
up between the two alternatives (Situation A and Situation B) presented in each choice 
set.  In agreement with results from the DCE component, consumers reported that the 
most important attribute was the doctor's advice (ͱͲʹ/ͱ͸Ͷ; ͶͶ.ͷ%), with duration of 
symptoms a distant second (ͳͲ/ͱ͸Ͷ; ͱͷ.Ͳ%).  The least important attribute was “Past 
experience” — whether they had taken antibiotics for similar symptoms previously, 
although in the DCE the least important attribute seemed to be whether they could 
take time off to recover.  However, the differences between the relative importance of 
the “Past experience” attribute and the “Time off” attribute are not great.   
When asked to choose a course of action for the same DCE without a forced choice to 
fill the antibiotic prescription (Box ͲͲ, attribute levels in bold), ͳͶ (ͱ͹.ʹ%) consumers 
would fill the prescription immediately, ʹͱ (ͲͲ.Ͱ%) would obtain the antibiotics but 
only take it if no better in Ͳ days, ͹͵ (͵ͱ.ͱ%) would take a wait-and-see approach and 
would only use the prescription if no better in Ͳ days, and ͸ (ʹ.ͳ%) would not fill the 
prescription at all.  The remaining Ͷ (ͳ.Ͳ%) offered other responses ranging from 
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Box ͲͲ. 
You have had a runny nose, sneezing, a sore throat and a dry cough for Ͳ weeks.  
You have managed these symptoms in your usual way, which may include a 
combination of rest, home remedies, vitamin supplements, commercial immune 
boosters, and cold/flu/cough products.  As you are still feeling unwell, you decide 
to consult a doctor, as you have an important event coming up and can’t take 
time off to recover.  After examining you, the doctor gives you a prescription for 
antibiotics because you can't come back for a reassessment in Ͳ days.  Doctor 
says to start the antibiotic treatment if you feel worse or no better in Ͳ 
days.  In the past, you have taken antibiotics for similar symptoms before.   
Cͳ.  Which response best describes what you would do?  
☐Fill the antibiotic prescription right away and take it.  
☐Fill the antibiotic prescription right away and only take it if you are worse 
or no better in Ͳ days. 
☐Wait Ͳ days.  If no better, you would fill the antibiotic prescription and take 
it. 
☐Not fill the antibiotic prescription at all. 
☐Other response (please tell us) ________________________________ 
 
Consumers were also asked what they would usually do with an unused antibiotic 
prescription.  Many would keep the prescription until it expired (ͷ͵/ͱ͸Ͷ; ʹͰ.ͳ%), ʹͱ 
(ͲͲ.Ͱ%) would keep the prescription for another time they became unwell, ͵ͱ (Ͳͷ.ʹ%) 
would discard the prescription right away.  The remaining ͱ͹ (ͱͰ.Ͳ%) responses ranged 
from tending to forget about the prescription to keeping it for a few weeks before 
discarding it. 
The complexity of the DCE seemed acceptable as most respondents found it to be easy 
(ʹͶ.Ͳ%) or very easy (ͱ͹.ʹ%), and only ͸.ͱ% (ͱ͵ respondents) found it difficult. 
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 SUMMARY 
In the GP DCE, all attributes were important in influencing GP preferences apart from 
the “Familiarity with patient” attribute.  The attribute levels which exerted the 
strongest influence on GP decision-making when compared against the reference levels 
were: “Duration of symptoms – ͱ week”, “Patient expectations – Says they want 
antibiotics”, “Life event – No” (the patient had no important events or deadlines 
coming up), and “Reassessment – No” (the patient is unable to return for 
reassessment). 
In the consumer DCE, all attributes were important in influencing consumer 
preferences.  The attribute levels which exerted the strongest influence on consumer 
decision-making when compared against the reference levels were: “Doctor’s advice – 
Says it’s probably a viral infection and antibiotics won’t help”, “Duration of symptoms – 
ͱ week”, “Life event – No” (the consumer did not have an important event or deadline 
coming up), “Past experience – No” (the consumer had not taken antibiotics for similar 
symptoms in the past), and “Time off – No” (the consumer is unable to take time off 
from work/study to recover). 
In answer to Research Question Ͳ, the GP DCE results point to the following factors 
having a dominant influence in driving decisions to prescribe an antibiotic: (a) duration 
of symptoms and (b) patient expectations for antibiotics.  For consumers, GP advice 
regarding the use of the delayed antibiotic prescription was of primary importance in 
their decision on whether to fill the prescription.  Dominant factors in both DCEs 
corroborated what GPs and consumers reported in Section C of the survey to be the 
most important attribute in their decision-making for the DCE scenarios presented.   
In line with mixed methods research and as outlined in Chapter ͳ, Section ͳ.ͳ.ͱ, the 
next chapter — Chapter Ͷ — contains the discussion and synthesis of these results 
(Mixing Ͳ). 
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 Discussion, Synthesis and Research 
Contributions 
This chapter is in three parts.  It begins with a discussion and synthesis of results previously 
reported in Chapter ʹ — semi-structured interviews, and Chapter ͵ — discrete choice 
experiments (presented in Section Ͷ.ͱ), in line with a mixed methods approach (Tashakkori & 
Teddlie, ͲͰͱͰ) and culminates in a hypothesis.  The discussion and synthesis of results is 
juxtaposed against the literature where appropriate.  Intentional application of the research 
paradigm — pragmatism, is woven into the section.  The chapter then moves on to discuss 
research strengths and limitations of the study overall, strengths and limitations in the 
application of the selected methods, as well as reflections on how the research has shaped the 
researcher in Section Ͷ.Ͳ.  The chapter concludes with a section on research contributions — 
both theoretical and methodological, implications for policy and practice, and 
recommendations arising from this research pertinent to Australia’s National Antimicrobial 
Resistance Strategy ͲͰͱ͵ – ͲͰͱ͹ (Section Ͷ.ͳ).   
 
 DISCUSSION AND SYNTHESIS OF QUALITATIVE AND QUANTITATIVE RESULTS 
Consistent with pragmatism, the insights from investigating what influences antibiotic use from 
the multiple perspectives of GPs, community pharmacists and consumers (Research Question ͱ) 
were richer due to the various worldviews — whether implicit or acknowledged — held by the 
interview participants.  In this section, discussion and synthesis focusses in turn on GPs, 
community pharmacists and consumers. 
 
6.1.1 Focus on GPs 
Patient expectations — an important barrier which is surmountable 
The challenges and barriers to desirable antibiotic prescribing practices had been identified in 
the literature and established in Section Ͳ.ͱ.ͱ.  Consistent with the barriers established in the 
literature, patient expectations for antibiotics remained one of the significant challenges for the 
GP cohort interviewed.  Underscoring these qualitative findings, the results of the GP DCE 
survey showed that amongst the attributes available for trade-off in the DCE scenario, the 
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patient's agenda for antibiotics exerted a relatively dominant influence on GPs to prescribe 
antibiotics (second only to the duration of symptoms experienced by the patient).  GP 
respondents for the DCE survey all identified as either prescribing about the same amount of 
antibiotics as other GPs (͵Ͷ.͵%) or prescribe less than other GPs (ʹͳ.͵%).  Hence, patient 
expectation is likely to exert an even greater influence on other GPs. 
The finding that patient expectations drive GP prescribing decisions corroborates that of 
another recent study where more than ͵Ͱ% of Australian GPs surveyed reported that they 
would prescribe antibiotics for an upper respiratory tract infection to meet patient expectations 
(Fletcher-Lartey et al., ͲͰͱͶ).   
From the GP interviews, it is clear that knowledge-practice dissonance ensues when GPs 
capitulate to patient demands for antibiotics, either against evidence-based practice (where 
evidence is available) or against the GP’s best clinical judgment.  Despite the GP’s intentions to 
practice evidence-based medicine, this resolve can break down when faced with the 
uncomfortable and awkward situation of managing patient expectations when these 
expectations diverge from best practice, particularly for early career GPs.   
Early career GPs seemed to be less successful in convincing patients that it was in their best 
interest to refrain from using antibiotics, similar to a recent study involving GP Registrars 
(Dallas et al., ͲͰͱʹ).  Experienced GPs tended to be able to successfully steer patients away from 
antibiotics where they are unwarranted.  They do this in a way that maintains good doctor-
patient rapport, using an approach developed over many years of practice in dealing with 
patient demands and/or expectations for antibiotics.  An interesting point brought up by some 
GPs was that perhaps the patients who present at the clinic with an agenda for antibiotics were 
a biased sample of the general population as those who were prudent with antibiotics may not 
seek a GP consult in the first place.  As explained in the EABE model (Chapter ʹ, Section ʹ.͵) 
GPs who are skilful in communicating their decision not to prescribe antibiotics as part of the 
patient education process (coupled with a thorough clinical consultation) are more likely to be 
able to defuse what could be an emotionally and professionally awkward situation.   
Although only one of the GPs interviewed explicitly mentioned shared decision-making (SDM), 
elements of the successful strategies used during clinic consultation are common to SDM i.e. 
information sharing, intentional engagement and involvement of the patient in considering 
treatment options and risks, taking into account patient values (Hoffman, Montori, & Del Mar, 
ͲͰͱʹ) — which when conducted well can enhance patient satisfaction and confidence in the 
decision (Edwards & Elwyn, ͲͰͰͶ).  A basic framework for incorporating SDM into 
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consultations are provided by Hoffman et al. (ͲͰͱʹ).  Given the complexity of managing patient 
expectations while maintaining (or even increasing) patient trust and good doctor-patient 
relationship, well-honed strategies and advanced communication skills which may include SDM 
are needed. 
The findings of the consumer DCE show that GPs are influential in consumer decision-making.  
So much so, that pre-emptive strategies such as the use of posters that “nudge” in the 
consultation room can be successful in reducing prescribed antibiotics (Meeker et al., ͲͰͱʹ).  
These posters consist of a commitment letter which included the GP’s photograph and 
signature, declaring the GP’s commitment to guidelines for appropriate antibiotic prescribing, a 
commitment to act in the patient’s best interest, as well as a short explanation of why 
antibiotics may not be appropriate in many cases.  The results suggested that these posters 
introduced a virtuous meme cycle, positively influencing GP prescribing behaviour (ͱ͹.ͷ% 
reduction in inappropriate antibiotic prescribing) as well as shaping patient expectations 
(Meeker et al., ͲͰͱʹ). 
 
Prescribing practices of medical colleagues — cultural meme and etiquette 
An unexpected finding was that the other overarching challenge mentioned by GPs were the 
prescribing practices of other medical colleagues.  Although prescribing etiquette had been 
cited in literature as one of the reasons that shape prescribing culture (A. Broom, Broom, & 
Kirby, ͲͰͱʹ; Charani et al., ͲͰͱͳ), the clinical context was that of a hospital where a medical 
hierarchy is often imposed and where social capital is accrued through conforming with 
perceived norms and practices of specialities, peers and senior colleagues (A. Broom et al., 
ͲͰͱʹ).  Hence, junior doctors tend to shy away from critiquing the prescribing patterns of other 
more senior colleagues, and their prescribing practices are in turn shaped by these colleagues.   
In contrast, GPs have relative autonomy in their clinics with little or no medical hierarchy, with 
the exception perhaps of being a GP Registrar under supervision (Dallas et al., ͲͰͱʹ).  Even so, 
as discussed in Chapter ʹ, Section ʹ.Ͳ.ͳ, GPs are somewhat affected by the aftermath of other 
GPs who may prescribe antibiotics more freely, whether in having to deal with: (a) patient 
confusion regarding the different treatment decisions, (b) subsequent patient 
demands/expectations for antibiotics, (c) a more resistant bacterial infection non-responsive to 
first-line antibiotics, and/or (d) troublesome side effects from antibiotics.  In the fight against 
antibiotic resistance, it would be desirable to have solidarity and consistency amongst GPs in 
judicious use of antibiotics. 
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Clinical practice and prescribing patterns are often shaped early in a GP’s career; and as pointed 
out by GPs interviewed for this study, some GPs’ prescribing practices had been shaped at a 
time when antibiotic resistance was not high on the agenda.  In a bid to “grow a prudent 
prescriber of antibiotics” rather than change one (which is more difficult to do), a prospective 
study — the ChAP study —involving GP Registrars is underway in Australia (van Driel et al., 
ͲͰͱͶ).  The investigators reasonably posit that appropriate antibiotic prescribing can be 
achieved by actively shaping the way GP Registrars practice.  Educational interventions used in 
the ChAP study include three online modules, one of which is on advanced communication 
training, and face-to-face workshops for both the Registrar and their GP supervisor (van Driel et 
al., ͲͰͱͶ).  It would be interesting to note whether such intentional training would yield a group 
of early career GPs who would not only be better equipped than those not involved in the study, 
but also demonstrate solidarity and consistency in the way they approach antibiotic prescribing.  
The outcomes of the study would be useful for informing future GP training programs. 
  
Uncertainty of diagnosis coupled with patient expectations exerts prescribing pressure 
As discussed in Chapter ʹ, Section ʹ.Ͳ.Ͳ, procedurally, the medical decision-making process for 
respiratory tract infections is not dissimilar to GPs weighing up treatment or management 
options for other types of illnesses — perhaps differing only in the details of diagnostic tests 
used, criteria for diagnosis, methods of assessment and monitoring, and frequency of review, 
taking into account the need for involvement of other medical (e.g. specialists) or allied health 
colleagues.  However, the uncertainty of diagnosis for respiratory tract infections (whether the 
pathogen is viral or bacterial) compounded with patient expectations for antibiotics — whether 
actual or perceived by the GP — exerts a measure of prescribing pressure on GPs.  Some GPs 
interviewed acknowledged that patient expectations sometimes affected their antibiotic 
prescribing patterns negatively — causing knowledge-practice dissonance, and a delayed 
antibiotic prescription is sometimes given as a “soft option”. 
These findings add a new angle to and complement that of Henriksen and Hansen (ͲͰͰʹ) who 
linked GP self-perception to prescribing behaviours (discussed in Chapter Ͳ, Section Ͳ.Ͳ.ͱ); and 
is in line with the findings of a recent literature review by Public Health England (ͲͰͱ͵).  
According to Henriksen and Hansen, GPs who felt pressured by both extrinsic and intrinsic 
factors prescribed in a way that protected their personal and professional self (in terms of 
clinical autonomy) (Henriksen & Hansen, ͲͰͰʹ).   
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Considering the findings of this research together with that of Henriksen and Hansen (ͲͰͰʹ) 
and Public Health England (ͲͰͱ͵), perhaps an additional aspect that could be further explored 
for GP educational interventions in order to prevent or disrupt knowledge-practice dissonance 
is to speak of GP enlightened self-interest.  For GPs, enlightened self-interest in terms of clinical 
practice which emerged from the semi-structured interviews were that prescribing practices 
which conserve antibiotics can: (a) prolong the usefulness of the dwindling armamentarium of 
antibiotics (i.e. GPs will have treatment options to offer patients), and (b) delay or reduce the 
likelihood of having to deal with antibiotic resistant infections in their patients during their 
clinical career. 
 
6.1.2 Focus on community pharmacists 
Community pharmacists — an underused resource 
Of note, GPs interviewed did not discuss community pharmacists or their (potential) role as a 
healthcare partner in mitigating patient expectations or in providing/reinforcing patient 
education regarding wise use of antibiotics.  Community pharmacists were rarely mentioned by 
GPs, and then only in the context of whether their annotations on the antibiotic prescription 
regarding dispensing would be followed by pharmacists.  This observation indicate that most 
GPs do not naturally view community pharmacists as an ally in the primary healthcare sector.  
This is not unexpected as the two professions have been engaged antagonistically for some time 
in defining and defending professional boundaries, at least at the national levels of the college 
and professional bodies such as the Royal Australian College of General Practitioners (RACGP), 
the Australian Medical Association (AMA), the Pharmacy Guild and the Pharmaceutical Society 
of Australia (PSA).  A recent example of such tensions is the pharmacist immunisation service 
provided by appropriately trained community pharmacists (Australian medical Association, 
ͲͰͱʹ; Pharmaceutical Society of Australia, ͲͰͱʹ; Pharmaceutical Society of Australia & 
Pharmacy Guild of Australia, ͲͰͱͶ) (a more complete treatment of the professional tensions 
between GPs and community pharmacists is beyond the scope of this research).  Nevertheless, 
progressive initiatives such as the recent proposal by the AMA to incentivise the integration of 
clinical pharmacists into GP clinics may prove to be synergistic in improving patient outcomes 
and reducing healthcare costs (Australian Medical Association, ͲͰͱ͵). 
Some community pharmacists interviewed were involved in the Queensland Government 
Pharmacists Immunisation Pilot (QPIP) which ran over two years.  The QPIP was successful 
with over ͳ͵ ͰͰͰ vaccinations for influenza, pertussis and measles being administered to adults 
Chapter Ͷ:  Discussion, Synthesis and Research Contributions
  ͲʹͲ 
during the trial.  Thirteen percent of consumers in the pilot were first-time recipients of the 
influenza vaccine (The Pharmacy Guild of Australia & Pharmaceutical Society of Australia, 
ͲͰͱͶ).  Following the success of the QPIP, the State of Queensland legislated the administration 
of these vaccines by appropriately trained pharmacists from 24 March 2016 via an amendment 
to Section 171 of the Health (Drugs and Poisons) Regulation 1996 (State of Queensland, 2016, 
p. 163).  Other states and territories in Australia have legislated or are about to legislate this 
practice (Pharmaceutical Society of Australia, 2017).  Continued support for the pharmacist 
immunisation program is essential as a public health and infection prevention measure. 
 
Disempowered to act as stewards of antibiotics 
As expected, community pharmacists largely played an advisory role, advising consumers in the 
context of self-care and/or self-management of minor illnesses and alleviation of bothersome 
symptoms e.g. upper respiratory tract symptoms.  Community pharmacists felt disempowered 
in their ability to act as stewards of antibiotic use, as they are: (a) not prescribers, and (b) not 
involved at the point of care where the decision is made to use antibiotics.  Currently, 
pharmacists are left out of the information-decision loop with regards to prescribers' decision-
making due in part to the structure and infrastructure of Australian primary healthcare.    The 
integration of clinical pharmacists into GP clinics which has been demonstrated to improve 
clinical and non-clinical outcomes including significant cost savings (Freeman, Rigby, Aloizos, & 
Williams, ͲͰͱͶ), and a robust (and well-used) personal e-healthcare record may help pave the 
way for breaking down these information silos and increase appropriate involvement of 
community pharmacists in the future.   
Community pharmacists do not see themselves as gatekeepers of antibiotic use in the primary 
healthcare setting unlike their colleagues in the hospital sector, where clinical pharmacists play 
a successful and key role in antimicrobial stewardship programs (Dresser & Nelson, ͲͰͱͰ; 
Magedanz, Silliprandi, & dos Santos, ͲͰͱͲ; Wickens et al., ͲͰͱͳ).  Even so, hospital pharmacists 
experience individual and role-based constraints, as well as inter-professional and 
organisational challenges such as the medical hierarchy, jurisdictional ambiguity and 
insufficient staffing (A Broom, Broom, Kirby, Plage, & Adams, ͲͰͱ͵; A Broom, Broom, Kirby, & 
Scambler, ͲͰͱ͵).  Hence, the challenge to involve and embed community pharmacists in 
antibiotic stewardship in the primary healthcare sector is even greater given the lack of clinical 
governance that effectively straddles both general practice and community pharmacy.  It is clear 
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that the model for antibiotic stewardship currently used in hospitals would need to be re-
worked to suit the primary healthcare sector. 
The current funding model for community pharmacy imposes a perverse barrier to prudent use 
of antibiotics, in that there is no clear financial incentive to refuse the dispensing of late 
presentations of antibiotic prescriptions beyond the index infection.  Currently, under the Ͷth 
Community Pharmacy Agreement there is provision for financial claims under the Medication 
Adherence Programs:  Clinical Interventions (Australian Government & Department of Health, 
ͲͰͱ͵).  However, the refusal to dispense late presentations of antibiotic prescriptions does not 
fit neatly into the categories set out in the guidance document for such a claim (Pharmaceutical 
Society of Australia, ͲͰͱͱ). 
 
6.1.3 Focus on consumers 
Patient education must address information needs 
GPs and community pharmacists interviewed reported that they provide consumers with 
necessary information about the antibiotics prescribed such as dosage, frequency of dose 
administration, side effects and its management, and checking on allergies.  In contrast, 
consumers interviewed acknowledged that while basic information was often provided (not 
always), they were frustrated with the lack of specific information about the antibiotics 
prescribed.  Regardless of whether they asked their healthcare professional, consumers wanted 
unambiguous instructions from GPs when prescribed antibiotics, particularly when a delayed 
antibiotic prescription was given so that inappropriate medicine-taking behaviours could be 
avoided.  Consumers were also curious about the rationale for antibiotic selection and confused 
about the same antibiotic being prescribed for seemingly different infections (see Chapter ʹ, 
Section ʹ.ʹ.ͱͰ). 
An information gap was found in the duration of treatment for antibiotics.  When questioned by 
the community pharmacist, consumers often did not know the duration of treatment intended 
by the GP.  This was more obvious in the case of repeat antibiotic prescriptions where 
consumers were unsure about the duration of treatment, and hence whether the repeat was 
required.  Consumer interviews corroborated this finding from the community pharmacists 
interviewed.  Australian data showed that for ten of the commonly used oral antibiotics ͱͰ - 
ͲͰ% of first repeats were being dispensed more than Ͳ months after the original prescription — 
potentially signalling inappropriate use by consumers (Drug Utilisation Sub Committee, ͲͰͱ͵). 
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Public health campaigns — getting seen  
It was somewhat surprising and disappointing that consumers were largely oblivious to the 
public health campaigns on awareness of antibiotic resistance (and prudent use of antibiotics) 
despite these being stepped up in recent years by NPS MedicineWise and the Australian 
Commission on Safety and Quality for Health Care, and using increasingly innovative 
approaches comparable with that of the USA, UK and Europe (Centers for Disease Control and 
Prevention, ͲͰͱͶa; European Centre for Disease Prevention and Control, ͲͰͱͶ; Public Health 
England, ͲͰͱͶ).  The challenge remains for getting campaign materials and resources noticed by 
consumers amid other marketing collateral (commercial or otherwise) vying for consumer 
attention.   
Similarly, it was also disappointing that most community pharmacists did not mention being 
involved in these campaigns either for Antibiotic Awareness Week (a global and national event 
usually held in mid-November, a concession that Australia and other southerly countries have 
to make in deference to the northern hemisphere's winter season) or seasonal campaigns 
leading up to the winter months for Australia.  Despite being a targeted audience for healthcare 
educational interventions by NPS MedicineWise, less than half the GPs interviewed mentioned 
the resources, educational information and tools on the topic of antibiotic resistance or 
antibiotic use, or the antibiotic prescribing report personalised for each GP.    
 
Public health campaigns — getting through? 
Evaluations of Australian public health campaigns i.e. the impact of the annual Antibiotic 
Awareness Week in improving consumer knowledge and changing behaviours have not been 
formally conducted33.  As such, the cost effectiveness and success (or otherwise) of these 
initiatives are not known.  However, consumer research by NPS MedicineWise show that only ͱ 
in ͳ people know that colds and most coughs are caused by viruses, and less than half of those 
surveyed realise that antibiotics are ineffective against viruses, while ͷͶ% of those with an ear, 
nose, throat or chest infection expect to receive antibiotics from their GP (NPS MedicineWise, 
ͲͰͱͳb).  As a result of the mid-year Winter is Coming campaign which ran in ͲͰͱ͵, Australian 
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consumers who were exposed to the two TV commercials had improved understanding of 
antibiotic resistance (NPS MedicineWise, ͲͰͱ͵).  More people reported positive behaviours, 
with the proportion of consumers who would ask their GP for antibiotics for a cold/flu 
decreasing from ͱͷ% in ͲͰͱʹ to ͱͳ% in ͲͰͱ͵ (NPS MedicineWise, ͲͰͱ͵).   
Recent evaluations of the UK Antibiotic Guardian campaign showed mixed results.  Although 
there was an enhancement of knowledge overall post-campaign, positive behaviour change was 
more likely in consumers with prior awareness of antibiotic resistance than those without prior 
awareness (Chaintarli et al., ͲͰͱ͵). 
 
The meaning of antibiotic resistance — language and message 
As detailed in Chapter ʹ, Section ʹ.ʹ.͸, The phrase "antibiotic resistance" was understood and 
interpreted in various ways by consumers.  Antibiotic resistance was conceptualised in four 
ways, some of which overlapped, while others were incorrect.  These were: (a) as a property of 
the body — body becomes resistant to antibiotics, (b) as a property of the medication — 
antibiotic is no longer effective, (c) as a property of the bacteria — the bacterium is resistant to 
the antibiotic, and (d) as a property of a collective — society is immune to antibiotics.  The first 
three ways of conceptualising antibiotic resistance corroborates that of previous research 
(Brookes-Howell et al., ͲͰͱͲ; Wellcome Trust, ͲͰͱ͵) which found that when the term is 
understood, it is impactful.   
Interviews with GPs and community pharmacists revealed that these health professionals tend 
to explain the concept of antibiotic resistance in ways which consumers interpret as alluding to 
the notions of (a), (b) and (c) outlined above.  Hence, health professionals should use alternate 
phrases such as “antibiotic resistant bacteria” and/or “antibiotic resistant infections” which were 
found to be clearer to consumers (Wellcome Trust, ͲͰͱ͵).  This applies equally to all public-
facing materials — media, campaigns, consumer/patient education, online and hardcopy 
resources. 
 
Decision-making — an exercise in enlightened self interest 
The bottom line for consumer decision-making regarding the use of antibiotics or the avoidance 
of antibiotics for minor illnesses came down to enlightened self-interest for either the current 
self or the future self.  While many recognised that responsible behaviour in antibiotic use 
mitigated antibiotic resistance, societal good remained an impersonal abstraction.  Apart from 
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their own judicious behaviour with antibiotics when prescribed, consumers largely seemed 
overwhelmed by the issue of antibiotic resistance — too large an issue for any one 
sector/professional or interest group, but one that should and must be tackled collectively by all 
stakeholders.  This sentiment was echoed by the community pharmacists and GPs interviewed, 
although it could be argued that GPs are in one of the pivotal roles which could directly affect 
antibiotic consumption, and hence antibiotic resistance.  The One Health movement gaining 
momentum worldwide is addressing antibiotic resistance synergistically, tackling the issue from 
all angles — human consumption, antibiotic use in agribusiness, in veterinary science and the 
environment.  The Longitude Prize's Antibiotic Challenge which ends in September ͲͰͱ͹ is 
another initiative aimed at catalysing innovations in rapid diagnostics which would help reduce 
clinical uncertainty, and hence, inform the use of antibiotics (Longitude Prize, ͲͰͱͶ).  Apart 
from enlightened self-interest mentioned previously, the findings from the consumer DCE 
survey underscores the dominant influence of GPs' advice on consumer behaviour regarding the 
use of antibiotics.  This finding demonstrated that consumer desire for specific information 
regarding antibiotics prescribed, should it be clearly provided by the GP, will most likely lead to 
compliance by the consumer. 
 
6.1.4 The EABE model as program theory 
A new model — the EABE model (Section ʹ.͵) was derived from the semi-structured interviews 
to explain the phenomenon of what influences antibiotic use from the perspectives of GPs, 
community pharmacists and consumers, and to inform individual and collective action on how 
to enable wise use of antibiotics.   
The EABE model was supported by the findings from the GP and consumer DCE surveys, both 
of which underscored not only the influence that GPs have on consumer behaviours on 
antibiotic use, but also the influence that consumers have on GP antibiotic prescribing 
behaviours.  Hence, in the EABE model the meta-categories of "Clinical Processes and 
Challenges" (subcategory "Patient expectations") and "Consumer Attitudes, Behaviours, Skills & 
Knowledge" (subcategory "Patient education vs. Information needs”) mutually influence and 
reinforce one another.  Antibiotic eupraxis is possible when these two meta-categories align, 
which in turn opens the way to effective engagement with antibiotic resistance (meta-category; 
subcategory "Mitigating antibiotic resistance"). 
This model can be further developed into “small theory” or program theory as it has the 
potential to: (a) guide specification of the components of a program or intervention, and (b) 
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articulate the assumptions and rationale about mechanisms that link a program’s processes and 
inputs to outcomes (Davidoff, Dixon-Woods, Leviton, & Michie, ͲͰͱ͵). 
 
6.1.5 Hypothesis 
Taken as a whole, the results from both the qualitative and quantitative phases of the research 
converged into the following hypothesis:  that equipping GPs with clear strategies and 
communication skills to confidently convey their decision-making on the one hand; as well as 
equipping consumers with accurate information and communication skills to confidently 
convey their preference to avoid antibiotics where possible on the other hand; would lead to 
antibiotic eupraxis and the mitigation of antibiotic resistance.  This hypothesis has been visually 
encapsulated in the EABE model. 
Returning to the research aim — which was to establish the dominant factors influencing 
decisions to use antibiotics by GPs, community pharmacists and consumers in the Australian 
primary healthcare sector — it is clear from the findings of this research that modifiable 
factors34 i.e. patient expectations for antibiotics and GP's advice on the use of prescribed 
antibiotics are not only the two dominant factors, but are also mutually influencing factors for 
antibiotic decision-making on the part of GPs and consumers. 
 
 RESEARCH STRENGTHS AND LIMITATIONS 
The strengths and limitations of each research method has been dealt with previously in 
Chapter ͳ, Sections ͳ.ʹ.͸ and ͳ.͵.͸, and is not recapitulated here.  Instead, this section outlines 
the strengths and limitations of the research overall and the application of the methods vis-à-vis 
the researcher.  The section ends with reflections on how the research has impacted the 
researcher. 
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modifiable factor. 
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6.2.1 Strengths and limitations:  Overall research 
The strengths of this research lie in its use of mixed methods and the research design, which 
provided a more comprehensive picture of the dominant factors influencing decision-making in 
antibiotic use in the Australian primary healthcare sector (established in Chapter ͳ, Sections ͳ.Ͳ 
and ͳ.ͳ).  The complementarity of the mixed methods approach used in this research served not 
only to corroborate the findings from both the qualitative and the quantitative components, but 
also to mutually underscore the recurrent shared meanings.  This is possible due to the 
disruption of complete objectivity and complete subjectivity — what is often thought of as 
quantitative and qualitative, respectively — offered by pragmatism (Shannon-Baker, ͲͰͱͶ).  In 
this research, the dichotomies of positivist and interpretivist ways of knowing was successfully 
bridged via the transformation of selected interview data to further explore decision-making 
regarding delayed antibiotic prescriptions, which importantly, was problematised through the 
qualitative phase (see Section ʹ.Ͷ The Bridge:  From Semi-Structured Interviews to Discrete 
Choice Experiments).  The resultant DCEs subsequently produced findings that gave 
quantifiable weight to the factors influencing prescriber and consumer decision-making in the 
context of antibiotic prescribing and consumption. 
There were several limitations to the study which is outlined in turn as follows:  
The use of convenience sampling for both the semi-structured interviews and the DCEs 
meant that only respondents with interest in the topic volunteered to participate.  In the case of 
the semi-structured interviews, GPs who participated could be those already practising prudent 
prescribing of antibiotics and hence, likely to prescribe less antibiotics than their peers.  Perhaps 
GPs who prescribe more antibiotics than their peers may have different views on the topic.  
Consumers who volunteered for the semi-structured interviews were those with high 
educational achievements (i.e. holding at least a bachelor’s degree).  However, despite the high 
level of education amongst consumers interviewed, there was diversity in the level of 
knowledge, awareness and concern held regarding antibiotic use and antibiotic resistance — 
some of which were erroneous.  This leads to the sobering realisation that consumers with 
perhaps less formal education and/or less awareness of the topic would hold at least the same if 
not more misconceptions about antibiotic use and antibiotic resistance. 
In the case of DCEs, due to convenience sampling, respondent characteristics were not perfectly 
reflective of the target populations.  Specifically, a higher proportion of GP respondents were 
female and trained in Australia, when compared to GPs registered to practise in Australia.  A 
higher proportion of consumer respondents were female, held a Bachelor’s degree, lived in a 
Chapter Ͷ:  Discussion, Synthesis and Research Contributions
  Ͳʹ͹ 
metropolitan area and were younger (median age), when compared to the general population in 
Australia.  Hence, the stated preferences for both the GP and consumer DCEs may not 
adequately represent those of Australian GPs or the general population aged ͱ͸ and above, 
respectively.  However, the results of both the GP and consumer DCEs provide useful insight 
into decision-making on antibiotic use for these respondents. 
The small sample size of the GP DCE — the small number of participants may be an 
indication that: (a) antibiotic resistance was not an area of interest, (b) GPs were experiencing 
survey-fatigue, and (c) GPs faced time constraints due to a high workload.  In addition, the DCE 
was not part of a recognised GP continuing professional development activity which would 
allow accumulation of points.   
Orme’s sample size calculation is an accepted rule of thumb for DCEs in peer-reviewed 
literature, and does not estimate power (Marshall et al., ͲͰͱͰ).  A small sample size affects the 
study in two ways:  it limits the study’s power i.e. the probability to detect the importance of 
attribute levels in influencing choice is reduced, with the null hypothesis being the attribute 
level is not important in influencing choice (Type ͱ error — rejecting the null hypothesis when it 
is true or Type Ͳ error — not rejecting the null hypothesis when it is false); and the 
representativeness of the respondents to the target population of interest.   
Given that the findings of the GP DCE are consistent with the responses for the most and the 
least important attributes in Section C of the DCE survey as well as findings from the qualitative 
component, it is unlikely that a Type ͱ error (saying that an attribute level is important in 
influencing choice when it is not) or Type Ͳ error (saying that an attribute level is not important 
in influencing choice when it is) was committed. 
The small number of GP participants for the DCE survey (together with respondent 
characteristics which were dissimilar to Australian GPs) means that the findings cannot be 
applied to all GPs as these are the stated preferences of the respondent GPs only.  Having said 
that, the results of the GP DCE provide important insight into choice preferences of respondent 
GPs, which can be cautiously used to inform policy and practice given the statistical significance 
of the estimated parameters and consistency with the qualitative findings. 
The scope and size of this research was constrained by the available time frame, research 
budget and human resources allocated to a PhD study.  As such, the EABE model was not able 
to be tested and verified in either a separate or a sub-study.  Further development and 
refinement of the EABE model would be required. 
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6.2.2 Strengths and limitations:  Application of the selected methods 
The professional background, training and skills which I brought to the research were 
conducive to the development of research instruments and the implementation of the research 
(see Appendix B.  About the Researcher).  However, inherent personal biases and blind spots 
may also have impacted negatively on the application of methods — the qualitative phase of the 
study is particularly vulnerable to this.   
The decision to use the Theoretical Domains Framework (TDF) as a lens for deductive coding in 
addition to the inductive codes, may have limited the richness and depth of what the data may 
show, had it been subject to other forms of analysis such as grounded theory or discourse 
analysis.  With this in mind, it will be worthwhile to re-analyse the raw qualitative data using 
one of these alternate theories as a separate undertaking — which I intend to do, dependent on 
the availability of funding for post-doctoral work in this area. 
The use of DCEs comes with its own constraints and limitations as detailed in Chapter ͳ, 
Section ͳ.͵.͸.  Additional limitations were the hypothetical nature of the scenario offered and 
perhaps the over-simplifying of the clinical context, which was a comment made by one of the 
GP DCE survey respondents.  However, despite these constraints there is useful knowledge to be 
gained from understanding how GPs trade-off between factors.   
For the strengths and limitations inherent in each method used, the reader is referred to 
Chapter ͳ, Sections ͳ.ʹ.͸ and ͳ.͵.͸, for the semi-structured interviews and the DCEs, 
respectively. 
 
6.2.3 Reflections on how the research impacted the researcher:  Learnings 
I emerged from this ͳ-year research journey a changed person — hopefully for the better — in 
more ways than one.  As a researcher, apart from the necessary skills gained and/or enhanced in 
qualitative and quantitative methods and analyses, embarking and completing this study has 
taught me humility.  Let me explain.   
First, the overwhelming trust and generosity of research participants, particularly those who 
were involved in the semi-structured interviews, took me by surprise.  Perspectives, thoughts, 
ideas, critique and self-examination (including those that were unflattering) were shared 
candidly — with me, a stranger.  To honour their trust and generosity, I have sincerely done my 
best to steward this information, analysed and reported it in the most robust way I know.  The 
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research-relevant assistance of mentors, supervisors, friends and colleagues — both practical 
and intellectual — have helped shape and sharpen my thinking and approach to the research. 
Second, the boundaries of qualitative and quantitative research are more fluid than I first 
thought (it is not black, or grey or white).  Learning about and performing mixed methods 
research was indeed an eye-opener for me — not unlike learning how to dance — clumsy steps 
at first, then becoming more graceful (and maybe someday, less effortful) as the work 
progressed.  While I embarked on the PhD journey in part as a surrogate capstone to my 
clinical, professional and academic achievements, I now know I still have much to learn. 
Third, as researchers, we are constrained by the methods we use, and if we are honest, limited 
by the worldviews we hold and inherent biases in our backgrounds (there is no such thing as a 
view from nowhere).  In this research, what I have investigated, discovered, and offered to 
readers, is but one possible interpretation of the phenomenon of antibiotic use in the primary 
healthcare sector, given my background (see Appendix B) and using the methods selected.  The 
possibility of multiple and varied interpretations is true not only of qualitative data — but as I 
have come to appreciate — of quantitative data as well.   
I am grateful for each of these learnings. 
 
 RESEARCH CONTRIBUTIONS 
The theoretical and methodological innovations discussed in Sections Ͷ.ͳ.ͱ and Ͷ.ͳ.Ͳ 
demonstrate the significance and novelty of this research.  The implications for policy and 
practice (Section Ͷ.ͳ.ͳ), together with the recommendations outlined in Section Ͷ.ͳ.ʹ show the 
significance and importance of this research. 
 
6.3.1 Theoretical innovation 
Two theoretical innovations are claimed.  First, the Theoretical Domains Framework (TDF) was 
used in this research in four novel ways:  (a) as the theoretical basis for establishing the 
dominant factors in decision-making in both an area (antibiotic use in the Australian primary 
healthcare sector) and in individuals (community pharmacists and consumers), naïve to the 
TDF, (b) as a coding framework for qualitative data gained from semi-structured interviews, (c) 
as a conceptual framework for the selection of attributes of interest for the DCEs, and (d) as a 
translation framework for recommendations to national programs targeting desired behaviour 
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change in antibiotic use.  In addition, the mapping of evidence to the TDF on antibiotic 
prescribing and antibiotic use in primary care had not been done before in peer-reviewed 
journals35.  This research therefore built upon existing knowledge, added to implementation 
science/behaviour change research, and extended the application of the TDF. 
Second, a new model was created to more fully explain the tensions between factors influencing 
antibiotic use, which was not easily surfaced using the TDF alone.  The Enabling Antibiotic 
Eupraxis (EABE) model was developed from the qualitative findings of this research, to both 
explain the phenomenon of what influences antibiotic use from the perspectives of GPs, 
community pharmacists and consumers, and to inform individual and collective action on how 
to enable wise use of antibiotics.  The EABE model was also supported by the findings from the 
quantitative phase. 
 
6.3.2 Methodological innovation 
An adaptation of the DCE method to reveal dominant drivers in decision-making on antibiotic 
use was necessary for the conduct of this research.  DCEs have usually been used to reveal 
factors that drive selection of jobs, goods or services.  In this research, the DCEs required 
situational framing with realistic decision points that would elicit: (a) dominant factors that 
drive GP antibiotic prescribing behaviour, and (b) dominant factors that drive consumer 
antibiotic prescription-filling behaviour.  This required adaptation of the DCE method, in that 
the attributes and levels were not characteristics of a job, product/good or service/test, but 
rather of the relevant personal and external circumstances related to the hypothetical scenarios.   
To the best of my knowledge, this research is novel in its use of DCEs in this manner and 
enabled better understanding of how one factor was traded against another, given the same 
hypothetical scenario, which has valuable and useful applications for policy and for practice. 
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6.3.3 Implications for policy and practice 
Regulatory changes as forcing functions 
The findings of this study support the enactment of PBS changes for oral antibiotics proposed 
by the DUSC as much needed forcing functions for more appropriate use of these medicines.  
Specifically, (a) the reduction of the period of validity for oral antibiotic prescriptions, and (b) 
the removal of repeat prescriptions for oral antibiotics (Department of Health & Pharmaceutical 
Benefits Advisory Committee, ͲͰͱ͵; Drug Utilisation Sub Committee, ͲͰͱ͵).  The majority of GP 
and community pharmacist interview participants supported both of these proposed actions.   
The importance of introducing a regulatory strategy to reduce the period of validity for oral 
antibiotic prescriptions to minimise/prevent inappropriate use, is underscored by the consumer 
DCE finding that ʹͰ.ͳ% would keep unused antibiotic prescriptions until it expired and ͲͲ% 
would keep it for another time they became unwell.  Reducing the period of validity for 
antibiotic prescriptions would prevent potential misuse of antibiotics, in that prescriptions 
being filled many weeks or months later are unlikely to be for the treatment of the same index 
infection.  GPs and community pharmacists interviewed suggested that for most patients a ͱ-
month period of validity for antibiotic prescriptions would be sufficient, after which it can no 
longer be dispensed.  This period of validity is reasonable as Australian data indicate that for the 
ͱͰ most commonly used antibiotics, between ͷͳ – ͹ͳ% of the prescriptions had been dispensed 
by the third day after prescribing (Drug Utilisation Sub Committee, ͲͰͱ͵).   
Repeat antibiotic prescriptions contribute to the potential “reservoir” of antibiotics accessible to 
consumers, which may not be used appropriately.  Australian data show that for three of the 
commonly used oral antibiotics, a high proportion of prescriptions contained a repeat — 
amoxicillin with clavulanic acid (Ͷ͸%), cephalexin (͵ͳ%) and roxithromycin (ͷͱ%) (Drug 
Utilisation Sub Committee, ͲͰͱ͵).  While it is difficult to ascertain the appropriateness of the 
prescribing of repeat prescriptions without matched data on clinical indications, it is of concern 
that for ten of the commonly used oral antibiotics ͱͰ – ͲͰ% of first repeats were being 
dispensed more than Ͳ months after the original prescription — potentially signalling 
inappropriate use by consumers (Drug Utilisation Sub Committee, ͲͰͱ͵).  Similarly, in this 
research, many consumers interviewed reported that they retained unused repeat prescriptions 
which were subsequently used when they became ill again with (perceived) similar symptoms 
— which may or may not be clinically appropriate.   
While GPs can currently adjust the settings in their prescribing software so as not to generate 
repeat prescriptions for antibiotics unintentionally, it was evident from the GP interviews that 
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not all GPs are aware of how to do this and/or may not remember to do so.  This finding 
corroborates that of a previous Australian study which found that almost ͷͰ% of computer-
generated antibiotic prescriptions included repeats, compared to only ʹͰ% of handwritten 
antibiotic prescriptions (Newby & Robertson, ͲͰͱͰ).  A national educational intervention 
targeted at GPs which provided the rationale and the process for how to adjust prescribing 
software settings to avoid automatic generation of repeat antibiotic prescriptions did not alter 
these proportions significantly (Newby & Robertson, ͲͰͱͰ).  Hence, removing oral antibiotic 
repeat prescriptions from the PBS would be the surest way to dis-incentivise the dispensing of 
unintentional repeat prescriptions. 
Enactment of these regulatory changes would need to provide for alternate means of accessing 
antibiotics — for example, via authority prescriptions or a longer period of prescription validity 
for selected indications.  GPs and community pharmacists interviewed were emphatic that 
appropriate access to antibiotics need to be ensured for patients who require longer courses of 
treatment, clinically appropriate prophylaxis, repeat treatment or larger quantities/doses (e.g. 
patients with cystic fibrosis, chronic obstructive pulmonary disease, osteomyelitis).  These views 
are in line with the DUSC proposal to the PBAC (Department of Health & Pharmaceutical 
Benefits Advisory Committee, ͲͰͱ͵).  
 
Education and training 
The findings from this research highlight the need to further equip GPs, community 
pharmacists and consumers to act individually and collectively to mitigate antibiotic resistance.  
Intentional and tailored education and training relevant to each of these groups would be 
needed.   
For GPs — all GPs but particularly early career GPs would benefit especially from being 
equipped with strategies to manage patient expectations and advanced communication skills to 
not only convey prescribing decisions confidently and persuasively to patients, but also to 
communicate unambiguously (especially in the case of how and when to use a delayed 
antibiotic prescription, should one be given) so as to help patients avoid inappropriate 
behaviours.  Given that the majority of prescribing decisions made by GP respondents regarding 
the DCE choice sets (ͳͰ͸/ʹͱʹ, ͷʹ.ʹ%) were that the antibiotic prescription issued would have 
been a delayed prescription, and that ͱ͹.ʹ% of consumer respondents to the DCE survey 
indicated that they would fill such a prescription right away and take it, clear instructions from 
the GP is important. 
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For consumers — the knowledge that their expectations have the power to influence antibiotic 
prescribing behaviour means that consumers can more fully participate as involved actors in the 
fight against antibiotic resistance.  Results of the GP DCE demonstrated that the modifiable 
factor of “Patient expectations” was dominant in influencing prescribing decisions.  Consumers 
need to understand that clear communication on their part to GPs regarding their preference to 
avoid antibiotics unless necessary, not only benefits their own health (through the avoidance of 
risks and side effects of taking antibiotics), but also serves as an effective way of conserving 
antibiotics. 
In other words, the findings of the DCEs that GPs and consumers mutually influence one 
another in decision-making should be leveraged in educational interventions for GPs and 
consumers alike.   
It is of concern that community pharmacists who serve as front-line health professionals in the 
community feel inadequately informed about antibiotic resistance and disempowered to act, as 
per the findings from the semi-structured interviews in this research.  Hence, for community 
pharmacists — education and training to upskill them with up-to-date knowledge of the extent 
of antibiotic resistance and its practical consequences, is a first step in removing the inertia to 
act.  Following this, concrete suggestions of what they can realistically do to mitigate antibiotic 
resistance, would go a long way towards engaging and involving community pharmacists.  
Promoting awareness amongst community pharmacists of activities/initiatives identified by the 
International Pharmaceutical Federation (FIP) to reduce reliance on antibiotics would be a key 
step (International Pharmaceutical Federation (FIP), ͲͰͱ͵) and signals (perhaps untapped) 
solidarity in the profession globally to mitigate the rise of antimicrobial resistance.  Activities 
that are most pertinent for pharmacists working in the primary healthcare sector in Australia 
include:  health promotion (promoting good hygiene, hand washing), promoting or providing 
vaccinations, advice on management of self-limiting viral infections, and appropriate referral to 
a GP (International Pharmaceutical Federation (FIP), ͲͰͱ͵).   
A one-stop website offering online resources to clinicians and patients to inform, guide, monitor 
and support antibiotic stewardship efforts in the primary healthcare sector, such as UK’s 
TARGET antibiotics toolkit (Royal College of General Practitioners, n.d.), would be a useful 
addition/enhancement of what is currently spread across multiple organisational websites (e.g. 
Australian Commission on Safety and Quality in Health Care, the Australian Government, 
Department of Health, NPS MedicineWise).  
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6.3.4 Recommendations 
The recommendations made in this section are based on the findings of this research, which are 
aligned with, corroborate and add to the implementation of: (a) the National AMR Strategy36: 
Objective ͱ – Increase awareness and understanding of antimicrobial resistance, its implications, 
and actions to combat it through effective communication, education and training, (b) the 
AURA ͲͰͱͶ report37, and (c) the recommendations of the International Pharmaceutical 
Federation (Australian Commission on Safety and Quality in Health Care, ͲͰͱͶ; Australian 
Government, ͲͰͱ͵; International Pharmaceutical Federation (FIP), ͲͰͱ͵; World Health 
Organization, ͲͰͱ͵). 
The findings of this research are anticipated by the Federal Department of Health for inclusion 
in Australia’s National Antimicrobial Strategy ͲͰͱ͵ – ͲͰͱ͹ Implementation Plan (Australian 
Government et al., ͲͰͱͶ, p. Ͳͳ) as part of the outputs of the Centre of Research Excellence in 
Reducing Healthcare Associated Infections (CRE-RHAI), following a national forum in late ͲͰͱ͵.   
 
Recommendation 1:  Enact regulatory changes to the PBS 
Government and policy makers to work with stakeholders and legislators to enact the proposed 
PBS changes to remove oral antibiotic repeats and to reduce the period of validity of oral 
antibiotic prescriptions, while ensuring accessibility of antibiotics where there is a proven 
clinical need (TDF Dͷ Reinforcement, TDF Dͱͱ Environmental context and resources, TDF Dͱʹ 
Behavioural regulation). 
 
Recommendation 2:  Embed community pharmacists into strategies to mitigate antibiotic 
resistance. 
Government and policy makers to work with stakeholders and/or legislators to: 
cclvi                                                     
 
36 The National AMR Strategy is in turn aligned with the WHO Global Action Plan. 
37 Page 148 of the report regarding next steps to review specific aspects of antibiotic prescribing under the 
PBS to identify opportunities for improved appropriateness of antibiotic use in the community.  
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2A.  Support the integration of community pharmacists into primary healthcare teams 
Continue to support the Pharmacist in General Practice Incentive Program (PGPIP) and to 
incorporate community pharmacists as part of the team in Health Care Homes.  Incorporating 
suitably trained community pharmacists in these ways not only ensures that consumer 
medication use is optimised, but also provides a resource for antibiotic stewardship in the clinic 
or team (TDF Dͱ Knowledge, TDF DͲ Skills, TDF Dͳ Social/Professional role and identity, TDF 
Dʹ Beliefs about capabilities, TDF DͶ Beliefs about consequences, TDF Dͷ Reinforcement, TDF 
D͹ Goals, TDF Dͱͱ Environmental context and resources, TDF Dͱʹ Behavioural regulation).   
Pharmacists who take up these clinic-based roles with responsibilities to contribute to antibiotic 
stewardship, need to be adequately upskilled, given clear guidance and resourced with tools by 
relevant national and professional bodies for antibiotic use and surveillance, clinical audit and 
consumer education. 
2B.  Support and legislate pharmacist immunisation programs as an infection prevention 
measure 
Continue to support and legislate community pharmacist immunisation programs as a public 
health and an infection prevention measure (TDF Dͱ Knowledge, TDF DͲ Skills, TDF Dͳ 
Social/Professional role and identity, TDF Dʹ Beliefs about capabilities, TDF DͶ Beliefs about 
consequences, TDF D͹ Goals, TDF Dͱͱ Environmental context and resources, TDF Dͱʹ 
Behavioural regulation). 
 
Recommendation 3:  Upskill community pharmacists regarding their role in mitigating 
antibiotic resistance 
Community pharmacist education and training providers to incorporate/enhance the following 
in their training curricula and/or educational interventions: (a) upskill pharmacists on up-to-
date knowledge of the extent of antibiotic resistance and its practical consequences, (b) 
promote awareness of activities identified by the International Pharmaceutical Federation that 
are pertinent to community pharmacists — health promotion (good hygiene, hand washing), 
promoting or providing vaccinations, advice on management of self-limiting viral infections, 
and appropriate referral to a GP, and (c) equipping pharmacists with the knowledge and skills 
for implementing these concrete actions (TDF Dͱ Knowledge, TDF DͲ Skills, TDF Dͳ 
Social/Professional role and identity, TDF Dʹ Belief about capabilities, TDF DͶ Beliefs about 
consequences, TDF Dͷ Reinforcement, TDF D͸ Intentions, TDF D͹ Goals, TDF Dͱͱ 
Environmental context and resources, TDF DͱͲ Social influences, TDF Dͱͳ Emotion). 
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Recommendation 4:  Incorporate new emphases and clearer terminology for public health 
campaigns 
Stakeholders and organisations responsible for consumer education and/or public health 
campaigns to: 
 4A.  Emphasise the power of consumers to directly reduce antibiotic prescribing 
Emphasise the message in consumer education and public health campaigns that consumers 
have the power to directly reduce antibiotic prescribing (and hence reduce antibiotic resistance) 
by clearly communicating their preference to avoid antibiotics for minor illnesses to the GPs 
(TDF Dͱ Knowledge, TDF DͲ Skills, TDF Dͳ Social/Professional role and identity, TDF Dʹ 
Beliefs about capabilities, TDF D͸ Intentions, TDF DͱͲ Social influences).   
4B.  Emphasise the role of a good GP 
Reframe public perception as to what constitutes a good GP, contextualised for conservation of 
antibiotics (TDF Dͱ Knowledge, TDF DͲ Skills, TDF Dͳ Social/Professional role and identity, 
TDF Dͷ Reinforcement, TDF D͹ Goals, TDF DͱͰ Memory, attention and decision processes, 
TDF DͱͲ Social influences).   
The principle being that a good GP: (a) understands your health concerns and acts in your best 
interest, (b) would conduct a thorough examination (i.e. clinical examination, medical history 
and appropriately order any tests) when deliberating on the best course of action, (c) would 
discuss their findings and potential courses of action with you in order to involve you in the 
decision-making process, and (d) would not prescribe antibiotics unless the benefits to your 
health outweighed the risks of treatment.  
4C.  Adopt clearer terminology — antibiotic resistant bacteria/infections 
Use the phrase “antibiotic resistant bacteria” and/or “antibiotic resistant infections” rather than 
“antibiotic resistance”, in order to more accurately convey the issue to consumers/patients (TDF 
Dͱ Knowledge, TDF Dͷ Reinforcement, TDF DͱͲ Social influences).  This applies to all public-
facing materials — media, campaigns, consumer/patient education, online and hardcopy 
resources. 
 
Recommendation 5:  Upskill GPs to manage patient expectations efficaciously  
GP education and training providers to incorporate/enhance the following in their training 
curricula and/or educational interventions: (a) strategies for managing patient expectations (see 
description for “preparing the ground” in Chapter ʹ, Section ʹ.Ͳ.Ͷ), (b) advanced 
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communication skills to not only convey prescribing decisions confidently and persuasively to 
patients, but also to communicate unambiguously (especially in the case of how and when to 
use a delayed antibiotic prescription, should one be given) so as to help patients avoid 
inappropriate behaviours (TDF Dͱ Knowledge, TDF DͲ Skills, TDF Dͳ Social/Professional role 
and identity, TDF Dʹ Beliefs about capabilities, TDF DͶ Beliefs about consequences, TDF Dͷ 
Reinforcement, TDF D͸ Intentions, TDF D͹ Goals, TDF DͱͲ Social influences, TDF Dͱͳ 
Emotion, TDF Dͱʹ Behavioural regulation). 
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 SUMMARY 
Decision-making on antibiotic use is a complex phenomenon.  In the discussion and synthesis 
of results (Section Ͷ.ͱ) this chapter showed how the use of mixed methods enabled a 
comprehensive investigation of the research aim and research questions, leading to a more 
nuanced understanding of the topic.  Research strengths and limitations (apart from those 
inherent in the selected methods which were discussed in Chapter ͳ, Sections ͳ.ʹ.͸ and ͳ.͵.͸) 
were discussed in Section Ͷ.Ͳ.  The significance, novelty and importance of this research was 
demonstrated in Section Ͷ.ͳ Research contributions, which concluded with five key 
recommendations towards: (a) the implementation of the National AMR Strategy ͲͰͱ͵ – ͲͰͱ͹: 
Objective ͱ – Increase awareness and understanding of antimicrobial resistance, its implications, 
and actions to combat it through effective communication, education and training, (b) the 
AURA ͲͰͱͶ report, and (c) the recommendations of the International Pharmaceutical 
Federation. 
The next chapter (Chapter ͷ) provides a succinct summary of this research and offers 
suggestions for future research. 
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 Conclusion 
In this chapter which concludes the thesis, a grand summation (Section ͷ.ͱ) comprising the 
following components is briefly provided: (a) the research problem, salient gaps in research, 
research aim and research questions; (b) research design and methods used; (c) main findings 
from both the qualitative and quantitative phase; (d) limitations and strengths of the research; 
and (e) research contributions.  Opportunities for future research are discussed next.  A 
concluding statement ends the chapter. 
 
 GRAND SUMMATION OF RESEARCH 
The research problem 
The ratification of the WHO Global Action Plan in ͲͰͱ͵ and the landmark declaration agreeing 
to combat antimicrobial resistance (AMR) signed by ͱ͹ͳ countries at the United Nations 
General Assembly in ͲͰͱͶ, have further escalated the urgency and established the importance of 
fighting antimicrobial resistance globally (General Assembly of the United Nations, ͲͰͱͶ; World 
Health Organization, ͲͰͱ͵).  The burden to health and to the economy is significant for both 
individuals and society.  It is estimated that if left unchecked, globally by ͲͰͲͰ, AMR will cause 
ͱͰ million deaths per year and cost up to a hundred trillion US dollars in lost Gross Domestic 
Product.  Currently in Australia, the cost of AMR is estimated to be over $Ͳ͵Ͱ million per year.  
The issue that despite much published research, it is not known which factors are dominant in 
influencing antibiotic use in the Australian primary healthcare sector, was problematized via 
the literature review in Chapter Ͳ.   
  
Salient gaps in research 
This research focussed on addressing the following gaps in research: (a) although some barriers 
and enablers to appropriate use of antibiotics affecting GPs and consumers are known, it is not 
clear which factors are most impactful on decision-making, and (b) research on GP prescribing 
behaviours and attitudes found in published literature were predominantly completed on those 
practising in the UK, Europe or the USA.  To date, limited research has been done with 
Australian GPs in this area.  The same can be said of consumers.  In the case of community 
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pharmacists, little qualitative research has been done to understand how those practising in 
Australia view the issue of AMR, their professional role in mitigating the rise of AMR and their 
perceptions of what influences the use of antibiotics.   
 
Research aim and research questions 
This research aimed to establish the dominant factors influencing decisions to use antibiotics by 
GPs, community pharmacists and consumers in the Australian primary healthcare sector, so as 
to inform ongoing national programs to reduce antibiotic use.   
Two research questions (RQ) were posed and addressed: 
RQͱ.  What influences antibiotic use from the perspectives of GPs, community pharmacists and 
consumers? 
RQͲ.  How do GPs and consumers trade-off on factors influencing antibiotic use? 
 
Research design and methods 
A mixed methods research design was used (QUAL  QUAN), comprising semi-structured 
interviews for the substantial qualitative component followed by DCEs for the quantitative 
component.  Justification for the selection of these methods were provided in Chapter ͳ, 
Sections ͳ.ʹ and ͳ.͵.  A schematic representation of the research design was presented in 
Chapter ͳ, Section ͳ.ͳ.ͱ.   
In alignment with mixed methods, the points of interface between the qualitative and 
quantitative components were made explicit.  There were two instances of interface or "mixing" 
— the transformation from qualitative data to quantitative research instrument (see Chapter ʹ, 
Section ʹ.Ͷ) and the discussion and synthesis of results (Chapter Ͷ, Section Ͷ.ͱ).   
 
Research outcomes:  Main findings  
Detailed reporting of results was provided in Chapters ʹ and ͵.  The main findings of the 
qualitative component — semi-structured interviews — yielded the EABE model, which both 
explains the phenomenon of what influences antibiotic use from the perspectives of GPs, 
community pharmacists and consumers, and to inform individual and collective action on how 
to enable wise use of antibiotics.  Briefly, the EABE model shows how the meta-categories of 
Clinical Processes & Challenges, Consumer Attitudes, Behaviours, Skills & Knowledge, and 
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Engaging with Antibiotic Resistance, lie in tension and converge when aligned to allow 
antibiotic eupraxis.  The model is illustrated in Chapter ʹ, Section ʹ.͵.  The EABE model was 
supported by the main findings of the GP and the consumer DCE surveys. 
The main findings of the quantitative component — DCEs — were: (a) that GP's advice was the 
dominant factor influencing consumer behaviours on antibiotic use, and (b) that patient 
expectations for antibiotics was the dominant (modifiable) factor influencing GP antibiotic 
prescribing behaviours.   
Taking together, the results of the qualitative and quantitative components gave rise to the 
hypothesis that:  equipping GPs with clear strategies and communication skills to confidently 
convey their decision-making on the one hand; as well as equipping consumers with accurate 
information and communication skills to confidently convey their preference to avoid 
antibiotics where possible on the other hand; would lead to antibiotic eupraxis and the 
mitigation of antibiotic resistance.   
 
Strengths and limitations of the research 
The strengths and limitations of this research have been discussed at these various levels: (a) for 
each method used (Chapter ͳ, Sections ͳ.ʹ.͸ and ͳ.͵.͸), (b) for the research overall, (c) for the 
application of the methods, and (d) reflections by the researcher — (b) to (d) in Chapter Ͷ, 
Section Ͷ.Ͳ.   
 
Research contributions 
This research addressed the research aim and the two research questions posed (Chapters ʹ to 
Ͷ).  Qualitative perspectives of Australian community pharmacists and consumers on antibiotic 
resistance, their roles in mitigating the rise of AMR and their perceptions of what influences 
antibiotic use from this research, are novel and contributes towards reducing a research gap 
(Chapter Ͳ, Section Ͳ.͵).  The qualitative perspective of Australian GPs on antibiotic prescribing 
are an addition to the current literature which is dominated by research from the UK, Europe or 
the USA.  This research has also (for the first time, to the best of my knowledge) quantified 
preferences for decision-making in antibiotic prescribing and antibiotic consumption.  
Dominant factors that influence GP and consumer decision-making in these areas have been 
established. 
Chapter ͷ:  Conclusion  ͲͶʹ 
The significance and novelty of this research is evidenced by the theoretical and methodological 
innovations discussed in Chapter Ͷ (Sections Ͷ.ͳ.ͱ and Ͷ.ͳ.Ͳ).  The significance and importance 
of this research is demonstrated by the implications for policy and practice (Section Ͷ.ͳ.ͳ), 
together with the recommendations outlined in Section Ͷ.ͳ.ʹ. 
 
 FUTURE RESEARCH 
Opportunities for future research are presented as those which could potentially be completed 
as part of post-doctoral research and those which may require a larger investment.  Future 
research include, but are in no way limited to the following: 
Post-doctoral research 
 Research to investigate GPs' attitudes to personal use of antibiotics and the 
impact/influence on their prescribing practices; 
 Conduct a multi-career-stage GP DCE survey including final year medical students, GP 
Registrars, early, mid- and late-career GPs to compare prescribing attitudes and 
practices; 
 Compare GP DCE survey findings with real-time antibiotic prescribing data from 
MedicineInsight when publicly available, to refine and/or validate the DCE findings; and 
 Research on the DCE method such as attribute non-attendance perhaps for clinician 
cohorts 
Research requiring a team and/or larger investment 
 Develop, implement and evaluate new public health messages regarding antibiotic use 
and antibiotic resistance, informed by the findings of this research.  This would meet one 
of the objectives of the National AMR Strategy ͲͰͱ͵ – ͲͰͱ͹ i.e. to have an evidence base 
for behaviour change strategies/interventions;  
 Research on the effectiveness of previous public health campaigns e.g. Antibiotic 
Awareness Week in influencing consumer behaviour, from a health communication and 
health literacy perspective; and 
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 Application of the research design used in this study to another country38 or setting, 
either in the same or different topic area e.g. antibiotic use by dentist, nurse practitioners 
or in countries with similar healthcare structures  
 
 CONCLUDING STATEMENT 
This thesis both confirms and adds new findings to the collective evidence base for action 
against antibiotic resistance.  The significance, novelty and importance of this research were 
demonstrated in the results as well as in the research contributions.  Actors such as 
government, policy-makers and GPs, who have the authority, responsibility and resources to 
mitigate the rise of antibiotic resistance must now maintain and/or step up efforts, not only for 
individual and societal good in Australia, but also globally.  Community pharmacists need to 
engage and involve themselves in the fight against antibiotic resistance if they wish to retain a 
key role as a healthcare partner and provider.  Consumers have more power to influence GPs' 
antibiotic prescribing patterns than they currently realise — this should be leveraged as much 
as possible.  Antibiotic resistance knows no sovereign borders — so must our collective efforts 
in addressing this issue.   
 
cclxv                                                     
 
38 Interest to collaborate has been expressed by Dr Akke Vellinga, Epidemiologist from the School of 
Medicine at NUI Galway in the UK in August ͲͰͱͶ.  Discussions are ongoing. 
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Appendix B:  About the Researcher 
This PhD was undertaken as a continuation of a journey of what has been a multi-faceted 
career — not just in the discipline of pharmacy, but more broadly in the field of medicines 
management, as detailed in subsequent paragraphs below.  The seed for the research aim and 
research questions was planted in ͲͰͱͳ while working as the Design Lead for NPS 
MedicineWise39 — creating possible healthcare and educational interventions for a multi-year 
program to reduce antimicrobial resistance by Ͳ͵% over ͵ years.  While reviewing the 
literature to sift through the evidence for "which messages directly impacted on behaviour", I 
realised that there was a paucity of research in this area.  Although there was some research 
on factors that would have an impact on prescribing patterns and consumer behaviours, it was 
mostly non-Australian data.  In addition, it was unclear which factors were most important, 
and hence, what aspect to leverage for public health campaigns.  This early seed has evolved 
and changed a little, as is necessary, during the course of the ͳ-year PhD. 
My professional background is in clinical pharmacy — having been conferred a Bachelor in 
Pharmacy (ͱ͹͹ͳ) and a Master in Clinical Pharmacy (ͲͰͰͲ), both by The University of 
Queensland, Australia.  My clinical/working experience was gained in the healthcare sector 
serving in public and private hospitals, in both metropolitan and rural/regional areas — 
primarily in Australia, but also in Singapore and Malaysia.  I have worked for the not-for-profit 
sector and in academia — focusing on various aspects of medicines management, including 
quality use of medicines and practitioner-training — in Australia and as a visiting lecturer in 
Sri Lanka.    
My skills are diverse and include academic detailing/social marketing, implementation 
science, management of complex state-wide projects and programs, information systems 
implementation, relationship management of multi-disciplinary stakeholders, development 
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39 NPS MedicineWise is a national not-for-profit organisation that enables quality use of 
medicines and medical tests. Up to date, evidence-based information about medicines, health 
conditions, medical tests, and practical tools/resources are designed and disseminated via 
various modalities to health professionals and consumers to influence better decision-making 
and better health outcomes. 
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and delivery of innovative educational interventions for clinicians, and development and 
delivery of education and training programs for undergraduates, postgraduates and health 
professionals.   
Looking back at the trajectory of my career and reflecting on the achievements that have given 
me the most satisfaction, I recognise that my worldview leans towards that of social 
democracy.  I worked in Australian public healthcare institutions at a time when funding was 
scarce (when is it not?) but was wisely invested in a way which allowed local innovation and 
best practice to be freely shared and piloted elsewhere (intra and interstate), refined and/or 
tailored, and spread — all in a relatively short span of time, which minimised the reinvention 
of wheels.   
I work best with people and organisations whose values are aligned with equity — in the 
context of medicines management that would be: (a) equity of access and quality use of 
medicines, and (b) equity of access to competent and safe healthcare practitioners — doctors, 
pharmacists, nurses, allied health professionals.   
My area of expertise is in enabling quality use of medicines (including safe systems) and in 
developing a skilled medicines management workforce (safe prescribers and safe 
practitioners) — for which I was awarded the Advanced Practice Pharmacist credential by the 
Australian Pharmacy Council in late ͲͰͱ͵.  My practice and contribution to healthcare has 
changed the way clinical pharmacists provide medication management services in Queensland 
public hospitals.  I have had the pleasure and privilege of leading and working with many 
multi-disciplinary colleagues and team members to make this happen — doctors, pharmacists, 
pharmacy support staff, nurses, ICT experts, directors and executives.  Together with able and 
inspiring colleagues and mentors, I have contributed to the national agenda on non-medical 
prescribing40 including delineating prescribing competencies41, and developed and co-
delivered clinical education and training for International Medical Graduates on safe 
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40 Prescribing of medication by health practitioners other than doctors and dentists e.g. nurse 
practitioners, pharmacists, physiotherapists. 
41Published paper:  Lum E, Mitchell C, Coombes I. (ͲͰͱͳ). The competent prescriber: ͱͲ core 
competencies for safe prescribing.  Aust Prescr, ͳͶ, ͱͳ-ͱͶ.  Published report:  National Health Workforce 
Planning and Research Collaboration. (ͲͰͱͰ). Non-medical prescribing: An exploration of likely nature 
of, and contingencies for, developing a nationally consistent approach to prescribing by non-medical 
health professionals.  Final report by Nissen L, Kyle G, Stowasser D, Lum E, Jones A, McLean C, Gear C.   
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prescribing.  I also co-created and co-delivered a prescribing training program for pharmacists 
and allied health practitioners — for which I was awarded the QUT Vice Chancellor's 
Performance Award (Team Award) in late ͲͰͱʹ. 
Reflections on how this research project has impacted me, the researcher — were offered in 
Chapter Ͷ, Section Ͷ.Ͳ.ͳ. 
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Appendix C:  Literature Search Strategy 
 
Search criteria:  Peer-reviewed journal articles; English language; abstract available; published 
between January ͲͰͰͰ and March ͲͰͱʹ; human; adults. 
 
Search ͱ:  To identify barriers and enablers of antibiotic use for GPs, community pharmacists 
and consumers, respectively (contextualised for respiratory tract infections). 
Search ͱA: General Practitioners 
S1: antibiotic* OR antimicrobial OR antibiotic resistance OR antimicrobial resistance 
S2: decision?making OR judg?ment OR prescrib* 
S3: doctor OR prescri* OR general practitioner OR gp 
S4: ambulatory OR primary care OR primary health?care 
S5: S1 AND S2 AND S3 
S6: S4 AND S5 
Subject headings:  
Anti-bacterial agents; practice patterns, physicians’; respiratory tract infections; primary health care; drug 
prescriptions; drug utilization; ambulatory care; family practice; physicians, family; health knowledge, 
attitudes, practice; drug resistance, microbial; inappropriate prescribing; general practice; physicians, 
primary care. 
Yield:  554 articles (Medline – 389; CINAHL – 17; PsycINFO – 60; SCOPUS – 88) 
After screening of titles/abstracts:  281 articles (Medline – 207; CINAHL – 4; PsycINFO – 30; SCOPUS – 40) 
Total after duplicates removed:  253 articles 
 
Search ͱB:  Community Pharmacists 
S1: antibiotic* OR antimicrobial OR antibiotic resistance OR antimicrobial resistance OR antibiotic use 
S2: pharmacist OR community pharmac* 
S3: (S1 AND S2) NOT hospital 
Subject headings: 
Anti-bacterial agents; pharmacists; community pharmacy services; self medication; drug prescription; health 
knowledge, attitudes, practice; professional role; pharmacies; patient education as topic; respiratory tract 
infections; attitude of health personnel; practice patterns, physicians’. 
Yield:  150 articles (Medline – 56; CINAHL – 2; PsycINFO – 17; SCOPUS – 75) 
After screening of titles/abstracts:  43 articles (Medline – 24; CINAHL – 0; PsycINFO – 12 SCOPUS – 7) 
Total after duplicates removed:  37 articles 
  Ͳ͸Ͷ 
Search ͱC:  Consumers 
S1: antibiotic* OR antimicrobial OR antibiotic resistance OR antimicrobial resistance OR antibiotic use 
S2: consumer OR patient or public 
S3: ambulatory OR primary care OR primary health?care 
S4: S1 AND S2 AND S3 
S5: S4 AND (perceptions or attitudes or opinion or experience)  
Subject headings: None used to narrow search further due to low number of articles. 
Yield:  625 articles (Medline – 388; CINAHL – 9; PsycINFO – 68; SCOPUS – 160) 
After screening of titles/abstracts:  52 articles (Medline – 23; CINAHL – 1; PsycINFO – 12; SCOPUS – 16) 
Total after duplicates removed:  43 articles 
 
Search Ͳ:  To explore medical decision-making contextualised for prescribing  
S1: decision?making OR judg?ment 
S2: medical OR prescrib* 
S3: S1 AND S2 
Subject headings: 
Clinical competence; decision making; judgment; health knowledge, attitudes, practice; practice patterns, 
physicians’; decision support techniques. 
Yield:  224 articles (Medline – 55; CINAHL – 5; PsycINFO – 99; SCOPUS – 65) 
After screening of titles/abstracts:  19 articles (Medline – 6; CINAHL – 0; PsycINFO – 7; SCOPUS – 6) 












  Ͳ͸ͷ 
Search ͳ:  To identify behaviour change strategies for GPs and consumers  
Search ͳA:  General Practitioners 
S1: antibiotic* OR antimicrobial OR antibiotic resistance OR antimicrobial resistance 
S2: (intervention or strategies) OR behavio?r 
S3: doctor OR prescri* OR general practitioner OR gp 
S4: S1 AND S2 AND S3 
S5: S4 NOT hospital 
Subject headings: 
Anti-bacterial agents; practice patterns, physicians’; respiratory tract infections; drug prescriptions; health 
knowledge, attitudes, practice; family practice; inappropriate prescribing; primary health care; general 
practice; drug resistance, microbial. 
Yield:  422 articles (Medline – 198; CINAHL – 5; PsycINFO – 40; SCOPUS – 179) 
After screening of titles/abstracts:  123 articles (Medline – 81; CINAHL – 5; PsycINFO – 9; SCOPUS – 28) 
Total after duplicates removed:  118 articles 
 
Search ͳB:  Consumers 
S1: antibiotic* OR antimicrobial OR antibiotic resistance OR antimicrobial resistance 
S2: (intervention or strategies) OR behavio?r 
S3: consumer OR patient OR public 
S4: S1 AND S2 AND S3 
S5: S4 NOT hospital 
Subject headings: 
Anti-bacterial agents; respiratory tract infections; health knowledge, attitudes, practice; drug resistance, 
bacterial; patient education as topic. 
Yield:  412 articles (Medline – 202; CINAHL – 17; PsycINFO – 8; SCOPUS – 185) 
After screening of titles/abstracts:  73 articles (Medline – 35; CINAHL – 5; PsycINFO – 3; SCOPUS – 30) 
Total after duplicates removed:  70 articles 
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Appendix D:  Interview Guide — General Practitioners 
 
Semi-structured Interview:  Indicative Questions 
Purpose of interview: To capture participant views on (ͱ) what influences antibiotic 
prescribing and usage, and (Ͳ) the notion of antibiotic resistance as a 
problem that requires individuals to play a mitigating role.   
Participants:  General Practitioners 
 
Opening the interview Thank them for meeting with me + start to build rapport. 
Introduce self and the research. 
 
Confirm available time e.g. “the interview will take about 10 to 15 minutes, is that 
still OK with your schedule?” 
Ask if any questions re: participant info.   
Obtain signed Consent Form from participant. 
 
Frame the intent of the interview in one sentence and set the context:  
"Interviewing GPs to understand your views on antibiotic prescribing in the 
context of your clinical practice.  So there are no right or wrong answers.  I simply 
want to understand the reality of your clinical practice.  But if there’s a question 
that you’d rather not talk about, that’s OK, just let me know and we can skip over 
it.  Otherwise, if you’re happy to chat, just go ahead.  Does that sound OK?" 
 
Confirm re: OK with audio recording. 
Start audio recording. 
Demographic questions 
 
Let’s start with getting to know a bit about you and your practice … 
 
Could you tell me where you’ve gained your training and where you’ve practiced? 
WHERE QUAL GAINED (where you gained your qualifications to practice) 
YEARS OF PRACTICE (and about how many years have you been a GP for?) 
WHERE PRACTICED (could you give me an idea of where you’ve practiced?) 
WORKING ARRANGEMENTS (how many hours of clinical time do you do per week? 
CLINIC STRUCTURE & PROFESSIONAL ARRANGEMENTS (What structure does this clinic 
run on?  Corporate/ partnership? What is your professional arrangement with this 
clinic (owner/ partner/ contracted/ employed) 
 
Do you mentor or supervise medical students or trainees? 
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Set 1 
To understand what GPs consider 
when prescribing antibiotics (adult 
patients) 
In the context of respiratory tract infections … 
 
What factors do you consider when thinking through whether the patient needs 
antibiotics or not? (personal clinical approach) 
What would you do if the need for antibiotics is uncertain?  
 
In a situation where you don’t think an antibiotic is needed, what would you do if 
the patient says they want/expect antibiotics? 
 
More generally, what are some challenges you’ve come across regarding antibiotic 
prescribing? 
Set 2 
To explore the issue of antibiotic 
resistance 
Changing gears a little, to talk about antibiotic resistance… 
 
When you hear the words ‘antibiotic resistance’ what comes to mind? 
In your view, is antibiotic resistance an issue that GPs think about when making a 
prescribing decision? 
 
In your view, is antibiotic resistance an issue that would affect the community at 
large right now?  Or how far away into the future? 
 
What do you think GPs can do to reduce antibiotic resistance?  
Thinking about your own practice, what strategies have you used? 
 
Taking off your hat as a GP for a moment: 
As a private individual, what is your personal approach to antibiotic use? 
To what extent do you think antibiotic resistance could affect you personally – 
your own health or your family’s health? 
 
Is there anything else you’d like to say or add? 
Set 3 (if time allows) 
Views on proposed PBS changes 
 
The advisory committee to the PBS is considering a couple of strategies to reduce 
antibiotic usage.  One is to remove oral antibiotic repeats from the PBS, essentially 
requiring the patient to come back for a review before another course can be 
written.  The other is to reduce the period of validity for oral antibiotic 
prescriptions.   
 
What do you think of these ideas?  
Is there anything else you’d like to say or add? 
Follow up questions + regular 
paraphrasing during interview to 
check meaning (member checking) 
Questions to clarify e.g. Do you mean ….? 
What about …? 
 
Probing questions Tell me more about that …? 
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Could you give me an example of that …? 
What if …? 
Closing the interview and 
grounding the participant 
Is it OK to contact you if I have further questions when I work through the 
recording?  How would you like to be contacted? 
 
I’ll be collating interview responses into a brief de-identified report, would you like 
a copy of that? 
 
Thank you for sharing your views with me and for your time today (+ handover 
interview incentive in envelope — movie vouchers)  
 
Do you know of other GP colleagues in Brisbane who would be interested to be 
interviewed? (obtain details) 
 
Retrieve recorder. 
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Appendix E:  Interview Guide — Community Pharmacists 
 
Semi-structured Interview:  Indicative Questions 
Purpose of interview: To capture participant views on (ͱ) what influences antibiotic seeking 
and usage (when would the pharmacist advise to seek antibiotics or 
refer on to GP), (Ͳ) dispensing repeat prescriptions of antibiotics that is 
beyond a reasonable period for continuation of treatment, and (ͳ) the 
notion of antibiotic resistance as a problem that requires individuals to 
play a mitigating role.   
Participants:  Community Pharmacists 
 
Opening the interview 
 
Thank them for meeting with me + start to build rapport. 
Introduce self and the research. 
Frame the intent of the interview in one sentence:  Interviewing CPs to 
understand your views on antibiotic usage in the community. 
 
Confirm available time e.g. “the interview will take about half an hour, is that still 
OK with your schedule?” 
Ask if any questions re: participant info.  Obtain signed Consent Form from 
participant. 
 
Confirm re: OK with audio recording.   
Start audio recording. 
Demographic questions Let’s start with getting to know a bit about you and your practice … 
 
Could you tell me a bit about your pharmacy training and where you’ve practiced? 
WHERE QUAL GAINED (Where you gained your qualifications to practice?)  
YEARS OF PRACTICE (And about how many years have you been a community 
pharmacist for?)  
WHERE PRACTICED (Could you give me an idea of where you’ve practiced?) 
P/TIME, F/TIME (Ask about working arrangements:  full time, part time, sessional?) 
 
Do you mentor or supervise Pharmacy students or interns? 
Set 1 Now I’m going to ask a few questions about how you normally practice as a 
pharmacist.  There are no right or wrong answers, I simply want to understand the 
reality of your clinical practice.  If there’s a question that you don’t want to talk 
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about – that’s OK, just let me know.  Otherwise, if you are OK to talk about it then 
just go ahead … 
 
In the context of managing the common cold or cough, could you tell me what 
self-management strategies you would normally advise a consumer to use? 
 
What would lead you to refer the consumer to a GP? 
 
In the context of a respiratory tract infection, what would be a situation where 
you would specifically advise the consumer to see a GP for antibiotics? 
 
Does your service include providing a medical certificate? 
How often does it get used, by say consumers with the common cold or cough? 
Set 2 Let’s talk about access to antibiotics… 
 
In your view, how do consumers decide whether to seek antibiotics? 
Many medicines to treat minor ailments are available over the counter.  Have you 
ever been asked for an antibiotic over the counter? 
 
What is your view of having repeats on antibiotic prescriptions? 
 
The next few questions are again about how you normally practice as a 
pharmacist.  There are no right or wrong answers, I simply want to understand the 
reality of your clinical practice.  As before, if there’s a question that you’d rather 
not talk about – that’s OK, just let me know.  Otherwise, if you are OK to talk 
about it then just go ahead … 
 
What would you normally do, if a consumer presented a repeat prescription for an 
antibiotic that is legally valid but beyond what would be a reasonable period for 
continuation of treatment? 
What kinds of questions would you ask the consumer, if you thought the repeat 
script was presented beyond a reasonable period for continuation of treatment? 
What would you consider a reasonable period (between original and repeat 
presentation of an antibiotic script?) 
 
(Optional follow up:  .. if consumer was known to the pharmacist, vs if unknown to 
the pharmacist) 
 
Changing gears a little… 
 
What information or advice do you normally give a patient, when dispensing 
antibiotics? 
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Do people ever bring leftover antibiotics back to the pharmacy for destruction? 
What do you tell people to do with any leftover antibiotics?   
(prompt:  if pack size is larger than course prescribed) 
Set 3 I’d like to move on to talk about another aspect of antibiotic use… 
 
When you hear the words ‘antibiotic resistance’ what comes to mind?   
Can you tell me in your own words how you would explain antibiotic resistance to 
a consumer? 
 
In your view, is antibiotic resistance an issue that would affect the community at 
large?  Right now?  OR how far away into the future? 
 
What do you think community pharmacists can do to reduce antibiotic resistance?  
Thinking about your own practice as a pharmacist, what strategies have you used? 
 
Taking off your hat as a community pharmacist… 
To what extent do you think antibiotic resistance affects you personally – your 
own health or your family’s health? 
Can you think of things that you can do as a private individual that can help reduce 
antibiotic resistance? 
 
Is there anything else you’d like to add?   
Follow up questions + regular 
paraphrasing during interview to 
check meaning (member checking) 
Questions to clarify e.g. Do you mean ….? 
What about …? 
Probing questions Tell me more about that …? 
Could you give me an example of that …? 
What if …? 
Closing the interview and 
grounding the participant 
Is it OK to contact you if I have further questions when I work through the 
recording?  How would you like to be contacted? 
 
I’ll be collating interview responses into a brief de-identified report, which would 
include other interviews in addition to this one.  Would you like a copy of that? 
 
Thank you for sharing your views with me and for your time today (+ handover 
interview incentive in envelope — movie vouchers). 
 
Do you know of other community pharmacist colleagues in Brisbane who would 
be interested to be interviewed?  (Obtain details) 
 
Retrieve recorder. 
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Appendix F:  Interview Guide — Consumers 
 
Semi-structured Interview:  Indicative Questions 
Purpose of interview: To capture participant views on (ͱ) what influences antibiotic seeking 
and usage, and (Ͳ) the notion of antibiotic resistance as a problem that 
requires individuals to play a mitigating role.   
Participants:  Consumers 
 
Opening the interview 
 
Thank them for meeting with me + start to build rapport. 
Introduce self and the research.  
Frame the intent of the interview in one sentence:  Interviewing general public to 
understand your views on antibiotic usage in the community. 
 
Confirm available time e.g. “the interview will take between half an hour to 45 
minutes, is that still OK with your schedule?” 
Ask if any questions re: participant info.  Obtain signed Consent Form from 
participant. 
 
Confirm re: OK with audio recording.   
Start audio recording. 
Demographics Let’s start with getting to know a bit about you … 
 
Could you tell me a bit about yourself?   
(Have you always lived in Brisbane?) 
(Where you’re from, how long you’ve lived in Australia?) 
 
Do you have a regular GP that you go to? 
Do you have a regular pharmacy that you use? 








Now I’m going to ask a few questions about what you would normally do about a 
common cold or cough.  There are no right or wrong answers, I simply want to 
understand your views.  If there’s a question that you don’t want to talk about – 
that’s OK, just let me know.  Otherwise, if you are OK to talk about it then just  go 
ahead … 
 
When you get a common cold or cough, could you tell me what you would 
normally do to manage it? 
 

























(Would you consult your/a pharmacist?) 
(Could you tell me more about that?  … what does the pharmacist/pharmacy staff 
do or advise?) 
(Does your pharmacist offer a medical certificate service?) 
 
What would lead you to decide to see a GP?  
(OR   At what point would you decide to see a GP?) 
(could be other people (who?) who advises them to see a GP?) 
 
If you did go to the GP, what would be your expectations for that visit?   
 
Just changing our conversation a little … 
 
So, in your case … how would you feel or respond, if the GP said you didn’t need 
an antibiotic to get over the cough or cold? 
 
(Follow up question – optional)  How would you feel or respond, if the GP 
suggested some simple things you could do to manage the symptoms instead 
(without prescribing the antibiotic)? 
 
How would you feel or respond, if the GP seemed unsure of whether you needed 
an antibiotic, but gave you a prescription for it anyway? 
(Would you fill the prescription?) 
 
How much does the risk of complications from a cold or cough worry you?   
(prompt if needed e.g. getting sicker) 
 
How much does the risk of side effects of antibiotics worry you?   
(prompt if needed e.g. diarrhoea, thrush, nausea) 
Set 2 
 










Let’s talk about taking antibiotics …  
 
Have you taken antibiotics before for a cough or a cold (if no, ask about for other 
illnesses)? 
 
What information or advice did the GP give you about the antibiotics? (depending 
on the reply - whether for a cold/cough, or other illness) 
(Did they tell you how long to take the antibiotics for? Whether to fill it?  Whether 
to get the repeats?) 
 
What information or advice did the pharmacist give you about the antibiotics?   
 










Many people find it hard to remember to take antibiotics as prescribed.  What is 
your own experience of this? 
(Optional follow up:  About how often would you stop taking it when you feel 
better)? 
 
Thinking back to a time when you took antibiotics, say you’ve taken one course, 
and still did not feel well … what did you do then? 
(See another GP?  See own GP again?  Fill the repeat? …) 
 
GPs often prescribe antibiotics with repeats (so you can get another course of 
antibiotics).  What is your view on repeat prescriptions? 
What do you normally do with these repeat prescriptions? 
(Do you fill them?  When do you fill them?) 
What was your experience at the pharmacy when you’d presented a repeat 
prescription for an antibiotic, to be filled? 
(Filled, queried by pharmacist?) 
 
.. and what do you do with leftover antibiotics? 
 
About how many times a year would you say you’d be taking antibiotics? (for 
anything) 



















COMMUNITY & TIME 
Now I’d like to move on to talk about another aspect of antibiotic use… 
 
Again, I’m interested in your take on things, there are no right or wrong answers.  
If there’s a question that you don’t want to talk about – that’s OK, just let me 
know.  Otherwise, if you are OK to talk about it then just go ahead … 
 
When you hear the words ‘antibiotic resistance’ what comes to mind?     
Or Can you tell me in your own words what antibiotic resistance is? 
(prepare script to explain ABR if they have never heard of it) 
(or if a GP or pharmacist has explained in the past, ask what they remember of the 
explanation) 
 
Antibiotics and Antibiotic resistance have sometimes been mentioned in the news, 
TV, magazines or social media like Facebook or Twitter.  Do you remember seeing 
or hearing this mentioned? 
Can you tell me more about what you remember seeing/ hearing? 
(Which magazine/social media site; what was it about) 
[Could be campaign material, or sensational news] 
What did you think about it? (the article/ piece/ post) 
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In your view, is antibiotic resistance an issue that would affect the community at 
large?  Right now?  OR how far away into the future? 
 
What do you think can be done to manage antibiotic resistance?  
 
To what extent do you think antibiotic resistance affects you personally – your 
own health or your family’s health? 
 
Can you think of things that you can do as a private individual that can help reduce 
antibiotic resistance? 
 
Before we finish, is there anything else you’d like to say or add? 
Follow up questions + regular 
paraphrasing during interview to 
check meaning (member checking) 
Questions to clarify e.g. Do you mean ….? 
What about …? 
Probing questions Tell me more about that …? 
Could you give me an example of that …? 
What if …? 
Closing the interview and 
grounding the participant 
Just to wrap up, do you mind if I ask how old you are? 
… and do you have any long term or chronic illnesses? 
…(ask about highest level of education, if not disclosed by now) 
 
Is it OK to contact you if I have further questions when I work through the 
recording?  How would you like to be contacted? 
 
I’ll be collating interview responses into a brief de-identified report, would you like 
a copy of that? 
 
Thank you for sharing your views with me and for your time today (+ handover 
interview incentive — movie vouchers)   
 
Retrieve recorder. 
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Appendix G:  Standard Procedure for Booking Interviews 
 
ͱ. Ring (preferable)/email participant who expressed interest to be interviewed:  "Thank 
you for expressing interest in participating." [How did they hear about this study?] 
 
Ͳ. Agree on day and time for interview: 
 “Interview will take between ͱ͵-ͳͰ minutes depending on the conversation” 
 “Interview will be audio-recorded, are you OK with that?” 
 
ͳ. Venue address:   
 “I can travel to your clinic/workplace, or would you like to come to QUT Kelvin 
Grove campus?" 
 Obtain name & address of clinic/workplace 
 
ʹ. “I will send a confirmation email”, obtain/confirm their contact details: 
 Name (check how to spell their name) 
 Email  
 Phone (just in case need to contact on the day) 
 
͵. Email Participant Info Sheet and Consent Form:  Mention in email that the interview 
will be audio recorded.  Reminder to complete consent form and email back, or return 
on the day. 
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Appendix H:  Example of Coded Transcript Excerpt  
 
The two screenshots below show the same excerpt from a GP interview transcript in NVIVO® 
(left panel) with all its corresponding coding stripes displayed (right panel) for deductive and 
inductive codes. 
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Appendix I:  Interim Report for Interview Participants 
 
Summary of findings (Interim Report) for Interview Participants 
Prepared by: Elaine Lum, PhD Scholar, Queensland University of Technology, Australia 
 
This summary has been prepared for the General Practitioners, Community Pharmacists and 
Consumers who have generously given their time to be interviewed between April – October 
ͲͰͱ͵ as part of a PhD project entitled “Making decisions about antibiotic use in the Australian 
primary healthcare sector” (QUT Ethics approval number: ͱ͵ͰͰͰͰͰͱ͹Ͱ). 
 
Please do not circulate further, as detailed analysis of the data and the project is still ongoing.  
Thank you for your consideration. 
 
Main Findings 
A total of ͵ʹ semi-structured interviews were conducted in the Brisbane and Greater Brisbane 
area comprising ͱͰ General Practitioners, ͱͲ Community Pharmacists, and ͳͲ Consumers.  
Selected findings are outlined below. 
 
General Practitioners (GPs) 
GPs reported using a variety of mental algorithms when deciding whether or not to prescribe 
antibiotics to a patient presenting with a respiratory tract infection.  Considerations include 
(a) clinical need, (b) likelihood of bacterial infection, (c) medical history and co-morbidities of 
the patient, and (d) potential risks to the patient’s health (if the GP gets it wrong).  These were 
balanced with whether the patient was able to return for a second assessment if their 
condition worsened.  GPs were more likely to consider prescribing a delayed course of 
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antibiotics42, if the patient was unable to return for reassessment, in the event their condition 
was not better in a few days or if it worsened.  
Experienced GPs tended to be able to successfully steer patients away from antibiotics where 
antibiotics are clinically unwarranted.  They do this in a way that maintains good doctor-
patient rapport, using an approach developed over many years of practice in dealing with 
patient demands and/or expectations for antibiotics.  Some early career GPs reported that in 
frustration they sometimes gave in to patient demands for antibiotics as a way to end a 
stressful encounter.  Overall, GPs noted that patients who insisted on antibiotics are in the 
minority and that more patients seemed to be aware of not using antibiotics unless necessary. 
GPs were aware of antibiotic resistance becoming a problem in the community.  They 
acknowledged that GPs’ antibiotic prescribing patterns contributed in part to antibiotic 
resistance and were concerned with having to deal with antibiotic resistant infections during 
their lifetime of clinical practice.   
 
Community Pharmacists 
Community Pharmacists reported providing general advice and recommendations for over-
the-counter products for self-management of upper respiratory tract symptoms, to patients.  
Most Pharmacists would fill an original antibiotic prescription, due to (a) trusting and/or 
deferring to the clinical judgment of the GP, (b) a lack of clinical information on which to 
query the need for antibiotics, (c) the current funding model for pharmacies being largely 
based on the dispensing of prescriptions, and (d) the lack of financial incentive to act as 
gatekeepers of antibiotic use in the primary healthcare setting.  In contrast, when presented 
with a repeat prescription43 for an antibiotic, most would question the patient if it was beyond 
a reasonable period of time for treatment of the initial infection. 
ccci                                                     
 
42 A delayed course of antibiotics (also known as a delayed antibiotic prescription), is an antibiotic 
prescription given to a patient with instructions to use it only if their symptoms worsen or do not 
improve in a few days.  The delayed prescription is usually given to the patient during the initial 
consultation, although some GPs prefer to leave the prescription with clinic reception for the patient 
to collect at a later date. 
43 Repeat prescriptions enable a regular re-supply of the prescribed medicine without having to see 
the GP each time.  The number of repeats is authorised by the GP on the original prescription.  The 
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Community Pharmacists working in less affluent suburbs were concerned about the following 
trends: (a) that patients would often seek antibiotics from GPs as these were cheaper than 
purchasing self-management products for the common cold or cough, (b) children were being 
prescribed multiple courses of antibiotics, and (c) inadequate doses were being prescribed, 
particularly for children. 
Many Community Pharmacists felt disempowered in their ability to act to reduce 
inappropriate use of antibiotics, as they are not involved at the point of care where the 
decision is made to use antibiotics.   
 
Consumers 
Dominant themes for Consumer attitudes and behaviour regarding antibiotics were: (a) 
avoidance of antibiotic use unless clinically warranted, (b) antibiotics were useful but 
“weakened the body”, and (c) the use of complementary medicines as adjuncts to antibiotics 
or to strengthen the immune system.   
Key information needs of Consumers were: (a) unambiguous instructions from GPs when 
prescribed antibiotics, so that inappropriate medicine-taking behaviour can be avoided, (b) 
rationale for antibiotic selection, and (c) treatment duration. 
Consumer understanding of antibiotic resistance was conceptualised in three ways:  as a 
property of the body (body becomes resistant to antibiotics), the medication (antibiotic no 
longer effective), and the bacteria (bacteria is resistant).  Antibiotic resistance was perceived 
as an issue that would only affect the wider community in the future, although most 
recognised that it is a current challenge for hospitals.  Personal good health and/or avoidance 
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Pharmaceutical Benefits Scheme (PBS) Schedule lists medicines and the maximum number of 
repeats subsidised under the scheme.  Time intervals between supplies must meet PBS criteria.   
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What’s next? 
A structured survey based on these findings will be developed to investigate how Consumers 
and GPs weigh up factors influencing antibiotic use.   
Outcomes from the project overall (interviews and surveys) will be used to (a) inform 
Australian public health campaigns promoting conservation of antibiotics and (b) inform 
clinical resources for general practitioners and community pharmacists that support their 
roles as stewards of antibiotic use in the community.   
The outcomes of this research are anticipated by the Federal Department of Health for 
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Appendix J:  Template for Structured Reflections Post Interview 
Participant code: 
Day and date of interview: 
Time taken for interview: 
 
My impressions of how it went overall: 
 
What I could do better or differently: 
 
What were the main issues/themes that struck me in this interview? (Which research 
variables in the initial framework did the participant bear on most centrally?) 
 
 
Anything else that struck me as salient, interesting, illuminating or important in this 
interview? (What new assertions, propositions, hypotheses, speculations or hunches 
about the field were suggested by the participant?) 
 
Any questions that need following up/ clarification with this participant? 
 
 
What new (or remaining) target questions do I have in considering the next interview? 
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Appendix K:  Adapted Jeffersonian Transcription Notation 
Symbol Usage 
[text] Indicates text inserted by researcher. 
= Indicates the break and subsequent continuation of a single 
uninterrupted utterance. 
(number of seconds) e.g. (2) Indicates the time in seconds, of a pause in speech. 
(.) Indicates a micropause of less than a second in speech. 
- Indicates an abrupt halt or self-interruption in utterance. 
____ Underlined text indicates the speaker is emphasizing or stressing 
the speech/word. 
::: Indicates prolongation of an utterance. 
(text) Speech which is unclear or in doubt in the transcript. 
((text)) Annotation of non-verbal activity. 
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Appendix L:  Discrete Choice Experiment — General Practitioners 
 
This is the final version of the DCE survey for GPs, showing both Block ͱ and Block Ͳ choice 
sets in Section B, before survey logic (described in Chapter ͳ, Section ͳ.͵.ʹ) and HTML coding 
for the online survey platform — Key Survey® (Version ͸.ͷ.͵; (ͲͰͱͶ)).  Participants were 
presented with the same Section A and C of the survey, and randomised by the online survey 
platform to either Block ͱ or Block Ͳ choice sets for Section B.  Choice sets ͳ and ͱ͸ in each 
block are duplicates for the purpose of intra-participant consistency checks. 
 
 
Screening questions (prior to entering the survey) 
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SECTION A:  About you 
To start with, we would like to know a little about you.   








Aͳ.  In which country did you train as a GP?  
☐Australia 
☐Elsewhere – Please tell us:   
 
Aʹ. How long have you practiced as a GP, including as a GP Registrar? (years)   
 
  
A͵.  How long have you practiced in Australia, as a GP including as a GP Registrar?  (years) 
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Aͷ. What best describes where you practise? 










A͹. What best describes the ownership structure of your place of practice?  
☐Sole GP owned clinic 
☐Multi-GP owned clinic  
☐Corporate 
☐Government/Health service owned clinic 
☐Other (please tell us) __________________________ 
 
AͱͰ. What best describes how patients are billed at your place of practice? 
☐Bulk-billing clinic 
☐Bulk-billing available for selected patients (mixed-billing clinic) 
☐Private billing  
 
Aͱͱ. In general, how would you describe your antibiotic prescribing patterns?  
☐Prescribe more than other GPs 
☐About the same as other GPs 
☐Prescribe less than other GPs 
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INSTRUCTIONS 
Before we get into the main survey, here’s a brief explanation of what to expect. 
The survey questions are based on this scenario: 
SCENARIO 
An adult patient presents with a runny nose, sneezing, a sore throat and dry cough.  They 
have managed these symptoms in their usual way, which may include a combination of 
rest, home remedies, vitamin supplements, commercial immune boosters, and 
cold/flu/cough products.  As they are still feeling unwell, they decided to consult a 
doctor (you).   
The patient has no significant past medical history.  On examination, their temperature 
(tympanic) is ͳͷ.͸°C, throat appears slightly red and there is no exudate or cervical 
lymphadenopathy.  Chest is clear. 
 
You will be presented with ͱ͹ questions.  Each question contains a pair of situations, A and 
B.  Situation A is different from Situation B in these ways: 
ͱ. Duration of symptoms – the patient has had these symptoms for different lengths of 
time.  In the situations presented, this will be shown as ͱ week, Ͳ weeks or ͳ weeks. 
Ͳ. Life event – the patient has an important event or a deadline coming up.  This will be 
shown as either yes, they do or no, they don’t. 
ͳ. Reassessment – the patient is able to return for reassessment.  This will be shown as 
either yes, they can return for reassessment or no, they can’t. 
ʹ. Familiarity with patient.  One of two possibilities will be shown in each situation:  
(a) the patient is a regular patient (you have attended to them before, and you have a 
good doctor-patient relationship with them) or (b) this is a new patient.   
͵. Patient’s expectations – what the patient says.  One of three possibilities will be 
shown in each situation:  the patient (a) says they want antibiotics, (b) says they 
don’t want antibiotics unless necessary, or (c) says they want reassurance. 
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To get you familiar with the survey, this is what a typical question looks like:  
Based on the scenario, in which situation (A or B) would you be more likely to prescribe an antibiotic for the 
patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
2 weeks 3 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
Yes No 
Reassessment:  Patient is able to 
return for reassessment 
Yes No 
Familiarity with patient New patient Regular patient 
Patient’s expectations Says they want antibiotics Says they don’t want antibiotics 
unless necessary 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 
☐A delayed prescription 
 
We understand that in practice, you may or may not prescribe an antibiotic at all in any of 
these situations (a question at the end of the survey asks you about this).  However, to tease 
out the complexities of prescribing decisions, we want to understand how doctors trade-off 
between factors contained in these situations.  Hence, the questions do not offer the 'I would 
not prescribe' option, deliberately. 
Bear in mind that often the combinations within Situation A or Situation B may not be your 
ideal combination.  For each question, as you weigh up the combination in Situation A against 
those in Situation B, select as a whole the combination (i.e. Situation A or Situation B) in 
which you would be more likely to prescribe an antibiotic for the patient.  Please also 
indicate whether the prescription is for immediate use or a delayed prescription, to be used 
only if the patient is worse or no better in Ͳ days.  There are no right or wrong answers.  
We are simply interested in your choice between Situation A and Situation B, and the nature 
of the prescription (immediate treatment or delayed prescription). 
Was that explanation clear? 
☐Yes 
☐No (You can go back to read the explanation again by clicking the back button) 
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SECTION B:  Main survey 
This is now the start of the main survey.   
We understand that in practice, you may or may not prescribe an antibiotic at all in any of 
these situations (a question at the end of the survey asks you about this).  However, to 
tease out the complexities of prescribing decisions, we want to understand how doctors 
trade-off between factors contained in these situations.  Hence, the questions do not offer 
the 'I would not prescribe' option, deliberately. 
Bear in mind that often the combinations within Situation A or Situation B may not be your 
ideal combination.  For each question, as you weigh up the combination in Situation A 
against those in Situation B, select as a whole the combination (i.e. Situation A or Situation 
B) in which you would be more likely to prescribe an antibiotic for the patient.   
Please also indicate whether the prescription is for immediate use or a delayed prescription, 
to be used only if the patient is worse or no better in Ͳ days. 
There are no right or wrong answers.  We are simply interested in your choice between 







  ͳͱͲ 
Block ͱ  
B1Q1.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
2 weeks 3 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
Yes No 
Reassessment:  Patient is able to 
return for reassessment 
Yes No 
Familiarity with patient New patient Regular patient 
Patient’s expectations Says they want antibiotics Says they don’t want antibiotics 
unless necessary 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 




B1Q2.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
3 weeks 1 week 
Life event:  Patient has an important 
event or a deadline coming up 
No Yes 
Reassessment:  Patient is able to 
return for reassessment 
No Yes 
Familiarity with patient Regular patient New patient 
Patient’s expectations Says they don’t want 
antibiotics unless necessary 
Says they want reassurance 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 
☐A delayed prescription 
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B1Q3.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
3 weeks 1 week 
Life event:  Patient has an important 
event or a deadline coming up 
Yes No 
Reassessment:  Patient is able to 
return for reassessment 
No Yes 
Familiarity with patient Regular patient New patient 
Patient’s expectations Says they want reassurance Says they want antibiotics 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 




B1Q4.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
2 weeks 3 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
No Yes 
Reassessment:  Patient is able to 
return for reassessment 
No Yes 
Familiarity with patient New patient Regular patient 
Patient’s expectations Says they want reassurance Says they want antibiotics 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 
☐A delayed prescription 
 
  ͳͱʹ 
 
B1Q5.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
1 week 2 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
Yes No 
Reassessment:  Patient is able to 
return for reassessment 
Yes No 
Familiarity with patient Regular patient New patient 
Patient’s expectations Says they want reassurance Says they want antibiotics 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 




B1Q6.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
1 week 2 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
No Yes 
Reassessment:  Patient is able to 
return for reassessment 
Yes No 
Familiarity with patient New patient Regular patient 
Patient’s expectations Says they want antibiotics Says they don’t want antibiotics 
unless necessary 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 
☐A delayed prescription 
 
  ͳͱ͵ 
B1Q7.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
2 weeks 3 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
No Yes 
Reassessment:  Patient is able to 
return for reassessment 
No Yes 
Familiarity with patient Regular patient New patient 
Patient’s expectations Says they want antibiotics Says they don’t want antibiotics 
unless necessary 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 




B1Q8.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
3 weeks 1 week 
Life event:  Patient has an important 
event or a deadline coming up 
No Yes 
Reassessment:  Patient is able to 
return for reassessment 
Yes No 
Familiarity with patient Regular patient New patient 
Patient’s expectations Says they don’t want 
antibiotics unless necessary 
Says they want reassurance 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 
☐A delayed prescription 
 
  ͳͱͶ 
B1Q9.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
3 weeks 1 week 
Life event:  Patient has an important 
event or a deadline coming up 
Yes No 
Reassessment:  Patient is able to 
return for reassessment 
No Yes 
Familiarity with patient New patient Regular patient 
Patient’s expectations Says they want reassurance Says they want antibiotics 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 




B1Q10.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
1 week 2 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
No Yes 
Reassessment:  Patient is able to 
return for reassessment 
No Yes 
Familiarity with patient New patient Regular patient 
Patient’s expectations Says they don’t want 
antibiotics unless necessary 
Says they want reassurance 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 
☐A delayed prescription 
 
 
  ͳͱͷ 
B1Q11.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
3 weeks 1 week 
Life event:  Patient has an important 
event or a deadline coming up 
Yes No 
Reassessment:  Patient is able to 
return for reassessment 
Yes No 
Familiarity with patient New patient Regular patient 
Patient’s expectations Says they don’t want 
antibiotics unless necessary 
Says they want reassurance 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 




B1Q12.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
1 week 2 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
No Yes 
Reassessment:  Patient is able to 
return for reassessment 
Yes No 
Familiarity with patient Regular patient New patient 
Patient’s expectations Says they want reassurance Says they want antibiotics 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 
☐A delayed prescription 
 
 
  ͳͱ͸ 
B1Q13.Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
2 weeks 3 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
Yes No 
Reassessment:  Patient is able to 
return for reassessment 
Yes No 
Familiarity with patient New patient Regular patient 
Patient’s expectations Says they want reassurance Says they want antibiotics 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 




B1Q14.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
2 weeks 3 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
Yes No 
Reassessment:  Patient is able to 
return for reassessment 
No Yes 
Familiarity with patient Regular patient New patient 
Patient’s expectations Says they don’t want 
antibiotics unless necessary 
Says they want reassurance 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 
☐A delayed prescription 
 
 
  ͳͱ͹ 
B1Q15.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
1 week 2 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
Yes No 
Reassessment:  Patient is able to 
return for reassessment 
No Yes 
Familiarity with patient New patient Regular patient 
Patient’s expectations Says they want antibiotics Says they don’t want antibiotics 
unless necessary 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 




B1Q16.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
2 weeks 3 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
No Yes 
Reassessment:  Patient is able to 
return for reassessment 
No Yes 
Familiarity with patient Regular patient New patient 
Patient’s expectations Says they don’t want 
antibiotics unless necessary 
Says they want reassurance 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 
☐A delayed prescription 
 
  ͳͲͰ 
B1Q17.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
1 week 2 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
No Yes 
Reassessment:  Patient is able to 
return for reassessment 
Yes No 
Familiarity with patient Regular patient New patient 
Patient’s expectations Says they want antibiotics Says they don’t want antibiotics 
unless necessary 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 




B1Q18.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
3 weeks 1 week 
Life event:  Patient has an important 
event or a deadline coming up 
Yes No 
Reassessment:  Patient is able to 
return for reassessment 
No Yes 
Familiarity with patient Regular patient New patient 
Patient’s expectations Says they want reassurance Says they want antibiotics 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 
☐A delayed prescription 
 
 
  ͳͲͱ 
B1Q19.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
3 weeks 1 week 
Life event:  Patient has an important 
event or a deadline coming up 
Yes No 
Reassessment:  Patient is able to 
return for reassessment 
Yes No 
Familiarity with patient New patient Regular patient 
Patient’s expectations Says they want antibiotics Says they don’t want antibiotics 
unless necessary 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 
☐A delayed prescription 
 
  ͳͲͲ 
Block Ͳ 
B2Q1.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
1 week 2 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
Yes No 
Reassessment:  Patient is able to 
return for reassessment 
No Yes 
Familiarity with patient Regular patient New patient 
Patient’s expectations Says they want reassurance Says they want antibiotics 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 




B2Q2.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
2 weeks 3 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
Yes No 
Reassessment:  Patient is able to 
return for reassessment 
Yes No 
Familiarity with patient Regular patient New patient 
Patient’s expectations Says they don’t want 
antibiotics unless necessary 
Says they want reassurance 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 
☐A delayed prescription 
 
  ͳͲͳ 
B2Q3.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
3 weeks 1 week 
Life event:  Patient has an important 
event or a deadline coming up 
Yes No 
Reassessment:  Patient is able to 
return for reassessment 
No Yes 
Familiarity with patient Regular patient New patient 
Patient’s expectations Says they want antibiotics Says they don’t want antibiotics 
unless necessary 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 




B2Q4.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
1 week 2 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
No Yes 
Reassessment:  Patient is able to 
return for reassessment 
No Yes 
Familiarity with patient New patient Regular patient 
Patient’s expectations Says they want antibiotics Says they don’t want antibiotics 
unless necessary 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 
☐A delayed prescription 
 
  ͳͲʹ 
B2Q5.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
3 weeks 1 week 
Life event:  Patient has an important 
event or a deadline coming up 
No Yes 
Reassessment:  Patient is able to 
return for reassessment 
Yes No 
Familiarity with patient New patient Regular patient 
Patient’s expectations Says they want reassurance Says they want antibiotics 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 




B2Q6.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
3 weeks 1 week 
Life event:  Patient has an important 
event or a deadline coming up 
No Yes 
Reassessment:  Patient is able to 
return for reassessment 
No Yes 
Familiarity with patient New patient Regular patient 
Patient’s expectations Says they don’t want 
antibiotics unless necessary 
Says they want reassurance 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 
☐A delayed prescription 
 
 
  ͳͲ͵ 
B2Q7.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
1 week 2 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
Yes No 
Reassessment:  Patient is able to 
return for reassessment 
Yes No 
Familiarity with patient New patient Regular patient 
Patient’s expectations Says they don’t want 
antibiotics unless necessary 
Says they want reassurance 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 




B2Q8.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
2 weeks 3 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
No Yes 
Reassessment:  Patient is able to 
return for reassessment 
Yes No 
Familiarity with patient Regular patient New patient 
Patient’s expectations Says they want antibiotics Says they don’t want antibiotics 
unless necessary 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 
☐A delayed prescription 
 
  ͳͲͶ 
B2Q9.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
1 week 2 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
Yes No 
Reassessment:  Patient is able to 
return for reassessment 
No Yes 
Familiarity with patient Regular patient New patient 
Patient’s expectations Says they want reassurance Says they want antibiotics 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 




B2Q10.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
2 weeks 3 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
Yes No 
Reassessment:  Patient is able to 
return for reassessment 
Yes No 
Familiarity with patient New patient Regular patient 
Patient’s expectations Says they don’t want 
antibiotics unless necessary 
Says they want reassurance 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 
☐A delayed prescription 
 
 
  ͳͲͷ 
B2Q11.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
3 weeks 1 week 
Life event:  Patient has an important 
event or a deadline coming up 
Yes No 
Reassessment:  Patient is able to 
return for reassessment 
Yes No 
Familiarity with patient Regular patient New patient 
Patient’s expectations Says they want antibiotics Says they don’t want antibiotics 
unless necessary 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 




B2Q12.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
2 weeks 3 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
No Yes 
Reassessment:  Patient is able to 
return for reassessment 
No Yes 
Familiarity with patient New patient Regular patient 
Patient’s expectations Says they want reassurance Says they want antibiotics 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 
☐A delayed prescription 
 
 
  ͳͲ͸ 
B2Q13.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
2 weeks 3 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
Yes No 
Reassessment:  Patient is able to 
return for reassessment 
No Yes 
Familiarity with patient Regular patient New patient 
Patient’s expectations Says they want antibiotics Says they don’t want antibiotics 
unless necessary 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 




B2Q14.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
3 weeks 1 week 
Life event:  Patient has an important 
event or a deadline coming up 
No Yes 
Reassessment:  Patient is able to 
return for reassessment 
Yes No 
Familiarity with patient Regular patient New patient 
Patient’s expectations Says they want reassurance Says they want antibiotics 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 
☐A delayed prescription 
 
 
  ͳͲ͹ 
B2Q15.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
3 weeks 1 week 
Life event:  Patient has an important 
event or a deadline coming up 
No Yes 
Reassessment:  Patient is able to 
return for reassessment 
No Yes 
Familiarity with patient New patient Regular patient 
Patient’s expectations Says they want antibiotics Says they don’t want antibiotics 
unless necessary 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 




B2Q16.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
1 week 2 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
No Yes 
Reassessment:  Patient is able to 
return for reassessment 
Yes No 
Familiarity with patient Regular patient New patient 
Patient’s expectations Says they don’t want 
antibiotics unless necessary 
Says they want reassurance 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 
☐A delayed prescription 
 
  ͳͳͰ 
B2Q17.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
2 weeks 3 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
No Yes 
Reassessment:  Patient is able to 
return for reassessment 
Yes No 
Familiarity with patient New patient Regular patient 
Patient’s expectations Says they want reassurance Says they want antibiotics 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 




B2Q18.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
3 weeks 1 week 
Life event:  Patient has an important 
event or a deadline coming up 
Yes No 
Reassessment:  Patient is able to 
return for reassessment 
No Yes 
Familiarity with patient Regular patient New patient 
Patient’s expectations Says they want antibiotics Says they don’t want antibiotics 
unless necessary 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 
☐A delayed prescription 
 
 
  ͳͳͱ 
B2Q19.  Based on the scenario, in which situation (A or B) would you be more likely to prescribe an 
antibiotic for the patient? 
 Situation A Situation B 
Duration:  Patient has had symptoms 
for 
1 week 2 weeks 
Life event:  Patient has an important 
event or a deadline coming up 
Yes No 
Reassessment:  Patient is able to 
return for reassessment 
No Yes 
Familiarity with patient New patient Regular patient 
Patient’s expectations Says they don’t want 
antibiotics unless necessary 
Says they want reassurance 
I would be more likely to prescribe 
an antibiotic in … 





And this antibiotic prescription would be? 
☐For immediate use 
☐A delayed prescription 
 
  
  ͳͳͲ 
SECTION C 
Thinking back to the survey you’ve just completed, when you were weighing up between 
situation A and B: 
Cͱ.  Generally speaking, which was the most important characteristic to you? 
☐Duration of symptoms: How long the patient has had the symptoms for 
☐Life event: Whether the patient had an important event or a deadline coming up 
☐Reassessment:  Whether the patient was able to return for reassessment 
☐Familiarity with patient:  Whether it was a regular patient or new patient 
☐Patient’s expectations 
 
Why? ________________________________________________________________ (optional) 
 
CͲ.  Generally speaking, which was the least important characteristic to you?  
☐Duration of symptoms: How long the patient has had the symptoms for 
☐Life event: Whether the patient had an important event or a deadline coming up 
☐Reassessment:  Whether the patient was able to return for reassessment 











  ͳͳͳ 
A chance to choose differently 
In the main survey, we asked you to choose between situation A and situation B.  We know 
that in some instances, you may have wanted to make a different choice.  So for the next 
question based on the same scenario, we have presented more options for you to choose 
from.  
A new patient (adult) presents with a runny nose, sneezing, a sore throat and dry cough, 
which they’ve had for Ͳ weeks.  They have managed these symptoms in their usual way, 
which may include a combination of rest, home remedies, vitamin supplements, 
commercial immune boosters, and cold/flu/cough products.  As they are still feeling unwell 
and they have an important event coming up, they decided to consult a doctor (you).  
The patient says they want antibiotics. 
The patient has no significant past medical history.  On examination, their temperature 
(tympanic) is ͳͷ.͸c, throat appears slightly red and there is no exudate or cervical 
lymphadenopathy.  Chest is clear.  The patient can’t come back for a reassessment if 
they are not better or feel worse. 
 
Cͳ.  Which response best describes what you would do? 
☐Prescribe an antibiotic for immediate treatment 
☐Prescribe a delayed course of antibiotics 
☐Not prescribe an antibiotic 
☐Other response (please tell us) ________________________________ 
 









  ͳͳʹ 











  ͳͳ͵ 
Appendix M:  Discrete Choice Experiment — Consumers 
 
This is the final version of the DCE survey for consumers, showing both Block ͱ and Block Ͳ 
choice sets in Section B, before survey logic (described in Chapter ͳ, Section ͳ.͵.ʹ) and HTML 
coding for the online survey platform — Key Survey® (Version ͸.ͷ.͵; (ͲͰͱͶ)).  Participants 
were presented with the same Section A and C of the survey, and randomised by the online 
survey platform to either Block ͱ or Block Ͳ choice sets for Section B.  Choice sets ͳ and ͱ͸ in 
each block are duplicates for the purpose of intra-participant consistency checks. 
 
 
Screening questions (prior to entering the survey) 
 




Which statement below best describes your position toward using antibiotics? (please tick 
one) 
☐I would take antibiotics if advised to do so by the doctor. 
☐I avoid taking antibiotics at all costs, even if this was against medical advice  
 
 
  ͳͳͶ 
SECTION A:  About you 
 
To start with, we would like to know a little about you.   




AͲ.  How old are you? (years)   
 
 
Aͳ.  What is the highest level of education you have completed? 
☐Postgraduate degree (Master, Doctoral or PhD) 
☐Graduate Certificate or Graduate Diploma 
☐Bachelor degree 
☐Year ͱͲ 
☐Other – Please specify below: 
 
 
Aʹ.  How long have you lived in Australia?  (years) 
 
 













  ͳͳͷ 
AͶ. What best describes where you live?  
☐ Inner city/ Suburban 
☐ Provincial/ Regional 
☐ Rural/ Remote 
 







A͸.  In the past ͱͲ months, how many courses of antibiotics have you taken?  Please estimate. 
☐None 
☐One or two 
☐Three or four 
☐Five or more 
 
A͹.  Has a doctor ever said to you that you are more likely to need antibiotics because of a 








Aͱͱ.  Do you hold a healthcare or concession card?  (With this card, you would pay $Ͷ.ͲͰ for 




  ͳͳ͸ 
INSTRUCTIONS 
Before we get into the main survey, here’s a brief explanation of what to expect. 
The survey questions are based on this scenario: 
SCENARIO 
Imagine you have a runny nose, sneezing, a sore throat and a dry cough.  You have 
managed these symptoms in your usual way, which may include a combination of rest, 
home remedies, vitamin supplements, commercial immune boosters, and cold/flu/cough 
products.  As you are still feeling unwell, you decide to consult a doctor.   
After examining you, the doctor gives you a prescription for antibiotics because you can’t 
come back for a reassessment in Ͳ days. 
 
You will be presented with ͱ͹ questions.  Each question contains a pair of situations, A and 
B.  Situation A is different from situation B in these ways: 
ͱ. Duration of symptoms – you have had these symptoms for different lengths of time.  
In the situations presented this will be shown as ͱ week, Ͳ weeks or ͳ weeks. 
Ͳ. Life event – you have an important event or a deadline coming up.  This will be shown 
as either yes, you do have an important event or a deadline coming up or no, you 
don’t. 
ͳ. Time off – you are able to take time off from work/study to recover.  This will be 
shown as either yes, you can take time off to recover or no, you can’t. 
ʹ. Doctor’s advice – what the doctor said.  One of three possibilities will be shown in 
each situation: (a) doctor says it’s probably a viral infection and antibiotics won’t 
help, (b) doctor says to start antibiotic treatment if you feel worse or no better in 
Ͳ days, or (c) doctor leaves it to you to decide whether to take the antibiotics or 
not. 
͵. Past experience – you have taken antibiotics for similar symptoms before.  This will 
be shown as yes, you have or no, you haven’t. 
  ͳͳ͹ 
To get you familiar with the survey, this is what a typical question looks like: 
Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more likely 
to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
1 week 3 weeks 
Life event: 
You've an important event or a 
deadline coming up 
No Yes 
Time off: 
You're able to take time off from 
work/study to recover 
No Yes 
Doctor’s advice: Probably a viral infection and 
antibiotics won’t help 
You decide whether to take the 
antibiotics or not 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
No Yes 
I would be more likely to fill the 
antibiotic prescription in …  







For each question, we would like to know in which situation you would be more likely to fill 
the antibiotic prescription.  Please choose either Situation A or Situation B.   
We know that in some instances, you may want to make a different choice.  However, only 
two situations are presented.  Please choose the situation in which you are more likely to fill 
the antibiotic prescription. 
There are no right or wrong answers.  We are simply interested in your choice between 
Situation A and Situation B. 
Was that explanation clear? 
☐ Yes 




  ͳʹͰ 
SECTION B:  Main survey 
This is now the start of the main survey.   
We know that in some instances, you may want to make a different choice.  However, only 
two situations are presented.  Please choose the situation in which you are more likely to fill 
the antibiotic prescription. 
There are no right or wrong answers.  We are simply interested in your choice between 
Situation A and Situation B. 
 
Block ͱ 
B1Q1.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more 
likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
1 week 2 weeks 
Life event: 
You've an important event or a 
deadline coming up 
Yes No 
Time off: 
You're able to take time off from 
work/study to recover 
No Yes 
Doctor’s advice: Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Says it’s probably a viral infection 
and antibiotics won’t help 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
Yes No 
I would be more likely to fill the 
antibiotic prescription in …  







  ͳʹͱ 
B1Q2.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more likely 
to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
2 weeks 3 weeks 
Life event: 
You've an important event or a 
deadline coming up 
Yes No 
Time off: 
You're able to take time off from 
work/study to recover 
Yes No 
Doctor’s advice: Says it’s probably a viral infection 
and antibiotics won’t help 
Says you decide whether to take 
the antibiotics or not 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
No Yes 
I would be more likely to fill the 
antibiotic prescription in …  








B1Q3.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more likely 
to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
3 weeks 1 week 
Life event: 
You've an important event or a 
deadline coming up 
Yes No 
Time off: 
You're able to take time off from 
work/study to recover 
No Yes 
Doctor’s advice: Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Says it’s probably a viral infection 
and antibiotics won’t help 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
Yes No 
I would be more likely to fill the 
antibiotic prescription in …  






  ͳʹͲ 
B1Q4.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more likely 
to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
2 weeks 3 weeks 
Life event: 
You've an important event or a 
deadline coming up 
Yes No 
Time off: 
You're able to take time off from 
work/study to recover 
Yes No 
Doctor’s advice: Says you decide whether to take 
the antibiotics or not 
Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
Yes No 
I would be more likely to fill the 
antibiotic prescription in …  








B1Q5.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more likely 
to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
1 week 2 weeks 
Life event: 
You've an important event or a 
deadline coming up 
No Yes 
Time off: 
You're able to take time off from 
work/study to recover 
No Yes 
Doctor’s advice: Says it’s probably a viral infection 
and antibiotics won’t help 
Says you decide whether to take 
the antibiotics or not 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
No Yes 
I would be more likely to fill the 
antibiotic prescription in …  






  ͳʹͳ 
B1Q6.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more likely 
to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
3 weeks 1 week 
Life event: 
You've an important event or a 
deadline coming up 
No Yes 
Time off: 
You're able to take time off from 
work/study to recover 
No Yes 
Doctor’s advice: Says you decide whether to take 
the antibiotics or not 
Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
Yes No 
I would be more likely to fill the 
antibiotic prescription in …  








B1Q7.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more likely 
to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
3 weeks 1 week 
Life event: 
You've an important event or a 
deadline coming up 
No Yes 
Time off: 
You're able to take time off from 
work/study to recover 
Yes No 
Doctor’s advice: Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Says it’s probably a viral infection 
and antibiotics won’t help 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
No Yes 
I would be more likely to fill the 
antibiotic prescription in …  






  ͳʹʹ 
B1Q8.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more likely 
to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
1 week 2 weeks 
Life event: 
You've an important event or a 
deadline coming up 
Yes No 
Time off: 
You're able to take time off from 
work/study to recover 
Yes No 
Doctor’s advice: Says you decide whether to take 
the antibiotics or not 
Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
No Yes 
I would be more likely to fill the 
antibiotic prescription in …  








B1Q9.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more likely 
to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
2 weeks 3 weeks 
Life event: 
You've an important event or a 
deadline coming up 
No Yes 
Time off: 
You're able to take time off from 
work/study to recover 
No Yes 
Doctor’s advice: Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Says it’s probably a viral infection 
and antibiotics won’t help 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
No Yes 
I would be more likely to fill the 
antibiotic prescription in …  






  ͳʹ͵ 
B1Q10.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more 
likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
1 week 2 weeks 
Life event: 
You've an important event or a 
deadline coming up 
Yes No 
Time off: 
You're able to take time off from 
work/study to recover 
Yes No 
Doctor’s advice: Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Says it’s probably a viral infection 
and antibiotics won’t help 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
Yes No 
I would be more likely to fill the 
antibiotic prescription in …  








B1Q11.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more 
likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
2 weeks 3 weeks 
Life event: 
You've an important event or a 
deadline coming up 
No Yes 
Time off: 
You're able to take time off from 
work/study to recover 
Yes No 
Doctor’s advice: Says it’s probably a viral infection 
and antibiotics won’t help 
Says you decide whether to take 
the antibiotics or not 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
Yes No 
I would be more likely to fill the 
antibiotic prescription in …  






  ͳʹͶ 
B1Q12.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more 
likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
3 weeks 1 week 
Life event: 
You've an important event or a 
deadline coming up 
No Yes 
Time off: 
You're able to take time off from 
work/study to recover 
Yes No 
Doctor’s advice: Says you decide whether to take 
the antibiotics or not 
Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
Yes No 
I would be more likely to fill the 
antibiotic prescription in …  








B1Q13.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more 
likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
2 weeks 3 weeks 
Life event: 
You've an important event or a 
deadline coming up 
Yes No 
Time off: 
You're able to take time off from 
work/study to recover 
Yes No 
Doctor’s advice: Says you decide whether to take 
the antibiotics or not 
Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
No Yes 
I would be more likely to fill the 
antibiotic prescription in …  






  ͳʹͷ 
B1Q14.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more 
likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
1 week 2 weeks 
Life event: 
You've an important event or a 
deadline coming up 
No Yes 
Time off: 
You're able to take time off from 
work/study to recover 
No Yes 
Doctor’s advice: Says you decide whether to take 
the antibiotics or not 
Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
No Yes 
I would be more likely to fill the 
antibiotic prescription in …  








B1Q15.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more 
likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
2 weeks 3 weeks 
Life event: 
You've an important event or a 
deadline coming up 
Yes No 
Time off: 
You're able to take time off from 
work/study to recover 
No Yes 
Doctor’s advice: Says it’s probably a viral infection 
and antibiotics won’t help 
Says you decide whether to take 
the antibiotics or not 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
Yes No 
I would be more likely to fill the 
antibiotic prescription in …  






  ͳʹ͸ 
B1Q16.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more 
likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
3 weeks 1 week 
Life event: 
You've an important event or a 
deadline coming up 
No Yes 
Time off: 
You're able to take time off from 
work/study to recover 
Yes No 
Doctor’s advice: Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Says it’s probably a viral infection 
and antibiotics won’t help 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
Yes No 
I would be more likely to fill the 
antibiotic prescription in …  








B1Q17.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more 
likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
3 weeks 1 week 
Life event: 
You've an important event or a 
deadline coming up 
No Yes 
Time off: 
You're able to take time off from 
work/study to recover 
No Yes 
Doctor’s advice: Says it’s probably a viral infection 
and antibiotics won’t help 
Says you decide whether to take 
the antibiotics or not 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
No Yes 
I would be more likely to fill the 
antibiotic prescription in …  






  ͳʹ͹ 
B1Q18.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more 
likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
3 weeks 1 week 
Life event: 
You've an important event or a 
deadline coming up 
Yes No 
Time off: 
You're able to take time off from 
work/study to recover 
No Yes 
Doctor’s advice: Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Says it’s probably a viral infection 
and antibiotics won’t help 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
Yes No 
I would be more likely to fill the 
antibiotic prescription in …  








B1Q19.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more 
likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
1 week 2 weeks 
Life event: 
You've an important event or a 
deadline coming up 
Yes No 
Time off: 
You're able to take time off from 
work/study to recover 
No Yes 
Doctor’s advice: Says it’s probably a viral infection 
and antibiotics won’t help 
Says you decide whether to take 
the antibiotics or not 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
No Yes 
I would be more likely to fill the 
antibiotic prescription in …  






  ͳ͵Ͱ 
Block Ͳ 
B2Q1.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more 
likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
3 weeks 1 week 
Life event: 
You've an important event or a 
deadline coming up 
No Yes 
Time off: 
You're able to take time off from 
work/study to recover 
No Yes 
Doctor’s advice: Says you decide whether to take 
the antibiotics or not 
Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
No Yes 
I would be more likely to fill the 
antibiotic prescription in …  







  ͳ͵ͱ 
B2Q2.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more 
likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
3 weeks 1 week 
Life event: 
You've an important event or a 
deadline coming up 
Yes No 
Time off: 
You're able to take time off from 
work/study to recover 
No Yes 
Doctor’s advice: Says it’s probably a viral infection 
and antibiotics won’t help 
Says you decide whether to take 
the antibiotics or not 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
Yes No 
I would be more likely to fill the 
antibiotic prescription in …  








B2Q3.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more 
likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
1 week 2 weeks 
Life event: 
You've an important event or a 
deadline coming up 
No Yes 
Time off: 
You're able to take time off from 
work/study to recover 
Yes No 
Doctor’s advice: Says it’s probably a viral infection 
and antibiotics won’t help 
Says you decide whether to take 
the antibiotics or not 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
No Yes 
I would be more likely to fill the 
antibiotic prescription in …  






  ͳ͵Ͳ 
B2Q4.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more 
likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
2 weeks 3 weeks 
Life event: 
You've an important event or a 
deadline coming up 
No Yes 
Time off: 
You're able to take time off from 
work/study to recover 
No Yes 
Doctor’s advice: Says it’s probably a viral infection 
and antibiotics won’t help 
Says you decide whether to take 
the antibiotics or not 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
Yes No 
I would be more likely to fill the 
antibiotic prescription in …  








B2Q5.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more 
likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
1 week 2 weeks 
Life event: 
You've an important event or a 
deadline coming up 
Yes No 
Time off: 
You're able to take time off from 
work/study to recover 
No Yes 
Doctor’s advice: Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Says it’s probably a viral infection 
and antibiotics won’t help 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
Yes No 
I would be more likely to fill the 
antibiotic prescription in …  






  ͳ͵ͳ 
B2Q6.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more 
likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
3 weeks 1 week 
Life event: 
You've an important event or a 
deadline coming up 
Yes No 
Time off: 
You're able to take time off from 
work/study to recover 
No Yes 
Doctor’s advice: Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Says it’s probably a viral infection 
and antibiotics won’t help 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
No Yes 
I would be more likely to fill the 
antibiotic prescription in …  








B2Q7.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more 
likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
3 weeks 1 week 
Life event: 
You've an important event or a 
deadline coming up 
Yes No 
Time off: 
You're able to take time off from 
work/study to recover 
Yes No 
Doctor’s advice: Says it’s probably a viral infection 
and antibiotics won’t help 
Says you decide whether to take 
the antibiotics or not 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
Yes No 
I would be more likely to fill the 
antibiotic prescription in …  






  ͳ͵ʹ 
B2Q8.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more 
likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
3 weeks 1 week 
Life event: 
You've an important event or a 
deadline coming up 
Yes No 
Time off: 
You're able to take time off from 
work/study to recover 
Yes No 
Doctor’s advice: Says you decide whether to take 
the antibiotics or not 
Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
No Yes 
I would be more likely to fill the 
antibiotic prescription in …  







B2Q9.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be more 
likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
2 weeks 3 weeks 
Life event: 
You've an important event or a 
deadline coming up 
No Yes 
Time off: 
You're able to take time off from 
work/study to recover 
No Yes 
Doctor’s advice: Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Says it’s probably a viral infection 
and antibiotics won’t help 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
No Yes 
I would be more likely to fill the 
antibiotic prescription in …  






  ͳ͵͵ 
B2Q10.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be 
more likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
1 week 2 weeks 
Life event: 
You've an important event or a 
deadline coming up 
No Yes 
Time off: 
You're able to take time off from 
work/study to recover 
Yes No 
Doctor’s advice: Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Says it’s probably a viral infection 
and antibiotics won’t help 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
Yes No 
I would be more likely to fill the 
antibiotic prescription in …  







B2Q11.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be 
more likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
2 weeks 3 weeks 
Life event: 
You've an important event or a 
deadline coming up 
Yes No 
Time off: 
You're able to take time off from 
work/study to recover 
Yes No 
Doctor’s advice: Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Says it’s probably a viral infection 
and antibiotics won’t help 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
No Yes 
I would be more likely to fill the 
antibiotic prescription in …  






  ͳ͵Ͷ 
B2Q12.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be 
more likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
2 weeks 3 weeks 
Life event: 
You've an important event or a 
deadline coming up 
Yes No 
Time off: 
You're able to take time off from 
work/study to recover 
No Yes 
Doctor’s advice: Says you decide whether to take 
the antibiotics or not 
Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
Yes No 
I would be more likely to fill the 
antibiotic prescription in …  







B2Q13.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be 
more likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
1 week 2 weeks 
Life event: 
You've an important event or a 
deadline coming up 
No Yes 
Time off: 
You're able to take time off from 
work/study to recover 
Yes No 
Doctor’s advice: Says you decide whether to take 
the antibiotics or not 
Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
Yes No 
I would be more likely to fill the 
antibiotic prescription in …  






  ͳ͵ͷ 
B2Q14.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be 
more likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
2 weeks 3 weeks 
Life event: 
You've an important event or a 
deadline coming up 
No Yes 
Time off: 
You're able to take time off from 
work/study to recover 
No Yes 
Doctor’s advice: Says you decide whether to take 
the antibiotics or not 
Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
Yes No 
I would be more likely to fill the 
antibiotic prescription in …  








B2Q15.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be 
more likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
1 week 2 weeks 
Life event: 
You've an important event or a 
deadline coming up 
No Yes 
Time off: 
You're able to take time off from 
work/study to recover 
Yes No 
Doctor’s advice: Says it’s probably a viral infection 
and antibiotics won’t help 
Says you decide whether to take 
the antibiotics or not 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
Yes No 
I would be more likely to fill the 
antibiotic prescription in …  






  ͳ͵͸ 
B2Q16.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be 
more likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
3 weeks 1 week 
Life event: 
You've an important event or a 
deadline coming up 
Yes No 
Time off: 
You're able to take time off from 
work/study to recover 
Yes No 
Doctor’s advice: Says it’s probably a viral infection 
and antibiotics won’t help 
Says you decide whether to take 
the antibiotics or not 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
No Yes 
I would be more likely to fill the 
antibiotic prescription in …  








B2Q17.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be 
more likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
2 weeks 3 weeks 
Life event: 
You've an important event or a 
deadline coming up 
No Yes 
Time off: 
You're able to take time off from 
work/study to recover 
Yes No 
Doctor’s advice: Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Says it’s probably a viral infection 
and antibiotics won’t help 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
No Yes 
I would be more likely to fill the 
antibiotic prescription in …  






  ͳ͵͹ 
B2Q18.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be 
more likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
1 week 2 weeks 
Life event: 
You've an important event or a 
deadline coming up 
No Yes 
Time off: 
You're able to take time off from 
work/study to recover 
Yes No 
Doctor’s advice: Says it’s probably a viral infection 
and antibiotics won’t help 
Says you decide whether to take 
the antibiotics or not 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
No Yes 
I would be more likely to fill the 
antibiotic prescription in …  








B2Q19.  Based on the scenario, as you leave the doctor’s clinic, in which situation (A or B) would you be 
more likely to fill the antibiotic prescription (go to the pharmacy to get the antibiotics)? 
 Situation A Situation B 
Duration:  
You've had symptoms for 
1 week 2 weeks 
Life event: 
You've an important event or a 
deadline coming up 
Yes No 
Time off: 
You're able to take time off from 
work/study to recover 
No Yes 
Doctor’s advice: Says you decide whether to take 
the antibiotics or not 
Says to start antibiotic treatment if 
you feel worse or no better in 2 
days 
Past experience: 
You've taken antibiotics for similar 
symptoms before 
No Yes 
I would be more likely to fill the 
antibiotic prescription in …  






  ͳͶͰ 
SECTION C 
Thinking back to the survey you’ve just completed, when you were weighing up between 
situation A and B: 
Cͱ.  Generally speaking, which was the most important characteristic to you?  
☐Duration of symptoms: How long you’ve had the symptoms for 
☐Life event: Whether you have an important event or a deadline coming up 
☐Time off: Whether you were able to take time off from work/study to recover 
☐Doctor’s advice 





CͲ.  Generally speaking, which was the least important characteristic to you?  
☐Duration of symptoms: How long you’ve had the symptoms for 
☐Life event: Whether you have an important event or a deadline coming up 
☐Time off: Whether you were able to take time off from work/study to recover 
☐Doctor’s advice 









  ͳͶͱ 
A chance to choose differently 
In the main survey, we asked you to choose between situation A and situation B.  We know 
that in some instances, you may have wanted to make a different choice.  So, for the next 
question based on the same scenario, we have presented more options for you to choose 
from.   
You have had a runny nose, sneezing, a sore throat and a dry cough for Ͳ weeks.  You have 
managed these symptoms in your usual way, which may include a combination of rest, 
home remedies, vitamin supplements, commercial immune boosters, and cold/flu/cough 
products.  As you are still feeling unwell, you decide to consult a doctor, as you have an 
important event coming up and can’t take time off to recover.  After examining you, 
the doctor gives you a prescription for antibiotics because you can't come back for a 
reassessment in Ͳ days.  Doctor says to start the antibiotic treatment if you feel worse 
or no better in Ͳ days.  In the past, you have taken antibiotics for similar symptoms 
before.   
 
Cͳ.  Which response best describes what you would do?  
☐Fill the antibiotic prescription right away and take it.  
☐Fill the antibiotic prescription right away and only take it if you are worse or no 
better in Ͳ days. 
☐Wait Ͳ days.  If no better, you would fill the antibiotic prescription and take it. 
☐Not fill the antibiotic prescription at all. 
☐Other response (please tell us) ________________________________ 
 
  ͳͶͲ 
Cʹ. What do you usually do with an unused antibiotic prescription?  
☐Keep prescription for another time you become unwell. 
☐Keep prescription until it expires.  
☐Discard prescription right away. 
☐Other (please tell us) ____________________________ 
 













Thank you for participating in this survey! 
  ͳͶͳ 
Appendix N:  MXL Estimates for Consumer DCE Survey with Effects 
Coding — Full Dataset 
MXL estimates for Consumer DCE survey with effects coding – Full dataset (n = ͲͰ͵) 
Attribute Level Coefficient SE Prob. 
|z|>Z 




1 week -0.58** 0.08 0.0000 0.74** 0.08 0.0000 
2 weeks 0.03 0.05 0.5588 0.09 0.09 0.3672 
3 weeks^ 0.55#  -0.83#  
Life event  No -0.38** 0.05 0.0000 0.48** 0.06 0.0000 
Yes^ 0.38#  -0.48#  
Time off No 0.07 0.04 0.0682 0.36** 0.05 0.0000 
Yes^ -0.07#  -0.36#  
Doctor's advice Says it's probably a 
viral infection and 
antibiotics won't help 
-2.42** 0.16 0.0000 1.42** 0.11 0.0000 
Says you decide 
whether to take the 
antibiotics or not 
0.45** 0.07 0.0000 0.63** 0.08 0.0000 
Says to start 
antibiotic treatment 
if you feel worse or 
no better in 2 days^ 
1.97#  -2.05#  
Past experience No -0.12** 0.04 0.0008 0.26** 0.05 0.0000 
Yes^ 0.12#  -0.26#  
**p < 0.01 and *p < 0.05 
^ Omitted category/ reference level 
# Calculated as the negative sum of the estimated coefficients or SDs 
SE: Standard error 
SD: Standard deviation for estimated coefficients 
Prob. |z|>Z :  p-value for the Wald test 
The computation for MXL estimates converged after ͲͲ iterations, with a normal exit.  
The Log Likelihood (LL) was -ͱʹ͵ͷ.ʹͱ and the Akaike Information Criteria (AIC) was 
Ͱ.ͷ͹͸.  McFadden's pseudo R-squared was Ͱ.ʹͳ.   
The attribute level coefficient for “Time off – No” did not reach statistical significance 
in the parameter estimates, indicating that the ‘Time off” attribute was not important 
in influencing consumer decision-making.   
  ͳͶʹ 
MXL estimates for Consumer DCE survey with effects coding – Dataset with matched 
duplicated choice sets for respondents ͱ͸ – ͵ʹ years old (n = ͱ͸ͱ) 
  Attribute Level Coefficient SE Prob. 
|z|>Z 




1 week -0.75** 0.10 0.0000 0.82** 0.10 0.0000 
2 weeks 0.02 0.06 0.7278 0.17 0.11 0.1198 
3 weeks^ 0.73#  -0.99#  
Life event  No -0.51** 0.06 0.0000 0.52** 0.08 0.0000 
Yes^ 0.51#  -0.52#  
Time off No 0.18** 0.05 0.0002 0.41** 0.06 0.0000 
Yes^ -0.18#  -0.41#  
Doctor's advice Says it's probably a 
viral infection and 
antibiotics won't help 
-2.88** 0.20 0.0000 1.69** 0.17 0.0000 
Says you decide 
whether to take the 
antibiotics or not 
0.61** 0.09 0.0000 0.74** 0.09 0.0000 
Says to start 
antibiotic treatment 
if you feel worse or 
no better in 2 days^ 
2.27#  -2.43#  
Past experience No -0.17** 0.05 0.0002 0.30** 0.06 0.0000 
Yes^ 0.17#  -0.30#  
**p < 0.01 and *p < 0.05 
^ Omitted category/ reference level 
# Calculated as the negative sum of the estimated coefficients or SDs 
SE: Standard error 
SD: Standard deviation for estimated coefficients 
Prob. |z|>Z :  p-value for the Wald test 
The computation for MXL estimates converged after ͳͰ iterations, with a normal exit.  
The Log Likelihood (LL) was -ͱͱ͵͹.ͳͱ and the Akaike Information Criteria (AIC) was 
Ͱ.ͷͲͱ.  McFadden's pseudo R-squared was Ͱ.ʹ͹. 
 
 
  ͳͶ͵ 
Appendix O:  Human Research Ethics Approval 
QUT HREC stipulates that the Chief Investigator is the PhD Student’s Principal 
Supervisor (personal communication with Janette Lamb, Research Ethics Advisory 
Team, February ͲͰͱ͵). 
 
  ͳͶͶ 
Appendix P:  Research Dissemination 
 
Conferences 
Lum E, Page K, Nissen L, Doust J, Graves N. (ͲͰͱ͵). What consumers think, do and say 
about antibiotic use. Paper presented at the ͹th Health Services & Policy Research 
Conference, Melbourne, Australia. 
 
Lum E, Graves N, Page K, Doust J, Nissen L, Whitty J. (ͲͰͱ͵). Making decisions about 
antibiotic use in the Australian primary healthcare sector. Poster presented at 
Antimicrobials ͲͰͱ͵, the Annual Scientific Meeting of the Antimicrobial Society of 
Australia (ASA), Brisbane, Australia. 
 
Lum E, Graves N, Page K, Doust J, Nissen L, Whitty J. (ͲͰͱʹ). Making decisions about 
antibiotic use in the Australian primary healthcare sector. Poster presented at IHBI 
Inspires, the Annual Postgraduate Conference of the Institute of Health and 
Biomedical Innovation (IHBI), Gold Coast, Australia. 
 
Conference/Forum presentations of related work 
Page K, Lum E, Healey L. (ͲͰͱͶ).  What do consumers do with and think about 
antibiotics? Paper to be presented on ͲͲnd November ͲͰͱͶ at the ͵th International 
Conference of the Australasian College for Infection Prevention and Control (ACIPC). 
 
Page K, Lum E. (ͲͰͱͶ).  Consumer preferences and drivers for antibiotic usage.  Paper 
to be presented on ͱʹth November ͲͰͱͶ at the ͳrd Queensland Antimicrobial 
Resistance Forum:  One Health. 
 
Page K, Lum E. (ͲͰͱ͵).  Questionable antibiotic practices:  Obtaining reliable estimates 
of consumer behaviours.  Paper presented at the ʹth International Conference of the 
Australasian College for Infection Prevention and Control (ACIPC). 
 
  ͳͶͷ 
Publications in progress 
 Title/Working Title Type of Article Status 
1 A mixed methods study of antibiotic 
prescribing in primary healthcare:  
Dominant factors and trade-offs in 
decision-making. 
Data paper reporting on 
the results of the GP 
interviews and DCE. 
Manuscript submitted 
to a Scimago Q1 
journal. 
2 Australian consumer views of antibiotic 
use:  A qualitative study. 
Data paper reporting on 
the qualitative results of 
the consumer interviews. 
Manuscript submitted 
to a Scimago Q1 
journal. 
3 Consumer behaviours with delayed 
antibiotic prescriptions:  A discrete choice 
experiment. 
Data paper reporting on 




4 What community pharmacists in Australia 
think, say and do about antibiotic use.   
Data paper reporting on 





5 Choice modelling can contribute to the 
understanding of antibiotic prescribing 
and consumption behaviour 
Perspective/methods 
paper on the novel use of 




6 The EABE Model:  Visualising the tensions 
in antibiotic prescribing and consumption 
based on the Theoretical Domains 
Framework 
Theory paper presenting 
the EABE model as an 
extension of the TDF for 
antibiotic eupraxis. 
Manuscript on hold 
until publication of 
manuscripts 1, 2 and 4. 
 
  ͳͶ͸ 
 
